20439-47-8 | (1R,2R)-(-)-1,2-Diaminocyclohexane

Packsize	Purity	Availability	Price	Discounted Price
250mg	96%	in stock	$6.00	$4.00
1g	96%	in stock	$8.00	$6.00
5g	96%	in stock	$11.00	$8.00
10g	96%	in stock	$18.00	$13.00
25g	96%	in stock	$27.00	$19.00
100g	96%	in stock	$104.00	$73.00

Description

• Catalog Number: AB42770
• Chemical Name: (1R,2R)-(-)-1,2-Diaminocyclohexane
• CAS Number: 20439-47-8
• Molecular Formula: C6H14N2
• Molecular Weight: 114.1888
• MDL Number: MFCD00062985
• SMILES: N[C@@H]1CCCC[C@H]1N

Computed Properties

• Complexity: 62.9
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 2
• Heavy Atom Count: 8
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 2
• XLogP3: -0.3

Literature

• Effect of synthetic eel calcitonin, elcatonin, on cold and mechanical allodynia induced by oxaliplatin and paclitaxel in rats.

  European journal of pharmacology 20121205

• Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study).

  Medical oncology (Northwood, London, England) 20121201

• Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy.

  Investigational new drugs 20121201

• Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer.

  Investigational new drugs 20121201

• Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib.

  Medical oncology (Northwood, London, England) 20121201

• Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.

  International journal of cancer 20121201

• Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases.

  Journal of surgical oncology 20121201

• A full validated hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the quantification of oxaliplatin in human plasma ultrafiltrates.

  Journal of pharmaceutical and biomedical analysis 20121201

• Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01.

  Cancer 20121115

• Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application.

  International journal of pharmaceutics 20121115

• Biological characterization of folate-decorated biodegradable polymer-platinum(II) complex micelles.

  Molecular pharmaceutics 20121105

• Systemic treatment of advanced pancreatic cancer.

  Cancer treatment reviews 20121101

• Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatment.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20121101

• Impact of oxaliplatin-induced neuropathy: a patient perspective.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20121101

• Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.

  European journal of cancer care 20121101

• Superior cytotoxicity and DNA cross-link induction by oxaliplatin versus cisplatin at lower cellular uptake in colorectal cancer cell lines.

  Anti-cancer drugs 20121101

• Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.

  Journal of hepatology 20121101

• Homologous recombination mediates S-phase-dependent radioresistance in cells deficient in DNA polymerase eta.

  Carcinogenesis 20121101

• A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.

  Cancer chemotherapy and pharmacology 20121101

• The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy.

  Biomaterials 20121101

• Review: ototoxic characteristics of platinum antitumor drugs.

  Anatomical record (Hoboken, N.J. : 2007) 20121101

• S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.

  The Lancet. Oncology 20121101

• New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models.

  Annals of surgery 20121101

• Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis.

  World journal of gastroenterology 20121014

• Primary hepatic leiomyosarcoma with liver metastasis of rectal cancer.

  World journal of gastroenterology 20121014

• Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20121010

• Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.

  American journal of clinical oncology 20121001

• Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil/leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20121001

• Second-line chemotherapy for advanced gastric cancer in Korea.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20121001

• Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121001

• Intralymphatic delivery of platinum-based chemotherapeutics is possible: an experimental study.

  Journal of cancer research and clinical oncology 20121001

• Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20121001

• Membrane transporters as determinants of the pharmacology of platinum anticancer drugs.

  Current cancer drug targets 20121001

• Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20121001

• Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20121001

• Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20121001

• TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial.

  The Lancet. Oncology 20121001

• Delayed repeated intraperitoneal chemotherapy after cytoreductive surgery for colorectal and appendiceal carcinomatosis.

  Diseases of the colon and rectum 20121001

• Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.

  Annals of surgery 20121001

• Structures of oxaliplatin-oligonucleotide adducts from DNA.

  Journal of mass spectrometry : JMS 20121001

• Synergism in concomitant chemoradiotherapy of cisplatin and oxaliplatin and their liposomal formulation in the human colorectal cancer HCT116 model.

  Anticancer research 20121001

• [Reduction of angialgia during peripheral administration of oxaliplatin mixed with dexamethasone].

  Gan to kagaku ryoho. Cancer & chemotherapy 20121001

• Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.

  Chinese medical journal 20121001

• Oxaliplatin as part of adjuvant therapy for colon cancer: more complicated than once thought.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120920

• Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120920

• Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120920

• A new 'fully reduced' polyoxovanadate constructed from nanosized triangle-shaped [V(III)3V(IV)18P6O60(DACH)3]}9- cluster anions exhibiting ferrimagnetic interactions.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120917

• Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120910

• Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.

  Journal of gastrointestinal cancer 20120901

• Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer.

  Medical oncology (Northwood, London, England) 20120901

• GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma.

  Medical oncology (Northwood, London, England) 20120901

• Treatment decisions after diagnosis of metastatic colorectal cancer.

  Clinical colorectal cancer 20120901

• Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy.

  International journal of radiation oncology, biology, physics 20120901

• Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.

  Cancer 20120901

• Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence.

  International journal of radiation oncology, biology, physics 20120901

• Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: what have we learned from a decade of translational research?

  Critical reviews in oncology/hematology 20120901

• Chemotherapy for the biliary tract cancers: moving toward improved survival time.

  Journal of gastrointestinal cancer 20120901

• Oxaliplatin-induced hepatocellular injury and ototoxicity: a review of the literature and report of unusual side effects of a commonly used chemotherapeutic agent.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120901

• Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120901

• Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.

  Clinical colorectal cancer 20120901

• Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

  European radiology 20120901

• Development of pyridine-containing macrocyclic copper(II) complexes: potential role in the redox modulation of oxaliplatin toxicity in human breast cells.

  Free radical research 20120901

• Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases.

  Annals of surgical oncology 20120901

• Effects of PEG-liposomal oxaliplatin on apoptosis, and expression of Cyclin A and Cyclin D1 in colorectal cancer cells.

  Oncology reports 20120901

• Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A.

  Molecular pharmacology 20120901

• Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: a retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG).

  Acta oncologica (Stockholm, Sweden) 20120901

• Colon carcinoma in a child treated with oxaliplatin and antiangiogenic treatment regimens.

  Pediatric hematology and oncology 20120901

• S-1 for the treatment of gastrointestinal cancer.

  Expert opinion on pharmacotherapy 20120901

• Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.

  European journal of medicinal chemistry 20120901

• A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer.

  Anticancer research 20120901

• Influcence of localization of primary tumor on effectiveness of 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma: a retrospective study.

  Anticancer research 20120901

• Pharmacogenomics panel test for prevention toxicity in patient who receive Fluoropirimidine/Oxaliplatin-based therapy.

  European review for medical and pharmacological sciences 20120901

• Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.

  Neuro-oncology 20120901

• Revisiting [PtCl₂(cis-1,4-DACH)]: an underestimated antitumor drug with potential application to the treatment of oxaliplatin-refractory colorectal cancer.

  Journal of medicinal chemistry 20120823

• Understanding the interplay of weak forces in [3,3]-sigmatropic rearrangement for stereospecific synthesis of diamines.

  Accounts of chemical research 20120821

• A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy.

  Investigational new drugs 20120801

• Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer.

  Investigational new drugs 20120801

• Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer.

  International journal of clinical oncology 20120801

• A preclinical and clinical review of aflibercept for the management of cancer.

  Cancer treatment reviews 20120801

• Apoptosis index correlates with chemotherapy efficacy and predicts the survival of patients with gastric cancer.

  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20120801

• What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy?

  Annals of surgical oncology 20120801

• Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation.

  Medical care 20120801

• Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120801

• Oxaliplatin-related thrombocytopenia.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120801

• Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: a systematic review and meta-analysis.

  European journal of cancer (Oxford, England : 1990) 20120801

• Current developments in the management of locally advanced esophageal cancer.

  Current oncology reports 20120801

• Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension.

  Journal of gastroenterology and hepatology 20120801

• Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120801

• Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.

  Histopathology 20120801

• Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment.

  Neuromuscular disorders : NMD 20120801

• Cortical effect of oxaliplatin associated with sustained neuropathic pain: exacerbation of cortical activity and down-regulation of potassium channel expression in somatosensory cortex.

  Pain 20120801

• Intrahepatic and systemic therapy with oxaliplatin combined with capecitabine in patients with hepatic metastases from breast cancer.

  Breast (Edinburgh, Scotland) 20120801

• Modified FOLFOX-6 therapy for heavily pretreated advanced gastric cancer refractory to fluorouracil, irinotecan, cisplatin and taxanes: a retrospective study.

  Japanese journal of clinical oncology 20120801

• Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters.

  Cancer chemotherapy and pharmacology 20120801

• Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2.

  Anti-cancer drugs 20120801

• Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20120801

• A rare hematological adverse event induced by bevacizumab: severe thrombocytopenia.

  The American journal of medicine 20120801

• Splenomegaly during oxaliplatin-based chemotherapy for colorectal carcinoma.

  Anticancer research 20120801

• Applicability of histoculture drug response assays in colorectal cancer chemotherapy.

  Anticancer research 20120801

• A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120801

• Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120801

• [Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells].

  Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20120801

• [Severe hemorrhage in a patient with metastatic colorectal cancer - case 8/2012].

  Deutsche medizinische Wochenschrift (1946) 20120801

• Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.

  Journal of chemotherapy (Florence, Italy) 20120801

• Mucinous histology of colon cancer predicts poor outcomes with FOLFOX regimen in metastatic colon cancer.

  Journal of chemotherapy (Florence, Italy) 20120801

• Extravasation of oxaliplatin into the mediastinum: a case report and review of the literature.

  Clinical advances in hematology & oncology : H&O 20120801

• Mediastinal extravasation of oxaliplatin.

  Clinical advances in hematology & oncology : H&O 20120801

• Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120720

• Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.

  Science translational medicine 20120718

• A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20120715

• Oxaliplatin induced disseminated intravascular coagulation: A case report and review of literature.

  World journal of gastrointestinal oncology 20120715

• Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer.

  Annals of surgical oncology 20120701

• Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120701

• Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120701

• Slow-cycling therapy-resistant cancer cells.

  Stem cells and development 20120701

• The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120701

• The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues.

  Cancer immunology, immunotherapy : CII 20120701

• Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer.

  International journal of radiation oncology, biology, physics 20120701

• FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120701

• The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.

  Journal of surgical oncology 20120701

• Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancer.

  Molecular cancer therapeutics 20120701

• Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20120701

• Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.

  Annals of surgical oncology 20120701

• The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.

  Annals of surgical oncology 20120701

• Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization.

  Annals of surgical oncology 20120701

• Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis.

  Anti-cancer drugs 20120701

• Rectal cancer: state of the art in 2012.

  Current opinion in oncology 20120701

• Effects of sequential chemotherapy of FOLFIRI/FOLFOX on the endocrine axes of ACTH-cortisol and renin-angiotensin-aldosterone.

  Journal of neuro-oncology 20120701

• X-ACT: an important step on an unfinished journey.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120701

• Antitumor platinum(II) complexes of N-monoalkyl-1R, 2R-diaminocyclohexane derivatives with alkyl groups as hindrance.

  Journal of inorganic biochemistry 20120701

• A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

  The oncologist 20120701

• A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20120701

• Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

  The Lancet. Oncology 20120701

• Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20120701

• Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial.

  The Lancet. Oncology 20120701

• SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120701

• Preventive effect of traditional Japanese medicine on neurotoxicity of FOLFOX for metastatic colorectal cancer: a multicenter retrospective study.

  Anticancer research 20120701

• Efficacy of combination chemotherapy using oral fluoropyrimidine S-1 with oxaliplatin (SOX) against colorectal cancer in vivo.

  Anticancer research 20120701

• [Evaluation of modified OPTIMOX1 plus bevacizumab as the neoadjuvant therapy for highly advanced rectal cancers].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120701

• Characterization of biological responses of colorectal cancer cells to anticancer regimens.

  Journal of the Korean Surgical Society 20120701

• Systemic therapy of advanced pancreatic cancer: has the landscape changed?

  Clinical advances in hematology & oncology : H&O 20120701

• Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients.

  Pharmacogenomics 20120701

• [Relationship between single nucleotide polymorphism in repair gene XPD751 and prognosis in colorectal carcinoma patients].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20120701

• [Phase II clinical trial of docetaxel, platinum and S-1 for advanced gastric cancer].

  Zhonghua yi xue za zhi 20120626

• Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.

  Cancer 20120615

• Neoadjuvant chemotherapy with FOLFOX: improved outcomes in Chinese patients with locally advanced gastric cancer.

  Journal of surgical oncology 20120615

• A zinc(II) phthalocyanine conjugated with an oxaliplatin derivative for dual chemo- and photodynamic therapy.

  Journal of medicinal chemistry 20120614

• ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21.

  Cancer cell 20120612

• Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition.

  World journal of gastroenterology 20120607

• Heparan sulfate proteoglycan-mediated entry pathway for charged tri-platinum compounds: differential cellular accumulation mechanisms for platinum.

  Molecular pharmaceutics 20120604

• Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells.

  Investigational new drugs 20120601

• Prospective phase I study of capecitabine and oxaliplatin concurrent with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma, and retrospective comparison to concurrent 5-fluorouracil/radiation and gemcitabine/radiation.

  Journal of gastrointestinal cancer 20120601

• Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients.

  Medical oncology (Northwood, London, England) 20120601

• A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer.

  Investigational new drugs 20120601

• Clusterin and chemotherapy sensitivity under normoxic and graded hypoxic conditions in colorectal cancer.

  Journal of gastrointestinal cancer 20120601

• Phase II study of pemetrexed plus oxaliplatin for platinum-resistant advanced or metastatic non-small cell lung cancer patients.

  Medical oncology (Northwood, London, England) 20120601

• Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium.

  Investigational new drugs 20120601

• Natural resistance to apoptosis correlates with resistance to chemotherapy in colorectal cancer cells.

  Clinical and experimental medicine 20120601

• Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.

  European journal of cancer (Oxford, England : 1990) 20120601

• Pretherapeutic uracil and dihydrouracil levels of colorectal cancer patients are associated with sex and toxic side effects during adjuvant 5-fluorouracil-based chemotherapy.

  Cancer 20120601

• Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.

  Cancer 20120601

• Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120601

• Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120601

• Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer.

  Clinical colorectal cancer 20120601

• Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.

  Cancer 20120601

• Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.

  International journal of radiation oncology, biology, physics 20120601

• Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies.

  Clinical colorectal cancer 20120601

• Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.

  Cancer metastasis reviews 20120601

• Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer.

  Clinical colorectal cancer 20120601

• Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.

  International journal of radiation oncology, biology, physics 20120601

• The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer: results from the Nordic ACT trial.

  International journal of colorectal disease 20120601

• Literature review and practical aspects on the management of oxaliplatin-associated toxicity.

  Clinical colorectal cancer 20120601

• Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab.

  Clinical colorectal cancer 20120601

• Cetuximab combined with FOLFOX4 as the first-line treatment for advanced gastric cancer: report of 25 cases from a single institution.

  Hepato-gastroenterology 20120601

• Prophylactic adjuvant hepatic arterial infusion chemotherapy reduced hepatic metastases from Stage III colorectal cancer after curative resection.

  Hepato-gastroenterology 20120601

• Application of different methods to formulate PEG-liposomes of oxaliplatin: evaluation in vitro and in vivo.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120601

• Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers.

  Angiogenesis 20120601

• DNA polymerase ζ is a major determinant of resistance to platinum-based chemotherapeutic agents.

  Molecular pharmacology 20120601

• The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.

  Molecular cancer therapeutics 20120601

• Covalent binding of cisplatin impairs the function of Na(+)/K(+)-ATPase by binding to its cytoplasmic part.

  Biochemical pharmacology 20120601

• The effect of monosialotetrahexosylganglioside (GM1) in prevention of oxaliplatin induced neurotoxicity: a retrospective study.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20120601

• Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells.

  Cancer biotherapy & radiopharmaceuticals 20120601

• A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.

  Clinical and experimental nephrology 20120601

• Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20120601

• Conventional chemotherapy of advanced pancreatic cancer.

  Current drug targets 20120601

• Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer.

  Biomaterials 20120601

• A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma.

  Anti-cancer drugs 20120601

• Neuropathies associated with oxaliplatin therapy.

  Asia-Pacific journal of clinical oncology 20120601

• Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review.

  Asia-Pacific journal of clinical oncology 20120601

• Acute inflammatory demyelinating polyradiculoneuropathy in a patient receiving oxaliplatin-based chemotherapy.

  Asia-Pacific journal of clinical oncology 20120601

• Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES).

  Metallomics : integrated biometal science 20120601

• Stereoselective UV sensing of 1,2-diaminocyclohexane isomers based on ligand displacement with a diacridylnaphthalene N,N'-dioxide scandium complex.

  The Journal of organic chemistry 20120601

• FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study.

  Cancer chemotherapy and pharmacology 20120601

• Intraperitoneal and intravenous chemotherapy in peritoneal carcinomatosis.

  Hepato-gastroenterology 20120601

• Prediction of genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 in the survival of colorectal cancer receiving chemotherapy in the Chinese population.

  Hepato-gastroenterology 20120601

• Can immunohistochemistry of multidrug-resistant proteins replace the histoculture drug response assay in colorectal adenocarcinomas?

  Hepato-gastroenterology 20120601

• Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120601

• Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancers.

  Current oncology (Toronto, Ont.) 20120601

• Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

  Journal of the National Comprehensive Cancer Network : JNCCN 20120601

• Systemic therapy for advanced pancreatic neuroendocrine tumors: an update.

  Journal of the National Comprehensive Cancer Network : JNCCN 20120601

• [A case of advanced colon cancer with peritoneal dissemination effectively treated with modified FOLFOX6 chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120601

• [Impact of AJCC staging system (2010 edition) on the choice of postoperative adjuvant chemotherapy after radical resection of gastric cancer].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20120601

• Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen.

  Translational oncology 20120601

• A phase II study of capecitabine and lapatinib in advanced refractory colorectal adenocarcinoma: A Wisconsin Oncology Network study.

  Journal of gastrointestinal oncology 20120601

• Hepatoid adenocarcinoma of the peritoneal cavity: Prolonged survival after debulking surgery and 5-fluorouracil, leucovorin and oxaliplatin (FOLFOX) therapy.

  Journal of gastrointestinal oncology 20120601

• Hepatic arterial infusion in colorectal carcinoma: is anatomical targeting still relevant in an era of molecularly targeted therapy?

  Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20120601

• [Sensitivity to chemotherapeutic drugs of polyploid tumor cells induced by a spindle poison nocodazole].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20120601

• The role of capecitabine in locally advanced rectal cancer treatment: an update.

  Drugs 20120528

• Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection.

  British journal of cancer 20120522

• Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120520

• Salen-based chiral fluorescence polymer sensor for enantioselective recognition of α-hydroxyl carboxylic acids.

  The Journal of organic chemistry 20120518

• Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.

  The Cochrane database of systematic reviews 20120516

• Sequence-specific recognition of cancer drug-DNA adducts by HMGB1a repair protein.

  Biophysical journal 20120516

• Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120515

• Probing the mechanism and dynamic reversibility of trianglimine formation using real-time electrospray ionization time-of-flight mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20120515

• Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120510

• Diastereoselective imine-bond formation through complementary double-helix formation.

  Journal of the American Chemical Society 20120502

• Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120501

• The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature.

  Leukemia & lymphoma 20120501

• Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.

  Annals of surgical oncology 20120501

• Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter?

  Journal of surgical oncology 20120501

• Impact of preoperative targeted therapy on postoperative complications after resection of colorectal liver metastases.

  International journal of colorectal disease 20120501

• Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.

  Acta oncologica (Stockholm, Sweden) 20120501

• Targeting colorectal cancer stem cells with inducible caspase-9.

  Apoptosis : an international journal on programmed cell death 20120501

• A complex of cyclohexane-1,2-diaminoplatinum with an amphiphilic biodegradable polymer with pendant carboxyl groups.

  Acta biomaterialia 20120501

• Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20120501

• CIP2A is a predictor of poor prognosis in colon cancer.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120501

• Anticancer activity of methyl-substituted oxaliplatin analogs.

  Molecular pharmacology 20120501

• Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer. Treatment outcome outside clinical trials.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120501

• [Neoadjuvant radiochemotherapy with 5-FU plus oxaliplatin for locally advanced rectal cancer. First results from phase III trials].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120501

• Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20120501

• Novel potassium N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxylhex-1-yl]-L-amino acid dichloroplatinates(II) with high anti-tumor activity and low side reaction.

  Metallomics : integrated biometal science 20120501

• Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.

  Upsala journal of medical sciences 20120501

• [Chemotherapy in elderly frail patients with advanced colorectal cancer. MRC FOCUS 2 (UK Medical Research Council Fluorouracil, Oxaliplatin, and Capecitabine: Use and Sequencing)].

  Der Internist 20120501

• [A case of remnant liver metastases after resection of liver metastases from rectal cancer following treatment with 5-FU, L-OHP and CPT-11, with markedly effective treatment by cetuximab plus S-1].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120501

• Entrainment of the mammalian cell cycle by the circadian clock: modeling two coupled cellular rhythms.

  PLoS computational biology 20120501

• Infused chemotherapy use in the elderly after patent expiration.

  The American journal of managed care 20120501

• [Effect of siRNA for mutant p53 gene on biological behavior of gastric cancer cell line SGC7901].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20120501

• Prevalence of Delayed Nausea and/or Vomiting in Patients Treated With Oxaliplatin-Based Regimens for Colorectal Cancer.

  Journal of oncology practice 20120501

• Uptake of oxaliplatin and bevacizumab for treatment of node-positive and metastatic colon cancer.

  Journal of oncology practice 20120501

• Infused chemotherapy use in the elderly after patent expiration.

  Journal of oncology practice 20120501

• [Acetoacetate extract from Celastrus orbiculatus Thunb inhibits growth of RFP-xenografted human liver carcinoma].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20120501

• Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis.

  Journal of controlled release : official journal of the Controlled Release Society 20120430

• Asymmetric hydrolytic kinetic resolution with recyclable macrocyclic Co(III)-salen complexes: a practical strategy in the preparation of (R)-mexiletine and (S)-propranolol.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120423

• [ABCB1 polymorphisms in patients with Charcot-Marie-Tooth disease. A possible relationship with neurotoxicity due to cytostatic treatment].

  Medicina clinica 20120421

• Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?

  International journal of pharmaceutics 20120415

• Krüppel-like factor 11 differentially couples to histone acetyltransferase and histone methyltransferase chromatin remodeling pathways to transcriptionally regulate dopamine D2 receptor in neuronal cells.

  The Journal of biological chemistry 20120413

• E Platinum, a newly synthesized platinum compound, induces autophagy via inhibiting phosphorylation of mTOR in gastric carcinoma BGC-823 cells.

  Toxicology letters 20120405

• Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.

  JAMA 20120404

• Bevacizumab plus FOLFIRI-3 in chemotherapy-refractory patients with metastatic colorectal cancer in the era of biotherapies.

  Investigational new drugs 20120401

• Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer.

  Investigational new drugs 20120401

• Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy.

  The pharmacogenomics journal 20120401

• Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines.

  Investigational new drugs 20120401

• A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.

  Investigational new drugs 20120401

• Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel.

  International journal of cancer 20120401

• A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120401

• Cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer: results from the randomised phase II part of a phase I/II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120401

• A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases.

  Annals of surgical oncology 20120401

• Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.

  Pathology oncology research : POR 20120401

• Chemotherapy between the first and second stages of a two-stage hepatectomy for colorectal liver metastases: should we routinely recommend it?

  Annals of surgical oncology 20120401

• High lymph node yield is related to microsatellite instability in colon cancer.

  Annals of surgical oncology 20120401

• Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients: the introduction of a new measure.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120401

• Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation.

  Journal of hepatology 20120401

• Cellular pharmacokinetic/pharmacodynamic relationship of platinum cytostatics in head and neck squamous cell carcinoma evaluated by liquid chromatography coupled to tandem mass spectrometry.

  The Journal of pharmacology and experimental therapeutics 20120401

• Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120401

• Synthesis, in vitro cytotoxicity, and interaction with DNA of platinum(II) complexes with N-monocycloalkyl derivatives of 1R,2R-diaminocyclohexane as carrier ligands.

  ChemMedChem 20120401

• Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20120401

• Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.

  European journal of gastroenterology & hepatology 20120401

• A Japanese post-marketing surveillance of cetuximab (Erbitux®) in patients with metastatic colorectal cancer.

  Japanese journal of clinical oncology 20120401

• A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20120401

• Infections of Blastocystis hominis and microsporidia in cancer patients: are they opportunistic?

  Transactions of the Royal Society of Tropical Medicine and Hygiene 20120401

• Computational prediction of state anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomiting.

  Journal of clinical psychopharmacology 20120401

• The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.

  Langenbeck's archives of surgery 20120401

• Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model.

  Molecular imaging 20120401

• Bilateral acute ptosis leading to the diagnosis of a presumed metastatic gastric adenocarcinoma.

  Orbit (Amsterdam, Netherlands) 20120401

• Efficacy of the Chinese traditional medicinal herb Celastrus orbiculatus Thunb on human hepatocellular carcinoma in an orthothopic fluorescent nude mouse model.

  Anticancer research 20120401

• Comparison of the chemosensitivity of the primary lesion and a pancreatic metastasis of colon cancer: a case report.

  Anticancer research 20120401

• Colorectal cancer and thoracic surgeons: close encounters of the third kind.

  Expert review of anticancer therapy 20120401

• [Reduction of vascular pain due to drop-infusion of oxaliplatin (L-OHP) in peripheral vein with heated infusion route].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120401

• [Expression of allergic reactions to oxaliplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120401

• Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008.

  Croatian medical journal 20120401

• Down-regulation of p110β expression increases chemosensitivity of colon cancer cell lines to oxaliplatin.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20120401

• Prognostic significance of the lymph node ratio regarding recurrence and survival in rectal cancer patients treated with postoperative chemoradiotherapy.

  Gut and liver 20120401

• Oxaliplatin-induced lung toxicity. Case report and review of the literature.

  Current drug safety 20120401

• trans-1,2-Diaminocyclohexane mesoporous silica for asymmetric catalysis: enhancement of chirality through confinement space by the plug effect.

  Chemical communications (Cambridge, England) 20120325

• Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20120315

• Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy.

  Cancer 20120315

• Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.

  Journal of surgical oncology 20120315

• Synthesis and cytotoxicity of diam(m)ineplatinum(II) complexes with 2,2-bis(hydroxymethyl)malonate as the leaving group.

  Bioorganic & medicinal chemistry letters 20120315

• Solid-phase synthesis of oxaliplatin-TAT peptide bioconjugates.

  Dalton transactions (Cambridge, England : 2003) 20120314

• Postoperative adjuvant chemotherapy in rectal cancer operated for cure.

  The Cochrane database of systematic reviews 20120314

• Locally advanced pancreatic adenocarcinoma: update and progress.

  JOP : Journal of the pancreas 20120310

• What options are available for refractory pancreatic cancer?

  JOP : Journal of the pancreas 20120310

• Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells.

  World journal of gastroenterology 20120307

• Falls in persons with chemotherapy-induced peripheral neuropathy.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120301

• Retinal vein thrombosis in a patient with metastatic colon cancer receiving XELOX chemotherapy combined with bevacizumab pre-hepatic resection.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120301

• PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients.

  Journal of cellular physiology 20120301

• Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120301

• Breast and colorectal cancer survivors' knowledge about their diagnosis and treatment.

  Journal of cancer survivorship : research and practice 20120301

• Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.

  Clinical colorectal cancer 20120301

• Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer.

  Clinical colorectal cancer 20120301

• P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance.

  Oncogene 20120301

• PEG-liposomal oxaliplatin induces apoptosis in human colorectal cancer cells via Fas/FasL and caspase-8.

  Cell biology international 20120301

• Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity.

  Psychopharmacology 20120301

• Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen.

  Clinical colorectal cancer 20120301

• Panitumumab in combination with cytotoxic chemotherapy for the treatment of metastatic colorectal carcinoma.

  Clinical colorectal cancer 20120301

• Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

  Cancer chemotherapy and pharmacology 20120301

• The effect of postoperative pelvic irradiation after complete resection of metastatic rectal cancer.

  Journal of surgical oncology 20120301

• Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX.

  Cancer chemotherapy and pharmacology 20120301

• Fragmentation methods on the balance: unambiguous top-down mass spectrometric characterization of oxaliplatin-ubiquitin binding sites.

  Analytical and bioanalytical chemistry 20120301

• The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.

  Carcinogenesis 20120301

• Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer.

  Scandinavian journal of gastroenterology 20120301

• Pharmacogenomics and metastatic colorectal cancer: current knowledge and perspectives.

  Scandinavian journal of gastroenterology 20120301

• Delivery of active DACH-Pt anticancer species by biodegradable amphiphilic polymers using thiol-ene radical addition.

  Macromolecular bioscience 20120301

• Simultaneous surgery for primary colorectal cancer and metastatic lesions?

  Scandinavian journal of gastroenterology 20120301

• A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.

  European journal of cancer (Oxford, England : 1990) 20120301

• Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.

  Pain 20120301

• High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.

  Acta oncologica (Stockholm, Sweden) 20120301

• The economic pressures for biosimilar drug use in cancer medicine.

  Targeted oncology 20120301

• Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro.

  European journal of medicinal chemistry 20120301

• Current management and future strategies of gastric cancer.

  Yonsei medical journal 20120301

• Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin.

  The journal of pain : official journal of the American Pain Society 20120301

• Absence of transcriptomic signature of response to chemotherapy in metastatic colorectal carcinoma patients.

  Pharmacogenomics 20120301

• Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin.

  Cell cycle (Georgetown, Tex.) 20120301

• A possible link of oxaliplatin-induced neuropathy with potassium channel deficit.

  Muscle & nerve 20120301

• Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia.

  Nature cell biology 20120301

• Modeling the 5-fluorouracil area under the curve versus dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer patients receiving FOLFOX6.

  The oncologist 20120301

• Cetuximab sensitivity associated with oxaliplatin resistance in colorectal cancer.

  Anticancer research 20120301

• SN-38 overcomes chemoresistance of colorectal cancer cells induced by hypoxia, through HIF1alpha.

  Anticancer research 20120301

• Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer.

  Anticancer research 20120301

• Synthetic lethality of cohesins with PARPs and replication fork mediators.

  PLoS genetics 20120301

• Therapeutic strategy in unresectable metastatic colorectal cancer.

  Therapeutic advances in medical oncology 20120301

• Targeted therapy for hepatocellular carcinoma: novel agents on the horizon.

  Oncotarget 20120301

• Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: implications for adaptive dose escalation strategies.

  Acta oncologica (Stockholm, Sweden) 20120301

• Update of adjuvant chemotherapy for resected gastric cancer.

  Journal of gastric cancer 20120301

• A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

  Acta gastro-enterologica Belgica 20120301

• Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy.

  Nanotechnology 20120224

• Thermotherapy enhances oxaliplatin-induced cytotoxicity in human colon carcinoma cells.

  World journal of gastroenterology 20120221

• Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120220

• [A randomized clinical trial on the clinical efficacy and toxicities of single-agent paclitaxel liposome versus paclitaxel liposome plus oxaliplatin as first-line chemotherapy for advanced non-small cell lung cancer in elderly patients].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120220

• Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.

  Neuroscience 20120217

• Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer.

  Cancer 20120215

• In vitro biological evaluation of platinum(II) complexes with 1-(methoxy substituted benzyl) azetidine-3,3-dicarboxylato ligands.

  Bioorganic & medicinal chemistry 20120215

• Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120214

• Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.

  Journal of the National Cancer Institute 20120208

• Thermodynamics of translesion synthesis across a major DNA adduct of antitumor oxaliplatin: differential scanning calorimetric study.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120206

• A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer.

  Investigational new drugs 20120201

• Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients.

  Investigational new drugs 20120201

• Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.

  International journal of radiation oncology, biology, physics 20120201

• Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin.

  Cancer chemotherapy and pharmacology 20120201

• A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.

  Annals of surgical oncology 20120201

• T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.

  Annals of surgical oncology 20120201

• A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma.

  Cancer chemotherapy and pharmacology 20120201

• Risk of thromboembolic events after perioperative chemotherapy versus surgery alone for esophageal adenocarcinoma.

  Annals of surgical oncology 20120201

• Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection.

  Annals of surgical oncology 20120201

• Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20120201

• New treatment strategies in advanced neuroendocrine tumours.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120201

• Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer.

  Oncology reports 20120201

• Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?

  Anti-cancer agents in medicinal chemistry 20120201

• Hepatic arterial infusion of bevacizumab in combination with oxaliplatin reduces tumor growth in a rat model of colorectal liver metastases.

  Clinical & experimental metastasis 20120201

• Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.

  Gut 20120201

• Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer.

  Journal of cancer research and clinical oncology 20120201

• The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats.

  Behavioural brain research 20120201

• FOLFIRI plus bevacizumab 5 mg/kg versus 10 mg/kg as second-line therapy in patients with metastatic colorectal cancer who have failed first-line bevacizumab plus oxaliplatin-based therapy: a randomized phase III study (EAGLE Study).

  Japanese journal of clinical oncology 20120201

• Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe.

  Current medical research and opinion 20120201

• Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.

  Virchows Archiv : an international journal of pathology 20120201

• Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.

  Cancer research 20120201

• Genomics and pharmacogenomics of pancreatic adenocarcinoma.

  The pharmacogenomics journal 20120201

• Biliary-tract cancer: improving therapy by adding molecularly targeted agents.

  The Lancet. Oncology 20120201

• Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.

  The Lancet. Oncology 20120201

• Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.

  European journal of medicinal chemistry 20120201

• [Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20120201

• Investigation of a liposomal oxaliplatin drug formulation by capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry (CE-ICP-MS).

  Analytical and bioanalytical chemistry 20120201

• Use of pneumatic nebulization and laser ablation-inductively coupled plasma-mass spectrometry to study the distribution and bioavailability of an intraperitoneally administered Pt-containing chemotherapeutic drug.

  Analytical and bioanalytical chemistry 20120201

• Viewing metastatic colorectal cancer as a curable chronic disease.

  American journal of clinical oncology 20120201

• Medullary thyroid cancer and pseudocirrhosis: case report and literature review.

  Current oncology (Toronto, Ont.) 20120201

• More than 7-year survival of a patient following repeat hepatectomy for total 20 colon cancer liver metastases.

  Journal of the Korean Surgical Society 20120201

• Multivariate Analysis of the Survival Rate for Treatment Modalities in Incurable Stage IV Colorectal Cancer.

  Journal of the Korean Society of Coloproctology 20120201

• [A study on the effects of indomethacin and oxaliplatin on lymphangiogenesis in a nude mice model of transplantation with A549 human lung cancer].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20120201

• Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

  Lancet (London, England) 20120128

• Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy.

  Toxicology 20120127

• Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate.

  Chemical communications (Cambridge, England) 20120121

• Takotsubo cardiomyopathy and Fluorouracil: case report and review of the literature.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120110

• TFAP2E-DKK4 and chemoresistance in colorectal cancer.

  The New England journal of medicine 20120105

• Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis.

  British journal of cancer 20120103

• The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer.

  British journal of cancer 20120103

• Neoadjuvant bevacizumab, oxaliplatin, 5-fluorouracil, and radiation for rectal cancer.

  International journal of radiation oncology, biology, physics 20120101

• Characterization of nano oxaliplatin prepared by novel Fat Employing Supercritical Nano System, the FESNS®.

  Pharmaceutical development and technology 20120101

• A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling.

  Journal of cellular and molecular medicine 20120101

• Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120101

• Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST).

  Investigative radiology 20120101

• 5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity.

  Cancer chemotherapy and pharmacology 20120101

• Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial.

  Cancer chemotherapy and pharmacology 20120101

• A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20120101

• Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.

  European journal of cancer (Oxford, England : 1990) 20120101

• Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysis.

  Gastroenterology research and practice 20120101

• Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer.

  International journal of oncology 20120101

• Lipoplatin formulation review article.

  Journal of drug delivery 20120101

• Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20120101

• Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells.

  Oncology reports 20120101

• DNA-Platinum Thin Films for Use in Chemoradiation Therapy Studies.

  Bioinorganic chemistry and applications 20120101

• Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression.

  Cancer science 20120101

• Noble metal nanoparticles applications in cancer.

  Journal of drug delivery 20120101

• Organizing pneumonia associated with oxaliplatin-combined chemotherapy: a case report.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20120101

• Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC).

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20120101

• Oxaliplatin in the adjuvant treatment of colon cancer.

  CA: a cancer journal for clinicians 20120101

• The central vein access port and catheter in outpatient chemotherapy for colorectal cancer: a retrospective study of 101 patients.

  Surgery today 20120101

• [Treatment of metastatic colorectal cancer: an illustration of the changes in the cancer paradigms].

  Presse medicale (Paris, France : 1983) 20120101

• Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.

  Acta oncologica (Stockholm, Sweden) 20120101

• Oxaliplatin: a review of approved uses.

  Expert opinion on pharmacotherapy 20120101

• [Epidural analgesia for surgical treatment of peritoneal carcinomatosis: a risky technique?].

  Annales francaises d'anesthesie et de reanimation 20120101

• Creatinine clearance rate and nerve conduction velocity are effective in objectively assessing oxaliplatin-neuropathy in patients with colorectal carcinoma.

  Hepato-gastroenterology 20120101

• TOP1 gene copy numbers in colorectal cancer samples and cell lines and their association to in vitro drug sensitivity.

  Scandinavian journal of gastroenterology 20120101

• Adverse event profiles of 5-fluorouracil and capecitabine: data mining of the public version of the FDA Adverse Event Reporting System, AERS, and reproducibility of clinical observations.

  International journal of medical sciences 20120101

• Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway.

  International journal of biological sciences 20120101

• Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials.

  Journal of Cancer 20120101

• Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells.

  Anticancer research 20120101

• Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy.

  BMC cancer 20120101

• Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development.

  Journal of oncology 20120101

• Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy.

  Nutrition and cancer 20120101

• First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study.

  The oncologist 20120101

• CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab.

  Cancer investigation 20120101

• Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy.

  Journal of translational medicine 20120101

• Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states.

  Molecular pain 20120101

• Cleavage of pyrene-stabilized RNA bulge loops by trans-(±)-cyclohexane-1,2-diamine.

  Chemistry Central journal 20120101

• Aflibercept in the treatment of metastatic colorectal cancer.

  Clinical Medicine Insights. Oncology 20120101

• Linear Discriminant Functions in Connection with the micro-RNA Diagnosis of Colon Cancer.

  Cancer informatics 20120101

• The cost-effectiveness of different chemotherapy strategies for patients with poor prognosis advanced colorectal cancer (MRC FOCUS).

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101

• Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.

  Cancer cell international 20120101

• Cancers of unknown primary origin: current perspectives and future therapeutic strategies.

  Journal of translational medicine 20120101

• Biomarkers for antitumor activity of bevacizumab in gastric cancer models.

  BMC cancer 20120101

• 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer.

  International journal of nanomedicine 20120101

• In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration.

  PloS one 20120101

• Monoclonal antibodies and Fc fragments for treating solid tumors.

  Biologics : targets & therapy 20120101

• L type Ca²+ channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats.

  Molecular pain 20120101

• Drug transporter regulation in tumors by DNA methylation.

  Genome medicine 20120101

• Immunohistochemical profile for unknown primary adenocarcinoma.

  PloS one 20120101

• Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC).

  Journal of translational medicine 20120101

• A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer.

  Chemotherapy 20120101

• MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer?

  International journal of molecular sciences 20120101

• Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers.

  Frontiers in pharmacology 20120101

• S-1 combined with oxaliplatin as first line chemotherapy for Chinese advanced gastric cancer patients.

  Hepato-gastroenterology 20120101

• Osseous metastasis of cutaneous squamous cell carcinoma treated successfully with oxaliplatin, tegafur and leucovorin combination chemotherapy: a case report.

  International journal of clinical and experimental medicine 20120101

• A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics.

  Neoplasma 20120101

• Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948).

  PloS one 20120101

• FOLFOX4 in the adjuvant treatment of colon cancer in Asian patients.

  Hepato-gastroenterology 20120101

• Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii.

  Malaria journal 20120101

• DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.

  PloS one 20120101

• Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes.

  Journal of translational medicine 20120101

• Effect of neoadjuvant chemotherapy in hepatic steatosis.

  Chemotherapy 20120101

• Irinotecan-induced dysarthria.

  Case reports in oncology 20120101

• Retinoic acid-dependent signaling pathways and lineage events in the developing mouse spinal cord.

  PloS one 20120101

• The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer.

  BMC cancer 20120101

• Systemic delivery of oncolytic viruses: hopes and hurdles.

  Advances in virology 20120101

• Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects.

  Clinical & developmental immunology 20120101

• MutS homologue hMSH5: role in cisplatin-induced DNA damage response.

  Molecular cancer 20120101

• Long-term treatment of metastatic colorectal cancer with panitumumab.

  Clinical Medicine Insights. Oncology 20120101

• Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases.

  BMC cancer 20120101

• Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups.

  BMC cancer 20120101

• Insight into 144 patients with ocular vascular events during VEGF antagonist injections.

  Clinical ophthalmology (Auckland, N.Z.) 20120101

• Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101

• Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer.

  Radiation oncology (London, England) 20120101

• Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

  BMC cancer 20120101

• 'The Lower Threshold' phenomenon in tumor cells toward endogenous digitalis-like compounds: Responsible for tumorigenesis?

  Journal of carcinogenesis 20120101

• Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation.

  BMC biology 20120101

• A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial.

  BMC cancer 20120101

• Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.

  BMC cancer 20120101

• A case of type 2 diabetes and metastatic liver cancer exhibiting hypercholesterolemia with abnormal lipoproteins.

  Internal medicine (Tokyo, Japan) 20120101

• The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management.

  PloS one 20120101

• Fertility preservation in female cancer patients.

  ISRN obstetrics and gynecology 20120101

• State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.

  Clinical Medicine Insights. Oncology 20120101

• 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma.

  ISRN hematology 20120101

• Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery.

  PloS one 20120101

• Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).

  BMC cancer 20120101

• Isolated cardiac metastasis from colorectal cancer in a 35-year-old man.

  Case reports in medicine 20120101

• Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer.

  Chemotherapy research and practice 20120101

• Computational analysis of axonal transport: a novel assessment of neurotoxicity, neuronal development and functions.

  International journal of molecular sciences 20120101

• Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

  World journal of surgical oncology 20120101

• LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.

  BMC cancer 20120101

• Genetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resection.

  PloS one 20120101

• Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers.

  PloS one 20120101

• Hedgehog pathway as a drug target: Smoothened inhibitors in development.

  OncoTargets and therapy 20120101

• Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer.

  Cancer management and research 20120101

• The developing clinical problem of chemotherapy-induced hepatic injury.

  ANZ journal of surgery 20120101

• A phase I study of infusional 5-fluorouracil, leucovorin, oxaliplatin and irinotecan in Japanese patients with advanced colorectal cancer who harbor UGT1A1*1/*1,*1/*6 or *1/*28.

  Oncology 20120101

• Inhibition of Ca2+/calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in rats.

  Molecular pain 20120101

• [Pneumatosis cystoides intestinalis during palliative chemotherapy for colorectal cancer].

  Revue medicale de Bruxelles 20120101

• Scalable purification and characterization of the anticancer lunasin peptide from soybean.

  PloS one 20120101

• Soft-tissue metastasis revealing a pancreatic adenocarcinoma: one case report and a review of literature.

  The Pan African medical journal 20120101

• 30th german cancer congress, 22nd-25th february 2012, berlin.

  Ecancermedicalscience 20120101

• A multimodal approach to the management of neuroendocrine tumour liver metastases.

  International journal of hepatology 20120101

• Yeast toxicogenomics: genome-wide responses to chemical stresses with impact in environmental health, pharmacology, and biotechnology.

  Frontiers in genetics 20120101

• Fertility-sparing surgery in early epithelial ovarian cancer: a viable option?

  Obstetrics and gynecology international 20120101

• Novel therapies for aggressive B-cell lymphoma.

  Advances in hematology 20120101

• Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy.

  Oncology 20120101

• Fatal pneumonitis induced by oxaliplatin: description of three cases.

  Case reports in oncology 20120101

• Effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer: a meta-analysis of the published literature.

  PloS one 20120101

• Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?

  Clinical Medicine Insights. Oncology 20120101

• Securin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cells.

  PloS one 20120101

• Nerve excitability assessment in chemotherapy-induced neurotoxicity.

  Journal of visualized experiments : JoVE 20120101

• The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC).

  OncoTargets and therapy 20120101

• Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years.

  Chemotherapy 20120101

• Vorinostat approved in Japan for treatment of cutaneous T-cell lymphomas: status and prospects.

  OncoTargets and therapy 20120101

• Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation.

  Brain and behavior 20120101

• Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment.

  Clinical sarcoma research 20120101

• Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancer.

  PloS one 20120101

• Curcumin enhances cytotoxic effects of bortezomib in human multiple myeloma H929 cells: potential roles of NF-κB/JNK.

  International journal of molecular sciences 20120101

• Lymph node metastasis from colon carcinoma at 11 years after the initial operation managed by lymph node resection and chemoradiation: A case report and a review of the literature.

  International journal of surgery case reports 20120101

• Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA.

  PloS one 20120101

• Identification of novel human damage response proteins targeted through yeast orthology.

  PloS one 20120101

• 'Malignant' perivascular epithelioid cell neoplasm: risk stratification and treatment strategies.

  Sarcoma 20120101

• Metastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm?

  ISRN oncology 20120101

• Carbocisteine reduces the cytotoxicity of oxaliplatin.

  Zeitschrift fur Naturforschung. C, Journal of biosciences 20120101

• A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

  BMC cancer 20120101

• Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC.

  Gastroenterology research and practice 20120101

• Prolonged survival in a patient with neuroendocrine tumor of the cecum and diffuse peritoneal carcinomatosis.

  Case reports in gastroenterology 20120101

• Hyperthermic intraoperative thoracoabdominal chemotherapy.

  Gastroenterology research and practice 20120101

• Hepatocellular carcinoma: focus on different aspects of management.

  ISRN oncology 20120101

• Current knowledge on pancreatic cancer.

  Frontiers in oncology 20120101

• Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer.

  Frontiers in oncology 20120101

• Locally advanced cancer of the esophagus, current treatment strategies, and future directions.

  Frontiers in oncology 20120101

• Carboplatin-induced hypersensitivity reaction.

  Case reports in oncology 20120101

• Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma.

  Case reports in oncology 20120101

• PSA Response to Lenalidomide Therapy in a Pre-Treated Patient with Metastatic Prostate Cancer Refractory to Hormones and Chemotherapy: A Case Report.

  Case reports in oncology 20120101

• Nervous System of Periplaneta americana Cockroach as a Model in Toxinological Studies: A Short Historical and Actual View.

  Journal of toxicology 20120101

• A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas.

  International journal of surgical oncology 20120101

• Predictive Molecular Tumour Testing: What Are the Obstacles between Bench and Bedside?

  Chemotherapy research and practice 20120101

• A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers.

  Journal of Cancer 20120101

• Histological and molecular evaluation of patient-derived colorectal cancer explants.

  PloS one 20120101

• The current state of targeted agents in rectal cancer.

  International journal of surgical oncology 20120101

• The different induction mechanisms of growth arrest DNA damage inducible gene 45 β in human hepatoma cell lines.

  Chemotherapy 20120101

• Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection.

  International journal of nanomedicine 20120101

• Is palliative laparoscopic hyperthermic intraperitoneal chemotherapy effective in patients with malignant hemorrhagic ascites?

  Case reports in gastroenterology 20120101

• Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy.

  Case reports in oncology 20120101

• Complete Response of Isolated Para-aortic Lymph Node Recurrence from Rectosigmoid Cancer Treated by Chemoradiation Therapy with Capecitabine/Oxaliplatin plus Bevacizumab: A Case Report.

  Case reports in oncology 20120101

• Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study.

  Radiation oncology (London, England) 20120101

• An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

  Case reports in medicine 20120101

• Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma.

  Cancer management and research 20120101

• Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer.

  PloS one 20120101

• Early start of chemotherapy after resection of brain metastasis from colon cancer with synchronous multiple liver metastases.

  Case reports in oncology 20120101

• Acute Reversible Heart Failure Caused by Coronary Vasoconstriction due to Continuous 5-Fluorouracil Combination Chemotherapy.

  Case reports in oncology 20120101

• Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report.

  World journal of surgical oncology 20120101

• Cutaneous relapse of an ampullary carcinoma: an unusual presentation.

  BMJ case reports 20120101

• Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation can in vitro induce tumor cell death forms with immunogenic potential.

  Journal of immunotoxicology 20120101

• Antiemetic control with palonosetron in patients with gastrointestinal cancer receiving a fluoropyrimidine-based regimen in addition to either irinotecan or oxaliplatin: a retrospective study.

  Oncology 20120101

• Biweekly peglated liposomal doxorubicin/oxaliplatin for ovarian cancer resistant to taxane-platinum treatment: a Phase II study.

  Indian journal of cancer 20120101

• Preparation and In Vivo Evaluation of Dichloro(1,2-Diaminocyclohexane)platinum(II)-Loaded Core Cross-Linked Polymer Micelles.

  Chemotherapy research and practice 20120101

• New strategies against prostate cancer--Pt(II)-based chemotherapy.

  Current medicinal chemistry 20120101

• Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group.

  BMC cancer 20120101

• Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats.

  BMC complementary and alternative medicine 20120101

• Effect of tissue factor on invasion inhibition and apoptosis inducing effect of oxaliplatin in human gastric cancer cell.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• The effect of locoregional transarterial infusion chemotherapy on liver metastasis after gastric cancer resection.

  The Journal of international medical research 20120101

• Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials.

  Oncology 20120101

• Bing and neel syndrome.

  Case reports in hematology 20120101

• Oxaliplatin sensitizes OS cells to TRAIL-induced apoptosis via down-regulation of Mcl1.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• ACR appropriateness criteria®  resectable rectal cancer.

  Radiation oncology (London, England) 20120101

• Hepatic arterial infusion with irinotecan, oxaliplatin, and floxuridine plus systemic chemotherapy as first-line treatment of unresectable liver metastases from colorectal cancer.

  Onkologie 20120101

• Combination of trastuzumab and triple FLOT chemotherapy (5-fluorouracil/leucovorin, oxaliplatin, and docetaxel) in patients with HER2-positive metastatic gastric cancer: report of 3 cases.

  Onkologie 20120101

• A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.

  PloS one 20120101

• Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging.

  PloS one 20120101

• Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer.

  OncoTargets and therapy 20120101

• Synergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116.

  PloS one 20120101

• Bevacizumab-induced reversible thrombocytopenia in a patient with adenocarcinoma of colon: rare adverse effect of bevacizumab.

  Case reports in oncological medicine 20120101

• Novel drugs targeting the epidermal growth factor receptor and its downstream pathways in the treatment of colorectal cancer: a systematic review.

  Chemotherapy research and practice 20120101

• A delayed reaction to oxaliplatin.

  Journal of investigational allergology & clinical immunology 20120101

• Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.

  International surgery 20120101

• [Platinum agent-induced nephrotoxicity via organic cation transport system].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101

• Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling.

  Cancer letters 20111227

• Therapeutic effects of combined oxaliplatin and S-1 in older patients with advanced gastric cardiac adenocarcinoma.

  World journal of gastroenterology 20111221

• Steric modifications tune the regioselectivity of the alkane oxidation catalyzed by non-heme iron complexes.

  Inorganic chemistry 20111219

• Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis.

  Cancer research 20111215

• Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111210

• Interactions of an asymmetric amine with a non-C2 symmetric Cu-salen complex: an EPR/ENDOR and HYSCORE investigation.

  Physical chemistry chemical physics : PCCP 20111207

• Adjuvant therapy for early colon cancer: current status.

  Drugs 20111203

• Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.

  Investigational new drugs 20111201

• Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116.

  Investigational new drugs 20111201

• Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases.

  Investigational new drugs 20111201

• Oxaliplatin-induced acute thrombocytopenia.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20111201

• Metastatic lymph node targeted chemosensitivity test for gastric cancer.

  The Journal of surgical research 20111201

• Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy.

  Medical oncology (Northwood, London, England) 20111201

• Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen).

  Medical oncology (Northwood, London, England) 20111201

• Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20111201

• Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study.

  International journal of radiation oncology, biology, physics 20111201

• Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial.

  Cancer chemotherapy and pharmacology 20111201

• A case of heavily pretreated rectal cancer with disseminated intravascular coagulation that improved following reintroduction of FOLFOX plus bevacizumab.

  International journal of clinical oncology 20111201

• Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.

  International journal of radiation oncology, biology, physics 20111201

• Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency.

  Cancer chemotherapy and pharmacology 20111201

• Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20111201

• Arterial therapies of colorectal cancer metastases to the liver.

  Abdominal imaging 20111201

• Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies.

  Annals of surgical oncology 20111201

• Analysis for prognostic factors of 60-day mortality: evaluation of an irinotecan-based phase III trial performed in the first-line treatment of metastatic colorectal cancer.

  Clinical colorectal cancer 20111201

• Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.

  European journal of haematology 20111201

• Alternative spliced variants as biomarkers of colorectal cancer.

  Current drug metabolism 20111201

• Pharmacokinetic and metabolism determinants of fluoropyrimidines and oxaliplatin activity in treatment of colorectal patients.

  Current drug metabolism 20111201

• Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target.

  Molecular & cellular proteomics : MCP 20111201

• Successful twin pregnancy outcome after in utero exposure to FOLFOX for metastatic colon cancer: a case report and review of the literature.

  Clinical colorectal cancer 20111201

• Combination adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin after liver transplantation for hepatocellular carcinoma: a preliminary open-label study.

  Investigational new drugs 20111201

• A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer.

  Clinical colorectal cancer 20111201

• Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination.

  Angiogenesis 20111201

• Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.

  Experimental neurology 20111201

• Novel activity of acriflavine against colorectal cancer tumor cells.

  Cancer science 20111201

• Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group (GETUG V01).

  European urology 20111201

• Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.

  Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20111201

• A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: a Japanese experience.

  Surgery today 20111201

• Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.

  Annals of surgery 20111201

• Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20111201

• The efficacy and safety of panitumumab administered concomitantly with FOLFIRI or Irinotecan in second-line therapy for metastatic colorectal cancer: the secondary analysis from STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS status.

  Clinical colorectal cancer 20111201

• A new platinum-complex showing easy preparation, promising anti-tumor activity, and better efficacy and distribution properties than oxaliplatin.

  Molecular bioSystems 20111201

• S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111201

• Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study.

  Drug safety 20111201

• The evolution of adjuvant therapy in the treatment of early-stage colon cancer.

  Clinical colorectal cancer 20111201

• Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?

  The oncologist 20111201

• Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?

  The oncologist 20111201

• Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer.

  Asia-Pacific journal of clinical oncology 20111201

• Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells.

  Cell death & disease 20111201

• [A case of hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based chemotherapy after neoadjuvant chemotherapy for liver metastases from colon cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111201

• [Comparison of the toxicities and efficacies of the combination chemotherapy regimens in advanced gastric cancer patients who achieved complete response after chemotherapy].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111201

• Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cell lines.

  Anticancer research 20111201

• Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy.

  Anticancer research 20111201

• Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).

  Anticancer research 20111201

• Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity.

  Anticancer research 20111201

• Multi-center phase II study of FLOX for advanced colorectal cancer patients in Japan: SWIFT 3 study.

  Anticancer research 20111201

• [Synchronous primary endometrial and fallopian tube cancers: one case report].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111201

• Vulvar yolk sac tumor mixed with embryonal carcinoma in a peri-pubertal girl: a case report.

  Taiwanese journal of obstetrics & gynecology 20111201

• A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis.

  Cancer research and treatment : official journal of Korean Cancer Association 20111201

• Prognostic factors of second and third line chemotherapy using 5-fu with platinum, irinotecan, and taxane for advanced gastric cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20111201

• Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer.

  Journal of the Korean Society of Coloproctology 20111201

• Surgical stress-induced oxaliplatin-associated interstitial pneumonitis.

  The American surgeon 20111201

• Metastasis to the breast from colonic adenocarcinoma.

  Journal of the Korean Surgical Society 20111201

• Have the changes in treatment of rectal cancer made a significant difference to our patients?

  Oncology (Williston Park, N.Y.) 20111201

• New polymer-platinum (II) antitumor conjugates.

  Journal of controlled release : official journal of the Controlled Release Society 20111130

• A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.

  Cancer letters 20111128

• Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells.

  British journal of cancer 20111122

• The pivotal role of intracellular calcium in oxaliplatin-induced inhibition of neurite outgrowth but not cell death in differentiated PC12 cells.

  Chemical research in toxicology 20111121

• Effects of solvents on in vitro potencies of platinum compounds.

  DNA repair 20111110

• Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds.

  Dalton transactions (Cambridge, England : 2003) 20111107

• The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20111101

• Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).

  Annals of oncology : official journal of the European Society for Medical Oncology 20111101

• A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20111101

• Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients.

  Cancer chemotherapy and pharmacology 20111101

• Chemotherapy/chemoradiation in anal cancer: a systematic review.

  Cancer treatment reviews 20111101

• Clinical efficacy of chemotherapy combined with verapamil in metastatic colorectal patients.

  Cell biochemistry and biophysics 20111101

• The status of EGFR-associated genes could predict the outcome and tumor response of chemo-refractory metastatic colorectal patients using cetuximab and chemotherapy.

  Journal of surgical oncology 20111101

• Portal pneumatosis as a complication of neoadjuvant chemoradiotherapy for rectal cancer: a case report.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20111101

• Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.

  European journal of cancer (Oxford, England : 1990) 20111101

• Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.

  Anti-cancer drugs 20111101

• Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.

  Annals of surgical oncology 20111101

• Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101

• Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study.

  Acta oncologica (Stockholm, Sweden) 20111101

• Antitumor dinuclear platinum(II) complexes derived from a novel chiral ligand.

  Bioorganic & medicinal chemistry letters 20111101

• Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin.

  European journal of medicinal chemistry 20111101

• A patient with a metastatic gastroenteropancreatic endocrine carcinoma causing hyperinsulinaemic hypoglycaemia and the carcinoid syndrome.

  Annals of clinical biochemistry 20111101

• Oxaliplatin-induced coronary vasospasm manifesting as Kounis syndrome: a case report.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101

• Alternative end points to evaluate a therapeutic strategy in advanced colorectal cancer: evaluation of progression-free survival, duration of disease control, and time to failure of strategy--an Aide et Recherche en Cancerologie Digestive Group Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101

• mRNA gene expression correlates with histologically diagnosed chemotherapy-induced hepatic injury.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20111101

• Cetuximab plus FOLFIRINOX (ERBIRINOX) as first-line treatment for unresectable metastatic colorectal cancer: a phase II trial.

  The oncologist 20111101

• [Pharmacology of platinum compounds: differences between the three molecules and factors of interpatient variability].

  Bulletin du cancer 20111101

• Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20111101

• [Chemotherapy-induced peripheral neuropathy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• Microsatellite instability in colorectal cancer: time to stop hiding!

  Oncotarget 20111101

• Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models.

  Anticancer research 20111101

• Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer.

  Anticancer research 20111101

• Platinum anticancer drugs. From serendipity to rational design.

  Annales pharmaceutiques francaises 20111101

• [Therapeutic effect of mFOLFOX6 for synchronous unresectable liver metastases from colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [The clinical outcome of mFOLFOX6 treatment for colorectal cancer patients who underwent resection of liver metastasis -comparison between synchronous and metachronous liver metastasis].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [The Relationship between the efficacy of mFOLFOX6 treatment and the expression of TS, DPD, TP, and ERCC-1 in unresectable colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [mFOLFOX6 and FOLFIRI/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• Polysilsesquioxane nanoparticles for targeted platin-based cancer chemotherapy by triggered release.

  Angewandte Chemie (International ed. in English) 20111024

• rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy.

  World journal of gastroenterology 20111014

• A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens.

  Investigational new drugs 20111001

• Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer.

  Investigational new drugs 20111001

• Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer.

  The pharmacogenomics journal 20111001

• Transcatheter arterial chemoembolization with docetaxel-loaded microspheres controls heavily pretreated unresectable liver metastases from colorectal cancer: a case study.

  International journal of clinical oncology 20111001

• Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients.

  Cancer chemotherapy and pharmacology 20111001

• Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20111001

• Modified FOLFOX6 with oxaliplatin stop-and-go strategy and oral S-1 maintenance therapy in advanced colorectal cancer: CCOG-0704 study.

  International journal of clinical oncology 20111001

• Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?

  Cancer 20111001

• MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study.

  Annals of surgical oncology 20111001

• Re-challenging patients with oxaliplatin allergy: the successful use of a standardised pre-medication protocol in a single institute.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20111001

• Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy?

  Annals of surgical oncology 20111001

• Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.

  European urology 20111001

• Role of polyamines in determining the cellular response to chemotherapeutic agents: modulation of protein kinase CK2 expression and activity.

  Molecular and cellular biochemistry 20111001

• The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure.

  Cancer immunology, immunotherapy : CII 20111001

• [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20111001

• Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20111001

• Conversion chemotherapy using cetuximab plus FOLFIRI followed by bevacizumab plus mFOLFOX6 in patients with unresectable liver metastases from colorectal cancer.

  Japanese journal of clinical oncology 20111001

• Speciation of oxaliplatin adducts with DNA nucleotides.

  Metallomics : integrated biometal science 20111001

• Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111001

• Synthesis, antiproliferative activity and DNA binding study of mixed ammine/cyclohexylamine platinum(II) complexes with 1-(substituted benzyl) azetidine-3, 3-dicarboxylates.

  European journal of medicinal chemistry 20111001

• [Chemotherapy and rectal cancer].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20111001

• FOLFIRINOX: a small step or a great leap forward?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111001

• Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000-05): an open-label, randomised, phase 3 trial.

  The Lancet. Oncology 20111001

• Use of uridine triacetate for the management of fluorouracil overdose.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20111001

• Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20111001

• The effects of the intraperitoneal administration of oxaliplatin and 5-FU on the healing of colonic anastomoses: an experimental study.

  Techniques in coloproctology 20111001

• Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers?

  Molecular diagnosis & therapy 20111001

• [Chemotherapy-associated steatohepatitis in patients with colorectal cancer and surgery on hepatic metastasis: clinical validation of a histopathological scoring system and preoperative risk assessment].

  Zeitschrift fur Gastroenterologie 20111001

• Oxaliplatin scale and National Cancer Institute-Common Toxicity Criteria in the assessment of chemotherapy-induced peripheral neuropathy.

  Anticancer research 20111001

• The role of chemotherapy in metastatic gastric cancer.

  Anticancer research 20111001

• [Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111001

• Multidisciplinary approach of colorectal liver metastases.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20111001

• Durable remission of inoperable liver metastasis from rectal cancer after hepatic arterial infusion of oxaliplatin and 5-fluorouracil in combination with intravenous cetuximab.

  Current oncology (Toronto, Ont.) 20111001

• Colorectal cancer with multiple metastases: is palliative surgery needed?

  Journal of the Korean Society of Coloproctology 20111001

• Oxaliplatin-induced Pulmonary Fibrosis: Two Case Reports.

  Journal of the Korean Society of Coloproctology 20111001

• Synchronous double primary cancers associated with a choledochal cyst and anomalous pancreaticobiliary ductal union.

  Journal of the Korean Surgical Society 20111001

• Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.

  Nature medicine 20110925

• [Pemetrexed alone versus pemetrexed combined with oxaliplatin as salvage therapy in stage IV lung adenocarcinoma].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110920

• Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids.

  Cancer cell 20110913

• Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.

  British journal of cancer 20110906

• Longitudinal assessment of oxaliplatin-induced neuropathy.

  Neurology 20110906

• Steroids, cancer and vertebral fractures: a dreaded combination.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110901

• Cytotoxics compounded sterile preparation control by HPLC during a 16-month assessment in a French university hospital: importance of the mixing bags step.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110901

• A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma.

  Journal of gastrointestinal cancer 20110901

• Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer.

  Critical reviews in oncology/hematology 20110901

• A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110901

• Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy.

  Journal of neuro-oncology 20110901

• Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatment.

  Annals of surgical oncology 20110901

• Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.

  Annals of surgical oncology 20110901

• Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experience.

  Journal of surgical oncology 20110901

• Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma.

  Anti-cancer drugs 20110901

• AAPS workshop report: strategies to address therapeutic protein-drug interactions during clinical development.

  The AAPS journal 20110901

• Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agents.

  The Journal of pharmacology and experimental therapeutics 20110901

• Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110901

• Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.

  British journal of haematology 20110901

• Multidisciplinary discussion and management of rectal cancer: a population-based study.

  World journal of surgery 20110901

• Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study.

  British journal of haematology 20110901

• Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells.

  Molecular cancer therapeutics 20110901

• Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion.

  Recent patents on anti-cancer drug discovery 20110901

• Determination of the binding sites for oxaliplatin on insulin using mass spectrometry-based approaches.

  Analytical and bioanalytical chemistry 20110901

• Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110901

• Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a 'real world' analysis using Surveillance, Epidemiology, and End Results-Medicare data.

  Journal of the American Geriatrics Society 20110901

• A review of excision repair cross-complementation group 1 in colorectal cancer.

  Clinical colorectal cancer 20110901

• An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancer.

  Clinical colorectal cancer 20110901

• Durable complete responses in metastatic colorectal cancer treated with chemotherapy alone.

  Clinical colorectal cancer 20110901

• Fatal diffuse alveolar damage associated with oxaliplatin administration.

  Clinical colorectal cancer 20110901

• Body surface area-based dosing of 5-fluoruracil results in extensive interindividual variability in 5-fluorouracil exposure in colorectal cancer patients on FOLFOX regimens.

  Clinical colorectal cancer 20110901

• A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer.

  Clinical colorectal cancer 20110901

• Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study.

  The oncologist 20110901

• [Investigating the incidence of injection-site reactions associated with administration of oxaliplatin into a peripheral vein and management local adverse reactions].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110901

• [A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110901

• A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery.

  PLoS computational biology 20110901

• The case of the tingling toes.

  ONS connect 20110901

• Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20110901

• Efficacy and safety of oxaliplatin, 5-Fluorouracil, and folinic Acid combination chemotherapy as first-line treatment in metastatic or recurrent gastric cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20110901

• FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

  The New England journal of medicine 20110825

• Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.

  British journal of cancer 20110823

• Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.

  British journal of cancer 20110823

• Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820

• Adjuvant chemotherapy in colon cancer: ageism or appropriate care?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820

• Bid can mediate a pro-apoptotic response to etoposide and ionizing radiation without cleavage in its unstructured loop and in the absence of p53.

  Oncogene 20110818

• Targeting SRC in mucinous ovarian carcinoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110815

• En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2].

  Inorganic chemistry 20110815

• Platinum interference with siRNA non-seed regions fine-tunes silencing capacity.

  Journal of the American Chemical Society 20110810

• Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts.

  British journal of cancer 20110809

• The current landscape of locally advanced rectal cancer.

  Nature reviews. Clinical oncology 20110809

• Modulation of pancreatic cancer chemoresistance by inhibition of TAK1.

  Journal of the National Cancer Institute 20110803

• Role of Drp1, a key mitochondrial fission protein, in neuropathic pain.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20110803

• A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer: improved efficacy at the cost of increased toxicity.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20110801

• Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS.

  Investigational new drugs 20110801

• Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.

  Cancer chemotherapy and pharmacology 20110801

• Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells.

  Molecular biology reports 20110801

• The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen.

  International journal of clinical oncology 20110801

• Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors.

  Transfusion 20110801

• Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.

  Annals of surgical oncology 20110801

• Synergistic killing of colorectal cancer cells by oxaliplatin and ABT-737.

  Cellular oncology (Dordrecht) 20110801

• A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells.

  Cancer letters 20110801

• HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome.

  Gynecologic oncology 20110801

• Emerging pharmacotherapeutic strategies for cholangiocarcinoma.

  Expert opinion on pharmacotherapy 20110801

• Oxaliplatin neurotoxicity of sensory transduction in rat proprioceptors.

  Journal of neurophysiology 20110801

• Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.

  American journal of physiology. Gastrointestinal and liver physiology 20110801

• Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.

  The Journal of pharmacology and experimental therapeutics 20110801

• Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family members.

  International journal of oncology 20110801

• Trabectedin and its C subunit modified analogue PM01183 attenuate nucleotide excision repair and show activity toward platinum-resistant cells.

  Molecular cancer therapeutics 20110801

• Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110801

• Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.

  Gastroenterology 20110801

• Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.

  Gastroenterology 20110801

• Oxaliplatin uses JNK to restore TRAIL sensitivity in cancer cells through Bcl-xL inactivation.

  Gastroenterology 20110801

• Which one among the Pt-containing anticancer drugs more easily forms monoadducts with G and A DNA bases? A comparative study among oxaliplatin, nedaplatin, and carboplatin.

  Inorganic chemistry 20110801

• Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801

• Antitumor activities and interaction with DNA of oxaliplatin-type platinum complexes with linear or branched alkoxyacetates as leaving groups.

  Journal of inorganic biochemistry 20110801

• Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.

  Annals of surgery 20110801

• Predictors of the efficacy of FOLFIRI plus bevacizumab as second-line treatment in metastatic colorectal cancer patients.

  Surgery today 20110801

• A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer.

  The oncologist 20110801

• Emerging toxic neuropathies and myopathies.

  Neurologic clinics 20110801

• From chemotherapy to targeted therapy in adjuvant treatment for stage III colon cancer.

  Seminars in oncology 20110801

• New approaches to the treatment of pancreatic cancer: from tumor-directed therapy to immunotherapy.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20110801

• Yiqi zhuyu decoction combined with FOLFOX-4 as first-line therapy in metastatic colorectal cancer.

  Chinese journal of integrative medicine 20110801

• [Colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110801

• [Clinical significance of bolus 5-fluorouracil for recurrent or metastatic colorectal cancer treated with FOLFOX+ BevacizumabTherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110801

• The organotelluride catalyst LAB027 prevents colon cancer growth in the mice.

  Cell death & disease 20110801

• Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963).

  Chronobiology international 20110801

• An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.

  PLoS genetics 20110801

• An unusual case of carcinoma erysipelatoides originating from gastric adenocarcinoma.

  Annals of dermatology 20110801

• 3rd congress of the International Academy of Oral Oncology.

  The Lancet. Oncology 20110801

• Up-regulation of cyclooxygenase-2-derived prostaglandin E(2) in colon cancer cells resistant to 5-fluorouracil.

  Journal of the Korean Surgical Society 20110801

• Clinico-pathological significance of TNF alpha-induced protein3 (TNFAIP3) in Middle Eastern colorectal carcinoma.

  Clinical epigenetics 20110801

• [A randomized study of gemcitabine plus oxaliplatin versus gemcitabine plus cisplatin as the 1st line chemotherapy for advanced non-small cell lung cancer in elderly patients].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20110720

• Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo.

  International journal of cancer 20110715

• Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma.

  Cancer 20110715

• Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110715

• EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer.

  British journal of cancer 20110712

• Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial.

  British journal of cancer 20110712

• Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110710

• Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110710

• Chemotherapy: Metastatic pancreatic cancer--is FOLFIRINOX the new standard?

  Nature reviews. Clinical oncology 20110705

• Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110701

• Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20110701

• Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20110701

• Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.

  Annals of surgical oncology 20110701

• Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110701

• Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins.

  Cancer science 20110701

• Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation.

  Pain 20110701

• Assessment of cytotoxicity, apoptosis and DNA damages in Colo320 colorectal cancer cells selected for oxaliplatin resistance.

  Cell biochemistry and function 20110701

• Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model.

  Annals of surgery 20110701

• Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy.

  Cancer chemotherapy and pharmacology 20110701

• Metastatic pancreatic cancer: old drugs, new paradigms.

  Current opinion in oncology 20110701

• A randomised phase II study of docetaxel/oxaliplatin and docetaxel in patients with previously treated non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group trial (ATOM 019).

  European journal of cancer (Oxford, England : 1990) 20110701

• Patients operated on for initially unresectable colorectal liver metastases with missing metastases experience a favorable long-term outcome.

  Annals of surgery 20110701

• Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo.

  International journal of oncology 20110701

• Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer.

  Cancer chemotherapy and pharmacology 20110701

• Comparative study of the cell wall composition of broccoli, carrot, and tomato: structural characterization of the extractable pectins and hemicelluloses.

  Carbohydrate research 20110701

• Adjuvant treatment of colon cancer: what is next?

  Current opinion in oncology 20110701

• TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.

  Cancer research 20110701

• Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

  European journal of cancer (Oxford, England : 1990) 20110701

• Oxaliplatin, irinotecan, and gemcitabine: a novel combination in the therapy of progressed, relapsed, or refractory tumors in children.

  Journal of pediatric hematology/oncology 20110701

• Protective autophagy antagonizes oxaliplatin-induced apoptosis in gastric cancer cells.

  Chinese journal of cancer 20110701

• Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.

  Cell death & disease 20110701

• [Assessment of quality of life by questionnaires between S-1/CPT-11 and mFOLFOX6 in patients with advanced colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110701

• FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastases.

  Gan to kagaku ryoho. Cancer & chemotherapy 20110701

• [Eighty-five-year-old patient with recurrent rectal cancer effectively treated with CapeOX chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110701

• [Response in a case of advanced rectal cancer treated by chemoradiation with S-1/oxaliplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110701

• [A case of severe bevacizumab-induced ischemic pancolitis, treated with conservative management].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110701

• Muscle pain in models of chemotherapy-induced and alcohol-induced peripheral neuropathy.

  Annals of neurology 20110701

• [The effect of small GTPase Cdc42 on the multidrug resistance of oxaliplatin-resistant colon cancer cell lines].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20110701

• XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.

  British journal of cancer 20110628

• Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110620

• Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110620

• Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

  Lancet (London, England) 20110618

• First-line treatment of advanced colorectal cancer.

  Lancet (London, England) 20110618

• Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations.

  Cancer research 20110615

• A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer.

  British journal of cancer 20110607

• Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1).

  British journal of cancer 20110607

• Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

  The Lancet. Oncology 20110604

• The invasive malignancy from peritoneal epithelial cell: a report of four cases and review of literature.

  Medical oncology (Northwood, London, England) 20110601

• Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy.

  Medical oncology (Northwood, London, England) 20110601

• Tolerability of PLD/oxaliplatin regimen in recurrent ovarian cancer patients with previous fragility to carboplatin/paclitaxel treatment.

  American journal of clinical oncology 20110601

• Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance.

  Cancer chemotherapy and pharmacology 20110601

• Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis.

  Cancer chemotherapy and pharmacology 20110601

• Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin.

  Cancer chemotherapy and pharmacology 20110601

• No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer.

  American journal of clinical oncology 20110601

• Improved cytotoxicity and multidrug resistance reversal of chitosan based polymeric micelles encapsulating oxaliplatin.

  Journal of drug targeting 20110601

• Capecitabine-based chemotherapy for metastatic colorectal cancer.

  Journal of cancer research and clinical oncology 20110601

• Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing.

  Annals of surgical oncology 20110601

• Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population.

  Gut 20110601

• High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin.

  International journal of clinical oncology 20110601

• Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines.

  Annals of surgical oncology 20110601

• Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.

  Experimental neurology 20110601

• Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20110601

• Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer.

  Cancer science 20110601

• Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs.

  Free radical biology & medicine 20110601

• Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20110601

• PEG-liposomal oxaliplatin potentialization of antitumor efficiency in a nude mouse tumor-xenograft model of colorectal carcinoma.

  Oncology reports 20110601

• Update on treatment advances in combined-modality therapy for anal and rectal carcinomas.

  Current oncology reports 20110601

• BEYOND KRAS: Other markers and potential treatment strategies for KRAS mutant and wild-type patients.

  Current treatment options in oncology 20110601

• Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110601

• Intensive chemotherapy of metastatic colorectal cancer: weighing between safety and clinical efficacy: Evaluation of Masi G, Loupakis F, Salvatore L, et al. Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial. Lancet Oncol 2010;11:845-52.

  Expert opinion on biological therapy 20110601

• How do we apply adjuvant FOLFOX to Japanese patients with curatively resected colorectal cancer?

  Asia-Pacific journal of clinical oncology 20110601

• Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: a case series.

  Asia-Pacific journal of clinical oncology 20110601

• Tumor status at 12 weeks predicts survival in advanced colorectal cancer: findings from NCCTG N9741.

  The oncologist 20110601

• Use of bevacizumab in metastatic colorectal cancer: report from the Mexican opinion and analysis forum on colorectal cancer treatment with bevacizumab (September 2009).

  Drugs in R&D 20110601

• Oxaliplatin, colorectal cancer and predictive factors.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110601

• Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110601

• [Adjuvant chemotherapy for gastric cancer: more drugs do not mean better efficacy].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20110601

• Estimating preclinical efficacy targets utilizing cetuximab efficacy in KRAS mutant and wild-type colorectal cancer models.

  Anticancer research 20110601

• Abdominoperineal resection does not decrease quality of life in patients with low rectal cancer.

  Clinics (Sao Paulo, Brazil) 20110601

• A retrospective study of first-line combination chemotherapy in advanced colorectal cancer: a Korean single-center experience.

  Cancer research and treatment : official journal of Korean Cancer Association 20110601

• Predictive value of in vitro adenosine triphosphate-based chemotherapy response assay in advanced gastric cancer patients who received oral 5-Fluorouracil after curative resection.

  Cancer research and treatment : official journal of Korean Cancer Association 20110601

• Epidermal growth factor receptor mutations in colorectal cancer patients.

  Journal of the Korean Society of Coloproctology 20110601

• Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer.

  Journal of the Korean Society of Coloproctology 20110601

• Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.

  Clinical advances in hematology & oncology : H&O 20110601

• Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative.

  Clinical colorectal cancer 20110601

• A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer.

  Clinical colorectal cancer 20110601

• Prolonged oxaliplatin exposure alters intracellular calcium signaling: a new mechanism to explain oxaliplatin-associated peripheral neuropathy.

  Clinical colorectal cancer 20110601

• Primary adenosquamous carcinoma of the colon.

  Journal of the Korean Surgical Society 20110601

• Comparative nephrotoxicity of Cisplatin and nedaplatin: mechanisms and histopathological characteristics.

  Journal of toxicologic pathology 20110601

• Emerging therapies in pancreas cancer.

  Journal of gastrointestinal oncology 20110601

• Hepatic necrosis and hemorrhage following hyperthermic intraperitoneal chemotherapy with oxaliplatin: A review of two cases.

  Journal of gastrointestinal oncology 20110601

• Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study.

  British journal of cancer 20110524

• Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.

  Lancet (London, England) 20110521

• Do we need oncology trials tailored for the elderly or frail?

  Lancet (London, England) 20110521

• Randomized, placebo-controlled, phase III study of oxaliplatin, fluorouracil, and leucovorin with or without PTK787/ZK 222584 in patients with previously treated metastatic colorectal adenocarcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110520

• Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110520

• In vitro schedule-dependent interaction between melphalan and oxaliplatin in human colorectal cancer cell lines.

  The Journal of surgical research 20110515

• Quality control of pharmaceutical formulations containing cisplatin, carboplatin, and oxaliplatin by micellar and microemulsion electrokinetic chromatography (MEKC, MEEKC).

  Journal of pharmaceutical and biomedical analysis 20110515

• Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110515

• Stability of carboplatin and oxaliplatin in their infusion solutions is due to self-association.

  Dalton transactions (Cambridge, England : 2003) 20110514

• FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

  The New England journal of medicine 20110512

• Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer.

  British journal of cancer 20110510

• Synthesis of tri-substituted biaryl based trianglimines: formation of C3-symmetrical and non-symmetrical regioisomers.

  Organic & biomolecular chemistry 20110507

• Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma.

  World journal of gastroenterology 20110507

• Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity.

  Chembiochem : a European journal of chemical biology 20110502

• Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models.

  International journal of cancer 20110501

• Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study.

  Cancer chemotherapy and pharmacology 20110501

• Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death.

  Cancer chemotherapy and pharmacology 20110501

• Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs.

  Cancer chemotherapy and pharmacology 20110501

• Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity.

  Cancer chemotherapy and pharmacology 20110501

• Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in chemotherapy naive patients with extensive small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20110501

• Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110501

• Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110501

• New emerging drugs targeting the genomic integrity and replication machinery in ovarian cancer.

  Archives of gynecology and obstetrics 20110501

• Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients.

  Acta oncologica (Stockholm, Sweden) 20110501

• Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110501

• Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review.

  Angiogenesis 20110501

• A promising new regimen for the treatment of advanced extranodal NK/T cell lymphoma.

  Acta oncologica (Stockholm, Sweden) 20110501

• Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803.

  European journal of cancer (Oxford, England : 1990) 20110501

• The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?

  Cancer chemotherapy and pharmacology 20110501

• mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.

  Cancer research 20110501

• Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors.

  EMBO molecular medicine 20110501

• Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes?

  Journal of inorganic biochemistry 20110501

• Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.

  The oncologist 20110501

• Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer.

  Cancer investigation 20110501

• Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility.

  The oncologist 20110501

• Sustained response of adenocarcinoma of the urinary bladder to FOLFOX plus bevacizumab.

  Nature reviews. Urology 20110501

• Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma.

  The American journal of pathology 20110501

• Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20110501

• Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancer.

  The oncologist 20110501

• [Successful management with partial splenic embolization (PSE) of splenomegaly and thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110501

• Analgesic and antineuropathic drugs acting through central cholinergic mechanisms.

  Recent patents on CNS drug discovery 20110501

• Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.

  Health technology assessment (Winchester, England) 20110501

• Off-label use of oxaliplatin in patients with metastatic breast cancer.

  Anticancer research 20110501

• Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors.

  Oncotarget 20110501

• Impact of new drugs and biologics on colorectal cancer treatment and costs.

  The American journal of managed care 20110501

• [Efficacy and side effects of combination therapy of oxaliplatin and S-1 for colorectal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110501

• Impact of new drugs and biologics on colorectal cancer treatment and costs.

  Journal of oncology practice 20110501

• Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage.

  Journal of pharmaceutical and biomedical analysis 20110428

• Chiral diaminopyrrolic receptors for selective recognition of mannosides, part 1: design, synthesis, and affinities of second-generation tripodal receptors.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20110418

• Chemotherapy plus percutaneous radiofrequency ablation in patients with inoperable colorectal liver metastases.

  World journal of gastrointestinal oncology 20110415

• Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer.

  British journal of cancer 20110412

• Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration.

  British journal of cancer 20110412

• Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.

  British journal of cancer 20110412

• Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110410

• MSH3 mediates sensitization of colorectal cancer cells to cisplatin, oxaliplatin, and a poly(ADP-ribose) polymerase inhibitor.

  The Journal of biological chemistry 20110408

• Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.

  Investigational new drugs 20110401

• A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.

  Investigational new drugs 20110401

• Phase II trial of oxaliplatin and capecitabine after progression to first-line chemotherapy in androgen-independent prostate cancer patients.

  American journal of clinical oncology 20110401

• A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas.

  Acta oncologica (Stockholm, Sweden) 20110401

• Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model.

  European journal of pain (London, England) 20110401

• Dietary glycine protects from chemotherapy-induced hepatotoxicity.

  Amino acids 20110401

• Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110401

• Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110401

• Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.

  Cancer chemotherapy and pharmacology 20110401

• Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells.

  Pharmaceutical research 20110401

• Evaluation of in vitro cytotoxicity of 6-benzylaminopurine carboplatin derivatives against human cancer cell lines and primary human hepatocytes.

  Toxicology in vitro : an international journal published in association with BIBRA 20110401

• Involvement of substance P in peripheral neuropathy induced by paclitaxel but not oxaliplatin.

  The Journal of pharmacology and experimental therapeutics 20110401

• A phase II study of neoadjuvant and adjuvant chemotherapy with 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel in the treatment of previously untreated advanced esophageal adenocarcinoma.

  Japanese journal of clinical oncology 20110401

• R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20110401

• Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.

  Oncology reports 20110401

• Oxaliplatin as a radiosensitizing agent in rectal cancer.

  Anti-cancer drugs 20110401

• The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells.

  Clinical & experimental metastasis 20110401

• Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients.

  Japanese journal of clinical oncology 20110401

• Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans.

  Molecular cancer therapeutics 20110401

• Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.

  British journal of haematology 20110401

• Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy.

  Journal of surgical oncology 20110401

• Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin.

  Clinical journal of oncology nursing 20110401

• Lunasin induces apoptosis and modifies the expression of genes associated with extracellular matrix and cell adhesion in human metastatic colon cancer cells.

  Molecular nutrition & food research 20110401

• [Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110401

• [Two cases of advanced colorectal cancer which demonstrated the reversibility of oxaliplatin-mediated increase in splenic volume].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110401

• Combined KRAS and TP53 mutation status is not predictive in CAPOX-treated metastatic colorectal cancer.

  Anticancer research 20110401

• [Second line chemotherapy for pancreatic cancer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110401

• [A case of portal hypertension after the treatment of oxaliplatin based adjuvant chemotherapy for rectal cancer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110401

• [Comparison between the effects of irinotecan or oxaliplatin combined with capecitabine in the treatment of advanced gastric cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110401

• Atypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused review.

  Journal of clinical medicine research 20110401

• [Chemotherapy for advanced colorectal cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20110401

• [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients].

  Nihon rinsho. Japanese journal of clinical medicine 20110401

• Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma.

  North American journal of medical sciences 20110401

• Metastatic primary adenocarcinoma of the bladder in a twenty-five years old woman.

  Rare tumors 20110330

• CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients.

  British journal of cancer 20110329

• FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer.

  British journal of cancer 20110329

• Clinical reports of pulmonary metastasectomy for colorectal cancer: a citation network analysis.

  British journal of cancer 20110329

• The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies.

  International journal of cancer 20110315

• TOX4 and its binding partners recognize DNA adducts generated by platinum anticancer drugs.

  Archives of biochemistry and biophysics 20110315

• ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110315

• Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.

  Oncogene 20110310

• The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries.

  Neuroscience 20110310

• Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310

• Three-drug combination regimen in pancreatic cancer treatment: are we there yet?

  JOP : Journal of the pancreas 20110309

• Phase I study of preoperative chemoradiation with s-1 and oxaliplatin in patients with locally advanced resectable rectal cancer.

  International journal of radiation oncology, biology, physics 20110301

• Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcome.

  International journal of radiation oncology, biology, physics 20110301

• In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents.

  Cancer chemotherapy and pharmacology 20110301

• Plasma disposition of capecitabine and its metabolites 5'DFCR and 5'DFUR in a standard and dose-intensified monotherapy regimen.

  Cancer chemotherapy and pharmacology 20110301

• Gastrointestinal cancer educational case series: the history and management of complex cases in gi oncology. A 72 year-old man with metastatic gastric cancer.

  Journal of gastrointestinal cancer 20110301

• Metastatic colorectal cancer with severe liver dysfunction successfully treated using FOLFOX therapy.

  Journal of gastrointestinal cancer 20110301

• NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer.

  Surgery 20110301

• Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo.

  International journal of cancer 20110301

• Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice.

  Gut 20110301

• A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: cleavage and antitumor activity.

  Chirality 20110301

• Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastases.

  Annals of surgical oncology 20110301

• Role of organic cation transporter 1, OCT1 in the pharmacokinetics and toxicity of cis-diammine(pyridine)chloroplatinum(II) and oxaliplatin in mice.

  Pharmaceutical research 20110301

• Platinum resistant cancer cells conserve sensitivity to BH3 domains and obatoclax induced mitochondrial apoptosis.

  Apoptosis : an international journal on programmed cell death 20110301

• Organic cation transporter OCT/SLC22A and H(+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents.

  Biochemical pharmacology 20110301

• Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer.

  Anti-cancer drugs 20110301

• Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome?

  World journal of surgery 20110301

• Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110301

• Clinical usefulness of mitochondrial transcription factor A expression as a predictive marker in colorectal cancer patients treated with FOLFOX.

  Cancer science 20110301

• Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992-2008.

  Clinical & experimental metastasis 20110301

• Pharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosis.

  The AAPS journal 20110301

• miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.

  Acta biochimica et biophysica Sinica 20110301

• Arguments against toxic effects of chemotherapy on liver injury and regeneration in an experimental model of partial hepatectomy.

  Liver international : official journal of the International Association for the Study of the Liver 20110301

• BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer.

  British journal of cancer 20110301

• Targeted therapies for metastatic esophagogastric cancer.

  Current treatment options in oncology 20110301

• Topic update: effects of colorectal cancer treatments on female fertility and potential methods for fertility preservation.

  Diseases of the colon and rectum 20110301

• Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer.

  British journal of cancer 20110301

• Capecitabine monotherapy as salvage treatment after failure of chemotherapy containing oxaliplatin and irinotecan in patients with metastatic colorectal cancer.

  Asia-Pacific journal of clinical oncology 20110301

• Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20110301

• Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20110301

• The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums.

  Oncology nursing forum 20110301

• Physicochemical characterization of a PEGylated liposomal drug formulation using capillary electrophoresis.

  Electrophoresis 20110301

• The expression of ERCC1, RRM1, and BRCA1 in breast cancer according to the immunohistochemical phenotypes.

  Journal of Korean medical science 20110301

• Recent advances in anti-angiogenic therapy of cancer.

  Oncotarget 20110301

• [Etiology and management of venous pain during intravenous administration of oxaliplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110301

• The effect of cytostatics and hyperthermia on RAJI human lymphoma cells.

  Experimental oncology 20110301

• Efficacy and safety of hepatic arterial infusion of fluorouracil with leucovorin as salvage treatment for refractory liver metastases from colorectal cancer.

  The Korean journal of internal medicine 20110301

• Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer.

  Pharmacogenomics 20110301

• N-acetylcysteine and N-nitroarginine methyl ester attenuate Carboplatin-induced ototoxicity in dissociated spiral ganglion neuron cultures.

  Clinical and experimental otorhinolaryngology 20110301

• Consensus-phenotype integration of transcriptomic and metabolomic data implies a role for metabolism in the chemosensitivity of tumour cells.

  PLoS computational biology 20110301

• A case of life-threatening post-operative diffuse alveolar hemorrhage in patient with recent chemotherapy -A case report-.

  Korean journal of anesthesiology 20110301

• Effective panitumumab treatment in patients with heavily pre-treated metastatic colorectal cancer: a case series.

  Anticancer research 20110301

• Safe use of FOLFOX in two patients with metastatic colorectal carcinoma and severe hepatic dysfunction.

  Clinical colorectal cancer 20110301

• Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group.

  Clinical colorectal cancer 20110301

• A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors.

  Clinical colorectal cancer 20110301

• Responses and adverse effects of carboplatin-based chemotherapy for pediatric intracranial germ cell tumors.

  Korean journal of pediatrics 20110301

• Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29.

  Journal of gastrointestinal oncology 20110301

• Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

  World journal of gastroenterology 20110227

• A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours.

  British journal of cancer 20110215

• Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy.

  British journal of cancer 20110215

• Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity.

  British journal of cancer 20110215

• Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial.

  Investigational new drugs 20110201

• A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.

  Investigational new drugs 20110201

• The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer.

  The pharmacogenomics journal 20110201

• Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability.

  Cancer chemotherapy and pharmacology 20110201

• Combination effects of platinum drugs and N1, N11 diethylnorspermine on spermidine/spermine N1-acetyltransferase, polyamines and growth inhibition in A2780 human ovarian carcinoma cells and their oxaliplatin and cisplatin-resistant variants.

  Cancer chemotherapy and pharmacology 20110201

• Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer.

  International journal of cancer 20110201

• Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110201

• Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study.

  European radiology 20110201

• Acute thrombocytopenia: an unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization.

  Cardiovascular and interventional radiology 20110201

• The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.

  Breast cancer research and treatment 20110201

• A phase II study of outpatient biweekly gemcitabine-oxaliplatin in advanced biliary tract carcinomas.

  Japanese journal of clinical oncology 20110201

• The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients.

  European journal of cancer (Oxford, England : 1990) 20110201

• Optimizing the efficacy of first-line chemotherapy plus bevacizumab in metastatic colorectal cancer: analysis of multiple methods.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20110201

• Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines.

  Cancer science 20110201

• Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution.

  International journal of colorectal disease 20110201

• Are we turning to more than a first line treatment of metastatic colorectal cancer with high dose irinotecan?: A monocentric institution safety analysis of 46 patients.

  Clinics and research in hepatology and gastroenterology 20110201

• Functional genomics reveals diverse cellular processes that modulate tumor cell response to oxaliplatin.

  Molecular cancer research : MCR 20110201

• Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110201

• Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab.

  International journal of colorectal disease 20110201

• Clinical significance of tumor suppressor PTEN in colorectal carcinoma.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20110201

• A phase III randomized trial of gemcitabine-oxaliplatin versus carboplatin-paclitaxel as first-line therapy in patients with advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110201

• Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer.

  British journal of cancer 20110201

• Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer.

  Anti-cancer drugs 20110201

• Changing management and survival in patients with stage IV colorectal cancer.

  Diseases of the colon and rectum 20110201

• A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer.

  British journal of cancer 20110201

• Drug transporters of platinum-based anticancer agents and their clinical significance.

  Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20110201

• Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20110201

• Wnt5a as a predictor in poor clinical outcome of patients and a mediator in chemoresistance of ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110201

• [Recent results of research on cancer of the colon, gastric cancer, sarcoma and bronchial carcinoma].

  Deutsche medizinische Wochenschrift (1946) 20110201

• 5-Fluorouracil-induced Tako-Tsubo-like syndrome.

  Pharmacotherapy 20110201

• XELOX in colorectal cancer: a convenient option for the future?

  Expert review of gastroenterology & hepatology 20110201

• Oxaliplatin: a review in the era of molecularly targeted therapy.

  Current oncology (Toronto, Ont.) 20110201

• Making sense of anti-EGFR plus oxaliplatin-based therapy in the first-line treatment of metastatic colorectal cancer.

  Future oncology (London, England) 20110201

• Scan? Cure? Sure!

  The oncologist 20110201

• [Efficacy and safety of SOX regimen as neoadjuvant chemotherapy for advanced gastric cancer].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20110201

• [A case of advanced colon cancer successfully treated with cetuximab diagnosed as EGFR-positive by liver biopsy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110201

• [A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110201

• [Contribution of microCT structural imaging to preclinical evaluation of hepatocellular carcinoma chemotherapeutics on orthotopic graft in ACI rats].

  Bulletin du cancer 20110201

• [Immune enhancing effect of modified sijunzi decoction on patients with colorectal cancer undergoing chemotherapy].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20110201

• Synchronous colonic adenocarcinoma and pelvic schwannoma.

  Connecticut medicine 20110201

• Pharmacokinetics of oxaliplatin in gastrointestinal cancer patients with malignant ascites.

  Journal of chemotherapy (Florence, Italy) 20110201

• Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.

  Prescrire international 20110201

• Systematic review on infusion reactions associated with chemotherapies and monoclonal antibodies for metastatic colorectal cancer.

  Current clinical pharmacology 20110201

• [Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy].

  Zhonghua yi xue za zhi 20110125

• Single agent and combination studies of pralatrexate and molecular correlates of sensitivity.

  British journal of cancer 20110118

• LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway.

  World journal of gastroenterology 20110114

• Organometallic anticancer compounds.

  Journal of medicinal chemistry 20110113

• Translational proteomics: what can you do for true patients?

  Journal of proteome research 20110107

• The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x.

  The Journal of biological chemistry 20110107

• Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis.

  Journal of the National Cancer Institute 20110105

• Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting.

  Science translational medicine 20110105

• Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction.

  British journal of cancer 20110104

• Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer.

  British journal of cancer 20110104

• The herb medicine formula 'chong lou fu fang' increases the cytotoxicity of chemotherapeutic agents and down-regulates the expression of chemotherapeutic agent resistance-related genes in human gastric cancer cells in vitro.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial.

  Cancer chemotherapy and pharmacology 20110101

• Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin.

  Cancer chemotherapy and pharmacology 20110101

• Antitumor activity of an adenovirus harboring human IL-24 in colon cancer.

  Molecular biology reports 20110101

• Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy.

  Digestive diseases and sciences 20110101

• Technical feasibility of laparoscopic total mesorectal excision for patients with low rectal cancer after concurrent radiation and chemotherapy with bevacizumab plus FOLFOX.

  Surgical endoscopy 20110101

• Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation.

  Surgical endoscopy 20110101

• Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: oxaliplatin versus mitomycin C.

  Annals of surgical oncology 20110101

• In vitro drug responses in primary and metastatic colorectal cancers.

  Scandinavian journal of gastroenterology 20110101

• A multicenter phase-II study of 5-FU, leucovorin and oxaliplatin (FOLFOX6) in patients with pretreated metastatic colorectal cancer.

  Japanese journal of clinical oncology 20110101

• Sudden-onset pancytopenia with intracranial hemorrhage after oxaliplatin treatment: a case report and literature review.

  Japanese journal of clinical oncology 20110101

• New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer.

  Acta oncologica (Stockholm, Sweden) 20110101

• Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure.

  Journal of surgical oncology 20110101

• Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110101

• Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study.

  European journal of cancer (Oxford, England : 1990) 20110101

• Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.

  Gastroenterology 20110101

• Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy.

  Experimental neurology 20110101

• Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20110101

• Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death.

  Cancer biology & therapy 20110101

• Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: A pilot study of 31 patients.

  Journal of surgical oncology 20110101

• FOLFIRINOX: a new standard treatment for advanced pancreatic cancer?

  The Lancet. Oncology 20110101

• Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: multi-parametric assessment and direct evidence.

  Pain 20110101

• Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.

  Handbook of experimental pharmacology 20110101

• Chemotherapy: Failure of bevacizumab in early-stage colon cancer.

  Nature reviews. Clinical oncology 20110101

• Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics.

  Current medical research and opinion 20110101

• Current therapeutic approaches in metastatic and recurrent ewing sarcoma.

  Sarcoma 20110101

• Esophageal adenocarcinoma after laparoscopic gastric band placement for obesity.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20110101

• Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy?

  Annals of oncology : official journal of the European Society for Medical Oncology 20110101

• Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.

  Pharmacogenomics 20110101

• [Oncosurgical strategies for metastatic liver cancer].

  Cirugia espanola 20110101

• Adjuvant radiotherapy for rectal cancer: recent results, new questions.

  Clinics and research in hepatology and gastroenterology 20110101

• Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization.

  Surgery today 20110101

• A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as second-line treatment for advanced colorectal cancer: a Japanese experience.

  Surgery today 20110101

• Sage components enhance cell death through nuclear factor kappa-B signaling.

  Frontiers in bioscience (Elite edition) 20110101

• Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis.

  Journal of experimental & clinical cancer research : CR 20110101

• Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.

  Radiation oncology (London, England) 20110101

• Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study.

  BMC medical research methodology 20110101

• Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer.

  BMC cancer 20110101

• Comparison of the micronucleus and chromosome aberration techniques for the documentation of cytogenetic damage in radiochemotherapy-treated patients with rectal cancer.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20110101

• In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110101

• Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool.

  Cancer nursing 20110101

• Effect of small interfering RNA 3'-end overhangs on chemosensitivity to thymidylate synthase inhibitors.

  Silence 20110101

• Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats.

  Molecular pain 20110101

• Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis.

  Journal of oncology 20110101

• Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib.

  Journal of hematology & oncology 20110101

• Clinical, genetic, and pathological features of male pseudohermaphroditism in dog.

  Reproductive biology and endocrinology : RB&E 20110101

• A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer.

  Anticancer research 20110101

• Animal models of colitis-associated carcinogenesis.

  Journal of biomedicine & biotechnology 20110101

• A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.

  BMC medicine 20110101

• Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients.

  PloS one 20110101

• Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

  Molecular cancer 20110101

• [Surgery after chemotherapy: gastric cancer].

  Bulletin du cancer 20110101

• DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.

  PloS one 20110101

• Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial.

  BMC cancer 20110101

• Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.

  Advances in hematology 20110101

• A case of long partial response to combination therapy of bevacizumab and capecitabine for liver metastases of rectal cancer.

  Case reports in gastroenterology 20110101

• RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA.

  International journal of molecular sciences 20110101

• Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.

  International journal of molecular sciences 20110101

• Multidisciplinary approach and multimodal therapy in resected pancreatic cancer. Observational study.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20110101

• Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report.

  Journal of medical case reports 20110101

• A role of 18F-fluorodeoxyglucose positron emission/computed tomography in a strategy for abdominal wall metastasis of colorectal mucinous adenocarcinoma developed after laparoscopic surgery.

  World journal of surgical oncology 20110101

• A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.

  PloS one 20110101

• [Effective cetuximab monotherapy for a case of recurrence rectal cancer after multiple previous chemotherapy treatment (FOLFOX, FOLFIRI)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110101

• Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer.

  Radiation oncology (London, England) 20110101

• Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer.

  BMC cancer 20110101

• Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer.

  PloS one 20110101

• Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma.

  BMC biotechnology 20110101

• Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer.

  Journal of biomedicine & biotechnology 20110101

• From antiangiogenesis to hypoxia: current research and future directions.

  Cancer management and research 20110101

• Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.

  BMC cancer 20110101

• High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area.

  Journal of translational medicine 20110101

• Impact of KRAS Mutations on Management of Colorectal Carcinoma.

  Pathology research international 20110101

• EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer.

  BMC cancer 20110101

• A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma.

  Journal of hematology & oncology 20110101

• Titanium salan complexes displays strong antitumor properties in vitro and in vivo in mice.

  PloS one 20110101

• Irinotecan-cetuximab-bevacizumab as a salvage treatment in heavily pretreated metastatic colorectal cancer patients: a retrospective observational study.

  Chemotherapy 20110101

• Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer.

  International journal of medical sciences 20110101

• Long-term survival of a patient with multiple abdominal metastasis from endometrial carcinoma treated with multi-portal conformal re-irradiation and chemotherapy.

  Hematology/oncology and stem cell therapy 20110101

• A new rapid desensitization protocol for chemotherapy agents.

  Journal of investigational allergology & clinical immunology 20110101

• Prolonged neutropenia after neoadjuvant radiation therapy and chemotherapy using oxaliplatin and capecitabine for rectal cancer.

  Gastrointestinal cancer research : GCR 20110101

• TWIST1 is expressed in colorectal carcinomas and predicts patient survival.

  PloS one 20110101

• HDAC inhibition decreases the expression of EGFR in colorectal cancer cells.

  PloS one 20110101

• Extended venous thromboembolism prophylaxis for high-risk patients undergoing surgery for malignancy.

  Case reports in oncology 20110101

• Mature Results of a Prospective Randomized Trial Comparing 5-Flourouracil with Leucovorin to 5-Flourouracil with Levamisole as Adjuvant Therapy of Stage II and III Colorectal Cancer- The Israel Cooperative Oncology Group (ICOG) Study.

  Journal of Cancer 20110101

• An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development.

  Journal of Cancer 20110101

• A retrospective review of the frequency and nature of acute hypersensitivity reactions at a medium-sized infusion center: comparison to reported values and inconsistencies found in literature.

  Journal of Cancer 20110101

• [Ileitis following capecitabine use].

  Nederlands tijdschrift voor geneeskunde 20110101

• Apoptotic sphingolipid ceramide in cancer therapy.

  Journal of lipids 20110101

• Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity.

  PloS one 20110101

• Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines.

  Journal of experimental & clinical cancer research : CR 20110101

• Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes.

  Radiation oncology (London, England) 20110101

• Modified FOLFOX-4 as first-line and salvage treatment in advanced gastric cancer.

  Hepato-gastroenterology 20110101

• Radiofrequency ablation resulting in left lobe hypertrophy and improved resectability.

  Case reports in gastroenterology 20110101

• Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.

  BMC cancer 20110101

• Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma.

  BMC cancer 20110101

• Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice.

  Molecular pain 20110101

• Hepatic arterial infusion chemotherapy for liver metastases from gastric cancer: an analysis in Western patients.

  Tumori 20110101

• Capecitabine in combination with oxaliplatin as first-line therapy for advanced gastric cancer: a case report.

  Tumori 20110101

• Cancer stem cell subsets and their relationships.

  Journal of translational medicine 20110101

• Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study.

  Journal of translational medicine 20110101

• New developments in the treatment of metastatic gastric cancer: focus on trastuzumab.

  OncoTargets and therapy 20110101

• Critical appraisal of trastuzumab in treatment of advanced stomach cancer.

  Cancer management and research 20110101

• Safety and pharmacokinetics of motesanib in combination with panitumumab and gemcitabine-Cisplatin in patients with advanced cancer.

  Journal of oncology 20110101

• The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study.

  BMC surgery 20110101

• Effect of curcumin on cisplatin- and oxaliplatin-induced oxidative stress in human embryonic kidney (HEK) 293 cells.

  Renal failure 20110101

• Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group.

  BMC cancer 20110101

• Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.

  BMC cancer 20110101

• Concordance of self-reported and medical chart information on cancer diagnosis and treatment.

  BMC medical research methodology 20110101

• Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.

  Journal of translational medicine 20110101

• Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial.

  Trials 20110101

• Small invasive colon cancer with systemic metastasis: a case report.

  BMC gastroenterology 20110101

• Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer.

  Radiation oncology (London, England) 20110101

• Panitumumab (vectibix).

  AJNR. American journal of neuroradiology 20110101

• Acute arterial thrombosis after covered stent exclusion of bleeding mycotic pseudoaneurysm: treatment using catheter-directed thrombolysis.

  International journal of vascular medicine 20110101

• Systemic therapy for elderly patients with gastrointestinal cancer.

  Clinical Medicine Insights. Oncology 20110101

• Bevacizumab for the treatment of recurrent glioblastoma.

  Clinical Medicine Insights. Oncology 20110101

• Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy.

  Journal of translational medicine 20110101

• Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS.

  International journal of medical sciences 20110101

• Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study.

  BMC cancer 20110101

• Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells.

  PloS one 20110101

• Calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal cancer by modulating the intrinsic apoptotic pathway.

  PloS one 20110101

• Capecitabine in the management of colorectal cancer.

  Cancer management and research 20110101

• Quantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cells.

  PloS one 20110101

• Thujone-Rich Fraction of Thuja occidentalis Demonstrates Major Anti-Cancer Potentials: Evidences from In Vitro Studies on A375 Cells.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma.

  Radiation oncology (London, England) 20110101

• Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study.

  Radiation oncology (London, England) 20110101

• GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer.

  Hepato-gastroenterology 20110101

• Strain- and sex-dependent circadian changes in abcc2 transporter expression: implications for irinotecan chronotolerance in mouse ileum.

  PloS one 20110101

• Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• Gemcitabine and oxaliplatin combination chemotherapy for patients with refractory pancreatic cancer.

  Oncology 20110101

• Early start of chemotherapy after resection of primary colon cancer with synchronous multiple liver metastases: a case report.

  Case reports in oncology 20110101

• KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues.

  International journal of molecular sciences 20110101

• Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines.

  Journal of biomedical science 20110101

• Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy.

  Journal of translational medicine 20110101

• Matrix metalloproteinase-8 mediates the unfavorable systemic impact of local irradiation on pharmacokinetics of anti-cancer drug 5-Fluorouracil.

  PloS one 20110101

• Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC).

  Journal of ovarian research 20110101

• Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancer.

  PloS one 20110101

• Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.

  BMC cancer 20110101

• Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers.

  BMC cancer 20110101

• Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.

  BMC cancer 20110101

• Primary mucinous adenocarcinoma of the vermiform appendix with high grade microsatellite instability.

  Journal of Cancer 20110101

• Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer.

  Radiation oncology (London, England) 20110101

• Synthesis, characterization and biological evaluation of platinum(II) complexes with a chiral N-monosubstituted 1,2-cyclohexyldiamine derivative.

  Chemical & pharmaceutical bulletin 20110101

• Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer.

  Journal of medical economics 20110101

• Gastric cancer in India.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101

• Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells.

  Molecular cancer 20110101

• Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies.

  Cancer management and research 20110101

• A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy.

  Case reports in oncology 20110101

• Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement.

  BMC cancer 20110101

• Hepatic actinomycosis mimicking an isolated tumor recurrence.

  World journal of surgical oncology 20110101

• Multiple treatment comparison meta-analyses: a step forward into complexity.

  Clinical epidemiology 20110101

• Effects of bolus injection of 5-fluorouracil on steady-state plasma concentrations of 5-fluorouracil in Japanese patients with advanced colorectal cancer.

  International journal of medical sciences 20110101

• Common side effects and interactions of colorectal cancer therapeutic agents.

  The Journal of practical nursing 20110101

• Endopancreatic bile duct cholangiocarcinoma in a patient with peutz-jeghers syndrome.

  HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 20110101

• The effect of antivascular endothelial growth factor on the development of adhesion formation in laparotomized rats: experimental study.

  Gastroenterology research and practice 20110101

• First-line therapy for metastatic colorectal carcinoma: modified FOLFOX4 or FOLFIRI-bevacizumab.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• Efficacy, safety and prognostic features of resected colon carcinoma treated in 'real world' practice: a retrospective cohort-study.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis.

  Case reports in gastroenterology 20110101

• Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells.

  BMC pharmacology 20110101

• Neoadjuvant treatment of colorectal liver metastases is associated with altered contrast enhancement on computed tomography.

  Cancer imaging : the official publication of the International Cancer Imaging Society 20110101

• The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series.

  Journal of oncology 20110101

• Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells.

  Journal of molecular signaling 20110101

• Regulation of SRC family kinases in human cancers.

  Journal of signal transduction 20110101

• Anti-cancer natural products isolated from chinese medicinal herbs.

  Chinese medicine 20110101

• 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma.

  Oncology 20110101

• Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).

  PloS one 20110101

• A Rare Case of Secondary Bacterial Peritonitis from Clostridium perfringens in an Adult Patient with Noncirrhotic Ascites and a Krukenberg Tumor: Report of a Case.

  Case reports in medicine 20110101

• Reassessing the need for primary tumor surgery in unresectable metastatic colorectal cancer: overview and perspective.

  Therapeutic advances in medical oncology 20110101

• Adjuvant modified FOLFOX-4 in patients with stage III rectum adenocarcinoma.

  Asian Pacific journal of cancer prevention : APJCP 20110101

• Mutagenic Tests Confirm That New Acetylacetonate Pt(II) Complexes Induce Apoptosis in Cancer Cells Interacting with Nongenomic Biological Targets.

  Metal-based drugs 20110101

• Current therapeutic strategies for invasive and metastatic bladder cancer.

  OncoTargets and therapy 20110101

• Latest developments and emerging treatment options in the management of stomach cancer.

  Cancer management and research 20110101

• Short-term and medium-term clinical outcomes of laparoscopic-assisted and open surgery for colorectal cancer: a single center retrospective case-control study.

  BMC gastroenterology 20110101

• Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer.

  Vascular cell 20110101

• [Hypertension as a predictive factor of effect of bevacizumab in treatment of colorectal cancer].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110101

• Metals and breast cancer: risk factors or healing agents?

  Journal of toxicology 20110101

• Behavioral patterns associated with chemotherapy-induced emesis: a potential signature for nausea in musk shrews.

  Frontiers in neuroscience 20110101

• [Results of adjuvant chemotherapy (XELOX) of advanced colorectal cancer].

  Voprosy onkologii 20110101

• [Chemotherapy in patients with non-resectable colorectal cancer metastases to the liver: systemic or regional?].

  Voprosy onkologii 20110101

• Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).

  BMC cancer 20110101

• Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancer.

  Oncology 20110101

• Survival of patients with colon and rectal cancer in central and northern Denmark, 1998-2009.

  Clinical epidemiology 20110101

• Kinetic targeting of pegylated liposomal doxorubicin: a new approach to reduce toxicity during chemotherapy (CARL-trial).

  BMC cancer 20110101

• Drug therapy for hereditary cancers.

  Hereditary cancer in clinical practice 20110101

• Rhodococcus equi venous catheter infection: a case report and review of the literature.

  Journal of medical case reports 20110101

• The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy.

  BMC cancer 20110101

• Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).

  BMC cancer 20110101

• Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study.

  BMC cancer 20110101

• Flanking bases influence the nature of DNA distortion by platinum 1,2-intrastrand (GG) cross-links.

  PloS one 20110101

• Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas.

  Journal of translational medicine 20110101

• Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.

  PloS one 20110101

• Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy.

  Chinese medicine 20110101

• A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.

  BMC cancer 20110101

• Clinical management of gastric cancer: results of a multicentre survey.

  BMC cancer 20110101

• Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin.

  PloS one 20110101

• Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study.

  Radiation oncology (London, England) 20110101

• [Effectiveness of neoadjuvant chemoradiotherapy of locally advanced rectal cancer in conjunction with local hyperthermia and metronidazole].

  Voprosy onkologii 20110101

• Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions.

  PloS one 20110101

• Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma.

  BMC cancer 20110101

• Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study.

  Biology of sex differences 20110101

• Fermented wheat germ extract--nutritional supplement or anticancer drug?

  Nutrition journal 20110101

• KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy.

  Oncology 20110101

• Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations.

  International journal of medical sciences 20110101

• Translational medicine and reliability of single-nucleotide polymorphism studies: can we believe in SNP reports or not?

  International journal of medical sciences 20110101

• Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions.

  Radiation oncology (London, England) 20110101

• Chemotherapy in advanced bladder cancer: current status and future.

  Journal of hematology & oncology 20110101

• Current immunotherapeutic approaches in pancreatic cancer.

  Clinical & developmental immunology 20110101

• Remarkable inhibitory effects of hybrid liposomes on growth of human colon cancer cells through induction of cell cycle arrest along with apoptosis.

  International journal of nanomedicine 20110101

• Use of capecitabine in management of early colon cancer.

  Cancer management and research 20110101

• Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.

  PloS one 20110101

• Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer.

  BMC cancer 20110101

• Pulmonary toxicity with oxaliplatin and capecitabine/5-Fluorouracil chemotherapy: a case report and review of the literature.

  Onkologie 20110101

• An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma.

  Journal of translational medicine 20110101

• Gastroduodenal, intestinal and colonic permeability during anticancer therapy.

  Hepato-gastroenterology 20110101

• The efficacy of chemotherapy in patients with high-grade metastatic colon cancer.

  Hepato-gastroenterology 20110101

• Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer.

  World journal of surgical oncology 20110101

• Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis.

  BMC cancer 20110101

• Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?

  World journal of surgical oncology 20110101

• Postoperative chemoradiation for resected gastric cancer--is the Macdonald Regimen Tolerable? a retrospective multi-institutional study.

  Radiation oncology (London, England) 20110101

• Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10.

  Journal of clinical bioinformatics 20110101

• Platinum resistance in breast and ovarian cancer cell lines.

  Journal of experimental & clinical cancer research : CR 20110101

• Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors.

  Oncology 20110101

• Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.

  Journal of experimental & clinical cancer research : CR 20110101

• Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation.

  PloS one 20110101

• Pharmacological blockade of TRPM8 ion channels alters cold and cold pain responses in mice.

  PloS one 20110101

• Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.

  Journal of translational medicine 20110101

• Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).

  Onkologie 20110101

• Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer.

  Tumori 20110101

• Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: experience from a single institution.

  Journal of cardiothoracic surgery 20110101

• Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines.

  BMC cancer 20110101

• Targeted therapy in hepatocellular carcinoma.

  International journal of hepatology 20110101

• Unusual metachronous isolated inguinal lymph node metastasis from adenocarcinoma of the sigmoid colon.

  World journal of surgical oncology 20110101

• Clinical application of CT-guided (125)I seed interstitial implantation for local recurrent rectal carcinoma.

  Radiation oncology (London, England) 20110101

• Safety and efficacy of FOLFIRI-bevacizumab for metastatic colorectal carcinoma as second line treatment.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.

  International journal of hepatology 20110101

• Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.

  Journal of translational medicine 20110101

• Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.

  BMC cancer 20110101

• Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer.

  Genome biology 20110101

• Looking to the future: biomarkers in the management of pancreatic adenocarcinoma.

  International journal of molecular sciences 20110101

• The continuation of bevacizumab following disease progression in patients with metastatic colorectal cancer offers a survival benefit.

  Hepato-gastroenterology 20110101

• Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials.

  Oncology 20110101

• Isolated metastasis of colon cancer to the scapula: is surgical resection warranted?

  World journal of surgical oncology 20110101

• SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus.

  BMC cancer 20110101

• BRAF mutations in advanced cancers: clinical characteristics and outcomes.

  PloS one 20110101

• Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular Carcinoma.

  Gastrointestinal cancer research : GCR 20110101

• Translesion DNA synthesis in the context of cancer research.

  Cancer cell international 20110101

• Strong nuclear EGFR expression in colorectal carcinomas is associated with cyclin-D1 but not with gene EGFR amplification.

  Diagnostic pathology 20110101

• Prolonged survival of patients with metastatic colorectal cancer following first-line oxaliplatin-based chemotherapy with molecular targeting agents and curative surgery.

  Oncology 20110101

• Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.

  Oncology 20110101

• Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs.

  BMC cancer 20110101

• Immunogenicity of panitumumab in combination chemotherapy clinical trials.

  BMC clinical pharmacology 20110101

• Mitochondrial peroxiredoxin III is a potential target for cancer therapy.

  International journal of molecular sciences 20110101

• Laparoscopic low anterior resection for hematogenous rectal metastasis from gastric adenocarcinoma: a case report.

  World journal of surgical oncology 20110101

• Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.

  Journal of computer assisted tomography 20110101

• In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein.

  Breast cancer : basic and clinical research 20110101

• Synchronous Laparoscopic Radical Nephrectomy Left and Contralateral Right Hemicolectomy during the Same Endoscopic Procedure.

  ISRN surgery 20110101

• Adjuvant perioperative intraperitoneal chemotherapy in locally advanced colorectal carcinoma: preliminary results.

  ISRN surgery 20110101

• Metastatic bladder cancer: a review of current management.

  ISRN urology 20110101

• Small bowel adenocarcinoma presenting with refractory iron deficiency anemia - case report and review of literature.

  Case reports in oncology 20110101

• Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: national cancer institute, Mexico city, Mexico.

  ISRN oncology 20110101

• A very unusual presentation of metastatic colon cancer.

  ISRN oncology 20110101

• Ten-year survival after liver resection for colorectal metastases: systematic review and meta-analysis.

  ISRN oncology 20110101

• Novel strategy with gemcitabine for advanced pancreatic cancer.

  ISRN oncology 20110101

• A review on Balanites aegyptiaca Del (desert date): phytochemical constituents, traditional uses, and pharmacological activity.

  Pharmacognosy reviews 20110101

• An MSI tumor specific frameshift mutation in a coding microsatellite of MSH3 encodes for HLA-A0201-restricted CD8+ cytotoxic T cell epitopes.

  PloS one 20110101

• Fast track multi-discipline treatment (FTMDT trial) versus conventional treatment in colorectal cancer--the design of a prospective randomized controlled study.

  BMC cancer 20110101

• Isolated splenic metastasis from rectal carcinoma: a rare occurrence.

  Case reports in oncology 20110101

• Treatment of colorectal liver metastases.

  World journal of surgical oncology 20110101

• NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines.

  Molecular cancer 20110101

• Metachronous pulmonary and adrenal metastases after liver transplantation for hepatocarcinoma.

  World journal of surgical oncology 20110101

• A malignant mass in the breast is not always breast cancer.

  Case reports in oncology 20110101

• Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer.

  PloS one 20110101

• Psychometric validation of the Portuguese version of the Neuropathic Pain Symptoms Inventory.

  Health and quality of life outcomes 20110101

• Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials.

  BMC medical research methodology 20110101

• Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

  BMC cancer 20110101

• Hemolytic uremic syndrome induced by infusion of oxaliplatin: a case report.

  Tumori 20110101

• Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms.

  Clinical & developmental immunology 20110101

• Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies.

  OncoTargets and therapy 20110101

• Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo.

  International journal of nanomedicine 20110101

• Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes.

  International journal of nanomedicine 20110101

• Both hMutSα and hMutSß DNA mismatch repair complexes participate in 5-fluorouracil cytotoxicity.

  PloS one 20110101

• The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells.

  PloS one 20110101

• Oxaliplatin but not irinotecan impairs posthepatectomy liver regeneration in a murine model.

  International journal of hepatology 20110101

• Expression of circadian clock gene human Period2 (hPer2) in human colorectal carcinoma.

  World journal of surgical oncology 20110101

• The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.

  Trials 20110101

• Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis.

  World journal of surgical oncology 20110101

• Radiotherapy and 'new' drugs-new side effects?

  Radiation oncology (London, England) 20110101

• Tumor evasion from T cell surveillance.

  Journal of biomedicine & biotechnology 20110101

• The immune response to tumors as a tool toward immunotherapy.

  Clinical & developmental immunology 20110101

• A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival.

  BMC research notes 20110101

• Oxaliplatin-induced neuropathy in colorectal cancer.

  Journal of oncology 20110101

• Selective cytotoxicity against human osteosarcoma cells by a novel synthetic C-1 analogue of 7-deoxypancratistatin is potentiated by curcumin.

  PloS one 20110101

• S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells.

  Proteome science 20110101

• Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition.

  Cancer cell international 20110101

• Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment.

  World journal of surgical oncology 20110101

• DNA Interaction Studies of a New Platinum(II) Complex Containing Different Aromatic Dinitrogen Ligands.

  Bioinorganic chemistry and applications 20110101

• KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment.

  PloS one 20110101

• Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure.

  Journal of biological regulators and homeostatic agents 20110101

• Scheduled prospective tri-weekly modified FOLFOX6 maintenance chemotherapy in the treatment of metastatic colorectal cancer.

  Hepato-gastroenterology 20110101

• Monoclonal antibodies in gynecological cancer: a critical point of view.

  Clinical & developmental immunology 20110101

• Combination treatment with oxaliplatin and mangiferin causes increased apoptosis and downregulation of NFκB in cancer cell lines.

  African journal of traditional, complementary, and alternative medicines : AJTCAM 20110101

• Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.

  International journal of nanomedicine 20110101

• Novel immunotherapeutic strategies of gastric cancer treatment.

  Journal of biomedicine & biotechnology 20110101

• [The role of chemotherapy and targeted antiVEGF- and antiEGFR-therapy in metastatic colorectal cancer: a case report of long-term and intensive response].

  Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20110101

• The state of research into children with cancer across Europe: new policies for a new decade.

  Ecancermedicalscience 20110101

• Muscle metastases from gallbladder cancer.

  Ecancermedicalscience 20110101

• A phase II study of oxaliplatin with 5-FU/folinic acid and concomitant radiotherapy as a preoperative treatment in patients with locally advanced rectal cancer.

  Biomedical imaging and intervention journal 20110101

• Reduced lymph node harvest after neoadjuvant chemotherapy in gastric cancer.

  The Journal of international medical research 20110101

• Observation of curative efficacy and prognosis following combination chemotherapy with celecoxib in the treatment of advanced colorectal cancer.

  The Journal of international medical research 20110101

• FOLFOX (oxaliplatin and 5 fluorouracil/leucovorin) in patients with untreated metastatic gastric adenocarcinoma Phase II study.

  Indian journal of cancer 20110101

• Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis.

  Gastrointestinal cancer research : GCR 20110101

• Lipoplatin treatment in lung and breast cancer.

  Chemotherapy research and practice 20110101

• A regimen of taxol, Ifosfamide, and platinum for recurrent advanced squamous cell cancer of the anal canal.

  Chemotherapy research and practice 20110101

• Neoadjuvant treatment in rectal cancer: actual status.

  Chemotherapy research and practice 20110101

• Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data.

  International journal of surgical oncology 20110101

• Pharmacokinetic study of perioperative intravenous Ifosfamide.

  International journal of surgical oncology 20110101

• Colorectal liver metastases.

  International journal of surgical oncology 20110101

• Gastrointestinal complications in 147 consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.

  International journal of surgical oncology 20110101

• Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience.

  International journal of surgical oncology 20110101

• Minimally invasive evaluation and treatment of colorectal liver metastases.

  International journal of surgical oncology 20110101

• Treatment of pancreatic and periampullary cancers at a community hospital: successful application of tertiary care treatment standards.

  International journal of surgical oncology 20110101

• Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.

  Chemotherapy research and practice 20110101

• Developing central nervous system and vulnerability to platinum compounds.

  Chemotherapy research and practice 20110101

• Triple-negative breast cancer: adjuvant therapeutic options.

  Chemotherapy research and practice 20110101

• Neurotoxicity caused by the treatment with platinum analogues.

  Chemotherapy research and practice 20110101

• Predictors of sensitivity to preoperative chemoradiotherapy of rectal adenocarcinoma.

  Tumori 20110101

• The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: a three-center study from China.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: an institutional report.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• Evaluation of the efficacy of modified De Gramont and modified FOLFOX4 regimens for adjuvant therapy of locally advanced rectal cancer.

  Asian Pacific journal of cancer prevention : APJCP 20110101

• Pancreatic cancer: chemotherapy and radiotherapy.

  North American journal of medical sciences 20110101

• Inguinal lymph node metastasis of colon cancer.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101

• Endovascular treatment of a right-sided ureteroiliac fistula in a patient with a simultaneous left-sided ureteroileal fistula.

  Case reports in urology 20110101

• Role of neuroactive steroids in the peripheral nervous system.

  Frontiers in endocrinology 20110101

• Past, present, and future of molecular and cellular oncology.

  Frontiers in oncology 20110101

• Therapeutic targeting of cancer stem cells.

  Frontiers in oncology 20110101

• Gallbladder carcinosarcoma.

  BMJ case reports 20110101

• Generalized pairwise comparisons of prioritized outcomes in the two-sample problem.

  Statistics in medicine 20101230

• Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101220

• NGF protects dorsal root ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2.

  Neuroscience letters 20101217

• Guesstimates are not good enough for determining what is happening in routine care.

  British journal of cancer 20101207

• Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer.

  British journal of cancer 20101207

• Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells.

  Chemico-biological interactions 20101205

• Acute renal failure related to oxaliplatin-induced intravascular hemolysis.

  Medical oncology (Northwood, London, England) 20101201

• Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

  Investigational new drugs 20101201

• Capecitabine-induced cerebellar toxicity in a patient with metastatic colorectal cancer.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20101201

• The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer.

  Medical oncology (Northwood, London, England) 20101201

• Atypical presentation of acute neurotoxicity secondary to oxaliplatin.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20101201

• Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101201

• Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.

  Neurotoxicology 20101201

• Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101201

• Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro models.

  Molecular cancer therapeutics 20101201

• [Influence of pre-surgical chemotherapy on liver parenchyma and post-surgical outcome of patients subjected to hepatectomy due to colorectal carcinoma metastases].

  Cirugia espanola 20101201

• Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations.

  Molecular cancer therapeutics 20101201

• Effects of the HDAC inhibitor CG2 in combination with irinotecan, 5-fluorouracil, or oxaliplatin on HCT116 colon cancer cells and xenografts.

  Oncology reports 20101201

• Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

  The Lancet. Oncology 20101201

• Bevacizumab-based therapy and complication risk after colonic stent placement: is it time for a warning?

  Gastrointestinal endoscopy 20101201

• Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy.

  Asia-Pacific journal of clinical oncology 20101201

• Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma.

  Asia-Pacific journal of clinical oncology 20101201

• [Clinical usefulness of oral aprepitant for alleviation of delayed nausea and vomiting induced by mFOLFOX6--report of a case].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101201

• Oxaliplatin-induced pancreatitis: a case series.

  Anticancer research 20101201

• A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes.

  Anticancer research 20101201

• Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.

  Anticancer research 20101201

• Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinoma.

  Clinical colorectal cancer 20101201

• Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer.

  Clinical colorectal cancer 20101201

• Hepatic arterial infusion of 5-fluorouracil for patients with liver metastases from colorectal cancer refractory to standard systemic chemotherapy: a multicenter, retrospective analysis.

  Clinical colorectal cancer 20101201

• Exploratory study of hepatic arterial infusion oxaliplatin with systemic 5-fluorouracil/bevacizumab in patients with refractory solid tumor and extensive liver metastases.

  Clinical colorectal cancer 20101201

• Oxaliplatin-induced chronic peripheral neurotoxicity: a prospective analysis in patients with colorectal cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20101201

• Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia.

  Cell death & disease 20101201

• In vitro adenosine triphosphate based chemotherapy response assay in gastric cancer.

  Journal of gastric cancer 20101201

• KRAS status and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFOX chemotherapy.

  Journal of gastrointestinal oncology 20101201

• Cetuximab-induced hypomagnesaemia aggravates peripheral sensory neurotoxicity caused by oxaliplatin.

  Journal of gastrointestinal oncology 20101201

• BRAF p.Val600Glu (V600E) Testing for Assessment of Treatment Options in Metastatic Colorectal Cancer.

  PLoS currents 20101126

• Effects of a combretastatin A4 analogous chalcone and its Pt-complex on cancer cells: A comparative study of uptake, cell cycle and damage to cellular compartments.

  Biochemical pharmacology 20101115

• The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20101115

• Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients.

  British journal of cancer 20101109

• A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer.

  British journal of cancer 20101109

• Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial.

  British journal of cancer 20101109

• Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer.

  British journal of cancer 20101109

• The impact of new treatment options for advanced colorectal cancer on routine care: results of a retrospective analysis of 206 consecutive patients treated in a community-based oncology group practice in Germany.

  European journal of cancer care 20101101

• Sequential surgical resection of hepatic and pulmonary metastases from colorectal cancer.

  Langenbeck's archives of surgery 20101101

• Surgical morbidity and mortality of pediatric brain tumors: a single center audit.

  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20101101

• Molecular predictive and prognostic markers in colon cancer.

  Cancer treatment reviews 20101101

• Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer.

  Acta oncologica (Stockholm, Sweden) 20101101

• Survivin is regulated by interleukin-4 in colon cancer stem cells.

  Journal of cellular physiology 20101101

• The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity.

  Current cancer drug targets 20101101

• Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel.

  Current cancer drug targets 20101101

• Combination therapy of metronomic S-1 dosing with oxaliplatin-containing polyethylene glycol-coated liposome improves antitumor activity in a murine colorectal tumor model.

  Cancer science 20101101

• Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin.

  Journal of surgical oncology 20101101

• Poly (γ, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: a comparative study with clinically used platinum derivatives.

  Cancer science 20101101

• Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101101

• Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301).

  Gut 20101101

• Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results.

  Cancer science 20101101

• Resistance to platinum-based chemotherapy in lung cancer cell lines.

  Cancer chemotherapy and pharmacology 20101101

• Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine.

  British journal of cancer 20101101

• Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes.

  International journal of clinical pharmacology and therapeutics 20101101

• Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?

  Annals of surgery 20101101

• Radiation recall with anticancer agents.

  The oncologist 20101101

• Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.

  British journal of cancer 20101101

• [A retrospective survey on allergic reactions by oxaliplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• Surviving chemotherapy for colon cancer and living with the consequences.

  Journal of palliative medicine 20101101

• Sequential X-irradiation induced acquired resistance to oxaliplatin but increased sensitivity to cisplatin in two human teratoma cell lines in vitro.

  Anticancer research 20101101

• A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer.

  Anticancer research 20101101

• Colorectal cancer screening for average-risk North Americans: an economic evaluation.

  PLoS medicine 20101101

• Therapeutic implications of resistance to molecular therapies in metastatic colorectal cancer.

  Cancer treatment reviews 20101101

• Adjuvant colon cancer chemotherapy: where we are and where we'll go.

  Cancer treatment reviews 20101101

• Maintenance therapy in colon cancer.

  Cancer treatment reviews 20101101

• Human health risk assessment of pharmaceuticals in water: issues and challenges ahead.

  International journal of environmental research and public health 20101101

• Consensus recommendations for the use of anti-egfr therapies in metastatic colorectal cancer.

  Current oncology (Toronto, Ont.) 20101101

• Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.

  Chinese medical journal 20101101

• Characterization of two independent, exposure-time dependent paclitaxel-resistant human ovarian carcinoma cell lines.

  Human cell 20101101

• [Lower G. I./colon and rectum cancer. III. Current topics concerning postoperative adjuvant chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20101101

• [A case of colon cancer with multiple liver metastases effectively treated with hepatic arterial infusion followed by systemic chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [The expression of thymidylate synthase (TS) and excision repair complementing-1 (ERCC-1) protein in patients with unresectable colorectal cancer treated with mFOLFOX6 therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [Adjuvant chemotherapy with FOLFOX4 regimen after curative resection of liver metastases from colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [Hepatic resection after systemic chemotherapy for liver metastasis of colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [Clinical path for mFOLFOX6 describing criteria for reduction and suspension of drugs].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [Hepatic arterial infusion chemotherapy with oxaliplatin in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future.

  Oncotarget 20101101

• The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling.

  Oncotarget 20101101

• Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice.

  Journal of oncology practice 20101101

• Mechanisms of Cisplatin nephrotoxicity.

  Toxins 20101101

• {(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo.

  Journal of medicinal chemistry 20101028

• A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours.

  British journal of cancer 20101026

• A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.

  British journal of cancer 20101026

• A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer.

  British journal of cancer 20101026

• Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer.

  British journal of cancer 20101026

• Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101020

• [Operable colon cancer: initial strategy].

  La Revue du praticien 20101020

• [Management of metastatic colorectal cancer].

  La Revue du praticien 20101020

• Attenuation of activity in an endogenous analgesia circuit by ongoing pain in the rat.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20101013

• Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α.

  British journal of cancer 20101012

• Radiosensitizing drugs: lessons to be learned from the oxaliplatin story.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20101001

• Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials.

  International journal of radiation oncology, biology, physics 20101001

• Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101001

• A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101001

• Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101001

• Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.

  Annals of surgical oncology 20101001

• Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis.

  Annals of surgical oncology 20101001

• Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer.

  Japanese journal of clinical oncology 20101001

• Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab.

  Japanese journal of clinical oncology 20101001

• Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma.

  Cancer 20101001

• Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases.

  International journal of colorectal disease 20101001

• Protective effect of melatonin on oxaliplatin-induced apoptosis through sustained Mcl-1 expression and anti-oxidant action in renal carcinoma Caki cells.

  Journal of pineal research 20101001

• Virtual liver resection and volumetric analysis of the future liver remnant using open source image processing software.

  World journal of surgery 20101001

• Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.

  Journal of inorganic biochemistry 20101001

• Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling.

  International journal of radiation oncology, biology, physics 20101001

• Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.

  Anti-cancer drugs 20101001

• A phase II trial of oxaliplatin and trastuzumab in the treatment of HER2-positive metastatic breast cancer.

  Cancer investigation 20101001

• Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: preparation, characterization and in vitro cytotoxicity.

  European journal of medicinal chemistry 20101001

• [Impact of the hyperthermic intraperitoneal chemotherapy on the fluid-electrolytes changes and on the acid-base balance].

  Annales francaises d'anesthesie et de reanimation 20101001

• Irinotecan overcomes the resistance to 5-fluorouracil in human colon cancer xenografts by down-regulation of intratumoral thymidylate synthase.

  Oncology reports 20101001

• Acquired resistance to miriplatin in rat hepatoma AH109A/MP10 is associated with increased Bcl-2 expression, leading to defects in inducing apoptosis.

  Oncology reports 20101001

• [mRNA quantification. The next challenge in routine diagnostics].

  Der Pathologe 20101001

• A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced or metastatic adenocarcinoma of stomach and GE junction.

  Cancer investigation 20101001

• Genetic instability influences drug response in cancer cells.

  Current drug targets 20101001

• Effect of glutathione combined with cisplatin and oxaliplatin on the proliferation and apoptosis of lung carcinoma cell line.

  Toxicology mechanisms and methods 20101001

• Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101001

• Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparison.

  Clinical colorectal cancer 20101001

• Differences in efficacy and safety between capecitabine and infusional 5-fluorouracil when combined with irinotecan for the treatment of metastatic colorectal cancer.

  Clinical colorectal cancer 20101001

• A new [(1R,2R)-1,2-diaminocyclohexane]platinum(II) complex: formation by nitrate-acetonitrile ligand exchange.

  Acta crystallographica. Section C, Crystal structure communications 20101001

• [Current status and perspectives of biologics in the treatment of metastatic colorectal cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20101001

• Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines.

  Anticancer research 20101001

• Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.

  Anticancer research 20101001

• Hybrid polyacrylamide chiral stationary phases for HPLC prepared by surface-initiated photopolymerization.

  Journal of separation science 20101001

• Capecitabine for the treatment of advanced gastric cancer.

  Health technology assessment (Winchester, England) 20101001

• Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.

  Health technology assessment (Winchester, England) 20101001

• Gemox: a widely useful therapy against solid tumors-review and personal experience.

  Journal of chemotherapy (Florence, Italy) 20101001

• [Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20101001

• Chemotherapy of metastatic colorectal cancer.

  Prescrire international 20101001

• Molecular identification and targeting of colorectal cancer stem cells.

  Oncotarget 20101001

• A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours.

  British journal of cancer 20100928

• Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.

  British journal of cancer 20100928

• The status of platinum anticancer drugs in the clinic and in clinical trials.

  Dalton transactions (Cambridge, England : 2003) 20100921

• Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model.

  Cancer research 20100915

• Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma.

  British journal of cancer 20100907

• KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic.

  PLoS currents 20100902

• Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.

  Cancer chemotherapy and pharmacology 20100901

• Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL).

  Annals of oncology : official journal of the European Society for Medical Oncology 20100901

• Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100901

• Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder carcinoma.

  European journal of gastroenterology & hepatology 20100901

• Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver.

  Human gene therapy 20100901

• Pharmacokinetics and toxicodynamics of oxaliplatin in rats: application of a toxicity factor to explain differences in the nephrotoxicity and myelosuppression induced by oxaliplatin and the other platinum antitumor derivatives.

  Pharmaceutical research 20100901

• A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.

  Cancer 20100901

• A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study.

  Pediatric blood & cancer 20100901

• Fourier transform infrared (FTIR) spectroscopy to monitor the cellular impact of newly synthesized platinum derivatives.

  International journal of oncology 20100901

• Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100901

• [Prospective study of quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using oxaliplatin for peritoneal carcinomatosis].

  Bulletin du cancer 20100901

• Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases.

  The American journal of surgical pathology 20100901

• Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial.

  The Lancet. Oncology 20100901

• Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).

  The Lancet. Oncology 20100901

• BNP7787-mediated modulation of paclitaxel- and cisplatin-induced aberrant microtubule protein polymerization in vitro.

  Molecular cancer therapeutics 20100901

• Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group report in 30th Asia-Pacific Cancer Conference.

  Japanese journal of clinical oncology 20100901

• [A clinical study of paclitaxel combined with FOLFOX4 regimen as neoadjuvant chemotherapy for advanced gastric cancer].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20100901

• Sister Mary Joseph's nodule as a metastasis of ovarian adenocarcinoma.

  International journal of dermatology 20100901

• Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs.

  Asia-Pacific journal of clinical oncology 20100901

• [Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)].

  Revue de pneumologie clinique 20100901

• Modulation of gemcitabine accumulation by DNA-damaging agents: mechanisms and specificity in an in vitro model.

  Anticancer research 20100901

• [Clinical observation of transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100901

• [Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers].

  Yao xue xue bao = Acta pharmaceutica Sinica 20100901

• Expression of coxsackie and adenovirus receptor distinguishes transitional cancer states in therapy-induced cellular senescence.

  Cell death & disease 20100901

• Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells.

  Cell death & disease 20100901

• Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity.

  Therapeutic advances in medical oncology 20100901

• Management of intrathoracic leakage after radical total gastrectomy.

  Journal of thoracic disease 20100901

• Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in vivo neuropathic pain models.

  Neuroscience 20100825

• The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective study.

  British journal of cancer 20100824

• Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer.

  British journal of cancer 20100824

• Capecitabine for locally advanced and metastatic colorectal cancer: A review.

  World journal of gastrointestinal oncology 20100815

• Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan.

  British journal of cancer 20100810

• UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy.

  British journal of cancer 20100810

• The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20100801

• Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.

  Cancer chemotherapy and pharmacology 20100801

• Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?

  European journal of gastroenterology & hepatology 20100801

• Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?

  Annals of oncology : official journal of the European Society for Medical Oncology 20100801

• MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.

  Journal of cancer research and clinical oncology 20100801

• Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100801

• Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.

  Annals of surgical oncology 20100801

• Multimodal treatment options for bilobar colorectal liver metastases.

  Langenbeck's archives of surgery 20100801

• Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature.

  International journal of clinical oncology 20100801

• The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro.

  Cancer chemotherapy and pharmacology 20100801

• Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil.

  Transfusion medicine (Oxford, England) 20100801

• The role of targeted agents in preoperative chemoradiation for rectal cancer.

  Cancer 20100801

• Molecular markers in circulating tumour cells from metastatic colorectal cancer patients.

  Journal of cellular and molecular medicine 20100801

• Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20100801

• Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice.

  Cancer research 20100801

• Down-regulation of survivin by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20100801

• Consequences of chemotherapy on resection of colorectal liver metastases.

  Journal of visceral surgery 20100801

• Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20100801

• Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma.

  Clinical lymphoma, myeloma & leukemia 20100801

• [Treatment and outcome in small bowel cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100801

• [Performance of a portable continuous infusion pump (SUREFUSER A) in continuous infusion of 5-FU].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100801

• [Effect of anti-EGFR monoclonal antibody on chemosensitivity of human colon cancer cells and the mechanism].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100801

• [Oxaliplatin plus capecitabine for advanced gastric cancer: report of 38 cases].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20100801

• Survivin may be a Key Target for Oxaliplatin.

  Journal of the Korean Society of Coloproctology 20100801

• Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells.

  Journal of the Korean Society of Coloproctology 20100801

• Oncologic outcome after cessation or dose reduction of capecitabine in patients with colon cancer.

  Journal of the Korean Society of Coloproctology 20100801

• Significance of Follow-up in Detection of Pulmonary Metastasis of Colorectal Cancer.

  Journal of the Korean Society of Coloproctology 20100801

• Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib.

  World journal of gastroenterology 20100728

• Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.

  Biochemistry 20100727

• 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency.

  British journal of cancer 20100727

• Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.

  British journal of cancer 20100727

• Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom.

  British journal of cancer 20100727

• [A 24-hour continuous infusion of paclitaxel in the treatment of advanced esophageal cancer].

  Zhonghua yi xue za zhi 20100727

• Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100720

• Src family kinase inhibitor Saracatinib (AZD0530) impairs oxaliplatin uptake in colorectal cancer cells and blocks organic cation transporters.

  Cancer research 20100715

• Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer.

  World journal of gastroenterology 20100714

• Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases.

  British journal of cancer 20100713

• Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100710

• Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial.

  World journal of gastroenterology 20100707

• Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the '2010 ASCO Annual Meeting'. Chicago, IL, USA. June 4-8, 2010.

  JOP : Journal of the pancreas 20100705

• Pancreatic metastasis from colon carcinoma nine years after a hemicolectomy managed by distal pancreatectomy. A review of the literature regarding the role and outcome of pancreatic resection for colorectal metastasis.

  JOP : Journal of the pancreas 20100705

• Capecitabine/oxaliplatin as first-line treatment for metastatic colorectal cancer: a meta-analysis.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100701

• Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20100701

• Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques.

  Annals of surgical oncology 20100701

• Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy?

  European journal of neurology 20100701

• Immune-mediated pancytopenia induced by oxaliplatin: a case report.

  Transfusion 20100701

• Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective study.

  Anti-cancer drugs 20100701

• The integrity of colonic anastomoses following the intraperitoneal administration of oxaliplatin.

  International journal of colorectal disease 20100701

• Oral metastasis from primary transitional cell carcinoma of the renal pelvis: report of a case.

  International journal of oral and maxillofacial surgery 20100701

• Adenocarcinoma of the small bowel: changes in the landscape?

  Current opinion in oncology 20100701

• Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.

  Oncology reports 20100701

• Therapeutic effectiveness of slow-release PLGA-oxaliplatin microsphere on human colorectal tumor-bearing mice.

  Anti-cancer drugs 20100701

• Acute interstitial pneumonitis in a patient receiving a FOLFOX-4 regimen plus cetuximab treated with pulse therapy.

  International journal of clinical pharmacology and therapeutics 20100701

• Contribution of glutathione and MRP-mediated efflux to intracellular oxaliplatin accumulation.

  International journal of clinical pharmacology and therapeutics 20100701

• Plasma disposition of capecitabine (CCB) and its metabolites 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouracil (5'-DFUR) with two different capecitabine/oxaliplatin dosage regimens.

  International journal of clinical pharmacology and therapeutics 20100701

• Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer.

  Journal of surgical oncology 20100701

• Clinical and economic evaluation of first-line therapy with FOLFIRI or modified FOLFOX6 for metastatic colorectal cancer.

  Japanese journal of clinical oncology 20100701

• Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.

  Chinese journal of cancer 20100701

• Delayed urticaria with oxaliplatin.

  Contact dermatitis 20100701

• The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization.

  The Medical clinics of North America 20100701

• [Recent developments of pharmacogenomics in the treatment of colorectal cancers].

  Annales pharmaceutiques francaises 20100701

• A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer.

  Clinical colorectal cancer 20100701

• Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancer.

  Clinical colorectal cancer 20100701

• Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

  Current oncology (Toronto, Ont.) 20100701

• Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer.

  Current oncology (Toronto, Ont.) 20100701

• KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies.

  Current oncology (Toronto, Ont.) 20100701

• Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells.

  Anticancer research 20100701

• Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy.

  Anticancer research 20100701

• Hepatic arterial infusion with oxaliplatin, irinotecan and doxifluridine for unresectable liver metastases of colorectal cancer.

  Anticancer research 20100701

• Assessment of pancreatic carcinoma cell chemosensitivity using a three-dimensional culture system.

  Chinese medical journal 20100701

• [Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100701

• [Impact of S100P expression on clinical outcomes of gastric cancer patients with adjuvant chemotherapy of oxaliplatin and its mechanisms].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20100701

• Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects.

  Therapeutic advances in medical oncology 20100701

• A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours.

  British journal of cancer 20100629

• Advances in platinum chemotherapeutics.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20100625

• Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.

  The Journal of biological chemistry 20100618

• Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100615

• BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome.

  British journal of cancer 20100608

• Regarding: 'Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array'.

  British journal of cancer 20100608

• A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.

  Cell stem cell 20100604

• Transcription inhibition by platinum-DNA cross-links in live mammalian cells.

  Journal of the American Chemical Society 20100602

• Oligopyrenotides: abiotic, polyanionic oligomers with nucleic acid-like structural properties.

  Journal of the American Chemical Society 20100602

• Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer.

  Investigational new drugs 20100601

• Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab.

  Critical reviews in oncology/hematology 20100601

• Oxaliplatin-induced proximal renal tubular acidosis.

  Internal and emergency medicine 20100601

• Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments.

  Cancer letters 20100601

• A case of signet ring carcinoma of the appendix: dilemmas in differential diagnosis and management.

  Journal of gastrointestinal cancer 20100601

• Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines.

  Anti-cancer drugs 20100601

• Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.

  Molecular pharmacology 20100601

• Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.

  Anti-cancer drugs 20100601

• Out-of-pocket payment and cost-effectiveness of XELOX and XELOX plus bevacizumab therapy: from the perspective of metastatic colorectal cancer patients in Japan.

  International journal of clinical oncology 20100601

• Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20100601

• Cisplatin and oxaliplatin inhibit gap junctional communication by direct action and by reduction of connexin expression, thereby counteracting cytotoxic efficacy.

  The Journal of pharmacology and experimental therapeutics 20100601

• Diet, microRNAs and prostate cancer.

  Pharmaceutical research 20100601

• Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.

  Journal of inorganic biochemistry 20100601

• Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier.

  Anti-cancer drugs 20100601

• Dosing considerations for capecitabine-irinotecan regimens in the treatment of metastatic and/or locally advanced colorectal cancer.

  American journal of clinical oncology 20100601

• Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.

  The American journal of surgical pathology 20100601

• Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer.

  Pharmaceutical research 20100601

• Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study.

  Oncology reports 20100601

• Cetuximab enhances the effect of oxaliplatin on hypoxic gastric cancer cell lines.

  Oncology reports 20100601

• Is there a role for mitomycin C in metastatic colorectal cancer?

  Expert opinion on investigational drugs 20100601

• Molecular markers to individualize adjuvant therapy for colon cancer.

  Nature reviews. Clinical oncology 20100601

• Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20100601

• Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells.

  Cancer research 20100601

• Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20100601

• Genetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancer.

  Journal of Korean medical science 20100601

• Recently identified and potential targets for colon cancer treatment.

  Future oncology (London, England) 20100601

• Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20100601

• [Transition of chemotherapy for metastatic colorectal cancer and recent advances].

  Nihon rinsho. Japanese journal of clinical medicine 20100601

• Fresh platinum complexes with promising antitumor activity.

  Anti-cancer agents in medicinal chemistry 20100601

• Acute ototoxicity from a single infusion of oxaliplatin.

  Ear, nose, & throat journal 20100601

• [Nephrotoxicity induced by repeated cycles of oxaliplatin in a Japanese colorectal cancer patient with moderate renal impairment].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100601

• [Current medicinal treatment of metastasized colorectal carcinoma].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20100601

• [Clinical randomized controlled study on acupuncture for treatment of peripheral neuropathy induced by chemotherapeutic drugs].

  Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20100601

• Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20100601

• High frequency of hand foot syndrome with capecitabine.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20100601

• Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.

  British journal of cancer 20100525

• Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100520

• Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100520

• Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.

  Cancer 20100515

• Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.

  British journal of cancer 20100511

• Serum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX.

  World journal of gastroenterology 20100507

• N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU.

  Cancer chemotherapy and pharmacology 20100501

• Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100501

• The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100501

• Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).

  Annals of oncology : official journal of the European Society for Medical Oncology 20100501

• Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.

  Journal of cancer research and clinical oncology 20100501

• St. John's Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity.

  Biochemical pharmacology 20100501

• Regulation of apoptosis-associated lysosomal membrane permeabilization.

  Apoptosis : an international journal on programmed cell death 20100501

• An association between transient hypokalemia and severe acute oxaliplatin-related toxicity predominantly in women.

  Acta oncologica (Stockholm, Sweden) 20100501

• Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapy.

  Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20100501

• Gemcitabine-based cytotoxic doublets chemotherapy for advanced pancreatic cancer: updated subgroup meta-analyses of overall survival.

  Japanese journal of clinical oncology 20100501

• Ultra-fast HPLC-ICP-MS analysis of oxaliplatin in patient urine.

  Analytical and bioanalytical chemistry 20100501

• [Hepatotoxicity of metastatic colorectal cancer chemotherapy: systematic review].

  Bulletin du cancer 20100501

• Status of bi- and multi-nuclear platinum anticancer drug development.

  Anti-cancer agents in medicinal chemistry 20100501

• A better platinum-based anticancer drug yet to come?

  Anti-cancer agents in medicinal chemistry 20100501

• Capecitabine and oxaliplatin as second-line treatment in patients with carcinoma of unknown primary site.

  Acta oncologica (Stockholm, Sweden) 20100501

• Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100501

• A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie.

  Cancer chemotherapy and pharmacology 20100501

• Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20100501

• Current and emerging treatment strategies for anal cancer.

  Current oncology reports 20100501

• [The anti EGFR antibody indication between the Japanese and overseas guidelines].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100501

• Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20100501

• Cetuximab for the first-line treatment of metastatic colorectal cancer.

  Health technology assessment (Winchester, England) 20100501

• Treatment considerations in elderly colorectal cancer patients.

  Clinical advances in hematology & oncology : H&O 20100501

• [Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100501

• [Difference of colon cancer and rectal cancer-from the view of an oncological physician].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100501

• Safety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer.

  Therapeutic advances in medical oncology 20100501

• Colorectal cancer in the course of familial adenomatous polyposis syndrome ('de novo' pathogenic mutation of APC gene): case report, review of the literature and genetic commentary.

  Archives of medical science : AMS 20100430

• Surgery for colorectal liver metastases.

  British journal of cancer 20100427

• Cytotoxic activities of several geranyl-substituted flavanones.

  Journal of natural products 20100423

• Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites.

  World journal of gastroenterology 20100421

• Chemotherapeutic drugs inhibit ribosome biogenesis at various levels.

  The Journal of biological chemistry 20100416

• Determination of platinum traces contamination by graphite furnace atomic absorption spectrometry after preconcentration by cloud point extraction.

  Journal of hazardous materials 20100415

• Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation.

  Biochemical pharmacology 20100415

• Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin.

  Biochemical pharmacology 20100415

• Towards biomarker-dependent individualized chemotherapy: exploring cell-specific differences in oxaliplatin-DNA adduct distribution using accelerator mass spectrometry.

  Bioorganic & medicinal chemistry letters 20100415

• Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa.

  British journal of cancer 20100413

• Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin.

  Journal of the American Chemical Society 20100407

• Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction.

  Investigational new drugs 20100401

• Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates.

  Cancer chemotherapy and pharmacology 20100401

• Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100401

• Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.

  International journal of cancer 20100401

• Concomitant treatment of F98 glioma cells with new liposomal platinum compounds and ionizing radiation.

  Journal of neuro-oncology 20100401

• Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer.

  Journal of cancer research and clinical oncology 20100401

• Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100401

• Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100401

• Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100401

• KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy.

  Annals of surgical oncology 20100401

• Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20100401

• A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting.

  Japanese journal of clinical oncology 20100401

• Amelioration of oxaliplatin neurotoxicity by drugs in humans and experimental animals: a minireview of recent literature.

  Basic & clinical pharmacology & toxicology 20100401

• Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastases.

  Annals of surgical oncology 20100401

• Genome-wide identification of chemosensitive single nucleotide polymorphism markers in colorectal cancers.

  Cancer science 20100401

• Drug monitoring during FOLFOX6 therapy in a rectal cancer patient on chronic hemodialysis.

  Japanese journal of clinical oncology 20100401

• Adjuvant therapy for colon cancer: learning from the past to inform the future.

  Annals of surgical oncology 20100401

• Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection.

  Current HIV research 20100401

• Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?

  Acta oncologica (Stockholm, Sweden) 20100401

• TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer.

  Gene therapy 20100401

• Improving local control in rectal cancer: radiation sensitizers or radiation dose?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401

• Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401

• Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer.

  Bulletin du cancer 20100401

• Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.

  Annals of surgery 20100401

• Associations between glutathione S-transferase pi Ile105Val and glyoxylate aminotransferase Pro11Leu and Ile340Met polymorphisms and early-onset oxaliplatin-induced neuropathy.

  Cancer epidemiology 20100401

• The first example of MEEKC-ICP-MS coupling and its application for the analysis of anticancer platinum complexes.

  Electrophoresis 20100401

• Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.

  The oncologist 20100401

• Chemotherapy: How useful is adjuvant irinotecan in stage IV CRC?

  Nature reviews. Clinical oncology 20100401

• A case with cardiac tamponade as the first sign of primary gastric signet-ring cell carcinoma treated with combination therapy.

  Medical science monitor : international medical journal of experimental and clinical research 20100401

• Palliative chemotherapy for pancreatic malignancies.

  The Surgical clinics of North America 20100401

• A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy.

  Clinical colorectal cancer 20100401

• A phase II trial of FOLFOX6 and cetuximab in the first-line treatment of patients with metastatic colorectal cancer.

  Clinical colorectal cancer 20100401

• [Treatment of advanced and/or metastatic colorectal cancer with bevacizumab in combination with oxaliplatin-based chemotherapy (Folfox7 regimen)].

  Bulletin du cancer 20100401

• Panitumumab: a new frontier of target therapy for the treatment of metastatic colorectal cancer.

  Expert review of anticancer therapy 20100401

• Recent advances in combined modality therapy.

  The oncologist 20100401

• [Survey on the compliance of patients with continuous infusion of 5-fluorouracil via portable infusion pumps].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100401

• Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.

  PLoS medicine 20100401

• Current issues in the targeted therapy of advanced colorectal cancer.

  Discovery medicine 20100401

• LA-12 overcomes confluence-dependent resistance of HT-29 colon cancer cells to Pt (II) compounds.

  Anticancer research 20100401

• Glutathione modulators reverse the pro-tumour effect of growth factors enhancing WiDr cell response to chemotherapeutic agents.

  Anticancer research 20100401

• Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients.

  British journal of cancer 20100330

• Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I).

  British journal of cancer 20100330

• Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer.

  JAMA 20100317

• Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.

  British journal of cancer 20100316

• Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.

  British journal of cancer 20100316

• Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.

  World journal of gastroenterology 20100314

• Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer.

  World journal of gastroenterology 20100307

• Options for the treatment of gemcitabine-resistant advanced pancreatic cancer.

  JOP : Journal of the pancreas 20100305

• Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the '2010 ASCO Gastrointestinal Cancers Symposium'. Orlando, FL, USA. January 22-24, 2010.

  JOP : Journal of the pancreas 20100305

• Capecitabine and oxaliplatin for advanced esophagogastric cancer.

  The New England journal of medicine 20100304

• Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor.

  Journal of controlled release : official journal of the Controlled Release Society 20100303

• A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.

  Surgical oncology 20100301

• Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.

  Cancer chemotherapy and pharmacology 20100301

• Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma.

  Annals of hematology 20100301

• EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100301

• Hypoxic single-pass isolated hepatic perfusion of hypotonic Cisplatin: safety study in the pig.

  Annals of surgical oncology 20100301

• Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study.

  Gynecologic oncology 20100301

• An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.

  Gastroenterology 20100301

• Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?

  Annals of surgical oncology 20100301

• Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin.

  Anti-cancer drugs 20100301

• Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.

  Cancer science 20100301

• Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer.

  Current medical research and opinion 20100301

• Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience.

  Expert opinion on drug safety 20100301

• Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.

  The Lancet. Oncology 20100301

• Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials.

  International journal of oncology 20100301

• Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors.

  British journal of pharmacology 20100301

• Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.

  Annals of surgery 20100301

• Comparison of patient outcomes according to histology among pemetrexed-treated patients with stage IIIB/IV non-small-cell lung cancer in two phase II trials.

  Clinical lung cancer 20100301

• Neoadjuvant chemotherapy in MRI-staged rectal cancer.

  The Lancet. Oncology 20100301

• Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes.

  Chemistry & biodiversity 20100301

• [Analysis of a case of oxaliplatin - induced persistence sensory neuropathy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100301

• Tumor growth rate determines the timing of optimal chronomodulated treatment schedules.

  PLoS computational biology 20100301

• [Preliminary study of XELOX regimen as the first-line chemotherapy in advanced or recurrent gastric cancer].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100301

• [Efficacy and safety evaluation of docetaxel plus oxaliplatin and capecitabine in the treatment of advanced gastric adenocarcinoma: a single center non-controlled phase II clinical trial].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20100301

• Outcomes of modified FOLFOX-6 as first line treatment in patients with advanced gastric cancer in a single institution; retrospective analysis.

  Cancer research and treatment : official journal of Korean Cancer Association 20100301

• Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20100301

• Establishment and characterization of multidrug-resistant gastric cancer cell lines.

  Anticancer research 20100301

• FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases.

  Anticancer research 20100301

• Role of calcium/ magnesium infusion in oxaliplatin-based chemotherapy for colorectal cancer patients.

  Oncology (Williston Park, N.Y.) 20100301

• In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusion.

  The journal of extra-corporeal technology 20100301

• Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis.

  Histopathology 20100301

• [Chemotherapy-induced peripheral neuropathy: an unresolved issue].

  Neurologia (Barcelona, Spain) 20100301

• Systemic therapy for metastatic pancreatic adenocarcinoma.

  Therapeutic advances in medical oncology 20100301

• [Vinorelbine plus oxaliplatin versus vinorelbine plus cisplatin for advanced non-small cell lung cancer: a systematic review].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20100220

• Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100210

• Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100210

• Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer.

  British journal of cancer 20100202

• Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.

  British journal of cancer 20100202

• Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

  British journal of cancer 20100202

• Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer.

  Nanomedicine : nanotechnology, biology, and medicine 20100201

• Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20100201

• A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer.

  Cancer chemotherapy and pharmacology 20100201

• A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma.

  Cancer chemotherapy and pharmacology 20100201

• Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients.

  Cancer chemotherapy and pharmacology 20100201

• A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100201

• Phase I study of hepatic arterial infusion of oxaliplatin in advanced hepatocellular cancer: a brown university oncology group study.

  American journal of clinical oncology 20100201

• Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100201

• Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis.

  Planta medica 20100201

• Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression.

  The Prostate 20100201

• Novel bis-platinum complexes endowed with an improved pharmacological profile.

  Molecular pharmaceutics 20100201

• Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma.

  Cancer science 20100201

• Double primary adenocarcinomas of the jejunum and descending colon with lung metastases presenting rare immunohistochemical phenotypes: a case report.

  European journal of gastroenterology & hepatology 20100201

• Template synthesis of iron(II) complexes containing tridentate P-N-S, P-N-P, P-N-N, and tetradentate P-N-N-P ligands.

  Inorganic chemistry 20100201

• Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100201

• Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).

  British journal of pharmacology 20100201

• Matrix-assisted laser desorption/ionization imaging mass spectrometry of oxaliplatin derivatives in heated intraoperative chemotherapy (HIPEC)-like treated rat kidney.

  Rapid communications in mass spectrometry : RCM 20100201

• Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.

  Cancer research 20100201

• Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neck.

  The American journal of the medical sciences 20100201

• Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study.

  International journal of clinical oncology 20100201

• Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.

  Medical science monitor : international medical journal of experimental and clinical research 20100201

• Incorporating new data on colorectal cancer into nursing practice.

  Clinical journal of oncology nursing 20100201

• Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators.

  Seminars in oncology 20100201

• Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada.

  Current oncology (Toronto, Ont.) 20100201

• The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer.

  Cancer treatment reviews 20100201

• Perspectives for personalization in chemotherapy of advanced gastric cancer.

  Discovery medicine 20100201

• Pharmacological enhancement of autophagy induced in a hepatocellular carcinoma cell line by high-LET radiation.

  Anticancer research 20100201

• Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

  Anticancer research 20100201

• [Efficacy and toxicity analysis of XELOX and FOLFOX4 regimens as adjuvant chemotherapy for stage III colorectal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100201

• Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20100201

• Carbon nanotubes to deliver drug molecules.

  Journal of biomedical nanotechnology 20100201

• Immunogenic death of colon cancer cells treated with oxaliplatin.

  Oncogene 20100128

• Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.

  Oncogene 20100121

• C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.

  British journal of cancer 20100119

• Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status.

  British journal of cancer 20100119

• Synthesis and characterization of xanthene-bridged Schiff-base dimanganese(III) complexes: bimetallic catalysts for asymmetric oxidation of sulfides.

  Dalton transactions (Cambridge, England : 2003) 20100107

• Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin.

  World journal of gastroenterology 20100107

• Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.

  Journal of the National Cancer Institute 20100106

• Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.

  British journal of cancer 20100105

• Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients.

  British journal of cancer 20100105

• Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial.

  British journal of cancer 20100105

• Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody.

  British journal of cancer 20100105

• PTEN status in advanced colorectal cancer treated with cetuximab.

  British journal of cancer 20100105

• Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses.

  British journal of cancer 20100105

• Biomarkers of angiogenesis and their role in the development of VEGF inhibitors.

  British journal of cancer 20100105

• Combination antitumor effects of micelle-loaded anticancer drugs in a CT-26 murine colorectal carcinoma model.

  International journal of pharmaceutics 20100104

• Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner - meta-analysis of six randomized trials.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100101

• A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts.

  Cancer chemotherapy and pharmacology 20100101

• Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas.

  Journal of cancer research and clinical oncology 20100101

• A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• Redistribution of CD95 into the lipid rafts to treat cancer cells?

  Recent patents on anti-cancer drug discovery 20100101

• Combination intraperitoneal chemotherapy is superior to mitomycin C or oxaliplatin for colorectal carcinomatosis in vivo.

  Annals of surgical oncology 20100101

• Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20100101

• A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors.

  Acta oncologica (Stockholm, Sweden) 20100101

• An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate.

  Cancer 20100101

• Healthy clocks, healthy body, healthy mind.

  Trends in cell biology 20100101

• Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.

  The Lancet. Oncology 20100101

• Water-soluble organometallic analogues of oxaliplatin with cytotoxic and anticlonogenic activity.

  ChemMedChem 20100101

• Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel.

  International journal of oncology 20100101

• 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.

  Oncology reports 20100101

• Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin.

  Oncology reports 20100101

• [Rectal cancer and adjuvant chemotherapy: which conclusions?].

  Bulletin du cancer 20100101

• Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens.

  Cancer investigation 20100101

• Palliative treatment of unresectable metastatic colorectal cancer.

  Expert opinion on pharmacotherapy 20100101

• Colorectal cancer in Mexico: should a middle income country invest in screening or in treatment?

  The European journal of health economics : HEPAC : health economics in prevention and care 20100101

• Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.

  Pharmacogenomics 20100101

• [Clinical features of hypersensitivity reactions to oxaliplatin among Chinese colorectal cancer patients].

  Chinese journal of cancer 20100101

• Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in mice.

  Journal of experimental & clinical cancer research : CR 20100101

• Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode.

  European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes 20100101

• Targeting the EGF receptor for ovarian cancer therapy.

  Journal of oncology 20100101

• The evolving role of monoclonal antibodies in colorectal cancer: early presumptions and impact on clinical trial development.

  The oncologist 20100101

• Antivascular therapy for epithelial ovarian cancer.

  Journal of oncology 20100101

• Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.

  British journal of clinical pharmacology 20100101

• High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20100101

• Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer.

  Clinical lung cancer 20100101

• Complete response to FOLFOX4 therapy in a patient with advanced urothelial cancer: a case report.

  Journal of hematology & oncology 20100101

• [Oxaliplatin and leucovorin plus fluorouracil versus irinotecan and leucovorin plus fluorouracil combination chemotherapy as a first-line treatment in patients with metastatic or recurred gastric adenocarcinoma].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100101

• Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet.

  Acta oncologica (Stockholm, Sweden) 20100101

• Evolution of capecitabine dosing in colorectal cancer.

  Clinical colorectal cancer 20100101

• Colorectal cancer: response to sunitinib in a heavily pretreated colorectal cancer patient.

  Anti-cancer drugs 20100101

• Targeted therapies in epithelial ovarian cancer.

  Journal of oncology 20100101

• Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors.

  Journal of translational medicine 20100101

• TAp73 is one of the genes responsible for the lack of response to chemotherapy depending on B-Raf mutational status.

  Journal of translational medicine 20100101

• [Obliterative bronchiolitis with organising pneumonia following FOLFOX 4 chemotherapy].

  Revue des maladies respiratoires 20100101

• From basic research to clinical development of MEK1/2 inhibitors for cancer therapy.

  Journal of hematology & oncology 20100101

• Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study.

  Radiation oncology (London, England) 20100101

• Effect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/IVa esophageal squamous cell carcinoma.

  International journal of medical sciences 20100101

• Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer.

  BMC cancer 20100101

• [Does bevacizumab have a protective effect on hepatotoxicity induced by chemotherapy?].

  Journal de chirurgie 20100101

• [Chemotherapy's hepatotoxicity: what is the impact on surgery?].

  Journal de chirurgie 20100101

• [Nrf2 down-regulated cell line H460-N5 with Keap1 over-expression increased sensitivity to anti-cancer drugs].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20100101

• [Down-regulation of Nrf2 enhances the cytotoxicity of Oxaliplatin to H460 cells].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20100101

• Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinoma.

  BMC cancer 20100101

• Exploring the potential effect of Ocimum sanctum in vincristine-induced neuropathic pain in rats.

  Journal of brachial plexus and peripheral nerve injury 20100101

• Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer.

  BMC medical genetics 20100101

• Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications.

  Radiation oncology (London, England) 20100101

• Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation.

  Molecular cancer 20100101

• What else in gemcitabine-pretreated advanced pancreatic cancer? An update of second line therapies.

  Reviews on recent clinical trials 20100101

• Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.

  Molecular pain 20100101

• Transient bilateral abducens neuropathy with post-tetanic facilitation and acute hypokalemia associated with oxaliplatin: a case report.

  Journal of medical case reports 20100101

• [Prognostic analysis of patients with liver metastases from colorectal cancer treated with different modes of therapy].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100101

• Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer.

  Journal of hematology & oncology 20100101

• Playing games with a thrombus: a dangerous match. Paradoxical embolism from a huge central venous cathether thrombus: a case report.

  Cardiovascular ultrasound 20100101

• A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes.

  BMC cancer 20100101

• The synergistic effect of recombinant human endostatin (YH-16) combined with oxaliplatin on human colorectal carcinoma.

  The Journal of international medical research 20100101

• Treatment-related toxicity and supportive care in metastatic colorectal cancer.

  The journal of supportive oncology 20100101

• Mexiletine reverses oxaliplatin-induced neuropathic pain in rats.

  Journal of pharmacological sciences 20100101

• Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American society of clinical oncology.

  Journal of hematology & oncology 20100101

• Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

  Journal of hematology & oncology 20100101

• Circadian rhythm and its role in malignancy.

  Journal of circadian rhythms 20100101

• Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer.

  Chemotherapy 20100101

• Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer.

  BMC cancer 20100101

• Cancer-drug associations: a complex system.

  PloS one 20100101

• Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.

  BMC cancer 20100101

• Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer.

  BMC cancer 20100101

• Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: do we have indications for individual risk stratification?

  World journal of surgical oncology 20100101

• Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer.

  Journal of oncology 20100101

• Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab.

  Journal of translational medicine 20100101

• Screening mammography use and chemotherapy among female stage II colon cancer patients: a retrospective cohort study.

  BMC health services research 20100101

• Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study.

  World journal of surgical oncology 20100101

• Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients.

  Journal of experimental & clinical cancer research : CR 20100101

• A phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) as first-line chemotherapy in advanced gastric cancer: a Chinese single-center experience.

  Chemotherapy 20100101

• Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.

  Oncology 20100101

• Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth.

  Journal of ovarian research 20100101

• [Adjuvant therapy in colon cancer].

  Onkologie 20100101

• [Specific treatment situations in metastatic colorectal cancer].

  Onkologie 20100101

• [Treatment of rectal cancer].

  Onkologie 20100101

• [Radiochemotherapy for locally advanced anal cancer].

  Onkologie 20100101

• Comparison between intensified neoadjuvant treatment and standard preoperative chemoradiation for rectal cancer.

  Tumori 20100101

• Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report.

  Tumori 20100101

• Toxicology and drug delivery by cucurbit[n]uril type molecular containers.

  PloS one 20100101

• Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis.

  World journal of surgical oncology 20100101

• Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.

  BMC cancer 20100101

• Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.

  Trials 20100101

• Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials.

  Journal of experimental & clinical cancer research : CR 20100101

• Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.

  Radiation oncology (London, England) 20100101

• Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response.

  The Journal of international medical research 20100101

• Metastatic colorectal cancer: from improved survival to potential cure.

  Oncology 20100101

• Strategic options on behalf of patients with metastatic colorectal cancer: mass tumor murder versus serial tumor killing.

  Onkologie 20100101

• Oxaliplatin, irinotecan and capecitabine (OCX) for first-line treatment of advanced/metastatic colorectal cancer: a phase I trial (SAKK 41/03).

  Onkologie 20100101

• Meta-analysis of chemotherapy with irinotecan or oxaliplatin-involved regimen for untreated metastatic advanced colorectal cancer.

  Oncology research 20100101

• Primary appendiceal mucinous adenocarcinoma alongside with situs inversus totalis: a unique clinical case.

  World journal of surgical oncology 20100101

• Stage II and stage III colon cancer: treatment advances and future directions.

  Cancer journal (Sudbury, Mass.) 20100101

• Optimal delivery of cytotoxic chemotherapy for colon cancer.

  Cancer journal (Sudbury, Mass.) 20100101

• Ovarian metastasis following gallbladder carcinoma: a case report.

  European journal of gynaecological oncology 20100101

• Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial.

  Journal of translational medicine 20100101

• Update on management of seminoma.

  Indian journal of urology : IJU : journal of the Urological Society of India 20100101

• Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists.

  BMC cancer 20100101

• Feasibility study of docetaxel, oxaliplatin and capecitabine combination regimen in advanced gastric or gastroesophageal adenocarcinoma.

  Hematology/oncology and stem cell therapy 20100101

• Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.

  Chemotherapy 20100101

• Accurate non-invasive image-based cytotoxicity assays for cultured cells.

  BMC biotechnology 20100101

• Tumor promoting effects of CD95 signaling in chemoresistant cells.

  Molecular cancer 20100101

• Cancerous stem cells: deviant stem cells with cancer-causing misbehavior.

  Stem cell research & therapy 20100101

• A pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team members.

  BMC health services research 20100101

• Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients.

  BMC cancer 20100101

• Tako-tsubo cardiomyopathy in a patient with advanced colorectal adenocarcinoma.

  Case reports in medicine 20100101

• Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.

  Journal of experimental & clinical cancer research : CR 20100101

• Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors.

  BMC cancer 20100101

• The role of radiotherapy in multimodal treatment of pancreatic carcinoma.

  Radiation oncology (London, England) 20100101

• New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab.

  OncoTargets and therapy 20100101

• Anti-angiogenesis therapies: their potential in cancer management.

  OncoTargets and therapy 20100101

• Clinical relevance of KRAS in human cancers.

  Journal of biomedicine & biotechnology 20100101

• Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.

  BMC cancer 20100101

• New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.

  Molecular cancer 20100101

• Use of clofarabine for acute childhood leukemia.

  Biologics : targets & therapy 20100101

• Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine.

  Bioinorganic chemistry and applications 20100101

• Is Platinum Present in Blood and Urine from Treatment Givers during Hyperthermic Intraperitoneal Chemotherapy?

  Journal of oncology 20100101

• Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature.

  Journal of medical case reports 20100101

• First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity.

  Journal of translational medicine 20100101

• Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines.

  Chinese medicine 20100101

• Oxaliplatin in patients with metastatic colorectal cancer: efficacy and pharmacokinetics parameters.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20100101

• Mitomycin C and UFT/leucovorin as salvage treatment in patients with advanced colorectal cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20100101

• Tian Xian Liquid (TXL) induces apoptosis in HT-29 colon cancer cell in vitro and inhibits tumor growth in vivo.

  Chinese medicine 20100101

• Adverse Interaction between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters: A Review of the Literature Starting from a Case Report.

  Case reports in medicine 20100101

• Angiogenesis inhibitors in the treatment of prostate cancer.

  Journal of hematology & oncology 20100101

• 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice.

  BMC cancer 20100101

• PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1.

  Journal of experimental & clinical cancer research : CR 20100101

• Scope of nanotechnology in ovarian cancer therapeutics.

  Journal of ovarian research 20100101

• Leveraging learning from a phase III colorectal cancer clinical trial: outcomes, methodology, meta-analysis and pharmacogenetics.

  Transactions of the American Clinical and Climatological Association 20100101

• Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China.

  Hepato-gastroenterology 20100101

• Fever-range whole body thermotherapy combined with oxaliplatin: a curative regimen in a pre-clinical breast cancer model.

  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20100101

• The challenge of metastatic colorectal cancer.

  Clinical Medicine Insights. Oncology 20100101

• [Surgical and combined treatment of patients with metastatic liver and lymph nodes invasion by colorectal cancer].

  Khirurgiia 20100101

• DNA-Destabilizing Agents as an Alternative Approach for Targeting DNA: Mechanisms of Action and Cellular Consequences.

  Journal of nucleic acids 20100101

• Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy.

  BMC cancer 20100101

• Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins.

  BMC cancer 20100101

• Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.

  BMC cancer 20100101

• A multicenter phase II trial with irinotecan plus oxaliplatin as first-line treatment for inoperable/metastatic cancer of the biliary tract.

  Oncology 20100101

• Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer.

  Oncology 20100101

• Pre-Steady-State Kinetic Analysis of Truncated and Full-Length Saccharomyces cerevisiae DNA Polymerase Eta.

  Journal of nucleic acids 20100101

• Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro.

  Journal of experimental & clinical cancer research : CR 20100101

• The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study.

  Radiation oncology (London, England) 20100101

• Cellular responses to Cisplatin-induced DNA damage.

  Journal of nucleic acids 20100101

• Lowering the apoptotic threshold in colorectal cancer cells by targeting mitochondria.

  Cancer cell international 20100101

• Pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen in gastric cancer: a case report.

  Journal of hematology & oncology 20100101

• Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.

  Molecular pain 20100101

• Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients.

  BMC cancer 20100101

• Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST.

  Journal of Cancer 20100101

• Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer.

  Journal of experimental & clinical cancer research : CR 20100101

• Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.

  Molecular cancer 20100101

• Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer.

  BMC cancer 20100101

• Current and emerging therapies for the treatment of pancreatic cancer.

  OncoTargets and therapy 20100101

• Computational analysis of the effects of antineoplastic agents on axonal transport.

  Journal of pharmacological sciences 20100101

• Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy.

  Case reports in medicine 20100101

• Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.

  Molecular cancer 20100101

• Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells.

  Molecular cancer 20100101

• Toll-like receptors, tissue injury, and tumourigenesis.

  Mediators of inflammation 20100101

• Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.

  BMC surgery 20100101

• Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.

  Metal-based drugs 20100101

• Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer.

  Radiation oncology (London, England) 20100101

• SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.

  BMC cancer 20100101

• Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs.

  Nutrition and cancer 20100101

• Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in Germany.

  Onkologie 20100101

• Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.

  Molecular cancer 20100101

• Architecture of y-family DNA polymerases relevant to translesion DNA synthesis as revealed in structural and molecular modeling studies.

  Journal of nucleic acids 20100101

• Replication Past the γ-Radiation-Induced Guanine-Thymine Cross-Link G[8,5-Me]T by Human and Yeast DNA Polymerase η.

  Journal of nucleic acids 20100101

• A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.

  BMC cancer 20100101

• The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials.

  BMC cancer 20100101

• Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer.

  BMC cancer 20100101

• Pegylated liposomal doxorubicin in the management of ovarian cancer.

  Therapeutics and clinical risk management 20100101

• 'Poker' association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study.

  BMC cancer 20100101

• Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report.

  BMC cancer 20100101

• Treatment effect or secret nature: long-term remissions in metastatic pancreatic cancer.

  Onkologie 20100101

• Sustained partial remission of metastatic pancreatic cancer following systemic chemotherapy with gemcitabine and oxaliplatin plus adjunctive treatment with mistletoe extract.

  Onkologie 20100101

• Tumor antigen cross-presentation and the dendritic cell: where it all begins?

  Clinical & developmental immunology 20100101

• Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction.

  Radiation oncology (London, England) 20100101

• Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer.

  BMC cancer 20100101

• Assessment of angiogenic factor, vascular endothelial growth factor, serum and urine level changes in superficial bladder tumor immunotherapy by intravesical Bacillus Calmette-Guerin.

  Urology annals 20100101

• Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells.

  Journal of hematology & oncology 20100101

• Detection of carcinoembryonic antigen messenger RNA in blood using quantitative real-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinoma.

  Journal of translational medicine 20100101

• Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.

  BMC cancer 20100101

• Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer.

  Core evidence 20100101

• Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting.

  Core evidence 20100101

• Triple-negative breast cancer.

  Breast cancer research : BCR 20100101

• Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma.

  BMC cancer 20100101

• Stop and go FOLFOX plus bevacizumab chemotherapy in the first-line treatment of metastatic colorectal cancer.

  Oncology 20100101

• Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1.

  Metallomics : integrated biometal science 20100101

• Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.

  BMC cancer 20100101

• The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.

  BMC cancer 20100101

• Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons.

  Molecular pain 20100101

• DNA polymerase η protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy.

  Journal of translational medicine 20100101

• KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice.

  BMC cancer 20100101

• Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers.

  Molecular cancer 20100101

• Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition.

  BMC cancer 20100101

• Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors.

  Asian Pacific journal of cancer prevention : APJCP 20100101

• Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX.

  Oncology 20100101

• pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.

  PloS one 20100101

• Unresectable gastric cancer with gastric outlet obstruction and distant metastasis responding to intraperitoneal and folfox chemotherapy after palliative laparoscopic gastrojejunostomy: report of a case.

  World journal of surgical oncology 20100101

• DNA aptamers as molecular probes for colorectal cancer study.

  PloS one 20100101

• The colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information.

  BMC cancer 20100101

• Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.

  BMC cancer 20100101

• Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review.

  Cancer management and research 20100101

• Management of metastatic renal cell carcinoma in patients with poor prognosis.

  Cancer management and research 20100101

• Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials.

  Cancer management and research 20100101

• Analysis of KRAS Mutations of Exon 2 Codons 12 and 13 by SNaPshot Analysis in Comparison to Common DNA Sequencing.

  Gastroenterology research and practice 20100101

• CoFactor: Folate Requirement for Optimization of 5-Fluouracil Activity in Anticancer Chemotherapy.

  Journal of oncology 20100101

• Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20100101

• Novel Organotin(IV)-Schiff Base Complexes: Synthesis, Characterization, Antimicrobial Activity, and DNA Interaction Studies.

  Bioinorganic chemistry and applications 20100101

• Clinical trials and progress with paclitaxel in ovarian cancer.

  International journal of women's health 20100101

• Regulation of Cisplatin cytotoxicity by cu influx transporters.

  Metal-based drugs 20100101

• The spectrum of use of rituximab in chronic lymphocytic leukemia.

  OncoTargets and therapy 20100101

• Pharmacological therapy of neuroendocrine tumors.

  Tumori 20100101

• Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications.

  Case reports in oncology 20100101

• Early onset of platinum hypersensitivity in a dentist: a case report.

  Case reports in oncology 20100101

• Interstitial lung disease associated with FOLFOX chemotherapy.

  Journal of cancer research and therapeutics 20100101

• Good clinical and cost outcomes using dexrazoxane to treat accidental epirubicin extravasation.

  Journal of cancer research and therapeutics 20100101

• Allogeneic hematopoietic cell transplantation in the treatment of chronic lymphocytic leukemia: why and when?

  Mediterranean journal of hematology and infectious diseases 20100101

• Allogeneic transplantation for chronic lymphocytic leukemia.

  Mediterranean journal of hematology and infectious diseases 20100101

• Reintroduction of oxaliplatin: a viable approach to the long-term management of metastatic colorectal cancer.

  Oncology 20100101

• Cerebellar ataxia with complete clinical recovery and resolution of MRI lesions related to central pontine myelinolysis: case report and literature review.

  Case reports in neurology 20100101

• Cutaneous metastasis at a surgical drain site after gastric cancer resection.

  Case reports in oncology 20100101

• Gemcitabine and s-1 combination chemotherapy in patients with advanced biliary tract cancer: a retrospective study.

  Case reports in oncology 20100101

• An adsorptive transfer technique coupled with brdicka reaction to reveal the importance of metallothionein in chemotherapy with platinum based cytostatics.

  International journal of molecular sciences 20100101

• Proteomic profiles of mesenchymal stem cells induced by a liver differentiation protocol.

  International journal of molecular sciences 20100101

• Advances in the treatment of gastroenteropancreatic neuroendocrine tumors.

  Clinical and experimental gastroenterology 20100101

• Increased interleukin-6 activity associated with painful chemotherapy-induced peripheral neuropathy in women after breast cancer treatment.

  Nursing research and practice 20100101

• Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment.

  Toxins 20100101

• In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds.

  Clinical pharmacology : advances and applications 20100101

• Genotyping and infection rate of GBV-C among Iranian HCV- infected patients.

  Hepatitis monthly 20100101

• Transcatheter arterial chemoembolization is a feasible palliative locoregional therapy for breast cancer liver metastases.

  International journal of surgical oncology 20100101

• KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.

  Ontario health technology assessment series 20100101

• En bloc resection for right colon cancer directly invading duodenum or pancreatic head.

  Yonsei medical journal 20091231

• Novel and emerging approaches for the delivery of metallo-drugs.

  Dalton transactions (Cambridge, England : 2003) 20091228

• Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia.

  Pain 20091215

• Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part I: exploration of 5-6 fused rings as alternative S1 moieties.

  Bioorganic & medicinal chemistry 20091215

• Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: exploration of 6-6 fused rings as alternative S1 moieties.

  Bioorganic & medicinal chemistry 20091215

• Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer.

  British journal of cancer 20091215

• [Meta-analyses of oxaliplatin-based chemotherapy versus cisplatin-based chemotherapy in advanced gastric cancer].

  Zhonghua yi xue za zhi 20091215

• Surgery for rare aneurysm associated with colorectal cancer.

  World journal of gastroenterology 20091214

• Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients.

  Swiss medical weekly 20091212

• Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.

  Chemico-biological interactions 20091210

• KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091210

• Severe hiccups during chemotherapy: corticosteroids the likely culprit.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20091201

• Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines.

  Cancer chemotherapy and pharmacology 20091201

• Blepharoptosis following oxaliplatin administration.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20091201

• A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20091201

• A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma.

  Cancer chemotherapy and pharmacology 20091201

• Triweekly oxaliplatin plus oral capecitabine as first-line chemotherapy in elderly patients with advanced gastric cancer.

  American journal of clinical oncology 20091201

• Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy.

  Biochemical pharmacology 20091201

• Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer.

  Journal of surgical oncology 20091201

• In vivo antitumor efficacy of interleukin-21 in combination with chemotherapeutics.

  Cytokine 20091201

• Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer.

  Cancer treatment reviews 20091201

• Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: a placebo-controlled double-blind randomized phase II study (the GONE Study).

  Japanese journal of clinical oncology 20091201

• Second-line therapy for advanced pancreatic cancer: a review of the literature and future directions.

  Cancer treatment reviews 20091201

• Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer.

  Cancer science 20091201

• Stop and go: yes or no?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091201

• Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091201

• Treatment of metastatic colorectal cancer in the elderly.

  Current treatment options in oncology 20091201

• Antiproliferative effect and genotoxicity of novel synthesized palladium complexes with organoarsenic ligands.

  Journal of inorganic biochemistry 20091201

• Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials.

  British journal of cancer 20091201

• Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre randomised phase II study.

  British journal of cancer 20091201

• Implications of KRAS mutation status for the treatment of metastatic colorectal cancer.

  Targeted oncology 20091201

• Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20091201

• Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX.

  Translational oncology 20091201

• [Efficacy of cetuximab combined with chemotherapy on advanced colorectal cancer: a report of 53 cases].

  Ai zheng = Aizheng = Chinese journal of cancer 20091201

• Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer.

  Current oncology (Toronto, Ont.) 20091201

• [Chemotherapy for colorectal cancer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20091201

• [Use of anti-EGFR antibodies (cetuximab and panitumumab) in the treatment of metastatic colorectal cancer in KRAS wild type patients].

  Bulletin du cancer 20091201

• [Impact of mutational status of KRAS in the care of patients with colorectal cancer metastasis].

  Bulletin du cancer 20091201

• [Validation study of KRAS mutation in colorectal cancer].

  Magyar onkologia 20091201

• [Oxaliplatin-based regimen for the treatment of advanced or metastatic gastric/esophagogastric junction cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20091201

• Adaptive group sequential design for phase II clinical trials: a Bayesian decision theoretic approach.

  Statistics in medicine 20091130

• Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer: the FOCUS trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120

• [Comparison of the Clinical Effects of Paclitaxel and Paclitaxel plus Oxaliplatin as the Second-line Treatment of Advanced Non-small Cell Lung Cancer.].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20091120

• A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer.

  British journal of cancer 20091117

• Cisplatin adducts on a GGG sequence within a DNA duplex studied by NMR spectroscopy and molecular dynamics simulations.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20091116

• Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer.

  International journal of radiation oncology, biology, physics 20091115

• Chemotherapy induces ATP release from tumor cells.

  Cell cycle (Georgetown, Tex.) 20091115

• Current data and strategy in glioblastoma multiforme.

  Journal of medicine and life 20091115

• ProLindac (AP5346): a review of the development of an HPMA DACH platinum Polymer Therapeutic.

  Advanced drug delivery reviews 20091112

• Inhibition of constitutive and cxc-chemokine-induced NF-kappaB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells.

  British journal of cancer 20091103

• Curcumin induces apoptosis-independent death in oesophageal cancer cells.

  British journal of cancer 20091103

• Human serum albumin interaction with oxaliplatin studied by capillary isoelectric focusing with the whole column imaging detection and spectroscopic method.

  Journal of pharmaceutical and biomedical analysis 20091101

• Antineoplastic activity of idazoxan hydrochloride.

  Cancer chemotherapy and pharmacology 20091101

• Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer.

  Cancer chemotherapy and pharmacology 20091101

• Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin.

  Cancer chemotherapy and pharmacology 20091101

• Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.

  Cancer chemotherapy and pharmacology 20091101

• New insights into the biotransformation and pharmacokinetics of oxaliplatin.

  Journal of pharmaceutical sciences 20091101

• Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20091101

• Down-regulation of alphav integrin by retroviral delivery of small interfering RNA reduces multicellular resistance of HT29.

  Cancer letters 20091101

• Future directions in neoadjuvant therapy of rectal cancer: maximizing pathological complete response rates.

  Cancer treatment reviews 20091101

• Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphisms.

  Annals of oncology : official journal of the European Society for Medical Oncology 20091101

• Treatment for colorectal liver metastases: a review.

  Langenbeck's archives of surgery 20091101

• A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer.

  International journal of colorectal disease 20091101

• Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy?

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20091101

• Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20091101

• Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat.

  Pain 20091101

• Bid and calpains cooperate to trigger oxaliplatin-induced apoptosis of cervical carcinoma HeLa cells.

  Molecular pharmacology 20091101

• OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma.

  Cardiovascular and interventional radiology 20091101

• Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth.

  Expert opinion on investigational drugs 20091101

• [Chemotherapy of colorectal cancer].

  Der Internist 20091101

• Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20091101

• Chemotherapy: Adding oxaliplatin to the equation.

  Nature reviews. Clinical oncology 20091101

• Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver.

  The oncologist 20091101

• Satraplatin: leading the new generation of oral platinum agents.

  Expert opinion on investigational drugs 20091101

• Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs.

  Journal of natural products 20091101

• Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20091101

• [Therapeutic effect of docetaxel combined with oxaliplatin for treatment of recurrent epithelial ovarian cancer].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20091101

• Phase 2 trial of docetaxel, gemcitabine, and oxaliplatin combination chemotherapy in platinum- and paclitaxel-pretreated epithelial ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20091101

• Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin.

  Anticancer research 20091101

• [Predictive factors for histopathological liver injury in the patients who received preoperative systemic chemotherapy for colorectal liver metastases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [A case of liver metastasis treated by cetuximab monotherapy with partial response].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [Treatment for intrapelvic recurrence of rectal cancer--resection versus chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• [A case of esophageal cancer associated with colon cancer successfully treated with combination chemotherapy of FOLFOX and concurrent radiotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases.

  HPB : the official journal of the International Hepato Pancreato Biliary Association 20091101

• Overview of systemic therapy for colorectal cancer.

  Clinics in colon and rectal surgery 20091101

• Heterogeneity of adenosine triphosphate-based chemotherapy response assay in colorectal cancer--secondary publication.

  Yonsei medical journal 20091031

• Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells.

  British journal of cancer 20091020

• Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis.

  British journal of cancer 20091020

• Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study).

  British journal of cancer 20091020

• Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial.

  Cancer 20091015

• Synthesis, spectroscopic, structural characterization, electrochemical and antimicrobial activity studies of the Schiff base ligand and its transition metal complexes.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20091015

• Oral poly(ADP-ribose) polymerase-1 inhibitor BSI-401 has antitumor activity and synergizes with oxaliplatin against pancreatic cancer, preventing acute neurotoxicity.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20091015

• Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.

  Journal of the National Cancer Institute 20091007

• CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone.

  British journal of cancer 20091006

• Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group.

  British journal of cancer 20091006

• Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial.

  British journal of cancer 20091006

• Trinuclear C3-symmetric extension of Jacobsen's catalyst: synthesis, characterization, and catalytic properties of a chiral trinuclear Mn(III) triplesalen complex.

  Inorganic chemistry 20091005

• A phase I study of an oral simulated FOLFOX with high dose capecitabine.

  Investigational new drugs 20091001

• The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy.

  Critical reviews in oncology/hematology 20091001

• Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group.

  Cancer chemotherapy and pharmacology 20091001

• Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20091001

• Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin.

  Cancer chemotherapy and pharmacology 20091001

• Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma.

  Cancer chemotherapy and pharmacology 20091001

• Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer.

  Cancer chemotherapy and pharmacology 20091001

• Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.

  Cancer chemotherapy and pharmacology 20091001

• The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.

  Cancer chemotherapy and pharmacology 20091001

• Comparative proteomic analysis of colon cancer cells in response to oxaliplatin treatment.

  Biochimica et biophysica acta 20091001

• Effective treatment of advanced colorectal cancer by rapamycin and 5-FU/oxaliplatin monitored by TIMP-1.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20091001

• Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review.

  Pharmacy world & science : PWS 20091001

• EXAFS structural study of platinum-based anticancer drugs degradation in presence of sulfur nucleophilic species.

  Biochimie 20091001

• Health utility scores of colorectal cancer based on societal preference in Japan.

  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20091001

• Combination therapy with oxaliplatin and 5-fluorouracil in a patient with severe hepatic dysfunction associated with metastatic adenocarcinoma of the large bowel.

  Anti-cancer drugs 20091001

• Cytotoxic activities, cellular uptake, gene regulation, and optical imaging of novel platinum(II) complexes.

  Chemical research in toxicology 20091001

• Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.

  European journal of pharmacology 20091001

• Neurological adverse effects caused by cytotoxic and targeted therapies.

  Nature reviews. Clinical oncology 20091001

• Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1.

  Oncology reports 20091001

• Long-term outcome of unresectable metastatic colorectal cancer: does 'adjuvant' chemotherapy play a role after resection?

  Annals of surgery 20091001

• Artificial neural networks for prediction of response to chemoradiation in HT29 xenografts.

  International journal of radiation oncology, biology, physics 20091001

• Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.

  Brain : a journal of neurology 20091001

• Chemotherapy: Optimizing irinotecan regimens for colorectal cancer.

  Nature reviews. Clinical oncology 20091001

• Adenocarcinoma of the small bowel: a surgical dilemma.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20091001

• [Progress in chemotherapy for advanced gastric cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20091001

• Improved patient and regimen selection in locally advanced rectal cancer: who, how, and what next?

  Clinical colorectal cancer 20091001

• Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?

  Clinical colorectal cancer 20091001

• Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury.

  Clinical colorectal cancer 20091001

• Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab.

  Clinical colorectal cancer 20091001

• NCCTG Study N9741: leveraging learning from an NCI Cooperative Group phase III trial.

  The oncologist 20091001

• [A case of liver metastasis of rectal cancer, refractory to previous chemotherapy(5-FU/LV, irinotecan, oxaliplatin) responding to bevacizumab combined with FOLFIRI chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091001

• Cisplatin and oxaliplatin cytotoxic effects in sensitive and cisplatin-resistant human cervical tumor cells: time and mode of application dependency.

  Anticancer research 20091001

• Crystallization and crystal-packing studies of Chlorella virus deoxyuridine triphosphatase.

  Acta crystallographica. Section F, Structural biology and crystallization communications 20091001

• Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan.

  International journal of clinical oncology 20091001

• Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX).

  International journal of clinical oncology 20091001

• Successful treatment of metastatic pancreatic adenocarcinoma with combination chemotherapy regimens.

  International journal of clinical oncology 20091001

• [Adjuvant chemotherapy after radical liver resection in the treatment of metastases from colorectal carcinoma].

  Minerva chirurgica 20091001

• Status of non-classical mononuclear platinum anticancer drug development.

  Mini reviews in medicinal chemistry 20091001

• The overexpression of ERCC-1 is involved in the resistance of lung cancer cells to cetuximab combined with DDP.

  Cancer biology & therapy 20091001

• HDAC inhibitors, MS275 and SBHA, enhances cytotoxicity induced by oxaliplatin in the colorectal cancer cell lines.

  Biochemical and biophysical research communications 20090918

• Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer.

  British journal of cancer 20090915

• Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2).

  British journal of cancer 20090915

• Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot study.

  World journal of gastroenterology 20090914

• Coupling CP-MD simulations and X-ray absorption spectroscopy: exploring the structure of oxaliplatin in aqueous solution.

  The journal of physical chemistry. B 20090910

• Impaired p53 binding to importin: a novel mechanism of cytoplasmic sequestration identified in oxaliplatin-resistant cells.

  Oncogene 20090903

• International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.

  Journal of the National Cancer Institute 20090902

• Critical role of external axial ligands in chirality amplification of trans-cyclohexane-1,2-diamine in salen complexes.

  Journal of the American Chemical Society 20090902

• Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090901

• In vitro chemosensitivity based on depth of invasion in advanced colorectal cancer using ATP-based chemotherapy response assay (ATP-CRA).

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20090901

• A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer.

  Journal of surgical oncology 20090901

• Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity.

  Cancer chemotherapy and pharmacology 20090901

• Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.

  Acta radiologica (Stockholm, Sweden : 1987) 20090901

• Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials group.

  Journal of cancer survivorship : research and practice 20090901

• The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast Cancer.

  Japanese journal of clinical oncology 20090901

• The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.

  Annals of surgical oncology 20090901

• Allergic reactions to oxaliplatin in a single institute in Japan.

  Japanese journal of clinical oncology 20090901

• A phase II study of docetaxel and oxaliplatin for second-line treatment of urothelial carcinoma.

  Chemotherapy 20090901

• Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?

  European journal of cancer (Oxford, England : 1990) 20090901

• Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature previously presented: poster at the 2008 Gastrointestinal Cancer Symposium (Abstract No. 512).

  Expert opinion on investigational drugs 20090901

• Differences in repair of DNA cross-links between lymphocytes and epithelial tumor cells from colon cancer patients measured in vitro with the comet assay.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090901

• Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.

  The oncologist 20090901

• [Efficacy of FORFIRI regimen on oxaliplatin-based chemotherapy-failed advanced colorectal cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20090901

• [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20090901

• [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].

  Ai zheng = Aizheng = Chinese journal of cancer 20090901

• [Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].

  Ai zheng = Aizheng = Chinese journal of cancer 20090901

• Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines.

  British journal of pharmacology 20090901

• [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in gastric carcinoma].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20090901

• [A case of rectal cancer with liver metastases successfully treated with modified FOLFOX6 therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090901

• Chemotherapy, which drugs and when.

  European journal of cancer (Oxford, England : 1990) 20090901

• [The development of the first line treatment of metastatic colorectal cancer (mCRC)].

  Magyar onkologia 20090901

• Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer.

  Current oncology (Toronto, Ont.) 20090901

• Variant hypersensitivity reaction (HSR) presented with persistent dry cough after receiving oxaliplatin in a pancreatic cancer patient.

  Iranian journal of allergy, asthma, and immunology 20090901

• Medical treatment of advanced colorectal cancer in 2009.

  Therapeutic advances in medical oncology 20090901

• Divide and conquer: progress in the molecular stratification of cancer.

  Yonsei medical journal 20090831

• Cancer and chemotherapy.

  BMJ (Clinical research ed.) 20090824

• Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer.

  World journal of gastroenterology 20090821

• The role of apoptotic cell death in the radiosensitising effect of gemcitabine.

  British journal of cancer 20090818

• Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090810

• Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090810

• Irinotecan therapy and molecular targets in colorectal cancer: a systemic review.

  World journal of gastroenterology 20090807

• Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response.

  British journal of cancer 20090804

• Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.

  British journal of cancer 20090804

• Effect of an in-plane ligand on the electronic structures of bromo-bridged nano-wire Ni-Pd mixed-metal complexes, [Ni(1-x)Pd(x)(bn)2Br]Br2 (bn = 2S,3S-diaminobutane).

  Inorganic chemistry 20090803

• Gastric cancer.

  Critical reviews in oncology/hematology 20090801

• Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics.

  European journal of nuclear medicine and molecular imaging 20090801

• Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature.

  Anti-cancer drugs 20090801

• Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study.

  Pain 20090801

• Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090801

• FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090801

• Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experience.

  Cancer 20090801

• Oxaliplatin-induced painful neuropathy--flicker of hope or hopeless pain?

  Pain 20090801

• A case report of pathologically complete response of a huge rectal cancer after systemic chemotherapy with mFOLFOX6.

  Japanese journal of clinical oncology 20090801

• The case for selective use of pre-operative chemotherapy for hepatic colorectal metastases: more is not always better.

  Annals of surgical oncology 20090801

• Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients.

  Expert opinion on biological therapy 20090801

• Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models.

  Oncology reports 20090801

• Docetaxel and oxaliplatin as first-line therapy for advanced non-small cell lung cancer: a phase II trial.

  Journal of chemotherapy (Florence, Italy) 20090801

• Adjuvant chemotherapy for stages II, III and IV of colon cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090801

• In vitro evaluation of histone deacetylase inhibitors as combination agents for colorectal cancer.

  Anticancer research 20090801

• Chemoresponsiveness associated with canonical molecular changes in colorectal adenocarcinomas.

  Anticancer research 20090801

• A novel K-ras mutation in colorectal cancer. A case report and literature review.

  Anticancer research 20090801

• [First/second/third-line chemotherapy with molecular targeted drugs for colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090801

• [Chemotherapy and hepatectomy for liver metastasis from colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090801

• [Survey of oxaliplatin-associated peripheral sensory neuropathy using an interview-based questionnaire in patients with advanced colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090801

• [The pharmacokinetics and safety of oxaliplatin in a hemodialysis patient treated with mFOLFOX6 therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090801

• [Multicenter investigation of preventive measures against FOLFOX-induced neurotoxicity-a project of the 4th Chapter of the Oncology Research Group, Aichi Prefectural Society of Hospital Pharmacists].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090801

• [Very late development of hepatic metastases].

  Journal de chirurgie 20090801

• Family history of cancer rather than p53 status predicts efficacy of pegylated liposomal doxorubicin and oxaliplatin in relapsed ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20090801

• [Neoadjuvant chemotherapy of FLEEOX regimen for unresectable gastric cancer resulting from advanced abdominal lymph nodes metastases].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20090801

• Quantification of trace elements in natural samples by electrospray ionization mass spectrometry with a size-exclusion column based on the formation of metal-aminopolycarboxylate complexes.

  Analytical chemistry 20090801

• Metastatic rectal cancer to the breast.

  Rare tumors 20090722

• Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.

  British journal of cancer 20090721

• Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090720

• Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice.

  Neuroscience letters 20090717

• [Predictive biomarkers in colorectal cancer].

  Revue medicale suisse 20090715

• Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090710

• Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090710

• Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials.

  British journal of cancer 20090707

• Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.

  JOP : Journal of the pancreas 20090706

• Oxaliplatin-induced hyperexcitability syndrome in a patient with pancreatic cancer.

  JOP : Journal of the pancreas 20090706

• Simple cyclohexanediamine-derived primary amine thiourea catalyzed highly enantioselective conjugate addition of nitroalkanes to enones.

  Organic letters 20090702

• The role of salvage treatment in advanced colorectal cancer.

  Critical reviews in oncology/hematology 20090701

• Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study.

  Cancer chemotherapy and pharmacology 20090701

• A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20090701

• Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes.

  Cancer chemotherapy and pharmacology 20090701

• Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis.

  Cancer chemotherapy and pharmacology 20090701

• Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancer.

  Cancer chemotherapy and pharmacology 20090701

• A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma.

  Cancer chemotherapy and pharmacology 20090701

• A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer.

  Cancer chemotherapy and pharmacology 20090701

• A case of oxaliplatin overdose.

  Pediatric blood & cancer 20090701

• Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090701

• Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090701

• Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.

  Journal of controlled release : official journal of the Controlled Release Society 20090701

• Synchronous colorectal liver metastases: triumph of prospective randomized trials over observational bias leads to paradigm shift.

  Annals of surgical oncology 20090701

• Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.

  Cardiovascular and interventional radiology 20090701

• Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin.

  Cancer investigation 20090701

• Cisplatin-induced DNA damage activates replication checkpoint signaling components that differentially affect tumor cell survival.

  Molecular pharmacology 20090701

• The mechanism of the actions of oxaliplatin on ion currents and action potentials in differentiated NG108-15 neuronal cells.

  Neurotoxicology 20090701

• Clinical implications of microsatellite instability in sporadic colon cancers.

  Current opinion in oncology 20090701

• Oxaliplatin or irinotecan as adjuvant therapy for colon cancer: the results are in.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090701

• Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090701

• Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands.

  Journal of inorganic biochemistry 20090701

• Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study.

  European journal of cancer (Oxford, England : 1990) 20090701

• ERCC5 promoter polymorphisms at -763 and +25 predict the response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer.

  Cancer biology & therapy 20090701

• Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090701

• A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?

  European journal of cancer (Oxford, England : 1990) 20090701

• Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin.

  Journal of inorganic biochemistry 20090701

• Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI.

  Oncology reports 20090701

• 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer.

  Cancer research 20090701

• Genetic prognostic and predictive markers in colorectal cancer.

  Nature reviews. Cancer 20090701

• Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.

  Cancer research 20090701

• Bevacizumab plus oxaliplatin-based regimens for the treatment of colorectal cancer.

  Onkologie 20090701

• Base excision repair of reactive oxygen species-initiated 7,8-dihydro-8-oxo-2'-deoxyguanosine inhibits the cytotoxicity of platinum anticancer drugs.

  Molecular cancer therapeutics 20090701

• Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab.

  The Annals of pharmacotherapy 20090701

• Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.

  Anticancer research 20090701

• [Clinical research of bevacizumab in combination with irinotecan, fluorouracil and leucovorin for advanced metastatic colorectal cancer].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20090701

• [Effect of preliminary medication on oxaliplatin hypersensitivity].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090701

• [A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090701

• [A case of advanced gastric and rectal cancer (double cancer) successfully treated with mFOLFOX6 therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090701

• [Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].

  Ai zheng = Aizheng = Chinese journal of cancer 20090701

• Delayed reversible posterior encephalopathy syndrome following chemotherapy with oxaliplatin.

  Clinical colorectal cancer 20090701

• A case of 5-fluorouracil-induced acute psychosis.

  Clinical colorectal cancer 20090701

• [Comparison of therapeutic effects of chemotherapy combined with radiotherapy versus chemotherapy alone in initial treatment of advanced gastric adenocarcinoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090701

• Impact of irinotecan and oxaliplatin on overall survival in patients with metastatic colorectal cancer: a population-based study.

  Journal of oncology practice 20090701

• FOLFOX-4 Regimen as a First-line Therapy for Cuban Patients with Metastatic Colorectal Cancer.

  MEDICC review 20090701

• TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells.

  Cancer letters 20090628

• Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study.

  British journal of cancer 20090616

• Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy.

  International journal of cancer 20090615

• Cisplatin-induced nitrosylation of p53 prevents its mitochondrial translocation.

  Free radical biology & medicine 20090615

• New perspectives in the treatment of advanced or metastatic gastric cancer.

  World journal of gastroenterology 20090614

• Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090610

• Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090610

• A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer.

  British journal of cancer 20090602

• A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma.

  British journal of cancer 20090602

• Treatment in advanced colorectal cancer: what, when and how?

  British journal of cancer 20090602

• A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer.

  Investigational new drugs 20090601

• A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin's lymphoma.

  Cancer chemotherapy and pharmacology 20090601

• A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer.

  Investigational new drugs 20090601

• Role of copper transporters in resistance to platinating agents.

  Cancer chemotherapy and pharmacology 20090601

• Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer.

  Investigational new drugs 20090601

• Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090601

• Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090601

• Interstitial continuous infusion therapy in a malignant glioma model in rats.

  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20090601

• Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090601

• Irinotecan as palliative chemotherapy for metastatic colorectal cancer: evolving tactics following initial treatment.

  International journal of colorectal disease 20090601

• Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity.

  Anti-cancer drugs 20090601

• A patient with huge hepatocellular carcinoma who had a complete clinical response to p53 gene combined with chemotherapy and transcatheter arterial chemoembolization.

  Anti-cancer drugs 20090601

• Combination effects of SC144 and cytotoxic anticancer agents.

  Anti-cancer drugs 20090601

• Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study.

  Gynecologic oncology 20090601

• Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome.

  Journal of surgical oncology 20090601

• Interaction of antitumor platinum complexes with human liver microsomal cytochromes P450.

  Anti-cancer drugs 20090601

• Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer.

  Cancer research 20090601

• Blocking phosphoinositide 3-kinase activity in colorectal cancer cells reduces proliferation but does not increase apoptosis alone or in combination with cytotoxic drugs.

  Molecular cancer research : MCR 20090601

• Conditional drug screening shows that mitotic inhibitors induce AKT/PKB-insensitive apoptosis.

  Journal of chemical biology 20090601

• Oxaliplatin-induced transient ischaemic attack.

  Internal medicine journal 20090601

• [Chemotherapy of elderly patients with colorectal cancer].

  Magyar onkologia 20090601

• [Panitumumab-treatment of metastatic colorectal cancer].

  Magyar onkologia 20090601

• Epidermal growth factor receptor expression discrepancies in metastatic colorectal cancer patients treated with cetuximab plus irinotecan-based chemotherapy refractory to irinotecan and oxaliplatin.

  Diseases of the colon and rectum 20090601

• Current role of bevacizumab in colorectal cancer.

  Clinical advances in hematology & oncology : H&O 20090601

• [Efficacy and safety of combination of irinotecan and capecitabine in patients with metastatic colorectal cancer after failure of chemotherapy with oxaliplatin].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20090601

• [Chemotherapy and biological treatment in the complex management of large intestinal and rectal carcinomas. When, why, how?].

  Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti 20090601

• Dose escalation methods in phase I cancer clinical trials.

  Journal of the National Cancer Institute 20090520

• Chemistry and biology of DNA containing 1,N(2)-deoxyguanosine adducts of the alpha,beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal.

  Chemical research in toxicology 20090518

• Chemotherapy and immunotherapy in metastatic colorectal cancer.

  The New England journal of medicine 20090514

• Chemotherapy and immunotherapy in metastatic colorectal cancer.

  The New England journal of medicine 20090514

• Chemotherapy and immunotherapy in metastatic colorectal cancer.

  The New England journal of medicine 20090514

• Characterizing Pt-derived anticancer drugs from first principles: the case of oxaliplatin in aqueous solution.

  Chemphyschem : a European journal of chemical physics and physical chemistry 20090511

• Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells.

  British journal of cancer 20090505

• Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.

  Cancer chemotherapy and pharmacology 20090501

• Portal venous gas following chemotherapy for colorectal cancer liver metastasis.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20090501

• Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab.

  Pediatric blood & cancer 20090501

• Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study.

  Critical reviews in oncology/hematology 20090501

• Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090501

• Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090501

• Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20090501

• Recent progress in pathogenesis and management of colorectal cancer. Eighteenth International Symposium of the Hiroshima Cancer Seminar, November 2008.

  Cancer science 20090501

• Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.

  The journal of pain : official journal of the American Pain Society 20090501

• Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?

  World journal of surgery 20090501

• A phase 2 clinical trial of panitumumab monotherapy in Japanese patients with metastatic colorectal cancer.

  Japanese journal of clinical oncology 20090501

• Current management of anal canal cancer.

  Current oncology reports 20090501

• Preparation of mammalian expression vectors incorporating site-specifically platinated-DNA lesions.

  Bioconjugate chemistry 20090501

• Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in cisplatin-refractory germ cell tumor.

  Southern medical journal 20090501

• A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090501

• Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress.

  Cancer research 20090501

• A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.

  Annals of surgery 20090501

• Medical Oncology: IROX as second-line therapy for metastatic colorectal cancer.

  Nature reviews. Clinical oncology 20090501

• Medical Oncology: Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer.

  Nature reviews. Clinical oncology 20090501

• Retrospective analysis of S-1 monotherapy in patients with metastatic colorectal cancer after failure to fluoropyrimidine and irinotecan or to fluoropyrimidine, irinotecan and oxaliplatin.

  Japanese journal of clinical oncology 20090501

• Delayed oxaliplatin-induced sensorimotor polyneuropathy.

  Onkologie 20090501

• [Clinical study of postoperative intraperitoneal chemotherapy combined with systemic chemotherapy for serosa-involved colorectal cancer].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20090501

• First-line simplified GEMOX (S-GemOx) versus classical GEMOX in metastatic pancreatic cancer (MPA): results of a GERCOR randomized phase II study.

  Bulletin du cancer 20090501

• Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis.

  Anticancer research 20090501

• Interstitial lung disease associated with oxaliplatin: description of two cases.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090501

• The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.

  Gan to kagaku ryoho. Cancer & chemotherapy 20090501

• Oxaliplatin regulates DNA repair responding to ionizing radiation and enhances radiosensitivity of human cervical cancer cells.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20090501

• Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction.

  Yonsei medical journal 20090430

• Synthesis, characterization, and application of vanadium-salan complexes in oxygen transfer reactions.

  Inorganic chemistry 20090420

• Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation.

  The Journal of biological chemistry 20090417

• Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study.

  Cancer 20090415

• Second-line chemotherapy in advanced and metastatic CRC.

  The Cochrane database of systematic reviews 20090415

• Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study.

  British journal of cancer 20090407

• 'Natural history' of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20090401

• A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20090401

• A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.

  Cancer chemotherapy and pharmacology 20090401

• The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.

  Cancer chemotherapy and pharmacology 20090401

• A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma.

  Cancer chemotherapy and pharmacology 20090401

• A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20090401

• Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.

  European radiology 20090401

• Adjuvant therapy for colon cancer: present and perspectives.

  Cancer treatment reviews 20090401

• Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases.

  International journal of colorectal disease 20090401

• Shifting to first-line regimen after previous failure of irinotecan and oxaliplatin containing chemotherapies in unresectable metastatic colorectal cancer: a retrospective study of case analysis.

  International journal of colorectal disease 20090401

• Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function.

  The pharmacogenomics journal 20090401

• Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer.

  Anti-cancer drugs 20090401

• Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.

  Transfusion 20090401

• Costs associated with complications are lower with capecitabine than with 5-fluorouracil in patients with colorectal cancer.

  Cancer 20090401

• Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.

  Cell proliferation 20090401

• A phase II study of modified FOLFOX as first-line chemotherapy in elderly patients with advanced gastric cancer.

  Anti-cancer drugs 20090401

• Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases.

  Surgery 20090401

• Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer.

  Nature reviews. Clinical oncology 20090401

• Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha(2)delta-1 subunit.

  Biological & pharmaceutical bulletin 20090401

• 10 years of NICE: still growing and still controversial.

  The Lancet. Oncology 20090401

• [Colorectal cancers: prognostic and predictive factors of response to treatment].

  Bulletin du cancer 20090401

• A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines.

  Molecular cancer therapeutics 20090401

• Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin.

  Molecular cancer therapeutics 20090401

• Phase II trial of capecitabine and oxaliplatin in patients with adeno- and undifferentiated carcinoma of unknown primary.

  Onkologie 20090401

• Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.

  Expert review of anticancer therapy 20090401

• [A case report of FOLFOX treatment for primary duodenal carcinoma with multiple liver metastases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090401

• The role of meta-analysis in cancer clinical trials.

  International journal of clinical oncology 20090401

• Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix.

  Canadian journal of surgery. Journal canadien de chirurgie 20090401

• Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine.

  Chinese journal of integrative medicine 20090401

• What's new in ... colorectal cancer. Meaningful progress in therapy options.

  JAAPA : official journal of the American Academy of Physician Assistants 20090401

• [Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090401

• [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20090401

• [Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20090401

• Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.

  Clinical colorectal cancer 20090401

• The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer.

  British journal of cancer 20090324

• Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy.

  British journal of cancer 20090324

• A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers.

  The EMBO journal 20090318

• Clinically important aspects of lymph node assessment in colon cancer.

  Journal of surgical oncology 20090315

• Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310

• Relation between outcomes and localisation of p-mTOR expression in gastric cancer.

  British journal of cancer 20090310

• Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.

  British journal of cancer 20090310

• Advancements in the management of pancreatic cancer.

  JOP : Journal of the pancreas 20090309

• Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death.

  The EMBO journal 20090304

• Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.

  FEBS letters 20090304

• ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair.

  Cancer chemotherapy and pharmacology 20090301

• Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases.

  Journal of cancer research and clinical oncology 20090301

• Hyperthermic intraperitoneal perfusion chemotherapy--views on the observed variability in oxaliplatin pharmacokinetics.

  European journal of clinical pharmacology 20090301

• Pharmacogenetic analyses of hematotoxicity in advanced gastric cancer patients receiving biweekly fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

  Annals of oncology : official journal of the European Society for Medical Oncology 20090301

• Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients.

  European journal of cancer (Oxford, England : 1990) 20090301

• Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: the CORGI-L Study.

  European journal of cancer (Oxford, England : 1990) 20090301

• Caveolin-1 as a prognostic marker for local control after preoperative chemoradiation therapy in rectal cancer.

  International journal of radiation oncology, biology, physics 20090301

• Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.

  Cancer science 20090301

• XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis.

  Current medical research and opinion 20090301

• Discovery of a novel quinoxalinhydrazide with a broad-spectrum anticancer activity.

  Cancer biology & therapy 20090301

• Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.

  Cancer research 20090301

• Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases.

  Annals of surgery 20090301

• Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases.

  The Lancet. Oncology 20090301

• Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy.

  Current drug discovery technologies 20090301

• Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice.

  Journal of pharmacological sciences 20090301

• FDA review of a panitumumab (Vectibix) clinical trial for first-line treatment of metastatic colorectal cancer.

  The oncologist 20090301

• Localized squamous cell carcinoma of the esophagus: bimodality or trimodality approach?

  Future oncology (London, England) 20090301

• Second-line therapy in refractory pancreatic cancer. results of a phase II study.

  Onkologie 20090301

• Clinical and pharmacokinetics study of oxaliplatin in colon cancer patients.

  Journal of gastrointestinal and liver diseases : JGLD 20090301

• Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20090301

• Role of MAPKs in platinum-induced neuronal apoptosis.

  Neurotoxicology 20090301

• [FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090301

• Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group.

  British journal of cancer 20090224

• Effect of portal vein embolisation on the growth rate of colorectal liver metastases.

  British journal of cancer 20090224

• Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer.

  World journal of gastroenterology 20090221

• Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model.

  Journal of controlled release : official journal of the Controlled Release Society 20090220

• Spectroscopic investigation on the binding of antineoplastic drug oxaliplatin to human serum albumin and molecular modeling.

  Colloids and surfaces. B, Biointerfaces 20090215

• Phase I study of cediranib in combination with oxaliplatin and infusional 5-Fluorouracil in patients with advanced colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090215

• Complete peritonectomy and intraperitoneal chemotherapy for recurrent rectal cancer with peritoneal metastasis.

  World journal of gastroenterology 20090214

• Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090210

• Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090210

• A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090210

• Expanding the chemical nature of siRNAs: oxaliplatin as metalation reagent.

  Biochemical and biophysical research communications 20090206

• Novel chiral molecular tweezer from (+)-usnic acid.

  Organic letters 20090205

• Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.

  The New England journal of medicine 20090205

• Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.

  Cancer chemotherapy and pharmacology 20090201

• Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

  Cancer chemotherapy and pharmacology 20090201

• Cytotoxic, antioxidant activities and structure activity relationship of some newly synthesized terpenoidal oxaliplatin analogs.

  European journal of medicinal chemistry 20090201

• An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients.

  Lung cancer (Amsterdam, Netherlands) 20090201

• Impact of different anticancer regimens on biomarkers of angiogenesis in patients with advanced hepatocellular cancer.

  Journal of cancer research and clinical oncology 20090201

• Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.

  Journal of cancer research and clinical oncology 20090201

• Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay.

  International journal of colorectal disease 20090201

• Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090201

• The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs.

  Molecular pharmacology 20090201

• A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer.

  Annals of surgical oncology 20090201

• Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention.

  Annals of surgical oncology 20090201

• Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy.

  Journal of surgical oncology 20090201

• Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors.

  Cancer 20090201

• Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.

  Oncology reports 20090201

• Evolution of nonsurgical therapy for colorectal cancer.

  Nature clinical practice. Gastroenterology & hepatology 20090201

• Stability of oxaliplatin solution.

  The Annals of pharmacotherapy 20090201

• Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.

  American journal of clinical oncology 20090201

• Oxaliplatin, 5-fluorouracil, and leucovorin as second-line treatment for advanced pancreatic cancer.

  American journal of clinical oncology 20090201

• Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience.

  Anti-cancer drugs 20090201

• Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines.

  Anti-cancer drugs 20090201

• Extravasation of oxaliplatin: an infrequent and irritant toxicity.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20090201

• [Treatments of epithelial ovarian cancer by histologic subtype].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090201

• Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.

  Cancer investigation 20090201

• New-generation platinum agents for solid tumors.

  Future oncology (London, England) 20090201

• The CAIRO and FOCUS studies: which lesson is to be learned?

  The oncologist 20090201

• Definitive chemoradiotherapy with capecitabine and cisplatin in patients with esophageal cancer: a pilot study.

  Journal of Korean medical science 20090201

• The European contribution to 'Sugarbaker's protocol' for the treatment of colorectal peritoneal carcinomatosis.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20090201

• Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090131

• Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer.

  British journal of cancer 20090127

• Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience.

  British journal of cancer 20090127

• Deficient mismatch repair system in patients with sporadic advanced colorectal cancer.

  British journal of cancer 20090127

• Neutral and acidic hydrolysis reactions of the third generation anticancer drug oxaliplatin.

  The journal of physical chemistry. B 20090122

• gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.

  Cancer research 20090115

• Molecular therapy for the treatment of hepatocellular carcinoma.

  British journal of cancer 20090113

• Irinotecan plus carboplatin for patients with carcinoma of unknown primary site.

  British journal of cancer 20090113

• Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.

  Journal of the National Cancer Institute 20090107

• Administration of oxaliplatin to a pregnant woman with rectal cancer.

  Cancer chemotherapy and pharmacology 20090101

• Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis.

  Medical oncology (Northwood, London, England) 20090101

• Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer--an extended phase I MARGIT and AIO trial.

  International journal of radiation oncology, biology, physics 20090101

• Oxaliplatin-induced long QT syndrome in a patient with appendiceal adenocarcinoma.

  Acta oncologica (Stockholm, Sweden) 20090101

• Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20090101

• An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20090101

• Review article: benefits and risks of chemotherapy in elderly patients with metastatic colorectal cancer.

  Alimentary pharmacology & therapeutics 20090101

• A comparison of XELOX with FOLFOX-4 as first-line treatment for metastatic colorectal cancer.

  Nature clinical practice. Oncology 20090101

• Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer.

  Gynecologic oncology 20090101

• Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases.

  Annals of surgical oncology 20090101

• Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.

  Oncology 20090101

• Small-vessel vasculitis following treatment with combination 5-fluorouracil/folinic acid and oxaliplatin.

  Clinical and experimental dermatology 20090101

• Update on medication-induced peripheral neuropathy.

  Current neurology and neuroscience reports 20090101

• Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases.

  Journal of hepato-biliary-pancreatic surgery 20090101

• Intermittent therapy in the palliative treatment of metastatic colorectal cancer.

  Expert review of anticancer therapy 20090101

• Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

  BMC cancer 20090101

• Does doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?

  World journal of surgical oncology 20090101

• Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells.

  Cancer cell international 20090101

• Effects of oxaliplatin and 5-fluorouracil on the healing of colon anastomoses.

  Surgery today 20090101

• Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

  World journal of surgical oncology 20090101

• Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections.

  World journal of surgical oncology 20090101

• A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer.

  BMC surgery 20090101

• Oxaliplatin neurotoxicity--no general ion channel surface-charge effect.

  Journal of negative results in biomedicine 20090101

• Platinum neurotoxicity pharmacogenetics.

  Molecular cancer therapeutics 20090101

• In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models.

  Molecular cancer therapeutics 20090101

• Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer.

  Molecular cancer therapeutics 20090101

• The role of capecitabine in the management of tumors of the digestive system.

  Reviews on recent clinical trials 20090101

• Treatment of colorectal liver metastases: a review.

  Reviews on recent clinical trials 20090101

• [Evaluation of efficacy and safety of adjuvant analgesics for peripheral neuropathy induced by cancer chemotherapy in digestive cancer patients-a pilot study].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090101

• [Pharmacokinetic monitoring of 5-fluorouracil may improve the clinical benefit with an individualized regimen-a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090101

• Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancer.

  Oncology 20090101

• Influence of the hOCT2 inhibitor cimetidine on the cellular accumulation and cytotoxicity of oxaliplatin.

  International journal of clinical pharmacology and therapeutics 20090101

• Does celecoxib have a role in the treatment of patients with colorectal cancer?

  Clinical colorectal cancer 20090101

• Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer.

  Clinical colorectal cancer 20090101

• Panitumumab monotherapy in patients with metastatic colorectal cancer and cetuximab infusion reactions: a series of four case reports.

  Clinical colorectal cancer 20090101

• Oxaliplatin-mediated autoimmune thrombocytopenia.

  Clinical colorectal cancer 20090101

• Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations.

  Current oncology (Toronto, Ont.) 20090101

• Drug-induced immune hemolytic anemia.

  Expert opinion on drug safety 20090101

• Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology.

  Journal of hematology & oncology 20090101

• Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy.

  World journal of surgical oncology 20090101

• Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I(131) KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma.

  BMC cancer 20090101

• Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli.

  Molecular pain 20090101

• Hypersensitivity reactions: an increasingly recognized toxicity of platinum agents.

  Oncology 20090101

• Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review.

  Oncology 20090101

• Acute and long-term gastrointestinal consequences of chemotherapy.

  Best practice & research. Clinical gastroenterology 20090101

• The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin.

  PloS one 20090101

• Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma.

  Journal of experimental & clinical cancer research : CR 20090101

• Immunotherapy for liver tumors: present status and future prospects.

  Journal of biomedical science 20090101

• Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck.

  Journal of experimental & clinical cancer research : CR 20090101

• The role of UFT in metastatic colorectal cancer.

  Oncology 20090101

• Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study.

  Oncology 20090101

• Persistent neuropathy after treatment with cisplatin and oxaliplatin.

  Acta oncologica (Stockholm, Sweden) 20090101

• Synchronous colorectal adenocarcinoma and gastrointestinal stromal tumor in Meckel's diverticulum; an unusual association.

  World journal of surgical oncology 20090101

• An unusual presentation of hand-foot syndrome at the hidden area: the scrotum and penis.

  Acta oncologica (Stockholm, Sweden) 20090101

• Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide.

  Anticancer research 20090101

• Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin.

  Anti-cancer drugs 20090101

• Microsatellite instability: a predictive marker in metastatic colorectal cancer?

  Targeted oncology 20090101

• Efficacy and safety of capecitabine and oxaliplatin combination as second-line treatment in advanced colorectal cancer.

  American journal of therapeutics 20090101

• The spectrum of 5-fluorouracil cardiotoxicity.

  Anti-cancer drugs 20090101

• A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer.

  BMC cancer 20090101

• Update in antiepidermal growth factor receptor therapy in the management of metastatic colorectal cancer.

  Journal of oncology 20090101

• Feasibility study of biweekly capecitabine, oxaliplatin, and irinotecan in patients with untreated advanced gastric cancer.

  Tumori 20090101

• Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study.

  BMC cancer 20090101

• A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer.

  In vivo (Athens, Greece) 20090101

• Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics.

  PloS one 20090101

• Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial.

  BMC cancer 20090101

• Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy.

  Journal of hematology & oncology 20090101

• Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205.

  Cancer cell international 20090101

• Pharmacogenetics in chemotherapy of colorectal cancer.

  Best practice & research. Clinical gastroenterology 20090101

• Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers.

  Journal of oncology 20090101

• Role of oxaliplatin in the treatment of colorectal cancer.

  Therapeutics and clinical risk management 20090101

• Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab.

  Therapeutics and clinical risk management 20090101

• Fludarabine in the treatment of chronic lymphocytic leukemia: a review.

  Therapeutics and clinical risk management 20090101

• A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer.

  BMC cancer 20090101

• Best cases from the AFIP: urachal carcinoma.

  Radiographics : a review publication of the Radiological Society of North America, Inc 20090101

• A phase II trial of epirubicin plus oxaliplatin and fluorouracil as first-line chemotherapy for advanced gastric cancer.

  Ai zheng = Aizheng = Chinese journal of cancer 20090101

• Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.

  Chemotherapy 20090101

• Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy.

  World journal of surgical oncology 20090101

• A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases.

  BMC cancer 20090101

• Exploration of platinum-induced neuropathy should be based on both objective and subjective examinations.

  Acta oncologica (Stockholm, Sweden) 20090101

• Rapid correction of severe hyperglycaemia during hyperthermic intraperitoneal chemoperfusion with oxaliplatin.

  Acta chirurgica Belgica 20090101

• Refractory lympho-epithelial carcinoma of the nasopharynx: a case report illustrating a protracted clinical course.

  Head & neck oncology 20090101

• Recent advances in biomedical applications of accelerator mass spectrometry.

  Journal of biomedical science 20090101

• Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting.

  Therapeutics and clinical risk management 20090101

• [Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090101

• Rapid photothermal intracellular drug delivery using multiwalled carbon nanotubes.

  Molecular pharmaceutics 20090101

• [Laparoscopic surgery and adjuvant therapy for colon cancer].

  Onkologie 20090101

• [Neoadjuvant and surgical treatment for rectal cancer].

  Onkologie 20090101

• CellMiner: a relational database and query tool for the NCI-60 cancer cell lines.

  BMC genomics 20090101

• Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.

  Journal of translational medicine 20090101

• Current oncological treatment of patients with pancreatic cancer in germany: results from a national survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society.

  Oncology 20090101

• Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy.

  BMC cancer 20090101

• Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers.

  Molecular cancer 20090101

• Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB.

  Journal of translational medicine 20090101

• Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies.

  Journal of oncology 20090101

• Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats.

  International journal of biological sciences 20090101

• In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent.

  Metal-based drugs 20090101

• Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis.

  BMC cancer 20090101

• Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer.

  BMC cancer 20090101

• Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases.

  Hepato-gastroenterology 20090101

• Recent advances in the management of adenocarcinoma of the small intestine.

  Gastrointestinal cancer research : GCR 20090101

• Evolving treatment of advanced colon cancer.

  Annual review of medicine 20090101

• Vorinostat in solid and hematologic malignancies.

  Journal of hematology & oncology 20090101

• Genetic polymorphisms in the EGFR (R521K) and estrogen receptor (T594T) genes, EGFR and ErbB-2 protein expression, and breast cancer risk in Tunisia.

  Journal of biomedicine & biotechnology 20090101

• Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept.

  Journal of oncology 20090101

• Genomic advances and their impact on clinical trial design.

  Genome medicine 20090101

• ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside.

  Journal of hematology & oncology 20090101

• Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs.

  Molecular cancer 20090101

• Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101

• Semaphorin3F down-regulates the expression of integrin alpha(v)beta3 and sensitizes multicellular tumor spheroids to chemotherapy via the neuropilin-2 receptor in vitro.

  Chemotherapy 20090101

• Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report.

  Journal of hematology & oncology 20090101

• Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients.

  Journal of experimental & clinical cancer research : CR 20090101

• The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.

  BMC cancer 20090101

• Hepatoid adenocarcinoma of the stomach - a different histology for not so different gastric adenocarcinoma: a case report.

  International seminars in surgical oncology : ISSO 20090101

• Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer.

  BMC cancer 20090101

• Tumor biology and cancer therapy - an evolving relationship.

  Cell communication and signaling : CCS 20090101

• Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review.

  Journal of experimental & clinical cancer research : CR 20090101

• Advances in the pharmacological treatment of gastro-oesophageal cancer.

  Drugs & aging 20090101

• Response to oxaliplatin with cetuximab in minor salivary gland adenoid cystic carcinoma.

  Tumori 20090101

• Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia.

  Biologics : targets & therapy 20090101

• Pegylated liposomal doxorubicin in ovarian cancer.

  Therapeutics and clinical risk management 20090101

• Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs.

  Journal of experimental & clinical cancer research : CR 20090101

• Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.

  BMC cancer 20090101

• Sugar metabolism, redox balance and oxidative stress response in the respiratory yeast Kluyveromyces lactis.

  Microbial cell factories 20090101

• [Targeted biotherapy: a revolution in the management of patients with colorectal cancer?].

  Gastroenterologie clinique et biologique 20090101

• Pharmacogenomics in chemotherapy for GI tract cancer.

  Journal of gastroenterology 20090101

• Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.

  Oncology 20090101

• ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines.

  PloS one 20090101

• Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers.

  Biologics : targets & therapy 20090101

• Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.

  BMC cancer 20090101

• Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study.

  BMC cancer 20090101

• Late colonic stent perforation following chemotherapy.

  Endoscopy 20090101

• Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases.

  World journal of surgical oncology 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• [Docetaxel in the treatment of metastatic gastric cancer].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20090101

• [Targeted drugs for the treatment of disseminated colonic cancer].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20090101

• Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer.

  PloS one 20090101

• An efficient targeted drug delivery through apotransferrin loaded nanoparticles.

  PloS one 20090101

• Retroperitoneal abscess complicated with necrotizing fasciitis of the thigh in a patient with sigmoid colon cancer.

  World journal of surgical oncology 20090101

• IL-18 paradox in pancreatic carcinoma: elevated serum levels of free IL-18 are correlated with poor survival.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20090101

• DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells.

  BMC cancer 20090101

• Vulvar mucinous adenocarcinoma associated with Crohn's disease: report of two cases.

  Gynecologic and obstetric investigation 20090101

• Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.

  International journal of medical sciences 20090101

• Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer.

  Therapeutics and clinical risk management 20090101

• The tissue distribution in mice and pharmacokinetics in rabbits of oxaliplatin liposome.

  Journal of liposome research 20090101

• Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network.

  BMC cancer 20090101

• Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry.

  Journal of oncology 20090101

• Docetaxel: its role in current and future treatments for advanced gastric cancer.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20090101

• A genome-wide deletion mutant screen identifies pathways affected by nickel sulfate in Saccharomyces cerevisiae.

  BMC genomics 20090101

• Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue.

  Molecular pain 20090101

• Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma.

  BMC cancer 20090101

• The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer.

  Journal of experimental & clinical cancer research : CR 20090101

• Acute coronary syndrome associated with continuous 5-Fluorouracil infusion in a patient with metastatic colorectal cancer-a case report with a discussion on this clinical dilemma.

  Journal of gastrointestinal cancer 20090101

• Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly.

  Best practice & research. Clinical gastroenterology 20090101

• An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2nd or higher line chemotherapy regarding clinical benefit - PANUSCO.

  BMC cancer 20090101

• DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study.

  Journal of angiogenesis research 20090101

• DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.

  BMC medical genomics 20090101

• Drug-induced hematologic syndromes.

  Advances in hematology 20090101

• Nodular regenerative hyperplasia secondary to neoadjuvant chemotherapy for colorectal liver metastases.

  Case reports in medicine 20090101

• The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay.

  Radiation oncology (London, England) 20090101

• Automated mass action model space generation and analysis methods for two-reactant combinatorially complex equilibriums: an analysis of ATP-induced ribonucleotide reductase R1 hexamerization data.

  Biology direct 20090101

• Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications.

  BMC cancer 20090101

• APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.

  BMC cancer 20090101

• Isolated recurrence of distal adenocarcinoma of the extrahepatic bile duct on a draining sinus scar after curative resection: case report and review of the literature.

  World journal of surgical oncology 20090101

• Association of trial registration with the results and conclusions of published trials of new oncology drugs.

  Trials 20090101

• Oxaliplatin-induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicity.

  Oncology 20090101

• Vascular Endothelial Growth Factor plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

  Journal of oncology 20090101

• KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.

  PloS one 20090101

• New targets for the treatment of follicular lymphoma.

  Journal of hematology & oncology 20090101

• The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone.

  Trials 20090101

• Inhibition of transcription by platinum antitumor compounds.

  Metallomics : integrated biometal science 20090101

• The cancer stem cell concept in progression of head and neck cancer.

  Journal of oncology 20090101

• The increasing role of pharmacogenetics in the treatment of gastrointestinal cancers.

  Gastrointestinal cancer research : GCR 20090101

• The long and winding road to useful predictive factors for anti-EGFR therapy in metastatic colorectal carcinoma: the KRAS/BRAF pathway.

  Oncology 20090101

• Deoxycholate, an endogenous cytotoxin/genotoxin, induces the autophagic stress-survival pathway: implications for colon carcinogenesis.

  Journal of toxicology 20090101

• Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases.

  HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 20090101

• Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101

• Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview.

  Nutrition and cancer 20090101

• Irinotecan associated with cetuximab given every 2 weeks versus cetuximab weekly in metastatic colorectal cancer.

  Journal of cancer research and therapeutics 20090101

• Weekly paclitaxel/ docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication.

  Asian Pacific journal of cancer prevention : APJCP 20090101

• Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer.

  International surgery 20090101

• Targeted therapies in the management of colorectal carcinoma: role of bevacizumab.

  OncoTargets and therapy 20090101

• Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients.

  OncoTargets and therapy 20090101

• Targeting cancers in the gastrointestinal tract: role of capecitabine.

  OncoTargets and therapy 20090101

• First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab.

  OncoTargets and therapy 20090101

• Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab.

  OncoTargets and therapy 20090101

• The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib.

  OncoTargets and therapy 20090101

• Recurrent pneumonia due to an appendiceal mucinous cystadenocarcinoma: a rare presentation of a rare malignancy.

  Clinical medicine. Oncology 20090101

• Oxaliplatin-induced lung fibrosis.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20090101

• Standard First-Line Chemotherapy for Metastatic Gastric Cancer in Japan Has Met the Global Standard: Evidence From Recent Phase III Trials.

  Gastrointestinal cancer research : GCR 20090101

• Evolving role of cetuximab in the treatment of colorectal cancer.

  Cancer management and research 20090101

• Excision-repair cross-complementing 1 predicts response to cisplatin-based neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.

  Molecular medicine reports 20090101

• Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer.

  Breast cancer : basic and clinical research 20090101

• Oxaliplatin-induced coronary artery spasm: first report of an important side-effect.

  BMJ case reports 20090101

• Developments in treating metastatic colorectal cancer: Recent international reports from ASCO 2007 and 2008.

  Clinical and experimental gastroenterology 20090101

• Recent advances in the management of carcinoma of the rectum.

  Clinical and experimental gastroenterology 20090101

• Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer.

  Clinical and experimental gastroenterology 20090101

• Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance.

  Ecancermedicalscience 20090101

• Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients.

  Medical devices (Auckland, N.Z.) 20090101

• Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081220

• The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines.

  Cancer letters 20081218

• Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081215

• Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.

  Cancer research 20081215

• Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081210

• Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer.

  British journal of cancer 20081209

• Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells.

  British journal of cancer 20081202

• Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20081201

• Improving platinum(II)-based anticancer drug delivery using cucurbit[n]urils.

  Journal of inorganic biochemistry 20081201

• Healing of colonic anastomoses after immediate postoperative intraperitoneal administration of oxaliplatin.

  International journal of colorectal disease 20081201

• Increased tissue diffusion of oxaliplatin during laparoscopically assisted versus open heated intraoperative intraperitoneal chemotherapy (HIPEC).

  Annals of surgical oncology 20081201

• Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.

  The Journal of pharmacology and experimental therapeutics 20081201

• Effect of ABCG2 on cytotoxicity of platinum drugs: interference of EGFP.

  Toxicology in vitro : an international journal published in association with BIBRA 20081201

• 'Out of blue' Lhermitte's sign: three cases due to low cumulative doses of oxaliplatin.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081201

• Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis.

  International journal of oncology 20081201

• Emerging drugs for colorectal cancer.

  Expert opinion on emerging drugs 20081201

• Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081201

• Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.

  Clinical colorectal cancer 20081201

• Updated options for liver-limited metastatic colorectal cancer.

  Clinical colorectal cancer 20081201

• Chemotherapy for metastatic gastric cancer in Japan.

  International journal of clinical oncology 20081201

• [Prevention of oxaliplatin-related neurotoxicity by glutathione infusions].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081201

• [Single nucleotide polymorphism analysis in the GSTP1 and ABCC2 genes about neuropathy by the Oxaliplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081201

• [Changes in peripheral neuropathy and platinum concentrations in patients undergoing surgery following modified FOLFOX6 therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081201

• A phase II study of 5-fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as first-line treatment for patients with advanced gastric cancer.

  Journal of chemotherapy (Florence, Italy) 20081201

• Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab.

  Therapeutics and clinical risk management 20081201

• Vinflunine in the treatment of bladder cancer.

  Therapeutics and clinical risk management 20081201

• Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy.

  Therapeutics and clinical risk management 20081201

• Small molecule tyrosine kinase inhibitors in pancreatic cancer.

  Biologics : targets & therapy 20081201

• The insulin-like growth factor system and its receptors: A potential novel anticancer target.

  Biologics : targets & therapy 20081201

• First-line therapeutic strategies in metastatic colorectal cancer.

  Oncology (Williston Park, N.Y.) 20081130

• Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081120

• ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer.

  World journal of gastroenterology 20081107

• Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice.

  British journal of cancer 20081104

• Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer.

  British journal of cancer 20081104

• Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines.

  British journal of cancer 20081104

• Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours.

  British journal of cancer 20081104

• Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

  British journal of cancer 20081104

• Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20081101

• Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.

  Cancer chemotherapy and pharmacology 20081101

• Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma.

  Archives of gynecology and obstetrics 20081101

• Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for stage II and III rectal cancer.

  International journal of radiation oncology, biology, physics 20081101

• Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma.

  International journal of radiation oncology, biology, physics 20081101

• Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group.

  International journal of colorectal disease 20081101

• Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081101

• Separation and characterization of oxaliplatin dinucleotides from DNA using HPLC-ESI ion trap mass spectrometry.

  Analytical and bioanalytical chemistry 20081101

• Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.

  Drug metabolism and disposition: the biological fate of chemicals 20081101

• Overexpression of cFLIPs inhibits oxaliplatin-mediated apoptosis through enhanced XIAP stability and Akt activation in human renal cancer cells.

  Journal of cellular biochemistry 20081101

• FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer.

  Cancer investigation 20081101

• [Molecular targets for colon cancer. VEGF, EGFR - and what else?].

  Der Pathologe 20081101

• Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer.

  Anti-cancer drugs 20081101

• Multicenter Phase II study of cetuximab plus irinotecan in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin and fluoropyrimidines.

  Japanese journal of clinical oncology 20081101

• The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat.

  Neurotoxicology 20081101

• Capecitabine-associated cerebellar ataxia.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081101

• Impact of oxaliplatin and a novel DACH-platinum complex in the gene expression of HCT116 colon cancer cells.

  Oncology reports 20081101

• A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081101

• Variation in the cost of medications for the treatment of colorectal cancer.

  The American journal of managed care 20081101

• [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues].

  Ai zheng = Aizheng = Chinese journal of cancer 20081101

• [Relative dose intensity of FOLFOX4 regimen].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• [Remarkable effect of gemcitabine-oxaliplatin (GEMOX) therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• [Epiphora in a patient receiving FOLFOX therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• Fatal pneumonitis induced by oxaliplatin.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20081101

• Appendiceal carcinoma: a diagnostic and therapeutic challenge.

  Postgraduate medicine 20081101

• Role of combined-modality therapy in the management of locally advanced rectal cancer.

  Clinical colorectal cancer 20081101

• Chemical-genetic profiling of imidazo[1,2-a]pyridines and -pyrimidines reveals target pathways conserved between yeast and human cells.

  PLoS genetics 20081101

• [New perspectives in predicting response to chemotherapy in colorectal cancer].

  Gastroenterologia y hepatologia 20081101

• [Third-line treatment of intermittent hepatic arterial infusion for unresectable liver metastases from colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• [Problems involved in the resection of pulmonary metastasis from colorectal cancer in the era of new anticancer drugs].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• [The validity of full administration of 5-fluorouracil, irinotecan, and oxaliplatin to unresectable or recurrent colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• [Establishment of a cisplatin-induced human nasopharyngeal carcinoma drug-resistant cell line and its biological characteristics].

  Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery 20081101

• Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice?

  Journal of oncology practice 20081101

• GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.

  British journal of cancer 20081021

• Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients.

  British journal of cancer 20081021

• Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer.

  British journal of cancer 20081021

• Platinum drug adduct formation in the nucleosome core alters nucleosome mobility but not positioning.

  Chemistry & biology 20081020

• Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer.

  Cancer 20081015

• Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.

  Philosophical transactions. Series A, Mathematical, physical, and engineering sciences 20081013

• Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

  Journal of medicinal chemistry 20081009

• Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial.

  British journal of cancer 20081007

• Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy.

  British journal of cancer 20081007

• Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells.

  Molecular pharmaceutics 20081006

• Transcription factor-binding sites in the thymidylate synthase gene: predictors of outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin?

  The pharmacogenomics journal 20081001

• Oxaliplatin-induced immune mediated thrombocytopenia.

  Cancer chemotherapy and pharmacology 20081001

• Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.

  Cancer chemotherapy and pharmacology 20081001

• Surrogate endpoints for overall survival in early colorectal cancer from the clinician's perspective.

  Statistical methods in medical research 20081001

• Management and survival trends in advanced colorectal cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20081001

• Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081001

• Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081001

• Comparative antiallodynic activity of morphine, pregabalin and lidocaine in a rat model of neuropathic pain produced by one oxaliplatin injection.

  Neuropharmacology 20081001

• Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases.

  Annals of surgical oncology 20081001

• Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis.

  Annals of surgical oncology 20081001

• Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.

  The Annals of pharmacotherapy 20081001

• Synthesis of hydroxypropylcellulose-poly(acrylic acid) particles with semi-interpenetrating polymer network structure.

  Biomacromolecules 20081001

• Neuropathies in the context of malignancies.

  Current opinion in neurology 20081001

• New lessons from 'old' chemotherapy in colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001

• Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001

• Bevacizumab in advanced colorectal cancer: a challenge to the current paradigm.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001

• A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20081001

• N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081001

• Chemotherapy for colorectal cancer liver metastases.

  The oncologist 20081001

• [Prophylactic effect of amifostine on oxaliplatin-related neurotoxicity in patients with digestive tract tumors].

  Ai zheng = Aizheng = Chinese journal of cancer 20081001

• Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.

  The oncologist 20081001

• An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma.

  Journal of the National Comprehensive Cancer Network : JNCCN 20081001

• Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies.

  Gan to kagaku ryoho. Cancer & chemotherapy 20081001

• Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay.

  Journal of Korean medical science 20081001

• [Is it possible to individualize prescription of medical treatment in colorectal cancer? The clinician point of view].

  Bulletin du cancer 20081001

• The confused cancer patient: a case of 5-fluorouracil-induced encephalopathy.

  Current oncology (Toronto, Ont.) 20081001

• Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.

  Journal of chemotherapy (Florence, Italy) 20081001

• [Efficacy and tolerability of the combination of oxaliplatin, ifosfamide, and epirubicin in treatment of recurrent or platinum-resistant ovarian epithelial cancer patients].

  Zhonghua fu chan ke za zhi 20081001

• Review of docetaxel in the treatment of gastric cancer.

  Therapeutics and clinical risk management 20081001

• Neuropharmacology.

  Indian journal of pharmacology 20081001

• Development and validation of an inductively coupled plasma mass spectrometry method with optimized microwave-assisted sample digestion for the determination of platinum at ultratrace levels in plasma and ultrafiltrate plasma.

  Journal of pharmaceutical and biomedical analysis 20080929

• Survival from cancer of the oesophagus in England and Wales up to 2001.

  British journal of cancer 20080923

• Survival from cancer of the stomach in England and Wales up to 2001.

  British journal of cancer 20080923

• [Efficacy of oxaliplatin plus 5-fluorouracil/leucovorin calcium combined with concurrent radiotherapy for local advanced gastric cancer].

  Zhonghua yi xue za zhi 20080923

• Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignancies.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080920

• Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer.

  British journal of cancer 20080916

• Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.

  British journal of cancer 20080916

• Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.

  World journal of gastroenterology 20080907

• The degradation pathways in chloride medium of the third generation anticancer drug oxaliplatin.

  The journal of physical chemistry. B 20080904

• Speeding up the evaluation of new agents in cancer.

  Journal of the National Cancer Institute 20080903

• Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?

  British journal of cancer 20080902

• Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy.

  British journal of cancer 20080902

• A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer.

  British journal of cancer 20080902

• Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer.

  British journal of cancer 20080902

• Does OPTIMOX strategy ('stop-and-go' approach) also work in treatment of pancreatic cancer with oxaliplatin-based regimens?

  JOP : Journal of the pancreas 20080902

• Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.

  Cancer chemotherapy and pharmacology 20080901

• Pharmacokinetics of heated intraperitoneal oxaliplatin.

  Cancer chemotherapy and pharmacology 20080901

• Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin.

  Journal of cancer research and clinical oncology 20080901

• Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer.

  Critical reviews in oncology/hematology 20080901

• NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells.

  Nitric oxide : biology and chemistry 20080901

• Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.

  The Journal of allergy and clinical immunology 20080901

• Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion.

  European journal of clinical pharmacology 20080901

• Liver resection for colorectal liver metastases in older patients.

  Critical reviews in oncology/hematology 20080901

• Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front.

  Histochemistry and cell biology 20080901

• Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study.

  The Lancet. Oncology 20080901

• [5-Fluorouracil-induced reticular hyperpigmentation].

  Actas dermo-sifiliograficas 20080901

• Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer.

  Anti-cancer drugs 20080901

• Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

  The British journal of surgery 20080901

• Platinums sensitize human epithelial tumor cells to lymphotoxin alpha by inhibiting NFkappaB-dependent transcription.

  Cancer biology & therapy 20080901

• Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.

  International journal of radiation oncology, biology, physics 20080901

• Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells.

  Molecular cancer therapeutics 20080901

• Novel opportunities for thymidylate metabolism as a therapeutic target.

  Molecular cancer therapeutics 20080901

• Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells.

  Molecular cancer therapeutics 20080901

• Update on novel strategies to optimize cetuximab therapy in patients with metastatic colorectal cancer.

  Clinical colorectal cancer 20080901

• Sequential versus combination therapy in the treatment of patients with advanced colorectal cancer.

  Clinical colorectal cancer 20080901

• Treatment of recurrent metastatic colon cancer in the age of modern adjuvant therapy.

  Clinical colorectal cancer 20080901

• Early clinical results from chemoradiation with 5-fluorouracil and oxaliplatin for locally advanced rectal cancer.

  Clinical colorectal cancer 20080901

• [Chemotherapy for metastatic colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080901

• [Chemotherapy for human gastric cancer: a review].

  Revue medicale de Liege 20080901

• Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

  Biologics : targets & therapy 20080901

• Platinum resistance needs the mythbusters.

  Toxicology letters 20080828

• [A randomized clinical trial of combination of Aidi injection with Gemcitabine and Oxaliplatin regimen or Go regimen only in the treatment of advanced non-small-cell lung cancer.].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20080820

• A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.

  British journal of cancer 20080819

• A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.

  British journal of cancer 20080819

• Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer.

  British journal of cancer 20080819

• Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer.

  British journal of cancer 20080805

• Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial.

  British journal of cancer 20080805

• A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors.

  Cancer chemotherapy and pharmacology 20080801

• Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N1, N11 diethylnorspermine.

  Cancer chemotherapy and pharmacology 20080801

• Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation.

  Investigational new drugs 20080801

• Analysis of the mechanism of asymmetric amplification by chiral auxiliary trans-1,2-diaminocyclohexane bistriflamide.

  Chirality 20080801

• A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080801

• Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080801

• Female fertility and colorectal cancer.

  International journal of colorectal disease 20080801

• Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer.

  Investigational new drugs 20080801

• A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.

  Annals of surgical oncology 20080801

• Does oxaliplatin and paclitaxel combination show an activity of some extent in pretreated patients with germ-cell tumors?: Reply to the article 'A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors' by C. Theodore et al. (Ann Oncol 2008; doi: 10.1093/annonc/mdn122).

  Annals of oncology : official journal of the European Society for Medical Oncology 20080801

• Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer.

  Nature clinical practice. Oncology 20080801

• Are capecitabine and oxaliplatin as effective as fluorouracil and cisplatin for gastroesophageal cancer?

  Nature clinical practice. Gastroenterology & hepatology 20080801

• Phase I dose-escalating study of S-1 in combination with oxaliplatin for patients with advanced and/or metastatic colorectal cancer.

  Anti-cancer drugs 20080801

• Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.

  Bioorganic & medicinal chemistry 20080801

• Colorectal tumor cells treated with 5-FU, oxaliplatin, irinotecan, and cetuximab exhibit changes in 18F-FDG incorporation corresponding to hexokinase activity and glucose transport.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20080801

• S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.

  Oncology reports 20080801

• FOLFOX2 in the treatment of advanced colorectal cancer: a comparison between elderly and middle aged patients.

  Journal of chemotherapy (Florence, Italy) 20080801

• Pharmacogenetics in colorectal cancer: a systematic review.

  Pharmacogenomics 20080801

• Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy.

  Current cancer drug targets 20080801

• Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting.

  The oncologist 20080801

• Selected combination therapy with sorafenib: a review of clinical data and perspectives in advanced solid tumors.

  The oncologist 20080801

• Oxaliplatin-based chemotherapy in the management of colorectal cancer.

  Expert review of anticancer therapy 20080801

• Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.

  Journal of Korean medical science 20080801

• Neoadjuvant treatment with cetuximab, 5-Fluorouracil, folinic Acid and oxaliplatin in unresectable retroperitoneal recurrent colon cancer.

  Zeitschrift fur Gastroenterologie 20080801

• [FOLFOX versus PLF regimen in treatment of advanced gastric adenocarcinoma].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20080801

• Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial.

  American journal of clinical oncology 20080801

• Alternating XELFOX and XELFIRI in patients with metastatic colorectal cancer.

  American journal of clinical oncology 20080801

• Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response.

  American journal of clinical oncology 20080801

• [ERCC1 mRNA expression levels and outcome of gastric cancer patients receiving oxaliplatin-based chemotherapy].

  Zhonghua bing li xue za zhi = Chinese journal of pathology 20080801

• [Differential gene expression of the inhibitor of apoptosis proteins in docetaxel-resistant gastric cancer cells].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080801

• Inequity in colorectal cancer treatment and outcomes: a population-based study.

  British journal of cancer 20080722

• UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study.

  British journal of cancer 20080722

• Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080720

• P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.

  Oncogene 20080710

• EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality.

  British journal of cancer 20080708

• Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients.

  British journal of cancer 20080708

• Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.

  British journal of cancer 20080708

• ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation.

  British journal of cancer 20080708

• Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.

  Cancer chemotherapy and pharmacology 20080701

• Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases.

  Cancer chemotherapy and pharmacology 20080701

• Synthesis and anticancer activity of lipophilic platinum(II) complexes of 3,5-diisopropylsalicylate.

  European journal of medicinal chemistry 20080701

• Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080701

• Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer.

  International journal of radiation oncology, biology, physics 20080701

• Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080701

• A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance.

  European journal of clinical pharmacology 20080701

• Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.

  Annals of surgical oncology 20080701

• Disruption of signaling through SEK1 and MKK7 yields differential responses in hypoxic colon cancer cells treated with oxaliplatin.

  Molecular pharmacology 20080701

• A study of oxaliplatin-nucleobase interactions using ion trap electrospray mass spectrometry.

  Analytical and bioanalytical chemistry 20080701

• Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines.

  Biochemical pharmacology 20080701

• Combined cetuximab, capecitabine, oxaliplatin, and radiotherapy in rectal cancer: Dr. Jekyll or Mr. Hyde? In regard to Rödel et al. (Int J Radiat Oncol Biol Phys 2008;70:1081-1086.).

  International journal of radiation oncology, biology, physics 20080701

• Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma.

  Anti-cancer drugs 20080701

• Metastatic rectal cancer responding to third-line therapy employing bevacizumab after failure of oxaliplatin and irinotecan: case report.

  Japanese journal of clinical oncology 20080701

• FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature.

  Cancer investigation 20080701

• Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080701

• Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?

  The oncologist 20080701

• [Immune-mediated hemolytic anemia under oxaliplatin].

  Zeitschrift fur Gastroenterologie 20080701

• [Impact of single nucleotide polymorphisms in glutathione S transferase gene GSTP1 in the treatment with oxaliplatin based chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080701

• [Comparative survey on current status and the differences of treatment using modified FOLFOX6 regimen in patients with colorectal cancer in two general hospitals].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080701

• Combined chemotherapy of hydroxycampothecin with oxaliplatin as an adjuvant treatment for human colorectal cancer.

  The Tohoku journal of experimental medicine 20080701

• Dual biologic therapy in the first-line mCRC setting: implications of the CAIRO2 study.

  Clinical colorectal cancer 20080701

• Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology. Chicago, IL; May 30-June 3, 2008.

  Clinical colorectal cancer 20080701

• Regional chemotherapy for liver-limited metastatic colorectal cancer.

  Clinical colorectal cancer 20080701

• Incidence and management of colorectal cancer in liver transplant recipients.

  Clinical colorectal cancer 20080701

• A phase II study of cetuximab/irinotecan in patients with heavily pretreated metastatic colorectal cancer: predictive value of early specific toxicities.

  Clinical colorectal cancer 20080701

• Treatment of rectal cancer metastases to the thyroid gland: report of two cases.

  Clinical colorectal cancer 20080701

• [Establishing the method of collagen-gel droplet embedded culture drug sensitivity test with rat tail collagen].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20080701

• Major Advances in the Treatment of Cancer: What does a Non-Oncologist need to know?

  Sultan Qaboos University medical journal 20080701

• Preferences of patients with advanced colorectal cancer for treatment with oral or intravenous chemotherapy.

  The patient 20080701

• Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells.

  Toxicology letters 20080630

• Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells.

  World journal of gastroenterology 20080628

• Tip60 is regulated by circadian transcription factor clock and is involved in cisplatin resistance.

  The Journal of biological chemistry 20080627

• Instantaneous low temperature gelation by a multicomponent organogelator liquid system based on ammonium salts.

  Journal of the American Chemical Society 20080625

• Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients.

  British journal of cancer 20080617

• beta(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients.

  British journal of cancer 20080617

• Oxaliplatin-DNA adduct formation in white blood cells of cancer patients.

  British journal of cancer 20080617

• Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study.

  Cancer 20080615

• High-LET radiation combined with oxaliplatin induce autophagy in U-87 glioblastoma cells.

  Cancer letters 20080608

• A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers.

  British journal of cancer 20080603

• Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080601

• Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.

  Critical reviews in oncology/hematology 20080601

• Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080601

• A review on oxaliplatin-induced peripheral nerve damage.

  Cancer treatment reviews 20080601

• Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080601

• Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080601

• Advances in neoadjuvant therapy for colorectal cancer with liver metastases.

  Cancer treatment reviews 20080601

• Trans-cyclohexanediamines prevent thermal inactivation of protein: role of hydrophobic and electrostatic interactions.

  The protein journal 20080601

• Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.

  Alimentary pharmacology & therapeutics 20080601

• Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080601

• A phase II study of oxaliplatin and gemcitabine in advanced inoperable stage IIIB/IV non-small cell lung cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080601

• Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease: results of the Central European Cooperative Oncology Group Study ESGAS.1.2.001.

  Anti-cancer drugs 20080601

• Oxaliplatin doublets in non-small cell lung cancer: a literature review.

  Lung cancer (Amsterdam, Netherlands) 20080601

• Investigation of interaction between human hemoglobin A0 and platinum anticancer drugs by capillary isoelectric focusing with whole column imaging detection.

  Journal of separation science 20080601

• Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20080601

• Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases.

  Journal of surgical oncology 20080601

• Current and emerging therapies for metastatic colorectal cancer: applying research findings to clinical practice.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080601

• Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer.

  Pharmacotherapy 20080601

• Cutaneous adverse drug reactions during chemotherapy: consider non-antineoplastic drugs.

  Contact dermatitis 20080601

• Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080601

• A phase I and pharmacokinetic study of weekly oxaliplatin followed by paclitaxel in patients with solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080601

• Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer.

  American journal of clinical oncology 20080601

• Oxaliplatin plus gemcitabine as a salvage schedule for hormone-refractory prostate adenocarcinoma.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080601

• [Progression in palliative chemotherapy for advanced colorectal cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20080601

• Neoadjuvant chemoradiation for rectal cancer: is more better?

  Oncology (Williston Park, N.Y.) 20080601

• Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.

  Clinical therapeutics 20080601

• Systemic treatments for mesothelioma: standard and novel.

  Current treatment options in oncology 20080601

• Differential in vitro inhibitory effects of anticancer drugs on tumor-associated carbonic anhydrase isozymes CA IX and CA XII.

  Methods and findings in experimental and clinical pharmacology 20080601

• Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC).

  Therapeutics and clinical risk management 20080601

• 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.

  Molecular oncology 20080601

• Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab.

  Biologics : targets & therapy 20080601

• Chemotherapy and its effect on liver hypertrophy: implications for portal vein embolization and resection.

  Seminars in interventional radiology 20080601

• [Chemotherapy and renal toxicity].

  Bulletin du cancer 20080528

• [Systemic treatment of metastatic colorectal cancer].

  Revue medicale suisse 20080521

• A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer.

  British journal of cancer 20080520

• [Post-operative adjuvant treatment with oxaliplatin, fluorouracil, and leucovorin for local advanced gastric cancer].

  Zhonghua yi xue za zhi 20080513

• EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080510

• Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

  World journal of gastroenterology 20080507

• Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080501

• Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion.

  Annals of surgical oncology 20080501

• Indole-3-carbinol enhances anti-proliferative, but not anti-invasive effects of oxaliplatin in colorectal cancer cell lines.

  Biochemical pharmacology 20080501

• Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.

  The journal of pain : official journal of the American Pain Society 20080501

• Potential regional differences for the tolerability profiles of fluoropyrimidines.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501

• Re: Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080501

• Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080501

• Capecitabine and oxaliplatin for advanced esophagogastric cancer.

  The New England journal of medicine 20080501

• Peripheral sensory neuropathy--fighting cold with cold.

  The Lancet. Oncology 20080501

• [Chemotherapy associated hepatotoxicity in the treatment of advanced colorectal cancer (CRC)].

  Zeitschrift fur Gastroenterologie 20080501

• The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20080501

• Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer.

  Expert review of anticancer therapy 20080501

• Systemic treatment of colorectal cancer.

  Gastroenterology 20080501

• [A case of recurrent rectal cancer with lymphangiosis carcinomatosa successfully treated with modified FOLFOX6 therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080501

• [Reduction of oxaliplatin-related neurotoxicity by Gosha-jinki-gan].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080501

• Gefitinib in combination with oxaliplatin and 5-fluorouracil in irinotecan-refractory patients with colorectal cancer: a phase I study of the Arbeits gemeinschaft Internistische Onkologie (AIO).

  Onkologie 20080501

• Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies.

  Frontiers in bioscience : a journal and virtual library 20080501

• Metastatic pancreatic cancer 2008: is the glass less empty?

  The oncologist 20080501

• Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.

  Clinical advances in hematology & oncology : H&O 20080501

• Preoperative therapy in esophageal cancer.

  Clinical advances in hematology & oncology : H&O 20080501

• Colon cancer: update on adjuvant therapy.

  Clinical colorectal cancer 20080501

• Is XELOX equivalent to FOLFOX or other continuous-infusion 5-fluorouracil chemotherapy in metastatic colorectal cancer?

  Clinical colorectal cancer 20080501

• [Preliminary study of biweekly regimen of docetaxel, oxaliplatin, 5-fluorouracil and leucovorin for advanced gastric cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080501

• (2Z,2'Z,4E,4'E)-4,4'-(Cyclo-hexane-1,2-diyldinitrilo)dipent-2-en-2-ol.

  Acta crystallographica. Section E, Structure reports online 20080501

• ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen.

  British journal of cancer 20080422

• Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.

  British journal of cancer 20080422

• A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.

  British journal of cancer 20080422

• A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours.

  British journal of cancer 20080422

• Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420

• Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420

• Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420

• Targeting metastatic colorectal cancer in 2008: a long way from 5-FU.

  Oncology (Williston Park, N.Y.) 20080415

• [Combined surgical and oncological management of colorectal liver metastases].

  Ugeskrift for laeger 20080414

• Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410

• Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer.

  British journal of cancer 20080408

• Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study.

  British journal of cancer 20080408

• Enhanced DNA-PK-mediated RPA2 hyperphosphorylation in DNA polymerase eta-deficient human cells treated with cisplatin and oxaliplatin.

  DNA repair 20080402

• A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.

  Cancer chemotherapy and pharmacology 20080401

• A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer.

  Cancer chemotherapy and pharmacology 20080401

• Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20080401

• The influence of temperature on antiproliferative effects, cellular uptake and DNA platination of the clinically employed Pt(II)-drugs.

  Journal of inorganic biochemistry 20080401

• Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum.

  Annals of surgical oncology 20080401

• A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080401

• Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20080401

• Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial.

  Expert review of anticancer therapy 20080401

• [A case of complete response in supraclavicular lymph node involvement from cancer of the sigmoid colon to FOLFOX4 therapy after laparoscopy-assisted colectomy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080401

• [Modified FOLFOX6 in a patient on hemodialysis with metastatic colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080401

• Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.

  Seminars in oncology 20080401

• [Responses of advanced esophageal cancer to chemotherapy and prognostic factors: a report of 138 cases].

  Ai zheng = Aizheng = Chinese journal of cancer 20080401

• [FOLFOX4 regimen versus DP(O)F regimen for advanced gastric cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20080401

• Chemotherapy in elderly patients with colorectal cancer.

  The oncologist 20080401

• Predictors of positive radial margin status in a population-based cohort of patients with rectal cancer.

  Current oncology (Toronto, Ont.) 20080401

• Occurrence of autoimmunity in a long-term survivor with metastatic colon carcinoma treated with a new chemo-immunotherapy regimen.

  Journal of chemotherapy (Florence, Italy) 20080401

• Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.

  British journal of cancer 20080325

• Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

  Lancet (London, England) 20080322

• Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320

• Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320

• Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.

  International journal of radiation oncology, biology, physics 20080315

• Current status and future prospects for satraplatin, an oral platinum analogue.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080315

• Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management.

  World journal of gastroenterology 20080314

• Sepsis from liver abscesses in metastatic colorectal carcinoma after chemoimmunotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080310

• Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?

  JOP : Journal of the pancreas 20080308

• Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.

  Pediatric blood & cancer 20080301

• Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080301

• Discrimination of enantiomers of alpha-amino acids by chiral derivatizing reagents from trans-1,2-diaminocyclohexane.

  Chirality 20080301

• Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer.

  Cancer chemotherapy and pharmacology 20080301

• Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate.

  British journal of clinical pharmacology 20080301

• Intermolecular chiral recognition processes probed by chiroptical luminescence.

  Chirality 20080301

• Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20080301

• Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080301

• Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.

  Gynecologic oncology 20080301

• Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en Oncologie phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301

• Oxaliplatin-related neurotoxicity: interest of calcium-magnesium infusion and no impact on its efficacy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301

• Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20080301

• Platinum resistance: the role of DNA repair pathways.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080301

• U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080301

• First-line treatment of advanced gastric cancer and hepatic dysfunction with oxaliplatin, 5-fluorouracil and cetuximab.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20080301

• Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration.

  Journal of analytical toxicology 20080301

• [Preoperative chemoradiotherapy with FOLFOX in low rectal cancer: a multicenter study].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20080301

• Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds.

  Molecular cancer therapeutics 20080301

• [Retrospective analysis of FOLFOX4 neurotoxicity for recovery from advanced colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080301

• Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer.

  Expert review of anticancer therapy 20080301

• Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.

  Pancreas 20080301

• Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.

  Current allergy and asthma reports 20080301

• New therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways.

  The oncologist 20080301

• [Pancreatic cancer: ten years of systemic therapy].

  Bulletin du cancer 20080301

• Sequential vs combination colorectal cancer therapy sparks debate.

  British journal of hospital medicine (London, England : 2005) 20080301

• Dose enhancement effect of anticaner drugs associated with increased temperature in vitro.

  Experimental oncology 20080301

• Cell cycle checkpoint models for cellular pharmacology of paclitaxel and platinum drugs.

  The AAPS journal 20080301

• Adjuvant chemotherapy for stage II colon cancer.

  Oncology (Williston Park, N.Y.) 20080301

• Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group.

  Clinical colorectal cancer 20080301

• Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer.

  Clinical colorectal cancer 20080301

• A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer.

  Clinical colorectal cancer 20080301

• Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma.

  Clinical colorectal cancer 20080301

• Phase II study of oxaliplatin in combination with continuous infusion of 5-fluorouracil/leucovorin as first-line chemotherapy in patients with advanced gastric cancer.

  Anti-cancer drugs 20080301

• A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients.

  Anti-cancer drugs 20080301

• Radiotherapy combined with gemcitabine and oxaliplatin in pancreatic cancer cells.

  Translational oncology 20080301

• Anti-cancer effects of xanthones from pericarps of mangosteen.

  International journal of molecular sciences 20080301

• Intestinal perforation in colorectal cancers treated with bevacizumab (Avastin).

  Cancer research and treatment : official journal of Korean Cancer Association 20080301

• Bevacizumab in the therapy for refractory metastatic colorectal cancer.

  Biologics : targets & therapy 20080301

• Erlotinib in the treatment of advanced pancreatic cancer.

  Biologics : targets & therapy 20080301

• Prospective phase II study of brachytherapy boost as a component of neo-adjuvant chemotherapy and external beam radiation therapy in locally advanced rectal cancer.

  Journal of the Egyptian National Cancer Institute 20080301

• A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study).

  British journal of cancer 20080226

• Recurrent priapism related to oxaliplatin infusion.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080220

• [Establishment and biological characteristics of a multi-drug resistant cell line A549/Gem.].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20080220

• Self-assembly of noncyclic bis-D- and L-tripeptides into higher order tubular constructs: design, synthesis, and X-ray crystal superstructure.

  The Journal of organic chemistry 20080215

• Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.

  British journal of cancer 20080212

• Clinical pharmacology of cancer therapies in older adults.

  British journal of cancer 20080212

• Double-stranded monohelical complexes from an unsymmetrical chiral Schiff-base ligand.

  Inorganic chemistry 20080204

• [Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].

  Schmerz (Berlin, Germany) 20080201

• Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.

  International journal of radiation oncology, biology, physics 20080201

• Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases.

  Respiratory medicine 20080201

• Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis.

  Annals of surgical oncology 20080201

• LEF-1 recognition of platinated GG sequences within double-stranded DNA. Influence of flanking bases.

  Journal of inorganic biochemistry 20080201

• Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080201

• A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080201

• GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: a phase II study.

  European journal of haematology 20080201

• Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?

  Nature clinical practice. Oncology 20080201

• 'Spontaneous,' delayed colon and rectal anastomotic complications associated with bevacizumab therapy.

  Journal of surgical oncology 20080201

• Site selectivity of platinum anticancer therapeutics.

  Nature chemical biology 20080201

• Capecitabine plus oxaliplatin for the treatment of colorectal cancer.

  Expert review of anticancer therapy 20080201

• Cetuximab plus FOLFOX-4 for fully resected stage III colon carcinoma: scientific background and the ongoing PETACC-8 trial.

  Expert review of anticancer therapy 20080201

• [A feasibility study of oxaliplatin (L-OHP) in combination with infusional 5-FU/l-LV (FOLFOX4 regimen) for advanced colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080201

• Administration of cetuximab every 2 weeks in the treatment of metastatic colorectal cancer: an effective, more convenient alternative to weekly administration?

  The oncologist 20080201

• Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.

  The oncologist 20080201

• New data question treatment for oxaliplatin neurotoxicity.

  Clinical journal of oncology nursing 20080201

• The impact of chemotherapy on overall survival and quality of life of patients with metastatic colorectal cancer: a review of phase III trials.

  Journal of chemotherapy (Florence, Italy) 20080201

• Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer.

  Journal of chemotherapy (Florence, Italy) 20080201

• Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors.

  American journal of clinical oncology 20080201

• A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.

  American journal of clinical oncology 20080201

• [Platinum salts hypersensitivity].

  Revue de pneumologie clinique 20080201

• [Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080201

• Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results.

  Therapeutics and clinical risk management 20080201

• Systemic and targeted therapy for advanced colon cancer.

  Expert review of gastroenterology & hepatology 20080201

• New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer.

  British journal of cancer 20080129

• Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial.

  British journal of cancer 20080129

• Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells.

  British journal of cancer 20080129

• A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.

  British journal of cancer 20080129

• [Molecular targeted therapy in colorectal cancer].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20080117

• [Palliative chemotherapy and radiotherapy for metastatic colorectal cancer].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20080117

• Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.

  International journal of cancer 20080115

• Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy.

  Cancer 20080115

• A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.

  British journal of cancer 20080115

• Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy.

  British journal of cancer 20080115

• Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy.

  British journal of cancer 20080115

• Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation.

  British journal of cancer 20080115

• Antitumour metal compounds: more than theme and variations.

  Dalton transactions (Cambridge, England : 2003) 20080114

• Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110

• Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110

• Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach.

  Inorganic chemistry 20080107

• Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome.

  International journal of pharmaceutics 20080104

• Antiproliferative and antimetastatic effects of the ethanolic extract of Phellinus igniarius (Linnearus: Fries) Quelet.

  Journal of ethnopharmacology 20080104

• Capecitabine and oxaliplatin for advanced esophagogastric cancer.

  The New England journal of medicine 20080103

• The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20080101

• Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction.

  Cancer chemotherapy and pharmacology 20080101

• Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin.

  Cancer chemotherapy and pharmacology 20080101

• Effect of hyperthermia and chemotherapeutic agents on TRAIL-induced cell death in human colon cancer cells.

  Journal of cellular biochemistry 20080101

• Tonsillar metastasis of oesophageal adenocarcinoma.

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20080101

• Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.

  International archives of allergy and immunology 20080101

• Third-line therapy for metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20080101

• Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20080101

• Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancer.

  Acta oncologica (Stockholm, Sweden) 20080101

• Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.

  Acta oncologica (Stockholm, Sweden) 20080101

• Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.

  Annals of surgical oncology 20080101

• Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080101

• Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score.

  Annals of surgical oncology 20080101

• Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature.

  Acta oncologica (Stockholm, Sweden) 20080101

• Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study.

  Annals of surgical oncology 20080101

• Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells.

  Cancer science 20080101

• Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study.

  Acta oncologica (Stockholm, Sweden) 20080101

• Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20080101

• Exposure-response relationships for oxaliplatin-treated colon cancer cells.

  Anti-cancer drugs 20080101

• The potential role of pemetrexed in gastrointestinal cancer.

  Chemotherapy 20080101

• T0 N1 adenocarcinoma of the colon following oxaliplatin-based neoadjuvant chemotherapy.

  Journal of surgical oncology 20080101

• Balanitin-6 and -7: diosgenyl saponins isolated from Balanites aegyptiaca Del. display significant anti-tumor activity in vitro and in vivo.

  International journal of oncology 20080101

• Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin.

  International journal of oncology 20080101

• Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.

  Journal of the American College of Surgeons 20080101

• Lessons learned from hyponatremia associated with hyperthermic intraperitoneal chemoperfusion with oxaliplatin.

  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20080101

• Severe hyponatremia, hyperglycemia, and hyperlactatemia are associated with intraoperative hyperthermic intraperitoneal chemoperfusion with oxaliplatin.

  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20080101

• Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis.

  Arthritis research & therapy 20080101

• [Influence of neoadjuvant chemotherapy on liver integrity and ischemic tolerance].

  Zeitschrift fur Gastroenterologie 20080101

• Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients.

  Neoplasma 20080101

• Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells.

  Molecular cancer 20080101

• Combining radiation with oxaliplatin: a review of experimental results.

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20080101

• Locally advanced and metastatic gastric cancer: current management and new treatment developments.

  Drugs 20080101

• Possible impact of the NHK special questioning cancer treatment in Japan on clinicians' prescriptions of oxaliplatin.

  Japanese journal of clinical oncology 20080101

• ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study.

  BMC cancer 20080101

• Guidelines for chemotherapy of biliary tract and ampullary carcinomas.

  Journal of hepato-biliary-pancreatic surgery 20080101

• A case of virilization induced by a Krukenberg tumor from gastric cancer.

  World journal of surgical oncology 20080101

• Triplet combination of fluoropyrimidines, oxaliplatin, and irinotecan in the first-line treatment of metastatic colorectal cancer.

  Clinical colorectal cancer 20080101

• Second-line management of metastatic colorectal cancer.

  Clinical colorectal cancer 20080101

• Phase II trial of T138067, a novel microtubule inhibitor, in patients with metastatic, refractory colorectal carcinoma.

  Clinical colorectal cancer 20080101

• Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness.

  Clinical colorectal cancer 20080101

• Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer.

  Clinical colorectal cancer 20080101

• NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.

  Journal of translational medicine 20080101

• Information from physicians and retention of information by patients - obstacles to the awareness of patients of progressing disease when life is near the end.

  BMC palliative care 20080101

• Canadian supportive care recommendations for the management of neutropenia in patients with cancer.

  Current oncology (Toronto, Ont.) 20080101

• Radiation recall dermatitis: case report and review of the literature.

  Current oncology (Toronto, Ont.) 20080101

• Bevacizumab: a review of its use in metastatic colorectal cancer.

  Drugs 20080101

• Panitumumab: human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer.

  Clinical therapeutics 20080101

• Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients--a prospective clinical study.

  Arthritis research & therapy 20080101

• Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies.

  Molecular pain 20080101

• Simultaneous modeling of concentration-effect and time-course patterns in gene expression data from microarrays.

  Cancer genomics & proteomics 20080101

• Chronic myeloid leukemia following the treatment of rectal adenocarcinoma.

  Medical oncology (Northwood, London, England) 20080101

• Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

  BMC cancer 20080101

• Drug waste minimisation and cost-containment in Medical Oncology: two-year results of a feasibility study.

  BMC health services research 20080101

• Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).

  Anticancer research 20080101

• Resistance against novel anticancer metal compounds: differences and similarities.

  Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20080101

• ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel.

  BMC cancer 20080101

• Nuclear Factor-kappa B as a Resistance Factor to Platinum-Based Antineoplasic Drugs.

  Metal-based drugs 20080101

• Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.

  Metal-based drugs 20080101

• Structural insights on the pamoic acid and the 8 kDa domain of DNA polymerase beta complex: towards the design of higher-affinity inhibitors.

  BMC structural biology 20080101

• Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.

  BMC cancer 20080101

• Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy.

  Molecular cancer 20080101

• The role of Herceptin in early breast cancer.

  International seminars in surgical oncology : ISSO 20080101

• Metastatic rectal adenocarcinoma within haemorrhoids: a case report.

  Journal of medical case reports 20080101

• Epidemiology and management options for colorectal cancer in children.

  Paediatric drugs 20080101

• Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence.

  Drugs 20080101

• Chemotherapy for metastatic gastric cancer: past, present, and future.

  Journal of gastroenterology 20080101

• Chemotherapy with gemcitabine in advanced biliary tract carcinoma.

  Reviews on recent clinical trials 20080101

• Management of the hepatic lymph nodes during resection of liver metastases from colorectal cancer: a systematic review.

  HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 20080101

• Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20080101

• Present treatment and future expectations in advanced pancreatic cancer.

  Anticancer research 20080101

• Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker.

  BMC cancer 20080101

• Hypothermia as an adjunct therapy to vesicant-induced skin injury.

  Eplasty 20080101

• NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?

  PPAR research 20080101

• A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment.

  BMC cancer 20080101

• Modified CAPOX (capecitabine plus oxaliplatin) regimen every two weeks as second-line treatment in patients with advanced colorectal cancer previously treated with irinotecan-based frontline therapy: a multicenter phase II study.

  Oncology 20080101

• Genotyping panel for assessing response to cancer chemotherapy.

  BMC medical genomics 20080101

• Comparative analysis of cell injury after exposure to antitumor platinum derivatives in kidney tubular epithelial cells.

  Chemotherapy 20080101

• A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.

  Chemotherapy 20080101

• Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.

  BMC cancer 20080101

• The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures.

  The international journal of biochemistry & cell biology 20080101

• Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy.

  Journal of experimental & clinical cancer research : CR 20080101

• High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.

  Arthritis research & therapy 20080101

• Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report.

  Acta oncologica (Stockholm, Sweden) 20080101

• Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison.

  BMC cancer 20080101

• Sinusoidal obstruction syndrome (veno-occlusive disease) in a patient receiving bevacizumab for metastatic colorectal cancer: a case report.

  Journal of medical case reports 20080101

• Early distant relapse after optimal local control in locally advanced rectal cancer.

  International seminars in surgical oncology : ISSO 20080101

• Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units.

  Anticancer research 20080101

• Adrenalectomy for solitary adrenal metastasis from colorectal cancer: A case report.

  Cases journal 20080101

• Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer.

  BMC cancer 20080101

• Bid participates in genotoxic drug-induced apoptosis of HeLa cells and is essential for death receptor ligands' apoptotic and synergistic effects.

  PloS one 20080101

• Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer.

  BMC cancer 20080101

• What oncologists tell patients about survival benefits of palliative chemotherapy and implications for informed consent: qualitative study.

  BMJ (Clinical research ed.) 20080101

• Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs.

  Metal-based drugs 20080101

• Current adjuvant and targeted therapies for pancreatic adenocarcinoma.

  Current medicinal chemistry 20080101

• Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy.

  BMC gastroenterology 20080101

• Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines.

  BMC cancer 20080101

• Role of caveolin 1, E-cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells.

  BMC medical genomics 20080101

• EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy.

  BMC cancer 20080101

• Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study.

  BMC cancer 20080101

• Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.

  BMC cancer 20080101

• The inverse starving test is not a suitable provocation test for Gilbert's syndrome.

  BMC research notes 20080101

• Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.

  Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20080101

• Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.

  Anticancer research 20080101

• Complete response after imatinib mesylate administration in a patient with chemoresistant stage IV seminoma.

  Anticancer research 20080101

• Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases.

  Anticancer research 20080101

• Late recurrence of large peri-stomal metastasis following abdomino-perineal resection of rectal cancer.

  World journal of surgical oncology 20080101

• Spotlight on bevacizumab in metastatic colorectal cancer.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20080101

• Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.

  Chemotherapy 20080101

• Long-term platinum retention after treatment with cisplatin and oxaliplatin.

  BMC clinical pharmacology 20080101

• Primary mucinous adenocarcinoma of appendix treated with chemotherapy and radiotherapy: a case report.

  Tumori 20080101

• EGFR expression in gallbladder carcinoma in North America.

  International journal of medical sciences 20080101

• Phase II trial of S-1 in combination with oxaliplatin in previously untreated patients with recurrent or inoperable biliary tract cancer.

  Chemotherapy 20080101

• [The combined treatment of colorectal cancer with liver metastases].

  Khirurgiia 20080101

• Gamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cells.

  Cell communication and signaling : CCS 20080101

• Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan.

  Journal of gastroenterology 20080101

• Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).

  World journal of surgical oncology 20080101

• Biweekly oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. A first-line multicenter phase II trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT).

  Anticancer research 20080101

• Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report.

  Anticancer research 20080101

• Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients.

  Anticancer research 20080101

• Fatal thrombocytopenia after oxaliplatin-based chemotherapy.

  Anticancer research 20080101

• Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems.

  BMC cancer 20080101

• [Adjuvant therapy of colon carcinoma].

  Onkologie 20080101

• [Multimodality treatment for colorectal cancer].

  Onkologie 20080101

• [Treatment of gastric cancer].

  Onkologie 20080101

• Effects of small interfering RNA targeting thymidylate synthase on survival of ACC3 cells from salivary adenoid cystic carcinoma.

  BMC cancer 20080101

• A study of lymph node ratio in stage IV colorectal cancer.

  World journal of surgical oncology 20080101

• Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).

  BMC cancer 20080101

• Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.

  Current medicinal chemistry 20080101

• A new concept for cancer therapy: out-competing the aggressor.

  Cancer cell international 20080101

• Alteration of Drug Sensitivity in Human Colon Cancer Cells after Exposure to Heat: Implications for Liver Metastasis Therapy using RFA and Chemotherapy.

  International journal of clinical and experimental medicine 20080101

• Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.

  Breast cancer research : BCR 20080101

• Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.

  BMC cancer 20080101

• Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study.

  Journal of occupational medicine and toxicology (London, England) 20080101

• Sequential or combination chemotherapy for a patient with mCRC?

  Cancer treatment reviews 20080101

• A dilemma in geriatric oncology: malignant bowel obstruction in an 81-year-old man.

  Cancer treatment reviews 20080101

• Neoadjuvant chemotherapy versus surgery alone for locally advanced gastric cancer: a retrospective comparative study.

  Hepato-gastroenterology 20080101

• Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients.

  PloS one 20080101

• Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine.

  BMC cancer 20080101

• The management of cancer in the elderly: targeted therapies in oncology.

  Immunity & ageing : I & A 20080101

• Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20080101

• Management of allergic reactions to oxaliplatin in colorectal cancer patients.

  The journal of supportive oncology 20080101

• Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.

  Anticancer research 20080101

• Role of neoadjuvant treatment in cT3N0M0 rectal cancer.

  Anticancer research 20080101

• Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?

  Digestive surgery 20080101

• The addition of bevacizumab to fluoropyrimidine, irinotecan and oxaliplatin-based therapy improves survival for patients with metastatic colorectal cancer (CRC): combined analysis of efficacy.

  Acta chirurgica Iugoslavica 20080101

• Current approaches to gastric cancer in Korea.

  Gastrointestinal cancer research : GCR 20080101

• Rationale for combining biotherapy in the treatment of advanced colon cancer.

  Gastrointestinal cancer research : GCR 20080101

• Chromosome 20q amplification regulates in vitro response to Kinesin-5 inhibitor.

  Cancer informatics 20080101

• The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells.

  Cancer informatics 20080101

• Chemotherapy for nonresectable colorectal cancer at a center during 25 years.

  Hepato-gastroenterology 20080101

• Adjuvant treatment of colorectal cancer.

  Gastrointestinal cancer research : GCR 20080101

• Advanced gastric cancer: an update and future directions.

  Gastrointestinal cancer research : GCR 20080101

• Transient elastography for the prediction of oxaliplatin-associated liver injury in colon cancer patients: a preliminary analysis.

  Journal of gastrointestinal cancer 20080101

• Medical resource use and cost of different first-line treatments for metastatic colorectal cancer in Brazil.

  Journal of medical economics 20080101

• A new chemoimmunotherapy regimen (OXAFI) for advanced hepatocellular carcinoma.

  Hematology/oncology and stem cell therapy 20080101

• Targeted treatment of advanced and metastaticbreast cancer with lapatinib.

  OncoTargets and therapy 20080101

• The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer.

  OncoTargets and therapy 20080101

• Direct evidence that heterogeneity necessitates and limits the use of multidrug chemotherapy in colon cancer.

  Molecular medicine reports 20080101

• Cancer care in Singapore.

  Biomedical imaging and intervention journal 20080101

• Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim.

  Biomedical imaging and intervention journal 20080101

• Oxaliplatin for metastatic colon cancer in a patient with renal failure.

  Clinical medicine. Oncology 20080101

• Successful downstaging of high rectal and recto-sigmoid cancer by neo-adjuvant chemo-radiotherapy.

  Clinical medicine. Oncology 20080101

• Leptomeningeal metastases in a patient with an extragonadal germ cell tumor.

  Clinical medicine. Oncology 20080101

• Adenocarcinoma Arising within a Colonic Diverticulum in a Patient with Recurrent Diverticulitis.

  Clinical medicine. Oncology 20080101

• Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas.

  Clinical medicine. Oncology 20080101

• Chemotherapeutic treatment of priapism in metastatic rectal cancer.

  Case reports in gastroenterology 20080101

• Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology.

  Ecancermedicalscience 20080101

• 2007 EORTC-NCI-ASCO annual meeting: molecular markers in cancer.

  Ecancermedicalscience 20080101

• Defeating cancer with antidepressants.

  Ecancermedicalscience 20080101

• Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo.

  Ecancermedicalscience 20080101

• Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases.

  Cancer 20071215

• FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.

  Cancer 20071215

• Tumors established with cell lines selected for oxaliplatin resistance respond to oxaliplatin if combined with cetuximab.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071215

• Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study.

  World journal of gastroenterology 20071214

• Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab.

  British journal of cancer 20071203

• Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

  Biophysical journal 20071201

• A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20071201

• Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system.

  European journal of cancer (Oxford, England : 1990) 20071201

• Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20071201

• The pain with platinum: oxaliplatin and neuropathy.

  European journal of cancer (Oxford, England : 1990) 20071201

• Bringing unresectable liver disease to resection with curative intent.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20071201

• Neurologic complications of chemotherapy agents.

  Current opinion in neurology 20071201

• Characterization of oxaliplatin-DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations.

  Chemical research in toxicology 20071201

• Treatment of advanced colorectal cancer in the elderly.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20071201

• Oxaliplatin-induced hypersensitivity reaction displaying marked elevation of immunoglobulin E.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20071201

• [Cytotoxic effect of epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in combination with oxaliplatin on lung cancer cell line A549].

  Ai zheng = Aizheng = Chinese journal of cancer 20071201

• [Efficacy of gemcitabine combined oxaliplatin on advanced pancreatic cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20071201

• Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report.

  Chest 20071201

• Broad funding for oxaliplatin in Ontario (finally!).

  Current oncology (Toronto, Ont.) 20071201

• Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome.

  Pharmacogenomics 20071201

• [Comparative study on treatment of advanced colorectal cancer by Aidi injection combined with FOLFOX4 regimen and by FOLFOX4 regimen alone].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20071201

• A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites.

  Japanese journal of clinical oncology 20071201

• The role of adjuvant chemotherapy in colon cancer.

  Surgical oncology 20071201

• Update on clinical data combining capecitabine with targeted agents in newly diagnosed colorectal cancer.

  Clinical colorectal cancer 20071201

• Update on clinical data with regimens inhibiting angiogenesis and epidermal growth factor receptor for patients with newly diagnosed metastatic colorectal cancer.

  Clinical colorectal cancer 20071201

• Exploring alternative individualized treatment strategies in colorectal cancer.

  Clinical colorectal cancer 20071201

• A retrospective on the inhibition of epidermal growth factor receptor as a therapeutic strategy for patients with relapsed metastatic colorectal cancer: impact on treatment of today's patients.

  Clinical colorectal cancer 20071201

• [Study on the efficacy and safety of high dose thymopentin combined with trans-artery chemoembolization for primary liver cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20071201

• Palonosetron as an anti-emetic and anti-nausea agent in oncology.

  Therapeutics and clinical risk management 20071201

• Targeted therapies in the management of metastatic bladder cancer.

  Biologics : targets & therapy 20071201

• Synthesis of bicyclic sigma receptor ligands with cytotoxic activity.

  Journal of medicinal chemistry 20071129

• [Adjuvant chemotherapy for colon cancer].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20071129

• New approaches in angiogenic targeting for colorectal cancer.

  World journal of gastroenterology 20071128

• Combining chemotherapy and targeted therapies in metastatic colorectal cancer.

  World journal of gastroenterology 20071128

• Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

  World journal of gastroenterology 20071128

• Progression-free survival is a surrogate for survival in advanced colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071120

• Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071120

• Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071120

• The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus.

  British journal of cancer 20071119

• Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer.

  British journal of cancer 20071119

• Cetuximab for the treatment of colorectal cancer.

  The New England journal of medicine 20071115

• New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071115

• Dinuclear zinc(II) complexes of symmetric Schiff-base ligands with extended quinoline sidearms.

  Dalton transactions (Cambridge, England : 2003) 20071114

• DNA damage induced by novel demethylcantharidin-integrated platinum anticancer complexes.

  Biochemical and biophysical research communications 20071109

• Molecular dynamic simulations of cisplatin- and oxaliplatin-d(GG) intrastand cross-links reveal differences in their conformational dynamics.

  Journal of molecular biology 20071109

• Long-term survival in a patient with acinar cell carcinoma of pancreas. A case report and review of literature.

  JOP : Journal of the pancreas 20071109

• A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.

  Annals of surgical oncology 20071101

• Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin.

  Annals of surgical oncology 20071101

• Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20071101

• Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20071101

• Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis.

  Cancer 20071101

• Medical treatment for advanced gastroesophageal adenocarcinoma.

  Current opinion in gastroenterology 20071101

• Reversible palpebral ptosis following oxaliplatin infusion.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20071101

• Surgery combined with intra-arterial chemotherapy for stage iv advanced gastric cancer.

  ANZ journal of surgery 20071101

• Comments on final report of the AIO Colorectal Cancer Group Study: fluorouracil/oxaliplatin versus capecitabine/oxaliplatin.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101

• Capecitabine plus oxaliplatin in metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101

• Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathway.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071101

• Rituximab, gemcitabine and oxaliplatin: an effective regimen in patients with refractory and relapsing mantle cell lymphoma.

  Leukemia & lymphoma 20071101

• Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo.

  Molecular cancer therapeutics 20071101

• [Efficacy of m-FOLFOX6 therapy for colorectal cancer in elderly patients].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071101

• Chemotherapy-induced suppression to adenoma or complete suppression of the primary in patients with stage IV colorectal cancer: report of four cases.

  European journal of gastroenterology & hepatology 20071101

• The usefulness of nerve conduction studies in objectively assessing oxaliplatin-induced peripheral neuropathy.

  The oncologist 20071101

• Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin.

  International journal of clinical pharmacology and therapeutics 20071101

• [Treatment of advanced gastric cancer with oxaliplatin plus 5-fluorouracil/ leucovorin (FOLFOX-4 chemotherapy)].

  Revista medica de Chile 20071101

• [Inhibitory effect of oxaliplatin in combination with hyperthermia on angiogenesis].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20071101

• Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study.

  British journal of cancer 20071022

• Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases.

  British journal of cancer 20071022

• PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients.

  British journal of cancer 20071022

• Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.

  World journal of gastroenterology 20071021

• Chemotherapy and cancer stem cells.

  Cell stem cell 20071011

• Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

  Cell stem cell 20071011

• Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071010

• Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071010

• [18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil.

  British journal of cancer 20071008

• In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.

  British journal of cancer 20071008

• Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial.

  British journal of cancer 20071008

• ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein.

  British journal of cancer 20071008

• The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study.

  Investigational new drugs 20071001

• Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy.

  Journal of cancer research and clinical oncology 20071001

• Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population.

  European journal of human genetics : EJHG 20071001

• Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.

  Annals of surgical oncology 20071001

• Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group.

  Annals of surgical oncology 20071001

• Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20071001

• A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.

  Anti-cancer drugs 20071001

• Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

  Cancer treatment reviews 20071001

• Enhancement of capecitabine efficacy by oxaliplatin in human colorectal and gastric cancer xenografts.

  Oncology reports 20071001

• Prognosis of small bowel adenocarcinoma treated with Mayo or Xelox regimen: a matched case-control study from a database of 581 patients with colorectal cancer.

  Oncology reports 20071001

• Effect of betulinic acid on anticancer drug-resistant colon cancer cells.

  Basic & clinical pharmacology & toxicology 20071001

• Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis.

  The Lancet. Oncology 20071001

• Effective second-line treatment with cetuximab and bevacizumab in a patient with hepatic metastases of colorectal cancer and hyperbilirubinemia.

  Onkologie 20071001

• COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.

  American journal of clinical oncology 20071001

• Colonic adenocarcinoma in a 13-year-old with cystic fibrosis.

  Journal of pediatric surgery 20071001

• Optimal chemotherapy treatment for women with recurrent ovarian cancer.

  Current oncology (Toronto, Ont.) 20071001

• Adjuvant therapy for stage II colon cancer: prognostic and predictive markers.

  Journal of the National Comprehensive Cancer Network : JNCCN 20071001

• Adjuvant therapy for colon cancer.

  Current gastroenterology reports 20071001

• First-line use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer.

  Clinical colorectal cancer 20071001

• Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan.

  Clinical therapeutics 20071001

• Comparative cytotoxicity of C-1311 in colon cancer in vitro and in vivo using the hollow fiber assay.

  Journal of chemotherapy (Florence, Italy) 20071001

• Gemcitabine combined with oxaliplatin (GEMOX) as salvage treatment in elderly patients with advanced ovarian cancer refractory or resistant to platinum: a single institution experience.

  Journal of chemotherapy (Florence, Italy) 20071001

• The impact of the introduction of irinotecan and oxaliplatin on the outcome of patients with advanced colorectal cancer.

  Journal of chemotherapy (Florence, Italy) 20071001

• Local-regional approach to diffuse malignant peritoneal mesothelioma.

  Gastroenterologie clinique et biologique 20071001

• Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy.

  Gastroenterologie clinique et biologique 20071001

• Current options for the management of rectal cancer.

  Current treatment options in oncology 20071001

• [Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20071001

• Satraplatin in the treatment of hormone-refractory metastatic prostate cancer.

  Therapeutics and clinical risk management 20071001

• Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920

• Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920

• Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920

• Stability of oxaliplatin in infusion bags containing 5% dextrose injection.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070915

• In vitro evaluation of cancer-specific NF-kappaB-CEA enhancer-promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines.

  British journal of cancer 20070911

• Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy.

  British journal of cancer 20070911

• Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients.

  Cancer chemotherapy and pharmacology 20070901

• Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.

  Journal of surgical oncology 20070901

• Re: Preoperative chemotherapy and the outcome of liver resection for colorectal metastases.

  World journal of surgery 20070901

• Low-dose BBR3610 toxicity in colon cancer cells is p53-independent and enhanced by inhibition of epidermal growth factor receptor (ERBB1)-phosphatidyl inositol 3 kinase signaling.

  Molecular pharmacology 20070901

• [Role of pharmacogenetics in chemotherapy of colorectal cancers].

  La Revue de medecine interne 20070901

• A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer.

  Current medical research and opinion 20070901

• Encapsulation of platinum(II)-based DNA intercalators within cucurbit[6,7,8]urils.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20070901

• Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070901

• High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20070901

• Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.

  Anti-cancer drugs 20070901

• Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer.

  Cancer 20070901

• [Laparoscopic ovarian transposition and cryopreservation of ovarian tissue before chemo-radiotherapy for rectal cancer].

  Gynecologie, obstetrique & fertilite 20070901

• PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

  The Lancet. Oncology 20070901

• Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?

  Liver international : official journal of the International Association for the Study of the Liver 20070901

• Economic analysis of a multicentre, randomised, phase III trial comparing FOLFOXIRI with FOLFIRI in patients with metastatic colorectal cancer in Greece.

  Current medical research and opinion 20070901

• Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.

  Japanese journal of clinical oncology 20070901

• 5T4-modified vaccinia ankara: progress in tumor-associated antigen-based immunotherapy.

  Expert opinion on biological therapy 20070901

• New developments in first- and second-line chemotherapy for transitional cell, squamous cell and adenocarcinoma of the bladder.

  Current opinion in urology 20070901

• Metastatic esophageal adenocarcinoma presenting in the iris.

  American journal of ophthalmology 20070901

• [Fifth-line chemotherapy for metastatic gastric cancer--a case responding to modified FOLFOX 6].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070901

• Molecular markers in colorectal cancer: genetic bases for a customised treatment.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070901

• A Phase II study of cetuximab (Erbitux) plus FOLFIRI for irinotecan and oxaliplatin-refractory metastatic colorectal cancer.

  Journal of Korean medical science 20070901

• Combined-modality therapy for rectal cancer: future prospects.

  Clinical colorectal cancer 20070901

• Two Doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer.

  Clinical colorectal cancer 20070901

• Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual.

  Clinical colorectal cancer 20070901

• Phase II trial of 5-fluorouracil/leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma: a cancer therapeutics research group study.

  Clinical colorectal cancer 20070901

• Phase II study of gemcitabine combined with platinum chemotherapy for recurrent epithelial ovarian cancer.

  Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20070901

• Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20070901

• Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.

  Advanced drug delivery reviews 20070831

• Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance.

  Advanced drug delivery reviews 20070831

• The cytotoxicity of high-linear energy transfer radiation is reinforced by oxaliplatin in human glioblastoma cells.

  Cancer letters 20070828

• Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity.

  Journal of controlled release : official journal of the Controlled Release Society 20070828

• Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells.

  British journal of cancer 20070828

• Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma.

  British journal of cancer 20070828

• A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status.

  British journal of cancer 20070820

• Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer.

  British journal of cancer 20070820

• First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer.

  Cancer 20070815

• Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070815

• Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070810

• ZNF143 interacts with p73 and is involved in cisplatin resistance through the transcriptional regulation of DNA repair genes.

  Oncogene 20070809

• Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.

  British journal of cancer 20070806

• Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer.

  British journal of cancer 20070806

• Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20070801

• Interventional management of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy.

  European radiology 20070801

• Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry.

  International archives of occupational and environmental health 20070801

• Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070801

• Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070801

• Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.

  Cancer 20070801

• p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells.

  Biochemical pharmacology 20070801

• EGFR-targeted therapies in colorectal cancer.

  Diseases of the colon and rectum 20070801

• Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.

  Biochemical pharmacology 20070801

• The resurgence of platinum-based cancer chemotherapy.

  Nature reviews. Cancer 20070801

• Development of a liquid chromatography-electrospray ionization tandem mass spectrometry method for detecting oxaliplatin-DNA intrastrand cross-links in biological samples.

  Chemical research in toxicology 20070801

• Sound footing or slippery slope? The value of secondary analyses of randomized trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801

• Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801

• Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070801

• Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070801

• Cytotoxic therapy for advanced pancreatic adenocarcinoma.

  Seminars in oncology 20070801

• Does radiation prevent 5-fluorouracil-induced colitis in the early phase of radiochemotherapy? A case report and literature review.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20070801

• [Bevacizumab (Avastin)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070801

• [A case of neurotoxicity reduced with goshajinkigan in modified FOLFOX6 chemotherapy for advanced colon cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070801

• [FOLFOX 4 in a patient with metastatic colorectal cancer on hemodialysis due to chronic renal failure].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070801

• Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070801

• [Efficacy of transcatheter arterial chemoembolization combined thalidomide on hepatocellular carcinoma: a controlled randomized trial].

  Ai zheng = Aizheng = Chinese journal of cancer 20070801

• [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20070801

• [Meta-analysis on gemcitabine of fixed-dose rate infusion plus oxaliplatin as first-line therapy for advanced pancreatic cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20070801

• Epidemiology, disease progression, and economic burden of colorectal cancer.

  Journal of managed care pharmacy : JMCP 20070801

• Neoadjuvant chemotherapy enables R0 resection of locally advanced rectal cancer in a patient with a previously irradiated pelvis.

  The British journal of radiology 20070801

• A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancer.

  American journal of clinical oncology 20070801

• New medical options for liver tumours.

  Clinical medicine (London, England) 20070801

• Alistipes finegoldii in blood cultures from colon cancer patients.

  Emerging infectious diseases 20070801

• Dinuclear platinum complexes with biological relevance based on the 1,2-diaminocyclohexane carrier ligand.

  Inorganic chemistry 20070723

• Phase transformation of the periodic mesoporous organosilicas assisted by organotrialkoxysilane.

  The journal of physical chemistry. B 20070719

• Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells.

  British journal of cancer 20070716

• Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard?

  Lancet (London, England) 20070714

• Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.

  Lancet (London, England) 20070714

• Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

  Lancet (London, England) 20070714

• Therapy of gastric mucosa associated lymphoid tissue lymphoma.

  World journal of gastroenterology 20070714

• Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007.

  JOP : Journal of the pancreas 20070709

• A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours.

  British journal of cancer 20070702

• Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines.

  International journal of cancer 20070701

• A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer.

  Gynecologic oncology 20070701

• Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070701

• Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20070701

• The activation of platinum(II) antiproliferative drugs in carbonate medium evaluated by means of a DNA-biosensor.

  Journal of inorganic biochemistry 20070701

• Neoadjuvant treatment in upper gastrointestinal adenocarcinomas: new paradigms from old concepts?

  Current opinion in oncology 20070701

• An economic evaluation of oxaliplatin for the adjuvant treatment of colon cancer in the United Kingdom (UK).

  European journal of cancer (Oxford, England : 1990) 20070701

• Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin.

  Expert opinion on investigational drugs 20070701

• Expression of epidermal growth factor receptor as a predictive factor for rectal cancer.

  Archives of Iranian medicine 20070701

• Radiotherapy for localized rectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070701

• Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.

  Gan to kagaku ryoho. Cancer & chemotherapy 20070701

• [A case of metastatic colon cancer to paraaortic lymph nodes and liver treated successfully with oxaliplatin combination chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070701

• Hepatic arterial infusion of oxaliplatin for a patient with hepatic metastases from colon cancer undergoing hemodialysis.

  Japanese journal of clinical oncology 20070701

• Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.

  Clinical colorectal cancer 20070701

• Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy.

  Clinical colorectal cancer 20070701

• Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.

  Anti-cancer drugs 20070701

• UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.

  Anti-cancer drugs 20070701

• Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate.

  Anti-cancer drugs 20070701

• [Anti-angiogenic treatment and colorectal cancer].

  Bulletin du cancer 20070701

• Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.

  Biochemical pharmacology 20070630

• [Impact on budget of new drugs for colorectal cancer treatment].

  Medicina clinica 20070623

• Enantioselective fluorescent recognition of chiral acids by cyclohexane-1,2-diamine-based bisbinaphthyl molecules.

  The Journal of organic chemistry 20070622

• Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group study.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070615

• Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.

  Biochemistry 20070605

• Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft.

  Carcinogenesis 20070601

• Inhibition of G1/S transition potentiates oxaliplatin-induced cell death in colon cancer cell lines.

  Biochemical pharmacology 20070601

• Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients.

  Annals of surgical oncology 20070601

• Chemotherapy of advanced gastric cancer.

  Cancer treatment reviews 20070601

• Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review.

  Cancer treatment reviews 20070601

• Evaluation of the risk of contamination of surgical personnel by vaporization of oxaliplatin during the intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC).

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20070601

• Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer.

  Anti-cancer drugs 20070601

• Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20070601

• Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.

  Cancer science 20070601

• The hope for today--the promise for tomorrow: will oncologists meet the challenge?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results.

  International journal of radiation oncology, biology, physics 20070601

• Phase I clinical trial of oxaliplatin in children and adolescents with refractory solid tumors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Her signaling in pancreatic cancer.

  Expert opinion on biological therapy 20070601

• A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer.

  Expert opinion on pharmacotherapy 20070601

• [A case of liver failure associated with liver damage due to mFOLFOX 6 after resection for multiple liver metastases from colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070601

• Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience.

  International journal of clinical oncology 20070601

• Role of repeated hepatectomy in the multimodal treatment of hepatic colorectal metastases.

  Archives of surgery (Chicago, Ill. : 1960) 20070601

• Outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer.

  Journal of Korean medical science 20070601

• Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.

  Japanese journal of clinical oncology 20070601

• Phase II study of oxaliplatin in japanese patients with metastatic colorectal cancer refractory to fluoropyrimidines.

  Japanese journal of clinical oncology 20070601

• A review of the role of capecitabine in the treatment of colorectal cancer.

  Therapeutics and clinical risk management 20070601

• Cetuximab in the management of colorectal cancer.

  Biologics : targets & therapy 20070601

• Current role of antibody therapy in patients with metastatic colorectal cancer.

  Oncogene 20070528

• A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer.

  British journal of cancer 20070521

• Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat.

  Toxicology 20070520

• trans-(1R,2R)-Diaminocyclohexane-functionalized mesoporous organosilica spheres as chiral stationary phase.

  Journal of chromatography. A 20070518

• A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer.

  British journal of cancer 20070507

• First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study.

  British journal of cancer 20070507

• New agents for treatment of advanced transitional cell carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070501

• Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells.

  Cancer chemotherapy and pharmacology 20070501

• Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: a review.

  International journal of colorectal disease 20070501

• The impact of different chelating leaving groups on the substitution kinetics of mononuclear Pt(II)(1,2-trans-R,R-diaminocyclohexane)(X-Y) complexes.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20070501

• A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070501

• Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.

  Oncology reports 20070501

• Diagnosis and surgical management of gallbladder cancer: a review.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20070501

• Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070501

• Integration of novel agents into combined-modality treatment for rectal cancer patients.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20070501

• FDA drug approval summary: panitumumab (Vectibix).

  The oncologist 20070501

• Management and preparedness for infusion and hypersensitivity reactions.

  The oncologist 20070501

• Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice.

  Neoplasia (New York, N.Y.) 20070501

• Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer.

  Clinical colorectal cancer 20070501

• Speciation analysis of platinum antitumoral drugs in impacted tissues.

  Talanta 20070430

• Vascular disrupting agents in clinical development.

  British journal of cancer 20070423

• An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer.

  British journal of cancer 20070423

• Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy.

  British journal of cancer 20070423

• Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070420

• [Expression of hexokinase-II gene in human colon cancer cells and the therapeutic significance of inhibition thereof].

  Zhonghua yi xue za zhi 20070417

• Safe liver resection following chemotherapy for colorectal metastases is a matter of timing.

  British journal of cancer 20070410

• Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study.

  British journal of cancer 20070410

• Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

  Cancer chemotherapy and pharmacology 20070401

• Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.

  Cancer chemotherapy and pharmacology 20070401

• Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study.

  Investigational new drugs 20070401

• Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat.

  Pain 20070401

• A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070401

• Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study.

  Cancer 20070401

• A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?

  ChemMedChem 20070401

• Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine.

  Journal of neurology 20070401

• Renal tubular acidosis due to oxaliplatin.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070401

• Cell cycle arrest by oxaliplatin on cancer cells.

  Fundamental & clinical pharmacology 20070401

• Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070401

• Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery.

  Annals of surgery 20070401

• Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.

  Journal of cardiothoracic and vascular anesthesia 20070401

• Chemotherapy for advanced gastric cancer: across the years for a standard of care.

  Expert opinion on pharmacotherapy 20070401

• Oxaliplatin in the treatment of colorectal cancer.

  Expert opinion on drug metabolism & toxicology 20070401

• Cetuximab plus irinotecan in refractory colorectal cancer patients.

  Expert review of anticancer therapy 20070401

• Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.

  Expert review of anticancer therapy 20070401

• Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.

  Expert review of anticancer therapy 20070401

• [Efficacy and toxicity of FOLFOX6 regimen in treating colorectal cancer patients with liver metastasis].

  Ai zheng = Aizheng = Chinese journal of cancer 20070401

• Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.

  Molecular cancer therapeutics 20070401

• [Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070401

• Adjuvant treatment of colon cancer: past, present and future.

  Journal of chemotherapy (Florence, Italy) 20070401

• The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20070401

• Primary seminal vesicle adenocarcinoma presenting as isolated metastasis to penis responding to chemotherapy and hormonal therapy.

  Urology 20070401

• Treatment of advanced pancreatic cancer.

  Seminars in oncology 20070401

• Adjuvant therapy for stage II and III colorectal cancer.

  Seminars in oncology 20070401

• Developing strategies for liver metastases from colorectal cancer.

  Seminars in oncology 20070401

• Size matters. What can we learn from a small randomized trial?

  Onkologie 20070401

• Optimizing palliative treatment of metastatic colorectal cancer in the era of biologic therapy.

  Oncology (Williston Park, N.Y.) 20070401

• Differential effects of ionizing radiation and platinum-derivative chemotherapy on apoptotic pathways in testicular germ cells.

  International journal of radiation biology 20070401

• Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials.

  British journal of cancer 20070326

• A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer.

  British journal of cancer 20070326

• Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070320

• Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.

  Cancer 20070315

• Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients.

  British journal of cancer 20070312

• Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels.

  British journal of cancer 20070312

• Pancreatic cancer: are we moving forward yet? Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 20th, 2007.

  JOP : Journal of the pancreas 20070310

• A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression.

  Cancer chemotherapy and pharmacology 20070301

• Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070301

• Diagnostic and predictive value of skin testing in platinum salt hypersensitivity.

  The Journal of allergy and clinical immunology 20070301

• Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.

  Anti-cancer drugs 20070301

• Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan.

  Oncology reports 20070301

• Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases.

  The British journal of surgery 20070301

• The roles of copper transporters in cisplatin resistance.

  Cancer metastasis reviews 20070301

• Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070301

• Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.

  Health technology assessment (Winchester, England) 20070301

• [Chemotherapy for elderly patients with colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070301

• Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients.

  The oncologist 20070301

• FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer.

  The oncologist 20070301

• Yale University School of Medicine: 2007 student thesis abstracts.

  The Yale journal of biology and medicine 20070301

• Hypokalemia secondary to capecitabine: a hidden toxicity?

  Therapeutics and clinical risk management 20070301

• [Medical therapy of progressive colorectal cancer].

  Praxis 20070227

• A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.

  British journal of cancer 20070226

• A phase I and pharmacokinetic study of indisulam in combination with carboplatin.

  British journal of cancer 20070226

• Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis.

  British journal of cancer 20070226

• A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma.

  British journal of cancer 20070226

• Old age: biologic versus chronologic.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070220

• [Oxaliplatin combined with gemcitabine in the treatment of patients with advanced non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20070220

• Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study.

  British journal of cancer 20070212

• Addition of weekly oxaliplatin to standard preoperative chemoradiation for locally advanced rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070210

• [Standard chemotherapy for colonic neoplasms].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070210

• Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.

  Cancer chemotherapy and pharmacology 20070201

• A phase I trial of oxaliplatin and topotecan in recurrent ovarian carcinoma.

  Gynecologic oncology 20070201

• Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Molecular mechanisms of resistance and toxicity associated with platinating agents.

  Cancer treatment reviews 20070201

• Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.

  Annals of surgical oncology 20070201

• Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy?

  Annals of surgical oncology 20070201

• Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?

  Cancer 20070201

• Preoperative chemotherapy and the outcome of liver resection for colorectal metastases.

  World journal of surgery 20070201

• Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial.

  Onkologie 20070201

• FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer.

  American journal of clinical oncology 20070201

• Circadian rhythms in the CNS and peripheral clock disorders: chronopharmacological findings on antitumor drugs.

  Journal of pharmacological sciences 20070201

• [A phase I study of modified FOLFOX 6 therapy for advanced colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070201

• [Introduction 'why is it multinational clinical trial now?'].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070201

• FOLFOX-4 regimen as fist-line chemotherapy in elderly patients with advanced gastric cancer: a safety study.

  Journal of chemotherapy (Florence, Italy) 20070201

• [Acute idiopathic polyneuritis: a potentially fatal neuropathy that is difficult to diagnose in patients receiving oxaliplatin].

  Gastroenterologie clinique et biologique 20070201

• Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea.

  Current oncology (Toronto, Ont.) 20070201

• [Pre-operative chemotherapy for patients with hepatic metastases from colorectal cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070201

• Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment.

  British journal of cancer 20070129

• Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.

  British journal of cancer 20070129

• Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors.

  Oncogene 20070125

• Asymmetric amplification in catalysis by trans-1,2-diaminocyclohexane bistriflamide.

  Organic letters 20070118

• Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial.

  British journal of cancer 20070115

• Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study.

  British journal of cancer 20070115

• Phase 1b dose escalation study of erlotinib in combination with infusional 5-Fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070115

• ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme.

  Chemical communications (Cambridge, England) 20070114

• Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10.

  Cancer letters 20070108

• Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20070101

• Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• [Colorectal liver metastases. Neoadjuvant chemotherapy: aspects of medical and surgical oncology].

  Der Internist 20070101

• Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070101

• Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070101

• [Chemotherapy in advanced gastric cancer--to ensure timely and appropriate switch to subsequent treatment options].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070101

• Management of recurrent testicular germ cell tumors.

  The oncologist 20070101

• The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells.

  Molecular cancer therapeutics 20070101

• In the shadow of bad news - views of patients with acute leukaemia, myeloma or lung cancer about information, from diagnosis to cure or death.

  BMC palliative care 20070101

• A computational model for functional mapping of genes that regulate intra-cellular circadian rhythms.

  Theoretical biology & medical modelling 20070101

• Biochemical mechanisms of cisplatin cytotoxicity.

  Anti-cancer agents in medicinal chemistry 20070101

• Searching for the magic bullet: anticancer platinum drugs which can be accumulated or activated in the tumor tissue.

  Anti-cancer agents in medicinal chemistry 20070101

• Colorectal cancer.

  Mayo Clinic proceedings 20070101

• Depression in cancer patients: a critical review.

  Clinical practice and epidemiology in mental health : CP & EMH 20070101

• Oxaliplatin hypersensitivity: case report and successful repeat desensitization.

  American journal of therapeutics 20070101

• Systemic anticancer therapy in gynecological cancer patients with renal dysfunction.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101

• Severe diarrhea in patients with advanced-stage colorectal cancer receiving FOLFOX or FOLFIRI chemotherapy: the development of a risk prediction tool.

  Clinical colorectal cancer 20070101

• A case of oxaliplatin-related posterior reversible encephalopathy syndrome.

  Clinical colorectal cancer 20070101

• Gemcitabine-oxaliplatin combination in heavily pretreated metastatic breast cancer: a pilot study on 43 patients.

  The breast journal 20070101

• Synergistic antitumor activity of oxaliplatin in combination with gemcitabine in pancreatic tumor-bearing mice.

  Chemotherapy 20070101

• Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features.

  Anticancer research 20070101

• Comparison of the combined action of oxaliplatin or cisplatin and radiation in cervical and lung cancer cells.

  International journal of radiation biology 20070101

• Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101

• Adjuvant chemotherapy for colon cancer: evidence on improvement in survival.

  Digestive diseases (Basel, Switzerland) 20070101

• Treatment of advanced hepatocellular carcinoma with gemcitabine plus oxaliplatin.

  Hepato-gastroenterology 20070101

• Current medical treatment of pancreatic neuroendocrine tumors.

  Hepato-gastroenterology 20070101

• Cyclophosphamide 'metronomic' chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.

  BMC cancer 20070101

• Caspase activation by anticancer drugs: the caspase storm.

  Molecular pharmaceutics 20070101

• Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms.

  Pathologie-biologie 20070101

• Phase I study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first line therapy in patients with non-resectable gastric cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• Review of the toxicology of three alkyl diamines.

  Drug and chemical toxicology 20070101

• Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach.

  BMC cancer 20070101

• Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.

  Anticancer research 20070101

• Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma.

  Cancer journal (Sudbury, Mass.) 20070101

• Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol.

  BMC cancer 20070101

• [Preliminary experience with hyperthermic intraperitoneal chemo-perfusion with oxaliplatin for the treatment of peritoneal carcinomatosis due to colorectal carcinoma].

  Chirurgia italiana 20070101

• Adjuvant treatment of colorectal cancer.

  CA: a cancer journal for clinicians 20070101

• Development and clinical indications of cetuximab.

  The International journal of biological markers 20070101

• Cetuximab in colon cancer.

  The International journal of biological markers 20070101

• Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.

  BMC cancer 20070101

• Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria.

  BMC cancer 20070101

• Method for evaluating prediction models that apply the results of randomized trials to individual patients.

  Trials 20070101

• Sphincter preservation in four consecutive phase II studies of preoperative chemoradiation: analysis of 247 T3 rectal cancer patients.

  Tumori 20070101

• Lack of cardiotoxicity with liposomal doxorubicin in an elderly case of ovarian cancer.

  Tumori 20070101

• A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium.

  BMC cancer 20070101

• Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil.

  Acta oncologica (Stockholm, Sweden) 20070101

• Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20070101

• Dose escalating clinical study of high dose infusional 5-fluorouracil and leukovorin (AIO regimen) plus alternate weekly administration of oxaliplatin and irinotecan in patients with advanced tumors of the gastrointestinal tract.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20070101

• Cetuximab: appraisal of a novel drug against colorectal cancer.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20070101

• Cost considerations in the treatment of colorectal cancer.

  PharmacoEconomics 20070101

• Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.

  World journal of surgical oncology 20070101

• Adjuvant therapy of colon cancer: current status and future directions.

  Cancer journal (Sudbury, Mass.) 20070101

• Prediction of short-term survival in patients with advanced nonsmall cell lung cancer following chemotherapy based on 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: a feasibility study.

  Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20070101

• A comparison of the platinum analogues in bladder cancer cell lines.

  Urologia internationalis 20070101

• HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin.

  Cancer treatment and research 20070101

• Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

  Cancer treatment and research 20070101

• Combination therapy targeting the tumor microenvironment is effective in a model of human ocular melanoma.

  Journal of translational medicine 20070101

• Chiral macrocyclic aliphatic oligoimines derived from trans-1,2-diaminocyclohexane.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20070101

• Phenoxodiol protects against Cisplatin induced neurite toxicity in a PC-12 cell model.

  BMC neuroscience 20070101

• A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer.

  Tumori 20070101

• Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer.

  Anticancer research 20070101

• Targeting base excision repair to improve cancer therapies.

  Molecular aspects of medicine 20070101

• Metastatic colorectal cancer: current systemic treatment options.

  Drugs 20070101

• [Updates on gemcitabine on metastatic breast cancer].

  Bulletin du cancer 20070101

• Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.

  Cancer investigation 20070101

• [Intestinal pneumatosis and portomesenteric gas: a case review].

  Revista de medicina de la Universidad de Navarra 20070101

• Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer.

  Medical oncology (Northwood, London, England) 20070101

• Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• An update on treatment advances for the first-line therapy of metastatic colorectal cancer.

  Cancer journal (Sudbury, Mass.) 20070101

• A rare case of a retroperitoneal enterogenous cyst with in-situ adenocarcinoma.

  World journal of surgical oncology 20070101

• [Angiogenesis targeting in gastro-intestinal cancers].

  Bulletin du cancer 20070101

• A life in passing: Jonathan Gray.

  Journal of translational medicine 20070101

• 5-fluorouracil, leucovorin and oxaliplatin plus bevacizumab in the first-line treatment of metastatic colorectal cancer: a single-institute study.

  Oncology 20070101

• Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma.

  Anticancer research 20070101

• A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors.

  Oncology 20070101

• Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas.

  Oncology 20070101

• Immunohistochemical identification of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal carcinoma: a case report.

  Journal of medical case reports 20070101

• [Treatment with cetuximab in metastatic colorectal cancer patients who do not express the epidermal growth factor receptor].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101

• The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.

  Best practice & research. Clinical gastroenterology 20070101

• The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer.

  Best practice & research. Clinical gastroenterology 20070101

• Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater.

  Water science and technology : a journal of the International Association on Water Pollution Research 20070101

• Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.

  Nuklearmedizin. Nuclear medicine 20070101

• Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer.

  BMC cancer 20070101

• Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway.

  PloS one 20070101

• Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study.

  Journal of translational medicine 20070101

• UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen.

  Oncology 20070101

• Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.

  Oncology 20070101

• A phase I study of combination of intravenous gemcitabine, oxaliplatin, and 5-FU with daily oral thalidomide (GOFT) in metastatic/locally advanced pancreatic carcinoma patients.

  Hepato-gastroenterology 20070101

• Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor Agents.

  Metal-based drugs 20070101

• An oxaliplatin + 5-fluorouracil bolus + folinic acid (BFOL) regimen as first-line treatment in metastatic colorectal cancer patients.

  Tumori 20070101

• 18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy.

  Tumori 20070101

• [The choice of treatment in advanced gastric cancer].

  Tumori 20070101

• DNA-metallodrugs interactions signaled by electrochemical biosensors: an overview.

  Bioinorganic chemistry and applications 20070101

• Well differentiated papillary mesothelioma.

  JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR) 20070101

• Pulmonary carcinoid tumours: indolent but not benign.

  Oncology 20070101

• Pulmonary fibrosis after chemotherapy with oxaliplatin and 5-fluorouracil for colorectal cancer.

  Oncology 20070101

• Epidermal growth factor receptor-directed therapy in esophageal cancer.

  Oncology 20070101

• Chemotherapy with gemcitabine and oxaliplatin in patients with advanced biliary tract cancer: a single-institution experience.

  Oncology 20070101

• Short time to progression under first-line chemotherapy is a negative prognostic factor for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancer.

  Oncology 20070101

• [Neoadjuvant chemotherapy of invasive cancer of the urinary bladder].

  Urologiia (Moscow, Russia : 1999) 20070101

• Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.

  Gastrointestinal cancer research : GCR 20070101

• Chemotherapy for advanced gastric cancer: review of global and Japanese status.

  Gastrointestinal cancer research : GCR 20070101

• Current status of adjuvant therapy for colon cancer.

  Gastrointestinal cancer research : GCR 20070101

• Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard.

  Gastrointestinal cancer research : GCR 20070101

• Second-line therapy for advanced colorectal cancer.

  Gastrointestinal cancer research : GCR 20070101

• Predictive and prognostic markers in colorectal cancer.

  Gastrointestinal cancer research : GCR 20070101

• Recent Developments in Cytotoxic Therapy for Advanced Gastric or Gastroesophageal Carcinoma: The Phase III Trials.

  Gastrointestinal cancer research : GCR 20070101

• Antiangiogenic agents in first-line and second-line therapy for advanced colorectal cancer.

  Gastrointestinal cancer research : GCR 20070101

• Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care.

  Core evidence 20070101

• Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas.

  Core evidence 20070101

• Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer.

  Core evidence 20070101

• FOLFIRI Is Tolerable after Subtotal Colectomy - A Patient with Familial Adenomatous Polyposis Who Developed Advanced Rectal Cancer.

  Case reports in gastroenterology 20070101

• Resection of colorectal liver metastases following neoadjuvant chemotherapy.

  Ecancermedicalscience 20070101

• Acquired TRAIL resistance in human breast cancer cells are caused by the sustained cFLIP(L) and XIAP protein levels and ERK activation.

  Biochemical and biophysical research communications 20061229

• Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy.

  Neurology 20061226

• A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens.

  British journal of cancer 20061218

• Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal.

  Blood 20061215

• Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding.

  Neurotoxicology 20061201

• A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.

  Cancer chemotherapy and pharmacology 20061201

• Oxaliplatin in inoperable or metastatic bladder cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061201

• Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20061201

• Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance.

  Genes, chromosomes & cancer 20061201

• Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II study.

  Lung cancer (Amsterdam, Netherlands) 20061201

• Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells.

  Toxicology letters 20061201

• Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: a GOAM phase II randomised study (FOCA trial).

  European journal of cancer (Oxford, England : 1990) 20061201

• Efficacy of oncolytic herpesvirus NV1020 can be enhanced by combination with chemotherapeutics in colon carcinoma cells.

  Human gene therapy 20061201

• [Routine chemotherapeutic drug treatment effectiveness predictive molecules and chemotherapeutic drug selection].

  Ai zheng = Aizheng = Chinese journal of cancer 20061201

• Successful gastrointestinal cancer drug development.

  Seminars in oncology 20061201

• Planned treatment interruptions and chemotherapy-free intervals in the treatment of metastatic colorectal cancer: time to start stopping?

  Seminars in oncology 20061201

• Is there a third-line therapy for metastatic colorectal cancer?

  Seminars in oncology 20061201

• Targeted agents for adjuvant therapy of colon cancer.

  Seminars in oncology 20061201

• Should preoperative or postoperative therapy be administered in the management of rectal cancer?

  Seminars in oncology 20061201

• Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping.

  Pharmacogenomics 20061201

• [Anaphylactic reaction to oxaliplatin--a case of colon cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061201

• Gefitinib in combination with 5-fluorouracil (5-FU)/folinic acid and irinotecan in patients with 5-FU/oxaliplatin- refractory colorectal cancer: a phase I/II study of the Arbeitsgemeinschaft für Internistische Onkologie (AIO).

  Onkologie 20061201

• Long-term survival of patients downstaged by oxaliplatin and 5-fluorouracil combination followed by rescue surgery for unresectable colorectal liver metastases.

  Gastroenterologie clinique et biologique 20061201

• Capecitabine and oxaliplatin (XELOX) for the treatment of patients with metastatic gastric cancer and severe liver dysfunction.

  The Korean journal of internal medicine 20061201

• Synthesis, characterization and cytotoxic activity of a new oxaliplatin analog.

  Yao xue xue bao = Acta pharmaceutica Sinica 20061201

• Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies.

  Oncology (Williston Park, N.Y.) 20061201

• Selective resistance of tetraploid cancer cells against DNA damage-induced apoptosis.

  Annals of the New York Academy of Sciences 20061201

• Role of erlotinib in the management of pancreatic cancer.

  Therapeutics and clinical risk management 20061201

• Phase II study of oxaliplatin, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as second line therapy.

  Cancer research and treatment : official journal of Korean Cancer Association 20061201

• Hypersensitivity reactions to oxaliplatin.

  Cancer research and treatment : official journal of Korean Cancer Association 20061201

• Hangman salen platforms containing two xanthene scaffolds.

  The Journal of organic chemistry 20061110

• Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer.

  British journal of cancer 20061106

• Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.

  Chinese medical journal 20061105

• Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study.

  Gynecologic oncology 20061101

• Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.

  Gynecologic oncology 20061101

• Surgery is an essential part of salvage treatment in refractory germ cell tumors.

  European urology 20061101

• Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor.

  European urology 20061101

• Serious delayed hypersensitivity reaction to oxaliplatin.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061101

• Correlation between tumor response to first-line chemotherapy and prognosis in advanced gastric cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061101

• Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).

  The Journal of pharmacology and experimental therapeutics 20061101

• Irinotecan in the treatment of colorectal cancer.

  Cancer treatment reviews 20061101

• Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?

  Annals of surgical oncology 20061101

• Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner.

  International journal of oncology 20061101

• Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.

  Cancer 20061101

• The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20061101

• EXAFS characterization of oxaliplatin anticancer drug and its degradation in chloride media.

  Journal of synchrotron radiation 20061101

• Benefits and risks of neoadjuvant therapy for liver metastases.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061101

• Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061101

• Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine.

  Anti-cancer drugs 20061101

• [What happened during these 12 years since CPT-11 was launched in Japan ?].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061101

• [Oxaliplatin in combination with calcium folinate and fluorouracil as neoadjuvant chemotherapy in the treatment of advanced gastric cancer].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20061101

• Panitumumab.

  Drugs of today (Barcelona, Spain : 1998) 20061101

• Severe sinusoidal lesions: a serious and overlooked complication of oxaliplatin-containing chemotherapy?

  Gastroenterologie clinique et biologique 20061101

• 5-fluorouracil and mitomycin-C: effective, low-cost chemotherapy for colorectal cancer.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20061101

• Prognostic factors predictive of response and survival to a modified FOLFOX regimen: importance of an increased neutrophil count.

  Clinical colorectal cancer 20061101

• Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061020

• [A randomized clinical trial on taxol plus oxaliplatin versus taxol plus cisplatin as first-line treatment in advanced non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20061020

• St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.

  Toxicology and applied pharmacology 20061015

• Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer.

  British journal of cancer 20061009

• High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy.

  British journal of cancer 20061009

• Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.

  Molecular pharmacology 20061001

• Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061001

• Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement by Bartlett et al.

  Annals of surgical oncology 20061001

• Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement.

  Annals of surgical oncology 20061001

• 5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results.

  Archives of medical research 20061001

• Pharmacogenomics of colorectal cancer prevention and treatment.

  Cancer investigation 20061001

• A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer.

  Anti-cancer drugs 20061001

• Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data.

  American journal of clinical oncology 20061001

• Recent advances in the systemic management of colorectal cancer.

  Future oncology (London, England) 20061001

• Therapy for metastatic colorectal cancer.

  The oncologist 20061001

• Update on capecitabine in colorectal cancer.

  The oncologist 20061001

• Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.

  The American journal of gastroenterology 20061001

• Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20061001

• Peritoneal carcinomatosis of colorectal origin.

  Gastroenterologie clinique et biologique 20061001

• Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.

  The journal of supportive oncology 20061001

• Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.

  Journal of chemotherapy (Florence, Italy) 20061001

• Bevacizumab in the treatment of metastatic colorectal cancer (mCRC) in second- and third-line settings.

  Seminars in oncology 20061001

• Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events.

  Seminars in oncology 20061001

• Bevacizumab in combination with chemotherapy: first-line treatment of patients with metastatic colorectal cancer.

  Seminars in oncology 20061001

• [Multicenter phase II study of modified FOLFIRI regimen in the advanced colorectal cancer patient refractory to fluoropyrimidine and oxaliplatin].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20061001

• Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.

  Current oncology (Toronto, Ont.) 20061001

• Is acute dyspnea related to oxaliplatin administration?

  World journal of gastroenterology 20060928

• Flexibility of inorganic tennis ball structures inducing anion selectivity.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20060918

• CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II.

  British journal of cancer 20060918

• Different accumulation of cisplatin, oxaliplatin and JM216 in sensitive and cisplatin-resistant human cervical tumour cells.

  Biochemical pharmacology 20060914

• Asymmetric transfer hydrogenation catalysed by hydrophobic dendritic DACH-rhodium complex in water.

  Organic & biomolecular chemistry 20060907

• A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.

  British journal of cancer 20060904

• In vitro toxicological evaluation of a dinuclear platinum(II) complex with acetate ligands.

  Archives of toxicology 20060901

• Adjuvant therapy in colon cancer--what, when and how?

  Annals of oncology : official journal of the European Society for Medical Oncology 20060901

• Emerging therapies for rectal cancer.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20060901

• Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20060901

• Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines.

  Oncology reports 20060901

• Metastatic colorectal cancer: Therapeutic options.

  Current treatment options in oncology 20060901

• Cancer of the gastroesophageal junction: Current therapy options.

  Current treatment options in oncology 20060901

• Towards a pan-European consensus on the treatment of patients with colorectal liver metastases.

  European journal of cancer (Oxford, England : 1990) 20060901

• Hypersensitivity reactions associated with oxaliplatin.

  Expert opinion on drug safety 20060901

• Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.

  Journal of mass spectrometry : JMS 20060901

• Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer.

  Anti-cancer drugs 20060901

• Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060901

• Organic cation transporters are determinants of oxaliplatin cytotoxicity.

  Cancer research 20060901

• Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease.

  Gastroenterology clinics of North America 20060901

• [Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].

  Ai zheng = Aizheng = Chinese journal of cancer 20060901

• ['Iatrogenic acute coronary syndrome'--59 year old patient with adenocarcinoma of ascending colon and stenocardia while receiving adjuvant chemotherapy with 5-fluorouracil].

  Zeitschrift fur Gastroenterologie 20060901

• Repression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cells.

  Molecular cancer therapeutics 20060901

• Do all patients with metastatic colorectal cancer need chemotherapy until disease progression?

  Clinical colorectal cancer 20060901

• Oxaliplatin, an anticancer agent that affects both Na+ and K+ channels in frog peripheral myelinated axons.

  General physiology and biophysics 20060901

• Pegylated liposomal doxorubicin in ovarian cancer.

  International journal of nanomedicine 20060901

• Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.

  International journal of nanomedicine 20060901

• Clinical pharmacokinetics of irinotecan-based chemotherapy in colorectal cancer patients.

  Current clinical pharmacology 20060901

• Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma.

  British journal of cancer 20060821

• Bayesian sample size calculations in phase II clinical trials using a mixture of informative priors.

  Statistics in medicine 20060815

• Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.

  Cancer 20060815

• Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.

  Cancer chemotherapy and pharmacology 20060801

• Toxic death-case after capecitabine + oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiency.

  Cancer chemotherapy and pharmacology 20060801

• A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.

  Cancer chemotherapy and pharmacology 20060801

• Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20060801

• Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studies.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20060801

• A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: the effects of prior exposure to chemotherapy.

  Journal of hepatology 20060801

• Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.

  The British journal of surgery 20060801

• A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma.

  International journal of radiation oncology, biology, physics 20060801

• Predicting the outcome of chemotherapy for colorectal cancer.

  Current opinion in pharmacology 20060801

• First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060801

• Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter.

  Cancer biology & therapy 20060801

• Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer.

  Gynecologic oncology 20060801

• Oxaliplatin-related neurotoxicity: how and why?

  Critical reviews in oncology/hematology 20060801

• Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060801

• 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20060801

• Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC).

  American journal of clinical oncology 20060801

• Surgical adjuvant therapy for colorectal cancer: current approaches and future directions.

  Annals of surgical oncology 20060801

• Oxaliplatin and axonal Na+ channel function in vivo.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060801

• New agents, combinations, and opportunities in the treatment of advanced and early-stage colon cancer.

  The Surgical clinics of North America 20060801

• Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer.

  Anti-cancer drugs 20060801

• Severe enteropathy associated with raltitrexed and oxaliplatin chemotherapy: report of two patients experiencing this rare, potentially lethal gastrointestinal adverse event.

  Anti-cancer drugs 20060801

• Laryngopharyngeal dysthesia (LPD) in oxaliplatin infusion (OXLP).

  The Journal of the Association of Physicians of India 20060801

• Pulmonary toxicity of 5-fluoracil and oxaliplatin.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060801

• [Short-term effects of chemotherapy combined with hydroxycamptothecine and oxaliplatin in treatment of recurrent and metastatic colorectal cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20060801

• Stage IB malignant thymoma in a Lynch syndrome patient with multiple cancers: response to incidental administration of oxaliplatin and 5-fluorouracil.

  Journal of chemotherapy (Florence, Italy) 20060801

• trans-Platinum planar amine compounds with [N2O2] ligand donor sets: effects of carboxylate leaving groups and steric hindrance on chemical and biological properties.

  Inorganic chemistry 20060724

• Turning point for colorectal cancer clinical trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060720

• Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060720

• An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer.

  British journal of cancer 20060717

• Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells.

  British journal of cancer 20060717

• Management of advanced colorectal cancer: state of the art.

  British journal of cancer 20060717

• Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.

  Cancer 20060715

• Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060715

• Xenografts of human hepatocellular carcinoma: a useful model for testing drugs.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060715

• Luminescent amidate-bridged one-dimensional platinum(II)-thallium(I) coordination polymers assembled via metallophilic attraction.

  Inorganic chemistry 20060710

• Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006.

  JOP : Journal of the pancreas 20060710

• The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients.

  British journal of cancer 20060703

• The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.

  British journal of cancer 20060703

• Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut.

  British journal of cancer 20060703

• Weekly oxaliplatin and preoperative radiotherapy as a new neoadjuvant therapy for locally-advanced rectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060701

• Oxaliplatin, folinic acid and 5-fluorouracil (OFF) in patients with recurrent advanced head and neck cancer: a phase II feasibility study.

  Oral oncology 20060701

• Bevacizumab in metastatic colorectal cancer: a left intracardiac thrombotic event.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060701

• Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20060701

• Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060701

• Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary.

  The British journal of surgery 20060701

• Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients.

  Lung cancer (Amsterdam, Netherlands) 20060701

• Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.

  International journal of oncology 20060701

• Incidence and management of bevacizumab-related toxicities in colorectal cancer.

  Expert opinion on drug safety 20060701

• Lysine 63-polyubiquitination guards against translesion synthesis-induced mutations.

  PLoS genetics 20060701

• Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.

  The Annals of thoracic surgery 20060701

• Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060701

• [Capecitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060701

• [IFL].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060701

• [FOLFOX].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060701

• The Saccharomyces cerevisiae orthologue of the human protein phosphatase 4 core regulatory subunit R2 confers resistance to the anticancer drug cisplatin.

  The FEBS journal 20060701

• [Adjuvant treatment of colorectal cancer].

  Bulletin du cancer 20060701

• The effects of the oral, pan-VEGF-R kinase inhibitor CEP-7055 and chemotherapy in orthotopic models of glioblastoma and colon carcinoma in mice.

  Molecular cancer therapeutics 20060701

• Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases.

  Molecular cancer therapeutics 20060701

• Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.

  Clinical colorectal cancer 20060701

• Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity.

  Clinical colorectal cancer 20060701

• Effects of recombinant human growth hormone on growth of human gastric carcinoma xenograft model in nude mice.

  World journal of gastroenterology 20060628

• Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study.

  British journal of cancer 20060619

• Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.

  British journal of cancer 20060619

• Apoptosis regulation in tetraploid cancer cells.

  The EMBO journal 20060607

• Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?

  Cancer chemotherapy and pharmacology 20060601

• Secondary acute promyelocytic leukemia following irinotecan and oxaliplatin for advanced colon cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR.

  Cancer chemotherapy and pharmacology 20060601

• Increased sensitivity of Hep G2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract.

  Archives of toxicology 20060601

• Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer.

  The European journal of health economics : HEPAC : health economics in prevention and care 20060601

• Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation.

  Virchows Archiv : an international journal of pathology 20060601

• A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Current issues in adjuvant treatment of stage II colon cancer.

  Annals of surgical oncology 20060601

• Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601

• Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.

  International journal of radiation oncology, biology, physics 20060601

• Neoadjuvant therapy with bevacizumab.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601

• FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Cetuximab for treatment of metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• First- and second-line therapy of metastatic colorectal cancer.

  Expert review of anticancer therapy 20060601

• Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.

  Gastroenterology 20060601

• Bevacizumab: new drug. Metastatic colorectal cancer: good in theory, not in practice.

  Prescrire international 20060601

• Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases.

  Prescrire international 20060601

• Safe use of oxaliplatin in a patient with metastatic breast cancer and combined renal and hepatic failure.

  Onkologie 20060601

• DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.

  Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20060601

• Epidermal growth factor receptor tyrosine kinase inhibitors: present and future role in gastrointestinal cancer treatment: a review.

  The oncologist 20060601

• Response to cetuximab and gemcitabine-oxaliplatin in an advanced case of intrahepatic cholangiocarcinoma.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20060601

• [The lethal effect of combined MDR1 antisense RNA with oxaliplatin and 5-FU on drug-resistant rectal carcinoma cells].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20060601

• [S-1 as a single agent for colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• Recent developments in the field of anticancer platinum complexes.

  Recent patents on anti-cancer drug discovery 20060601

• The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells.

  Biochemical pharmacology 20060528

• A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen.

  British journal of cancer 20060522

• Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer.

  British journal of cancer 20060522

• Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer.

  Cancer 20060515

• KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand.

  Cancer research 20060515

• Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060515

• A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients.

  British journal of cancer 20060508

• A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.

  British journal of cancer 20060508

• Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer.

  Frontiers in bioscience : a journal and virtual library 20060501

• Clinical pharmacokinetics of oxaliplatin and 5-fluorouracil administered in combination with leucovorin in Korean patients with advanced colorectal cancer.

  Journal of cancer research and clinical oncology 20060501

• N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060501

• Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties.

  Cancer treatment reviews 20060501

• Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells.

  International journal of oncology 20060501

• Adjuvant therapy for colon cancer.

  Current oncology reports 20060501

• Preoperative and adjuvant treatment of localized rectal cancer.

  Current oncology reports 20060501

• Multimodality treatment of esophageal cancer: a review of the current status and future directions.

  Current oncology reports 20060501

• Neurologic toxicities of cancer therapies.

  Current neurology and neuroscience reports 20060501

• Evolving role of antineoplastic agents in colorectal cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060501

• Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060501

• Antitumor efficacy of edotecarin as a single agent and in combination with chemotherapy agents in a xenograft model.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060501

• [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].

  Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20060501

• Phase I study of single-dose oxaliplatin in Japanese patients with malignant tumors.

  Japanese journal of clinical oncology 20060501

• Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer.

  Journal of gastroenterology and hepatology 20060501

• Optimal treatment of metastatic colorectal cancer.

  Expert review of anticancer therapy 20060501

• Advances in the adjuvant treatment of colorectal cancer.

  ANZ journal of surgery 20060501

• Targeted agents for adjuvant therapy of colon cancer.

  Clinical colorectal cancer 20060501

• Oxaliplatin-induced immune thrombocytopenia.

  Gastroenterologie clinique et biologique 20060501

• Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• [Palliative chemotherapy and CUP-syndrome: medical intentions versus patients' attitudes in decision making].

  Wiener medizinische Wochenschrift (1946) 20060501

• Monoclonal antibodies against epidermal growth factor receptor in advanced colorectal carcinoma: clinical efficacy and markers of sensitivity.

  Reviews on recent clinical trials 20060501

• Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer.

  British journal of cancer 20060424

• Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials.

  British journal of cancer 20060424

• Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial.

  British journal of cancer 20060424

• Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420

• Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420

• EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate.

  Inorganic chemistry 20060417

• Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060415

• Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies.

  British journal of cancer 20060410

• Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study.

  British journal of cancer 20060410

• A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer.

  British journal of cancer 20060410

• XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer.

  British journal of cancer 20060410

• A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer.

  British journal of cancer 20060410

• Accrual delayed in adjuvant bevacizumab trial.

  Journal of the National Cancer Institute 20060405

• Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.

  Cancer chemotherapy and pharmacology 20060401

• Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060401

• Chemotherapy for advanced pancreatic cancer.

  Best practice & research. Clinical gastroenterology 20060401

• Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro.

  Anti-cancer drugs 20060401

• UFT in combination with oxaliplatin: clinical phase I study in patients with advanced or metastatic solid tumors.

  Anti-cancer drugs 20060401

• In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.

  Anti-cancer drugs 20060401

• Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.

  Expert opinion on pharmacotherapy 20060401

• Xaliproden lessens oxaliplatin-mediated neuropathy.

  The Lancet. Oncology 20060401

• Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060401

• Richter's transformation in chronic lymphocytic leukemia.

  Seminars in oncology 20060401

• Postchemotherapy characteristics of hepatic colorectal metastases: remnants of uncertain malignant potential.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20060401

• Population pharmacokinetics of oxaliplatin (85 mg/m2) in combination with 5-fluorouracil in patients with advanced colorectal cancer.

  Therapeutic drug monitoring 20060401

• [Non-surgical treatment for pancreatic cancer].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20060401

• [Chemotherapy in rectal cancer].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060401

• Bowel cancer - guide for the GP.

  Australian family physician 20060401

• Intraventricular metastases from rectal-sigmoid adenocarcinoma.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060401

• Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts.

  Molecular cancer therapeutics 20060401

• Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.

  Japanese journal of clinical oncology 20060401

• [Molecular targets in colon cancer].

  Therapeutische Umschau. Revue therapeutique 20060401

• Ocular changes with oxaliplatin.

  Clinical journal of oncology nursing 20060401

• Oral mucositis.

  Clinical journal of oncology nursing 20060401

• Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers.

  Oncology (Williston Park, N.Y.) 20060401

• Adjuvant therapy for colorectal cancer: yesterday, today, and tomorrow.

  Oncology (Williston Park, N.Y.) 20060401

• Racemic N-aryl bis(amidines) and bis(amidinates): on the trail of enantioselective organolanthanide catalysts.

  Dalton transactions (Cambridge, England : 2003) 20060328

• Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.

  British journal of cancer 20060327

• Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer.

  British journal of cancer 20060327

• Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial.

  British journal of cancer 20060327

• FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG).

  British journal of cancer 20060327

• Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.

  Bioorganic & medicinal chemistry letters 20060315

• Recent advances in management of patients with platinum-refractory testicular germ cell tumors.

  Cancer 20060315

• [Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].

  Deutsche medizinische Wochenschrift (1946) 20060310

• Role of copper transporters in the uptake and efflux of platinum containing drugs.

  Cancer letters 20060308

• [The modern treatment of colorectal cancer. Present and future].

  Orvosi hetilap 20060305

• Lack of response of cetuximab plus oxaliplatin in advanced colorectal cancer patients resistant to both oxaliplatin and cetuximab plus irinotecan.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060301

• Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients.

  European journal of cancer (Oxford, England : 1990) 20060301

• New developments in chemotherapy for advanced non-small cell lung cancer.

  Current opinion in oncology 20060301

• Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.

  American journal of hematology 20060301

• The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?

  Annals of oncology : official journal of the European Society for Medical Oncology 20060301

• A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060301

• Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060301

• Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience.

  Investigational new drugs 20060301

• Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

  Cancer research 20060301

• Bis[(+/-)-trans-2-aminocyclohexylammonium] tetrathiomolybdate(VI) and trans-cyclohexane-1,4-diammonium tetrathiomolybdate(VI).

  Acta crystallographica. Section C, Crystal structure communications 20060301

• MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxal.

  Anti-cancer drugs 20060301

• Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer.

  Anti-cancer drugs 20060301

• Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study).

  Cancer investigation 20060301

• Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20060301

• Oxaliplatin-related acute myelogenous leukemia.

  The oncologist 20060301

• Pharmacokinetics of oxaliplatin and non-hematological toxicity in metastatic gastrointestinal cancer patients treated with chronomodulated oxaliplatin, 5-FU and sodium folinate in a pilot investigation.

  International journal of clinical pharmacology and therapeutics 20060301

• Clinical study of Jiawei Huangqi Guizhi Wuwu Decoction in preventing and treating peripheral neuro-sensory toxicity caused by oxaliplatin.

  Chinese journal of integrative medicine 20060301

• Oxaliplatin combined with 5-FU in second line treatment of advanced pancreatic adenocarcinoma. Results of a phase II trial.

  Gastroenterologie clinique et biologique 20060301

• Highlights From: the 2006 American Society of Clinical Oncology Gastrointestinal Cancers Symposium San Francisco, CA, January 2006.

  Clinical colorectal cancer 20060301

• Neoadjuvant treatment of unresectable liver metastases from colorectal cancer.

  Clinical colorectal cancer 20060301

• Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience.

  Clinical colorectal cancer 20060301

• Multicenter phase II study of fixed sequences of capecitabine combined with oxaliplatin or irinotecan in patients with previously untreated metastatic colorectal cancer.

  Clinical colorectal cancer 20060301

• Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver.

  Clinical colorectal cancer 20060301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060301

• Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies.

  Investigational new drugs 20060301

• Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study.

  British journal of cancer 20060227

• [Better treatment for patients with colorectal liver metastases].

  Nederlands tijdschrift voor geneeskunde 20060218

• Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.

  Journal of the National Cancer Institute 20060215

• [Recent progress in the treatment of colorectal cancer].

  Medizinische Klinik (Munich, Germany : 1983) 20060215

• MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?

  British journal of cancer 20060213

• Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?

  British journal of cancer 20060213

• c-FLIP inhibits chemotherapy-induced colorectal cancer cell death.

  Oncogene 20060209

• Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assay.

  DNA repair 20060203

• Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer.

  Gynecologic oncology 20060201

• Biological consequences of trinuclear platinum complexes: comparison of [[trans-PtCl(NH3)2]2mu-(trans-Pt(NH3)2(H2N(CH2)6-NH2)2)]4+ (BBR 3464) with its noncovalent congeners.

  Molecular pharmacology 20060201

• Hypersensitivity reactions to oxaliplatin: experience in a single institute.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Determination of different classes of amines with capillary zone electrophoresis and contactless conductivity detection.

  Electrophoresis 20060201

• Recent developments in the systemic therapy of advanced gastroesophageal malignancies.

  Expert opinion on investigational drugs 20060201

• Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201

• Irinotecan, oxaliplatin plus bolus 5-fluorouracil and low dose folinic acid every 2 weeks: a feasibility study in metastatic colorectal cancer patients.

  American journal of clinical oncology 20060201

• Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I study.

  American journal of clinical oncology 20060201

• Does the addition of oxaliplatin increase the risk of capecitabine-induced cardiotoxicity?

  Nature clinical practice. Oncology 20060201

• [Adjuvant treatment of colon cancer MOSAIC study's main results].

  Bulletin du cancer 20060201

• [Reflexion on a good strategy of use of oxaliplatine with 5-fluorouracil and its derivatives in patients with advanced colorectal cancer].

  Bulletin du cancer 20060201

• [Oxaliplatin in gastro-intestinal tract cancer except colorectal cancer].

  Bulletin du cancer 20060201

• [Oxaliplatin and ovarian cancer].

  Bulletin du cancer 20060201

• [Oxaliplatin and genito-urinary tumors].

  Bulletin du cancer 20060201

• [Induction chemotherapy and surgery of colorectal liver metastases].

  Bulletin du cancer 20060201

• [Oxaliplatin and preoperative chemoradiotherapy in rectal cancer].

  Bulletin du cancer 20060201

• [Progress in therapy for testicular tumors].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060201

• [Oxaliplatin neurotoxicity].

  Bulletin du cancer 20060201

• [A good cooperation between industry and French medical oncologists].

  Bulletin du cancer 20060201

• Peripheral neuropathy induced by oxaliplatin-based chemotherapy.

  The journal of supportive oncology 20060201

• The cardenolide UNBS1450 is able to deactivate nuclear factor kappaB-mediated cytoprotective effects in human non-small cell lung cancer cells.

  Molecular cancer therapeutics 20060201

• [Treatment of colorectal cancer liver metastases].

  Minerva medica 20060201

• Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Therapy).

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060201

• Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.

  British journal of cancer 20060130

• Primary thromboprophylaxis for cancer patients with central venous catheters--a reappraisal of the evidence.

  British journal of cancer 20060130

• Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.

  Dalton transactions (Cambridge, England : 2003) 20060128

• OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120

• Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial.

  British journal of cancer 20060116

• 'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'.

  British journal of cancer 20060116

• Lanthanide complexes of chiral 3 + 3 macrocycles derived from (1R,2R)-1,2-diaminocyclohexane and 2,6-diformyl-4-methylphenol.

  Dalton transactions (Cambridge, England : 2003) 20060114

• Analysis of cytotoxicities of platinum compounds.

  Cancer chemotherapy and pharmacology 20060101

• Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060101

• A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060101

• Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060101

• Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data.

  Anti-cancer drugs 20060101

• Delayed oxaliplatin-associated neurotoxicity following adjuvant chemotherapy for stage III colon cancer.

  Anti-cancer drugs 20060101

• A National Cancer Institute of Canada Clinical Trials Group Study--IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20060101

• What is the best sequence of chemotherapy in advanced colorectal cancer? Final results of a five-arm study.

  Chemotherapy 20060101

• Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma: clinical and pharmacokinetic data.

  Pancreas 20060101

• Unresectable hepatic colorectal metastases: need for new surgical strategies.

  Annals of surgical oncology 20060101

• Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.

  Annals of surgical oncology 20060101

• Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases.

  Journal of the American College of Surgeons 20060101

• Adjuvant therapy for colon cancer 2005: new options in the twenty-first century.

  Surgical oncology clinics of North America 20060101

• [Clinical administration of oxaliplatin for patients previously treated for refractory advanced or recurrent colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060101

• A case of bone metastasis of colon cancer that markedly responded to S-1/CPT-11 combination chemotherapy and became curable by resection.

  World journal of surgical oncology 20060101

• Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium folinate in metastatic gastrointestinal cancer patients: original analysis of non-hematological toxicity and patient characteristics in a pilot investigation.

  International journal of clinical pharmacology and therapeutics 20060101

• Crohn's disease leading to bowel cancer may be avoided by consumption of soya isoflavones: adjunct-chemotherapy with oxaliplatin.

  Medical hypotheses 20060101

• Advances in understanding drug-induced neuropathies.

  Drug safety 20060101

• Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma.

  International seminars in surgical oncology : ISSO 20060101

• An integrated psychological strategy for advanced colorectal cancer patients.

  Health and quality of life outcomes 20060101

• Benefits and risks of palliative capecitabine based therapy to elderly patients with advanced colorectal cancer: Danish single centre experiences.

  Acta oncologica (Stockholm, Sweden) 20060101

• Experiences with the use of oxaliplatin in esophageal carcinoma.

  Acta oncologica (Stockholm, Sweden) 20060101

• Expanded treatment options in the adjuvant therapy of colon cancer: implications for oncology nurses.

  Oncology nursing forum 20060101

• Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer.

  BMC cancer 20060101

• Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas.

  BMC cancer 20060101

• A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Studies on the synthesis, characterization, binding with DNA and activities of two cis-planaramineplatinum(II) complexes of the form: cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and 2,3-diaminopyridine.

  BMC chemical biology 20060101

• Deciphering cellular states of innate tumor drug responses.

  Genome biology 20060101

• Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer.

  Neoplasma 20060101

• Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy.

  Journal of translational medicine 20060101

• Liposomal oxaliplatin in the treatment of advanced cancer: a phase I study.

  Anticancer research 20060101

• Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer.

  Anticancer research 20060101

• Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan.

  Oncology 20060101

• Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group.

  BMC cancer 20060101

• New imidazole-coordinated chemotherapeutics with low epithelial toxicity.

  Cell biochemistry and biophysics 20060101

• HER 2/neu protein expression in colorectal cancer.

  BMC cancer 20060101

• Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial.

  BMC cancer 20060101

• Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.

  Molecular cancer 20060101

• Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.

  Molecular cancer 20060101

• Radiosensitizers in cervical cancer. Cisplatin and beyond.

  Radiation oncology (London, England) 20060101

• Is translational research compatible with preclinical publication strategies?

  Radiation oncology (London, England) 20060101

• Spotlight on bevacizumab in advanced colorectal cancer, breast cancer, and non-small cell lung cancer.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20060101

• Global analysis of gene function in yeast by quantitative phenotypic profiling.

  Molecular systems biology 20060101

• Stable disease in advanced colorectal cancer: therapeutic implications.

  Anticancer research 20060101

• Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.

  Anticancer research 20060101

• Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions.

  Drugs 20060101

• Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database.

  BMC cancer 20060101

• Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.

  Anticancer research 20060101

• Capecitabine-induced hypertriglyceridemia: a report of two cases.

  Anticancer research 20060101

• Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer.

  Anticancer research 20060101

• Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up.

  European neurology 20060101

• Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.

  Anticancer research 20060101

• Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation.

  Anticancer research 20060101

• Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines.

  Anticancer research 20060101

• Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?

  Molecular cancer 20060101

• Oxaliplatin overdosage successfully recovered with mild toxicities.

  Acta oncologica (Stockholm, Sweden) 20060101

• The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer.

  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20060101

• Mass spectrometry study of hemoglobin-oxaliplatin complexes in colorectal cancer patients and potential association with chemotherapeutic responses.

  Rapid communications in mass spectrometry : RCM 20060101

• Topical treatment with oxaliplatin for the prevention of port-site metastases in laparoscopic surgery for colorectal cancer.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20060101

• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: higher complication rate for oxaliplatin compared to Mitomycin C.

  Acta chirurgica Belgica 20060101

• Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas.

  BMC cancer 20060101

• A biological question and a balanced (orthogonal) design: the ingredients to efficiently analyze two-color microarrays with Confirmatory Factor Analysis.

  BMC genomics 20060101

• Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.

  BMC clinical pharmacology 20060101

• Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines.

  Digestion 20060101

• The role of chemotherapy in patients with established gastric cancer.

  Best practice & research. Clinical gastroenterology 20060101

• [Multimodal treatment in locally advanced esophageal cancer: a multicenter phase II study with neoadjuvant oxaliplatin, 5-fluorouracil, leucovorin and neoadjuvant radiotherapy: preliminary results].

  Chirurgia italiana 20060101

• Clinical application of oxaliplatin in epithelial ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Clinical predictors of severe toxicity in patients treated with combination chemotherapy with irinotecan and/or oxaliplatin for metastatic colorectal cancer: a single center experience.

  Medical oncology (Northwood, London, England) 20060101

• Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.

  Molecular cancer 20060101

• Chemotherapy with mitomycin C and capecitabine in patients with advanced colorectal cancer pretreated with irinotecan and oxaliplatin.

  Tumori 20060101

• Single-agent irinotecan as second-line weekly chemotherapy in elderly patients with advanced colorectal cancer.

  Tumori 20060101

• Diagnosis and management of hypersensitivity reactions caused by oxaliplatin.

  Journal of investigational allergology & clinical immunology 20060101

• Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study.

  Oncology 20060101

• Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study.

  Oncology 20060101

• The pathophysiology of oxaliplatin-induced neurotoxicity.

  Current medicinal chemistry 20060101

• Modeling biological rhythms in failure time data.

  Journal of circadian rhythms 20060101

• Recent progress in target therapy in colorectal cancer.

  Anticancer research 20060101

• Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.

  BMC cancer 20060101

• Radiation-sparing managements for cervical cancer: a developing countries perspective.

  World journal of surgical oncology 20060101

• Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer.

  The oncologist 20060101

• Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer.

  World journal of surgical oncology 20060101

• Molecular markers for gastric adenocarcinoma: an update.

  Molecular diagnosis & therapy 20060101

• Pharmacogenomics and colorectal cancer.

  Advances in experimental medicine and biology 20060101

• Is EGFR expression altered following postoperative chemotherapy for colorectal adenocarcinoma?

  World journal of surgical oncology 20060101

• Multiple-target chemotherapy (LV-modulated 5-FU bolus and continuous infusion, oxaliplatin, CPT- 11) in advanced 5-FU-refractory colorectal cancer: MTD definition and efficacy evaluation. A phase I-II study.

  Tumori 20060101

• [Advances in the treatment of metastatic colorectal cancer with bevacizumab].

  Tumori 20060101

• Metastatic adenocarcinoma of the colon presenting as a monarthritis of the hip in a young patient.

  World journal of surgical oncology 20060101

• Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer.

  BMC cancer 20060101

• FOLFOX-4 stop and go and capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer.

  Oncology 20060101

• Financial considerations in the conduct of multi-centre randomised controlled trials: evidence from a qualitative study.

  Trials 20060101

• Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.

  In vivo (Athens, Greece) 20060101

• 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study.

  In vivo (Athens, Greece) 20060101

• Hepatic metastases of colorectal cancer: locoregional intra-arterial treatment.

  Anticancer research 20060101

• [Chemotherapy agents, response rates and mechanisms of resistance in the therapy of the colorectal carcinoma].

  Magyar onkologia 20060101

• Oxaliplatin with raltitrexed and preoperative radiotherapy in T3-T4 extraperitoneal rectal cancer. A dose finding study.

  Tumori 20060101

• [Metastatic colorectal cancer: adjournments from ESMO 2006].

  Tumori 20060101

• [A review of chemotherapy for metastatic colon cancer].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20060101

• A dose-escalation study of pegylated liposomal Doxorubicin and oxaliplatin in patients with advanced solid tumors.

  Oncology 20060101

• Resection of small bowel adenocarcinoma liver metastasis combined with neoadjuvant and adjuvant chemotherapy results in extended disease-free period--a case report.

  International journal of gastrointestinal cancer 20060101

• The circadian timing system, a coordinator of life processes. implications for the rhythmic delivery of cancer therapeutics.

  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20060101

• Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology.

  Journal of biological regulators and homeostatic agents 20060101

• Phase I/II study of gemcitabine and oxaliplatin chemotherapy in combination with concurrent 3-D conformal radiotherapy for locally advanced non-small cell lung cancer.

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20060101

• Colorectal cancer: from epidemiology to current treatment.

  The Libyan journal of medicine 20060101

• Trans-arterial hepatic radioembolisation of yttrium-90 microspheres.

  Biomedical imaging and intervention journal 20060101

• Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• [A randomized clinical trial of chemotherapy combined with oxaliplatin and cisplatin plus navelbine in the treatment of advanced non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20051220

• In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo.

  British journal of cancer 20051212

• Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051210

• [Colorectal carcinoma in elderly patients].

  Praxis 20051207

• Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.

  Cancer chemotherapy and pharmacology 20051201

• Characterization of intact hemoglobin and oxaliplatin interaction by nanoelectrospray ionization tandem mass spectrometry.

  Clinical chemistry 20051201

• Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20051201

• Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels.

  British journal of pharmacology 20051201

• Presence of MLH1 protein aggravates the potential of the HSP90 inhibitor radicicol to sensitize tumor cells to cisplatin.

  International journal of oncology 20051201

• Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.

  Oncology reports 20051201

• Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study.

  European journal of cancer (Oxford, England : 1990) 20051201

• Pharmacogenetics of colorectal cancer.

  Expert opinion on pharmacotherapy 20051201

• Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin.

  American journal of clinical oncology 20051201

• Gastric and gastro-oesophageal cancer therapy.

  Expert opinion on pharmacotherapy 20051201

• [A randomized controlled trail of taxol-based combination regimens for advanced gastric cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20051201

• [Progression of adjuvant chemotherapy for colon cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20051201

• [Recent progress of chemotherapy for colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051201

• Molecular mechanisms and targeting of colorectal cancer.

  Seminars in oncology 20051201

• Metastatic colorectal cancer: first- and second-line treatment in 2005.

  Seminars in oncology 20051201

• Biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer: a multicenter phase II study.

  Journal of Korean medical science 20051201

• Rational development of oxaliplatin analogues --synthesis and preliminary structure-activity relationships.

  International journal of clinical pharmacology and therapeutics 20051201

• Expression profile of copper transporters in sensitive and cisplatin/oxaliplatin-resistant tumor cell lines.

  International journal of clinical pharmacology and therapeutics 20051201

• Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20051201

• Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP.

  Molecular cancer therapeutics 20051201

• Front-line therapy for advanced colorectal cancer: emphasis on chemotherapy.

  Seminars in oncology 20051201

• The role of bevacizumab as first-line therapy for colon cancer.

  Seminars in oncology 20051201

• Second-line treatment of patients with metastatic colorectal cancer.

  Seminars in oncology 20051201

• Adjuvant chemotherapy of stage III colon cancer.

  Seminars in oncology 20051201

• Cetuximab: new drug. Metastatic colorectal cancer: an inappropriate evaluation.

  Prescrire international 20051201

• Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.

  Prescrire international 20051201

• The emerging role of oxaliplatin in the treatment of gastric cancer.

  Journal of chemotherapy (Florence, Italy) 20051201

• [A randomized trial comparing oxaliplatin plus vinorelbine versus cisplatin plus vinorelbine for the treatment of patients with advanced non-small-cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20051201

• Management of extravasation of oxaliplatin.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20051201

• Editorial foreword.

  Therapeutics and clinical risk management 20051201

• Management of oxaliplatin-induced peripheral neuropathy.

  Therapeutics and clinical risk management 20051201

• Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.

  British journal of cancer 20051128

• A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer.

  British journal of cancer 20051128

• Rhombimines-cyclic tetraimines of trans-1,2-diaminocyclohexane shaped by the diaryl ether structural motif.

  The Journal of organic chemistry 20051125

• Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051120

• Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051120

• Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.

  British journal of cancer 20051114

• Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I-II trial.

  British journal of cancer 20051114

• Portal hypertension secondary to 90Yttrium microspheres: an unknown complication.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051110

• [Drug therapy of patients with metastatic colorectal cancer].

  Ugeskrift for laeger 20051107

• [Colorectal carcinoma].

  Praxis 20051102

• Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study.

  Cancer chemotherapy and pharmacology 20051101

• Chemotherapy for colorectal cancer--an overview of current management for surgeons.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20051101

• Synthesis and structure-activity relationships of mono- and dialkyl-substituted oxaliplatin derivatives.

  European journal of medicinal chemistry 20051101

• Synthesis, spectral study and cytotoxicity of platinum(II) complexes with 2,9-disubstituted-6-benzylaminopurines.

  Journal of inorganic biochemistry 20051101

• Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma.

  Cancer 20051101

• Chemotherapy and radiotherapy in the management of gastric cancer.

  Current opinion in gastroenterology 20051101

• A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.

  Cancer research 20051101

• Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.

  Nature clinical practice. Oncology 20051101

• Enhancing oxaliplatin-based regimens in colorectal cancer by inhibiting the epidermal growth factor receptor pathway.

  Clinical colorectal cancer 20051101

• Capecitabine/Oxaliplatin combinations in advanced colorectal cancer: summary of recent randomized studies.

  Clinical colorectal cancer 20051101

• FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancer.

  Clinical colorectal cancer 20051101

• Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis.

  Clinical colorectal cancer 20051101

• Oxaliplatin induces a delayed immune-mediated hemolytic anemia: a case report and review of the literature.

  Clinical colorectal cancer 20051101

• [Chronomodulated chemotherapy of oxaliplatin, 5-fluorouracil and folinic acid for advanced gastric cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20051101

• Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in management.

  Oncology (Williston Park, N.Y.) 20051101

• A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.

  British journal of cancer 20051031

• Mechanisms of cytotoxicity of selected organogold(III) compounds.

  Journal of medicinal chemistry 20051020

• [Randomized clinical study comparing gemcitabine and oxaliplatin versus gemcitabine and cisplatin for advanced non-small cell lung cancer in elderly patients].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20051020

• Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.

  British journal of cancer 20051017

• Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051015

• Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051015

• Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss.

  Cancer chemotherapy and pharmacology 20051001

• Modulation of drug cytotoxicity by Iressa (ZD1839) in pancreatic cancer cell lines.

  Cancer biology & therapy 20051001

• Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10.

  Oncology reports 20051001

• Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients.

  European journal of cancer (Oxford, England : 1990) 20051001

• Toxic neuropathy.

  Current opinion in neurology 20051001

• Preclinical evaluation of ZD1839 alone or in combination with oxaliplatin in a panel of human tumor cell lines -- implications for clinical use.

  Onkologie 20051001

• Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities.

  Anti-cancer drugs 20051001

• Systemic therapy for pancreatic cancer.

  Seminars in radiation oncology 20051001

• Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.

  Cancer research 20051001

• Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer.

  Journal of Korean medical science 20051001

• Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.

  Molecular cancer therapeutics 20051001

• Advanced colorectal cancer: current treatment and nursing management with economic considerations.

  Clinical journal of oncology nursing 20051001

• The management of poor-prognosis, non-seminomatous germ-cell tumours.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20051001

• Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer.

  The oncologist 20051001

• Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma.

  Leukemia & lymphoma 20051001

• Rapid evolution in colorectal cancer: therapy now and over the next five years.

  The oncologist 20051001

• Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation.

  Cancer biology & therapy 20051001

• [A case of metastatic colon cancer treated with oxaliplatin combination chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051001

• Gemcitabine combined with oxaliplatin is safe and effective in patients with previously untreated advanced pancreatic adenocarcinoma.

  Gastroenterologie clinique et biologique 20051001

• Oxaliplatin with biweekly low dose leucovorin and bolus and continuous infusion of 5-fluorouracil (modified FOLFOX 4) as a salvage therapy for patients with advanced gastric cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20051001

• Combination chemotherapy of oxaliplatin, 5-fluorouracil and low dose leucovorin in patients with advanced colorectal cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20051001

• Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats.

  British journal of cancer 20050919

• New drugs and dosage forms.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050915

• New 2+2, 3+3 and 4+4 macrocycles derived from 1,2-diaminocyclohexane and 2,6-diformylpyridine.

  Organic & biomolecular chemistry 20050907

• Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.

  British journal of cancer 20050905

• Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.

  Journal of cellular physiology 20050901

• CA-125 criteria for response evaluation in ovarian cancer.

  Gynecologic oncology 20050901

• Inhibition of cell proliferation, cytotoxicity and induction of apoptosis of 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene in gastrointestinal tumour cell lines and preliminary evaluation of its toxicity in vivo.

  Pharmacological research 20050901

• Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.

  European urology 20050901

• Gastric cancer. Treatment of advanced disease and new drugs.

  Frontiers in bioscience : a journal and virtual library 20050901

• Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.

  Biochemical pharmacology 20050901

• Capecitabine-warfarin interaction.

  The Annals of pharmacotherapy 20050901

• Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.

  Journal of cancer research and clinical oncology 20050901

• Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience.

  Japanese journal of clinical oncology 20050901

• Comparison between triple therapy with octreotide, galanin and serotonin vs. irinotecan or oxaliplatin in combination with 5-fluorouracil/leukovorin in human colon cancer.

  International journal of oncology 20050901

• Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitro.

  Oncology reports 20050901

• Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.

  Free radical biology & medicine 20050901

• Prognostic impact of race and ethnicity in the treatment of colorectal cancer.

  The Medical clinics of North America 20050901

• Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.

  Pharmacogenomics 20050901

• ERCC1 and clinical resistance to platinum-based therapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050901

• ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050901

• Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program.

  Clinical colorectal cancer 20050901

• Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors, including colorectal cancer.

  Clinical colorectal cancer 20050901

• Analysis of prognostic factors and applicability of Kohne's prognostic groups in patients with metastatic colorectal cancer treated with first-line irinotecan or oxaliplatin-based chemotherapy.

  Clinical colorectal cancer 20050901

• N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.

  Clinical colorectal cancer 20050901

• A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.

  Yonsei medical journal 20050831

• Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820

• Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma.

  Cancer 20050815

• 17-Allylamino-17-demethoxygeldanamycin overcomes TRAIL resistance in colon cancer cell lines.

  Biochemical pharmacology 20050815

• Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.

  British journal of cancer 20050808

• Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells.

  Environmental and molecular mutagenesis 20050801

• Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.

  Molecular pharmacology 20050801

• Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050801

• Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801

• Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry.

  Analytical and bioanalytical chemistry 20050801

• One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.

  Analytical and bioanalytical chemistry 20050801

• Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801

• Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801

• Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.

  International journal of oncology 20050801

• Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study.

  Investigational new drugs 20050801

• Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.

  Japanese journal of clinical oncology 20050801

• New-generation platinum drugs in the treatment of cisplatin-resistant cancers.

  Expert opinion on investigational drugs 20050801

• Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer.

  American journal of clinical oncology 20050801

• [Efficacy of NO regimen and NP regimen on advanced non-small cell lung cancer: a prospective randomized trial].

  Ai zheng = Aizheng = Chinese journal of cancer 20050801

• [Application of adenosine triphosphate tumor chemosensitive assay system to individual chemotherapy for hepatocellular carcinoma].

  Ai zheng = Aizheng = Chinese journal of cancer 20050801

• Current stage-specific chemotherapeutic options in colon cancer.

  Expert review of anticancer therapy 20050801

• Genome-wide requirements for resistance to functionally distinct DNA-damaging agents.

  PLoS genetics 20050801

• [Oxaliplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050801

• [Development of L-OHP (trade name; Elplat)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050801

• Recent updates on the role of chemotherapy in pancreatic cancer.

  Seminars in oncology 20050801

• Chemotherapeutic gemcitabine doublets in pancreatic carcinoma.

  Seminars in oncology 20050801

• Metastatic colorectal cancer: is there one standard approach?

  Oncology (Williston Park, N.Y.) 20050801

• [Pancreatic adenocarcinoma: therapeutical update].

  Anales de medicina interna (Madrid, Spain : 1984) 20050801

• Oxaliplatin/5-FU without leucovorin chemotherapy in metastatic colorectal cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20050801

• Thymidylate synthase, thymidine phosphorylase, VEGF and p53 protein expression in primary colorectal cancer for predicting response to 5-fluorouracil-based chemotherapy.

  Cancer research and treatment : official journal of Korean Cancer Association 20050801

• Adjuvant therapy of colon cancer: current status and future developments.

  Clinics in colon and rectal surgery 20050801

• Oral Xeloda plus bi-platinu two-way combined chemotherapy in treatment of advanced gastrointestinal malignancies.

  World journal of gastroenterology 20050728

• Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).

  British journal of cancer 20050725

• A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

  British journal of cancer 20050725

• Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.

  British journal of cancer 20050725

• Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.

  Cancer 20050715

• Potential new antitumor agents from an innovative combination of camphorato, a ramification of traditional Chinese medicine, with a platinum moiety.

  Bioorganic & medicinal chemistry letters 20050715

• Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.

  Journal of immunology (Baltimore, Md. : 1950) 20050715

• Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.

  British journal of cancer 20050711

• Role of genomic markers in colorectal cancer treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050710

• Systemic therapy for metastatic colorectal cancer: current options, current evidence.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050710

• Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study.

  Cancer chemotherapy and pharmacology 20050701

• High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050701

• Oxaliplatin-induced neurotoxicity and the development of neuropathy.

  Muscle & nerve 20050701

• A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050701

• The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC).

  European journal of cancer (Oxford, England : 1990) 20050701

• Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system.

  Cancer research 20050701

• Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy.

  Journal of surgical oncology 20050701

• FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050701

• Bevacizumab in the treatment of colorectal cancer.

  Expert opinion on biological therapy 20050701

• Chemotherapy for metastatic colorectal cancer.

  Journal of the National Comprehensive Cancer Network : JNCCN 20050701

• Adjuvant therapy: new treatment options with oxaliplatin-based chemotherapy.

  Clinical colorectal cancer 20050701

• Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study.

  Clinical colorectal cancer 20050701

• Changing patterns of bone and brain metastases in patients with colorectal cancer.

  Clinical colorectal cancer 20050701

• Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.

  Clinical colorectal cancer 20050701

• Chemotherapy dosing in the setting of liver dysfunction.

  Oncology (Williston Park, N.Y.) 20050701

• [New oncolytic agents and immunomodulators and their application].

  Nederlands tijdschrift voor geneeskunde 20050625

• [Chemotherapy of patients with colorectal carcinoma].

  Nederlands tijdschrift voor geneeskunde 20050625

• [Oxaliplatin combined with vinorelbine in the treatment of patients with advanced non-small cell lung cancer].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20050620

• Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis.

  Journal of surgical oncology 20050615

• Synergistic interaction between platinum-based antitumor agents and demethylcantharidin.

  Cancer letters 20050608

• Colorimetric enantiodiscrimination of alpha-amino acids in protic media.

  Journal of the American Chemical Society 20050608

• Novel molecular drug carrier: encapsulation of oxaliplatin in cucurbit[7]uril and its effects on stability and reactivity of the drug.

  Organic & biomolecular chemistry 20050607

• Catalytic asymmetric cyclopropanation at a chiral platform.

  Organic & biomolecular chemistry 20050607

• Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF.

  British journal of cancer 20050606

• In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.

  Cancer chemotherapy and pharmacology 20050601

• Renal toxicity of oxaliplatin.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050601

• Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050601

• Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.

  Anti-cancer drugs 20050601

• Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050601

• Exciton chirality in trans-1,2-diamidocyclohexanes: fluorescent chromophores.

  Chirality 20050601

• Hypersensitivity reactions to oxaliplatin in two asian patients.

  The Annals of pharmacotherapy 20050601

• Predicting drug response and toxicity based on gene polymorphisms.

  Critical reviews in oncology/hematology 20050601

• Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?

  Annals of oncology : official journal of the European Society for Medical Oncology 20050601

• Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients.

  Lung cancer (Amsterdam, Netherlands) 20050601

• [Systemic therapy for colorectal cancer].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20050601

• Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20050601

• Presence of cancerostatic platinum compounds in hospital wastewater and possible elimination by adsorption to activated sludge.

  The Science of the total environment 20050601

• Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases.

  Journal of the American College of Surgeons 20050601

• Synthesis, physicochemical and in vitro pharmacological investigation of new platinum (II) complexes with some cycloalkanespiro-5'-hydantoins.

  European journal of medicinal chemistry 20050601

• Gastrointestinal cancer: recent developments in medical oncology.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20050601

• Controversy in folinic acid administration after fluorouracil.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050601

• Combination chemotherapy for advanced pancreatic cancer--has its time finally come?

  The Lancet. Oncology 20050601

• Hypersensitivity reactions to oxaliplatin: what nurses need to know.

  Clinical journal of oncology nursing 20050601

• [Chemotherapy of pancreatic carcinoma].

  Praxis 20050601

• Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancer.

  Expert opinion on investigational drugs 20050601

• Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinoma.

  Thyroid : official journal of the American Thyroid Association 20050601

• Activity and toxicity of oxaliplatin and bolus fluorouracil plus leucovorin in pretreated colorectal cancer patients: a phase II study.

  Journal of experimental & clinical cancer research : CR 20050601

• Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.

  Clinical therapeutics 20050601

• A reporting system for the assessment of chemotherapy toxicity.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20050601

• The use of radiofrequency in cancer.

  British journal of cancer 20050523

• Tuning the size of macrocyclic cavities in trianglimine macrocycles.

  Organic & biomolecular chemistry 20050521

• FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520

• Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520

• Molecular determinants of cetuximab efficacy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520

• Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin.

  British journal of cancer 20050509

• A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.

  British journal of cancer 20050509

• Severe chemotherapy-induced diarrhea in patients with colorectal cancer: a cost of illness analysis.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20050501

• Successful desensitization to oxaliplatin.

  The Annals of pharmacotherapy 20050501

• Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• The use of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20050501

• Oxaliplatin-induced immune pancytopenia.

  Transfusion 20050501

• First-line therapy for advanced colorectal cancer.

  Current oncology reports 20050501

• Second-line therapy for advanced colorectal carcinoma.

  Current oncology reports 20050501

• Adjuvant therapy for colon cancer.

  Current oncology reports 20050501

• Chemotherapy for advanced pancreatic cancer: past, present, and future.

  Current oncology reports 20050501

• Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.

  International journal of radiation oncology, biology, physics 20050501

• New combinations in metastatic colorectal cancer: what are our expectations?

  The oncologist 20050501

• Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• Adjuvant therapy in colon cancer: which treatment in 2005?

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• [Off label drug use in adult patients treated by anticancer chemotherapy].

  Bulletin du cancer 20050501

• Emerging drugs for ovarian cancer.

  Expert opinion on emerging drugs 20050501

• Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours.

  Cancer treatment reviews 20050501

• Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.

  Clinical advances in hematology & oncology : H&O 20050501

• Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Con: Pumpin' FU (or, avoiding that oral fixation).

  Clinical advances in hematology & oncology : H&O 20050501

• Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma.

  British journal of cancer 20050425

• Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer.

  British journal of cancer 20050411

• Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug.

  Cancer chemotherapy and pharmacology 20050401

• Cellular processing of platinum anticancer drugs.

  Nature reviews. Drug discovery 20050401

• The evolving role of pemetrexed (Alimta) in lung cancer.

  Seminars in oncology 20050401

• Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer.

  Seminars in oncology 20050401

• Critical evaluation of current treatments in metastatic colorectal cancer.

  The oncologist 20050401

• Can cisplatin and infused 5-fluorouracil be replaced by oxaliplatin and capecitabine in the treatment of advanced oesophagogastric cancer? The REAL 2 trial.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20050401

• Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.

  Cancer treatment reviews 20050401

• [Oxaliplatin neurotoxicity: a report of three cases with post-operative exacerbation].

  Gastroenterologie clinique et biologique 20050401

• Cetuximab in previously treated colorectal cancer.

  Clinical colorectal cancer 20050401

• Irinotecan-based regimens in the adjuvant therapy of colorectal cancer.

  Clinical colorectal cancer 20050401

• Clinical management of oxaliplatin-associated neurotoxicity.

  Clinical colorectal cancer 20050401

• Current therapies for advanced colorectal cancer.

  Oncology (Williston Park, N.Y.) 20050401

• Management of advanced colorectal cancer in older patients.

  Oncology (Williston Park, N.Y.) 20050401

• Docetaxel in the management of advanced pancreatic cancer.

  Seminars in oncology 20050401

• Chemotherapy for advanced gastric cancer: slow but further progress.

  Cancer research and treatment : official journal of Korean Cancer Association 20050401

• Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells.

  British journal of cancer 20050328

• Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study.

  British journal of cancer 20050328

• Shape-complementarity in the recognition of tricarboxylic acids by a [3+3] polyazacyclophane receptor.

  The Journal of organic chemistry 20050318

• Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer.

  British journal of cancer 20050314

• A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours.

  British journal of cancer 20050314

• Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients.

  British journal of cancer 20050314

• Oxaliplatin activity in head and neck cancer cell lines.

  Cancer chemotherapy and pharmacology 20050301

• Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050301

• Innovations in antineoplastic therapy.

  The Nursing clinics of North America 20050301

• Advances in colon cancer chemotheapy: nursing implications.

  Home healthcare nurse 20050301

• Gastrointestinal Cancers--Second Annual Symposium. 27-29 January 2005, Hollywood, FL, USA.

  IDrugs : the investigational drugs journal 20050301

• Highlights from: the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, Hollywood, FL, January 2005.

  Clinical colorectal cancer 20050301

• Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancer.

  Clinical colorectal cancer 20050301

• Classification and occurrence of clinically significant drug interactions with irinotecan and oxaliplatin in patients with metastatic colorectal cancer.

  Clinical therapeutics 20050301

• [Preoperative chemoradiotherapy as neoadjuvant therapy for 35 patients with locally advanced lower rectal carcinoma].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20050301

• Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.

  British journal of cancer 20050227

• Chromatographic evaluation of poly (trans-1,2-cyclohexanediyl-bis acrylamide) as a chiral stationary phase for HPLC.

  Journal of chromatography. A 20050225

• Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050220

• Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050215

• Identification of a novel cardenolide (2''-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: structure-activity relationship analyses.

  Journal of medicinal chemistry 20050210

• Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach.

  Journal of medicinal chemistry 20050210

• [Platinum compounds: metabolism, toxicity and supportive strategies].

  Praxis 20050209

• The synthesis and conformation of oxygenated trianglimine macrocycles.

  Organic & biomolecular chemistry 20050207

• Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin.

  Biochemical and biophysical research communications 20050204

• Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma.

  Lung cancer (Amsterdam, Netherlands) 20050201

• The Raf kinase inhibitor BAY 43-9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines.

  Anti-cancer drugs 20050201

• A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.

  Critical reviews in oncology/hematology 20050201

• Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity?

  Annals of oncology : official journal of the European Society for Medical Oncology 20050201

• Controlling tumor growth by modulating endogenous production of reactive oxygen species.

  Cancer research 20050201

• Analysis of anticancer platinum(II)-complexes by microemulsion electrokinetic chromatography: separation of diastereomers and estimation of octanol-water partition coefficients.

  Electrophoresis 20050201

• Chemotherapy for advanced colorectal cancer: let's not forget how we got here (until we really can).

  Seminars in oncology 20050201

• Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.

  Seminars in oncology 20050201

• Adjuvant therapy of colon cancer.

  Seminars in oncology 20050201

• Combined modality treatment for rectal cancer.

  Seminars in oncology 20050201

• Pharmacogenetic influences on treatment response and toxicity in colorectal cancer.

  Seminars in oncology 20050201

• Intratumoral molecular or genetic markers as predictors of clinical outcome with chemotherapy in colorectal cancer.

  Seminars in oncology 20050201

• Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20050201

• [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].

  Bulletin du cancer 20050201

• Therapeutic options in the management of colon cancer: 2005 update.

  Clinical journal of oncology nursing 20050201

• Determination of binding constants and stoichiometries for platinum anticancer drugs and serum transport proteins by capillary electrophoresis using the Hummel-Dreyer method.

  Journal of separation science 20050201

• Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy.

  British journal of cancer 20050131

• Unfavourable expression of pharmacologic markers in mucinous colorectal cancer.

  British journal of cancer 20050131

• [Stomach cancer].

  La Revue du praticien 20050131

• Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050120

• Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.

  British journal of cancer 20050117

• Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050115

• Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles.

  Journal of controlled release : official journal of the Controlled Release Society 20050103

• cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance.

  Cancer chemotherapy and pharmacology 20050101

• Novel separation method for highly sensitive speciation of cancerostatic platinum compounds by HPLC-ICP-MS.

  Analytical and bioanalytical chemistry 20050101

• Oxaliplatin-associated neuropathy: a review.

  The Annals of pharmacotherapy 20050101

• Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.

  Critical reviews in oncology/hematology 20050101

• Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.

  Critical reviews in oncology/hematology 20050101

• Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations.

  Critical reviews in oncology/hematology 20050101

• Oxaliplatin: in operable colorectal cancer.

  Drugs 20050101

• Phase I dose escalation study of oxaliplatin combined with oral tegafur-uracil and leucovorin in patients with advanced gastric cancer.

  Anti-cancer drugs 20050101

• In vitro chemosensitivity to gemcitabine, oxaliplatin and zoledronic acid predicts treatment response in metastatic gastric cancer.

  Anti-cancer drugs 20050101

• Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050101

• The development of the FOLFOX regimens as a treatment standard of advanced colorectal cancer.

  Clinical colorectal cancer 20050101

• Evolution of FOLFOX regimens in the treatment of advanced colorectal cancer.

  Clinical colorectal cancer 20050101

• The addition of bevacizumab to FOLFOX4 prolongs survival in relapsed colorectal cancer: interim data from the ECOG 3200 trial.

  Clinical colorectal cancer 20050101

• [Second-line chemotherapy for advanced colorectal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050101

• New drugs for colorectal cancer (irinotecan, oxaliplatin, raltitrexed) meet expectations in routine practice: a single center's experience before and after their introduction.

  International journal of gastrointestinal cancer 20050101

• Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications.

  American journal of pharmacogenomics : genomics-related research in drug development and clinical practice 20050101

• Capecitabine: a review.

  Clinical therapeutics 20050101

• Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II study.

  Cancer investigation 20050101

• Addition of oxaliplatin to neo-adjuvant radiochemotherapy for irresectable rectal cancer, a phase I study.

  Anticancer research 20050101

• Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients.

  Medical hypotheses 20050101

• Anaphylaxis produced by oxaliplatin.

  Journal of investigational allergology & clinical immunology 20050101

• Neoadjuvant radiotherapy and radiochemotherapy for rectal cancer.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20050101

• Indications and effect on survival of standard chemotherapy in advanced colorectal cancer.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20050101

• New chemotherapeutic strategies in colorectal cancer.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20050101

• Resistance mechanisms following cisplatin and oxaliplatin treatment of the human teratocarcinoma cell line 2102EP.

  Anticancer research 20050101

• A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer.

  International journal of gastrointestinal cancer 20050101

• A Phase II study of oxaliplatin in urothelial cancer.

  Urologic oncology 20050101

• Stability of colon stem cell methylation after neo-adjuvant therapy in a patient with attenuated familial adenomatous polyposis.

  BMC gastroenterology 20050101

• Intact human holo-transferrin interaction with oxaliplatin.

  Rapid communications in mass spectrometry : RCM 20050101

• Haploinsufficiency for BRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes.

  BMC medical genetics 20050101

• (Neo-)adjuvant treatments in colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.

  BMC cancer 20050101

• Goblet cell carcinoid of the appendix.

  World journal of surgical oncology 20050101

• Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance.

  BMC cancer 20050101

• The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients.

  Oncology 20050101

• Overcoming cisplatin resistance by mTOR inhibitor in lung cancer.

  Molecular cancer 20050101

• Capecitabine as third line therapy in patients with advanced colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20050101

• Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.

  Anticancer research 20050101

• Chemoradiation is a tolerable therapy for older adults with esophageal cancer.

  Anticancer research 20050101

• Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients.

  Oncology 20050101

• Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy.

  Anticancer research 20050101

• Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches.

  Current medicinal chemistry 20050101

• Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients.

  Oncology 20050101

• Adjuvant treatment strategies for early colon cancer.

  Drugs 20050101

• Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.

  BMC cancer 20050101

• A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.

  Cancer investigation 20050101

• [ASCO 2005: Progression with oxaliplatin in the treatment of colorectal neoplasms].

  Tumori 20050101

• A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy.

  BMC cancer 20050101

• In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line.

  Acta oncologica (Stockholm, Sweden) 20050101

• Oxaliplatin-based chemotherapy for the treatment of a metastatic carcinoid tumor.

  International journal of gastrointestinal cancer 20050101

• Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy.

  In vivo (Athens, Greece) 20050101

• Irinotecan and oxaliplatin combination, as second-line treatment, in fluoropyrimidine-pretreated advanced colorectal cancer. A phase II study by the Hellenic Cooperative Oncology Group (HeCOG).

  Tumori 20050101

• An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial.

  Oncology 20050101

• Combination chemotherapy in advanced small bowel adenocarcinoma.

  Oncology 20050101

• [Biotherapy in colorectal cancer].

  Journal de chirurgie 20050101

• Antibody-based targeted therapy for gastric cancer.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20050101

• The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein.

  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 20050101

• Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer.

  Acta oncologica (Stockholm, Sweden) 20050101

• Survival after oxaliplatin therapy of irinotecan-pretreated advanced colorectal cancer patients.

  Hepato-gastroenterology 20050101

• [Irinotecan in combination with 5-fluorouracil and leucovorin in the treatment of metastatic colorectal cancer].

  Casopis lekaru ceskych 20050101

• Progresses in the medical treatment of advanced colorectal cancer.

  Roczniki Akademii Medycznej w Bialymstoku (1995) 20050101

• Advances in the treatment of metastatic colorectal cancer.

  The oncologist 20050101

• Evolving chemotherapy for advanced gastric cancer.

  The oncologist 20050101

• SW-620 cells treated with topoisomerase I inhibitor SN-38: gene expression profiling.

  Journal of translational medicine 20050101

• Rituximab, Ara-C, dexamethasone and oxaliplatin is safe and active in heavily pretreated patients with diffuse large B-cell lymphoma.

  Oncology 20050101

• [Intraperitoneal chemotherapy with oxaliplatin after complete cytoreduction for peritoneal carcinomatosis from colorectal carcinoma: preliminary experience].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20050101

• Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy.

  Tumori 20050101

• Neoadjuvant oxaliplatin-based chemotherapy for liver metastases from colorectal cancer. An Italian survey.

  Tumori 20050101

• Chemotherapy for colorectal cancer.

  Digestive surgery 20050101

• Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.

  Oncology research 20050101

• Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer Abstracted from: Andre T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51.

  Cancer treatment reviews 20041201

• Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.

  International journal of oncology 20041201

• First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041201

• Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041201

• Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

  Annals of surgery 20041201

• Which drug combination for colorectal cancer?

  Expert opinion on pharmacotherapy 20041201

• [Colorectal cancer: current treatment options].

  Zeitschrift fur Gastroenterologie 20041201

• Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.

  Expert review of anticancer therapy 20041201

• No correlation between GSH levels in human cancer cell lines and the cell growth inhibitory activities of platinum diamine complexes.

  Archiv der Pharmazie 20041201

• Experimental study of renal disorder caused by oxaliplatin in rat renal cortical slices.

  Clinical and experimental nephrology 20041201

• A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients.

  Bulletin du cancer 20041201

• Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.

  Molecular cancer therapeutics 20041201

• FOLFOX-4 in pre-treated patients with advanced transitional cell carcinoma of the bladder.

  Japanese journal of clinical oncology 20041201

• [Platinum derivatives].

  Nihon rinsho. Japanese journal of clinical medicine 20041201

• Dysphonia as an unusual toxic event of oxaliplatin-based chemotherapy.

  Journal of chemotherapy (Florence, Italy) 20041201

• Recent updates in the clinical use of platinum compounds for the treatment of gastrointestinal cancers.

  Seminars in oncology 20041201

• Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.

  Seminars in oncology 20041201

• Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma.

  Seminars in oncology 20041201

• Perspectives in the treatment of colorectal cancer.

  Seminars in oncology 20041201

• [Influence of chemotherapy on Th1/Th2 cytokine switching in stomach cancer patients].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20041201

• [Oxaliplatin plus capecitabine as a second line chemotherapy for patients with advanced gastric cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20041201

• [Short-term effects of chemotherapy with combination of hydroxycamptothecine and oxaliplatin in the treatment of advanced digestive tract cancers].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20041201

• Oxaliplatin-related neurotoxicity: is chelation the solution?

  Nature clinical practice. Oncology 20041201

• Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells.

  British journal of cancer 20041129

• Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.

  British journal of cancer 20041129

• Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.

  Cancer 20041115

• Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer.

  British journal of cancer 20041115

• Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters.

  The Journal of biological chemistry 20041105

• Guillain-Barré syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy.

  Anti-cancer drugs 20041101

• Tumor-based pharmacokinetics has greater significance for anticancer drugs than does blood-based pharmacokinetics.

  Clinical pharmacology and therapeutics 20041101

• [Palliative surgery combined with oxaliplatin-based chemotherapy in treatment of patients with advanced gastric cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20041101

• [Combination chemotherapy for gastric cancer including LV/5-FU].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041101

• Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

  Diseases of the colon and rectum 20041101

• Hypersensitivity Reactions to oxaliplatin: incidence and management.

  Oncology (Williston Park, N.Y.) 20041101

• Chemotherapy in metastatic colorectal cancer.

  Techniques in coloproctology 20041101

• Overview of phase I/II pemetrexed studies.

  Oncology (Williston Park, N.Y.) 20041101

• Pemetrexed in advanced colorectal cancer.

  Oncology (Williston Park, N.Y.) 20041101

• [Cisplatin and derivatives with radiation therapy: for what clinical use?].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20041101

• Prospective clinical trials using a pharmacogenetic/pharmacogenomic approach.

  Journal of chemotherapy (Florence, Italy) 20041101

• Platinums: extending their therapeutic spectrum.

  Journal of chemotherapy (Florence, Italy) 20041101

• Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis.

  The Journal of biological chemistry 20041029

• Accelerated approval of oncology products: a decade of experience.

  Journal of the National Cancer Institute 20041020

• Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil.

  British journal of cancer 20041018

• Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer.

  British journal of cancer 20041018

• Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX.

  British journal of cancer 20041018

• Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice: analyses of tumor heterogenity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-alpha (GST)-alpha, GST-mu, and GST-pi.

  Cancer 20041015

• Oxaliplatin in colon cancer.

  The New England journal of medicine 20041014

• The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.

  Molecular pharmacology 20041001

• Clinical and experimental study of oxaliplatin in treating human gastric carcinoma.

  World journal of gastroenterology 20041001

• New options and old dilemmas in the treatment of patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041001

• Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041001

• Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041001

• Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

  Annals of surgery 20041001

• Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study.

  Gynecologic oncology 20041001

• [Advances in palliative and adjuvant chemotherapy of colon cancer].

  Deutsche medizinische Wochenschrift (1946) 20041001

• Meta-analysis of new treatment strategies for metastatic colorectal cancer.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20041001

• Protein interactions with platinum-DNA adducts: from structure to function.

  Journal of inorganic biochemistry 20041001

• A review of oxaliplatin and its clinical use in colorectal cancer.

  Expert opinion on pharmacotherapy 20041001

• Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer.

  Clinical colorectal cancer 20041001

• Combining anti-VEGF approaches with oxaliplatin in advanced colorectal cancer.

  Clinical colorectal cancer 20041001

• Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.

  Chemical research in toxicology 20041001

• [Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].

  Medizinische Monatsschrift fur Pharmazeuten 20041001

• [Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)].

  Bulletin du cancer 20041001

• [Hypersensitivity reactions to chemotherapeutic antineoplastic agents].

  Recenti progressi in medicina 20041001

• Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience.

  American journal of clinical oncology 20041001

• Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA.

  Oncogene 20040930

• [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].

  Praxis 20040929

• The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.

  Cancer research 20040915

• Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer.

  British journal of cancer 20040913

• Implications of dose rounding of chemotherapy to the nearest vial size.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20040901

• A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.

  Virchows Archiv : an international journal of pathology 20040901

• Ultratrace voltammetric determination of DNA-bound platinum in patients after administration of oxaliplatin.

  Analytical and bioanalytical chemistry 20040901

• Two-stage liver resection and chemotherapy for bilobar colorectal liver metastases.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20040901

• Clinical overview: adjuvant therapy of gastrointestinal cancer.

  Cancer chemotherapy and pharmacology 20040901

• Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer.

  Cancer chemotherapy and pharmacology 20040901

• Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040901

• Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.

  International journal of radiation oncology, biology, physics 20040901

• Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20040901

• The role of pemetrexed in the treatment of gastrointestinal malignancy.

  Clinical colorectal cancer 20040901

• Current status of clinical studies for colorectal cancer in Taiwan.

  Clinical colorectal cancer 20040901

• Roles of infusional high-dose 5-fluorouracil with leucovorin in advanced colorectal cancer.

  Clinical colorectal cancer 20040901

• Evidence-based update of chemotherapy options for metastatic colorectal cancer.

  ANZ journal of surgery 20040901

• Compassionate-use oxaliplatin with bolus 5-fluorouracil/leucovorin in heavily pretreated patients with advanced colorectal cancer.

  Southern medical journal 20040901

• [New drugs for colorectal cancer].

  Praxis 20040901

• Synergistic interaction between gefitinib (Iressa, ZD1839) and paclitaxel against human gastric carcinoma cells.

  Anti-cancer drugs 20040901

• Oxaliplatin shows significant benefit over standard therapy in early-stage colon cancer.

  Oncology (Williston Park, N.Y.) 20040901

• Mayo regimen plus three different second-line chemotherapy regimens in sequential therapy in patients with advanced colorectal cancer (ACRC).

  Journal of experimental & clinical cancer research : CR 20040901

• The treatment of colorectal carcinoma: standard chemotherapy and beyond.

  Clinical advances in hematology & oncology : H&O 20040901

• Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.

  Journal of the National Comprehensive Cancer Network : JNCCN 20040901

• Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial.

  British journal of cancer 20040831

• Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer.

  British journal of cancer 20040831

• NMR solution structure of an oxaliplatin 1,2-d(GG) intrastrand cross-link in a DNA dodecamer duplex.

  Journal of molecular biology 20040827

• [Recent progress in chemotherapy for hepatocellular carcinoma].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040810

• Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.

  British journal of cancer 20040802

• UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer.

  British journal of cancer 20040802

• Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer.

  Cancer chemotherapy and pharmacology 20040801

• Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer.

  Investigational new drugs 20040801

• Effects of oxaliplatin and CPT-11 on cytotoxicity and nucleic acid incorporation of the fluoropyrimidines.

  Journal of cancer research and clinical oncology 20040801

• Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II study.

  European urology 20040801

• Chemotherapy for malignant pleural mesothelioma: past results and recent developments.

  Lung cancer (Amsterdam, Netherlands) 20040801

• Severe disabling sensory-motor polyneuropathy during oxaliplatin-based chemotherapy.

  Anti-cancer drugs 20040801

• Developments in combination chemotherapy for colorectal cancer.

  Expert review of anticancer therapy 20040801

• Synthesis, crystal structure and cytotoxicity of new oxaliplatin analogues indicating that improvement of anticancer activity is still possible.

  European journal of medicinal chemistry 20040801

• Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040801

• Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040801

• Oxaliplatin in non-seminomatous germ-cell tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040801

• Oxaliplatin toxicity masquerading as recurrent colon cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040801

• Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy.

  Gynecologic oncology 20040801

• [Efficacy of combined paclitaxel and oxaliplatin therapy in patients with pretreated advanced non-small cell lung cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20040801

• [Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis].

  Zentralblatt fur Chirurgie 20040801

• Current and future strategies for treating metastatic pancreatic cancer.

  Clinical advances in hematology & oncology : H&O 20040801

• A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.

  British journal of cancer 20040719

• New treatments for colon cancer.

  BMJ (Clinical research ed.) 20040717

• Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040715

• Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer.

  British journal of cancer 20040705

• Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003.

  Current opinion in oncology 20040701

• Nephrotoxicity of platinum complexes is related to basolateral organic cation transport.

  Kidney international 20040701

• Oxaliplatin/rituximab combination in the treatment of intermediate-low grade non-Hodgkin's lymphoma of elderly patients.

  Oncology reports 20040701

• Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040701

• Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040701

• Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infusional desensitization schedule.

  Anti-cancer drugs 20040701

• Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model.

  Anti-cancer drugs 20040701

• Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.

  Molecular pharmacology 20040701

• Lack of pharmacokinetic interaction between 5-fluorouracil and oxaliplatin.

  Clinical pharmacology and therapeutics 20040701

• Polyamine catabolism in platinum drug action: Interactions between oxaliplatin and the polyamine analogue N1,N11-diethylnorspermine at the level of spermidine/spermine N1-acetyltransferase.

  Molecular cancer therapeutics 20040701

• Chemotherapy in gastric cancer: a brief chronicle with emphasis on recent developments.

  The Israel Medical Association journal : IMAJ 20040701

• Retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer: the development of a preoperative chemotherapy strategy.

  Clinical colorectal cancer 20040701

• Pemetrexed: its promise in treating non-small-cell lung cancer.

  Oncology (Williston Park, N.Y.) 20040701

• [Experimental study of sensitivity to chemotherapeutic agents for human endometrial carcinoma cell line].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20040701

• Kinetic resolution of amines: a highly enantioselective and chemoselective acetylating agent with a unique solvent-induced reversal of stereoselectivity.

  Angewandte Chemie (International ed. in English) 20040621

• Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040615

• Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040615

• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  The New England journal of medicine 20040603

• Two steps forward in the treatment of colorectal cancer.

  The New England journal of medicine 20040603

• Complete remission of metastatic pancreatic cancer with cardiac involvement after gemcitabine, oxaliplatin and 46-h infusion of 5-fluorouracil/leucovorin.

  Journal of gastroenterology and hepatology 20040601

• A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040601

• An immediate hemolytic reaction induced by repeated administration of oxaliplatin.

  Transfusion 20040601

• Phase I study of the combination of oxaliplatin, irinotecan and continuous infusion 5-fluorouracil in digestive tumors.

  Anti-cancer drugs 20040601

• XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040601

• Oxaliplatin plus irinotecan and FU-FOL combination and pharmacokinetic analysis in advanced colorectal cancer patients.

  American journal of clinical oncology 20040601

• Genome-wide identification of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin C.

  Cancer research 20040601

• Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study.

  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20040601

• Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines.

  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20040601

• Oxaliplatin: practical guidelines for administration.

  Clinical journal of oncology nursing 20040601

• Current approaches to first-line treatment of advanced colorectal cancer.

  Clinical colorectal cancer 20040601

• Current status of second-line therapy for metastatic colorectal cancer.

  Clinical colorectal cancer 20040601

• An overview of adjuvant systemic chemotherapy for colon cancer.

  Clinical colorectal cancer 20040601

• Combined-modality therapy of rectal cancer with oxaliplatin-based regimens.

  Clinical colorectal cancer 20040601

• Oxaliplatin plus oral fluoropyrimidines in colorectal cancer.

  Clinical colorectal cancer 20040601

• Application of pharmacogenomics in the individualization of chemotherapy for gastrointestinal malignancies.

  Clinical colorectal cancer 20040601

• [Study on apoptosis of human hepatoma cell line HepG2 induced by oxaliplatin].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20040601

• [New therapy options in colorectal carcinoma].

  Therapeutische Umschau. Revue therapeutique 20040601

• Gemcitabine and oxaliplatinum: an effective regimen in a patient with progressive refractory mantle cell lymphoma.

  Leukemia & lymphoma 20040601

• The efficacy of a modified chronomodulated infusion of oxaliplatin, 5-fluorouracil and leucovorin in advanced colorectal cancer (preliminary data).

  Cancer research and treatment : official journal of Korean Cancer Association 20040601

• Synthesis and characterisation of macrocyclic diamino chiral crown ethers.

  Molecules (Basel, Switzerland) 20040531

• Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly.

  British journal of cancer 20040517

• Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma: final results of a single-institution Phase II study.

  Cancer 20040515

• Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.

  British journal of cancer 20040504

• A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.

  British journal of cancer 20040504

• Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma.

  European journal of haematology 20040501

• Influence of trans-1,2-diaminocyclohexane structure and mixed carboxylic/phosphonic group combinations on samarium-153 chelation capacity and stability.

  European journal of medicinal chemistry 20040501

• Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040501

• [Chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040501

• Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex.

  Pharmaceutical research 20040501

• Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced gastrointestinal cancers.

  Clinical colorectal cancer 20040501

• Progress in the development of novel treatments for colorectal cancer.

  Oncology (Williston Park, N.Y.) 20040501

• Current strategies in previously untreated advanced colorectal cancer.

  Oncology (Williston Park, N.Y.) 20040501

• Current status of adjuvant therapy for colorectal cancer.

  Oncology (Williston Park, N.Y.) 20040501

• A chiral molecular bowl containing three ferrocenes: synthesis and its efficiency in an optical resolution of 1,1'-bi-2-naphthol.

  Chemical communications (Cambridge, England) 20040421

• Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study.

  British journal of cancer 20040419

• A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.

  British journal of cancer 20040419

• High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

  British journal of cancer 20040419

• In vitro effects of recombinant human growth hormone on growth of human gastric cancer cell line BGC823 cells.

  World journal of gastroenterology 20040415

• New systemic frontline treatment for metastatic colorectal carcinoma.

  Cancer 20040415

• A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer.

  British journal of cancer 20040405

• Is overall survival a realistic primary end point in advanced colorectal cancer studies? A critical assessment based on four clinical trials comparing fluorouracil plus leucovorin with the same treatment combined either with oxaliplatin or with CPT-11.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040401

• The role of high-dose chemotherapy in relapsed germ cell tumors.

  World journal of urology 20040401

• Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin.

  The British journal of surgery 20040401

• Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040401

• Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells.

  Anti-cancer drugs 20040401

• Regional chemotherapeutic techniques for liver tumors: current knowledge and future directions.

  The Surgical clinics of North America 20040401

• [Indications and methods for adjuvant chemotherapy of colonic cancer].

  Pathologie-biologie 20040401

• Oxaliplatin: is it a new standard weapon for colorectal cancer?

  Cancer research and treatment : official journal of Korean Cancer Association 20040401

• Oxaliplatin with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (Modified FOLFOX 4) as first-line therapy for patients with metastatic colorectal cancer.

  Cancer research and treatment : official journal of Korean Cancer Association 20040401

• Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials.

  British journal of cancer 20040322

• Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040315

• Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient.

  Cancer chemotherapy and pharmacology 20040301

• Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.

  Muscle & nerve 20040301

• Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040301

• Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040301

• Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040301

• Systemic treatment of gastric cancer.

  European journal of gastroenterology & hepatology 20040301

• Systemic treatment of advanced colorectal carcinoma.

  European journal of gastroenterology & hepatology 20040301

• The NQR observation of spin-Peierls transition in an antiferromagnetic MX-chain complex [NiBr(chxn)2]Br2.

  Journal of the American Chemical Society 20040218

• Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040215

• Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040215

• Gefitinib ('Iressa', ZD1839) and new epidermal growth factor receptor inhibitors.

  British journal of cancer 20040209

• Kinetic study on the reactions of platinum drugs with glutathione.

  The Journal of pharmacology and experimental therapeutics 20040201

• Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20040201

• [Long term survival in metastatic colorectal cancer treated with leucovorin and 5-fluoro-uracil chemotherapy].

  La Revue de medecine interne 20040201

• Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trial.

  Cancer 20040201

• Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.

  Molecular cancer therapeutics 20040201

• Predicting recurrence risk for synchronous primary colon cancers.

  Clinical advances in hematology & oncology : H&O 20040201

• [Colorectal cancers: management of metastatic cancers].

  La Revue du praticien 20040131

• UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer.

  British journal of cancer 20040126

• Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?

  British journal of cancer 20040126

• Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study.

  British journal of cancer 20040126

• Mechanism of two-electron oxidation of deoxyguanosine 5'-monophosphate by a platinum(IV) complex.

  Journal of the American Chemical Society 20040121

• Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin-platinum(II) conjugates.

  Cancer letters 20040120

• FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040115

• [Therapy of colorectal carcinoma. To combine saves lives].

  MMW Fortschritte der Medizin 20040115

• Angiogenesis inhibitors in clinical development; where are we now and where are we going?

  British journal of cancer 20040112

• Cancer pharmacogenetics.

  British journal of cancer 20040112

• Definitive chemoradiation in patients with inoperable oesophageal carcinoma.

  British journal of cancer 20040112

• Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS).

  Journal of inorganic biochemistry 20040101

• A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101

• Scheduling of fluorouracil: a forget-me-not in the jungle of doublets.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101

• Hypersensitivity and idiosyncratic reactions to oxaliplatin.

  Cancer 20040101

• Molecular epidemiology: new insights into diagnosis and prognosis.

  Journal of surgical oncology 20040101

• Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101

• Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101

• First-line treatment strategies to improve survival in patients with advanced colorectal cancer.

  Drugs 20040101

• Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas.

  European journal of cancer (Oxford, England : 1990) 20040101

• Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico research.

  Cancer research 20040101

• [Principles of postoperative therapy in rectal carcinoma].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20040101

• FDA drug approval summaries: oxaliplatin.

  The oncologist 20040101

• Oxaliplatin.

  Nature reviews. Drug discovery 20040101

• Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy.

  Drugs & aging 20040101

• [Colon cancer: what is new in 2004?].

  Bulletin du cancer 20040101

• Treatment of colorectal cancer metastasis: the role of chemotherapy.

  Cancer metastasis reviews 20040101

• Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line.

  Anticancer research 20040101

• Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer.

  Anticancer research 20040101

• Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).

  Anticancer research 20040101

• The role of new agents in the treatment of colorectal cancer.

  Oncology 20040101

• Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: a multicenter non-randomized phase ii study.

  Medical oncology (Northwood, London, England) 20040101

• Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y.

  Journal of neuro-oncology 20040101

• Efficacy of treatment with irinotecan and oxaliplatin combination in FU-resistant metastatic colorectal cancer patients.

  Oncology 20040101

• Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer: a cost-minimization study.

  Tumori 20040101

• [January 2004: a month of success with oxaliplatin and hope for patients with colorectal cancer].

  Tumori 20040101

• 5-Fluorouracil: identification of novel downstream mediators of tumour response.

  Anticancer research 20040101

• Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma.

  Anticancer research 20040101

• New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers.

  The oncologist 20040101

• Targeted therapy of colorectal cancer: clinical experience with bevacizumab.

  The oncologist 20040101

• Oxaliplatin added to simplified bimonthly low-dose leucovorin and 5-FU for pretreated advanced colorectal cancer is effective and not affected by different previous 5-FU regimens.

  Cancer investigation 20040101

• Cisplatin and related anticancer drugs: recent advances and insights.

  Metal ions in biological systems 20040101

• [Oxaliplatin].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors.

  Oncology 20040101

• Effect of selenite combined with chemotherapeutic agents on the proliferation of human carcinoma cell lines.

  Biological trace element research 20040101

• Raltitrexed plus oxaliplatin in the treatment of metastatic colorectal cancer.

  Tumori 20040101

• [Neurotoxic effects of medications: an update].

  Revue medicale de Liege 20040101

• Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma.

  BMC cancer 20040101

• Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.

  The International journal of biological markers 20040101

• Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer.

  BMC cancer 20040101

• Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer.

  BMC cancer 20040101

• Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer.

  Anticancer research 20040101

• 5FU and oxaliplatin-containing chemotherapy in two dihydropyrimidine dehydrogenase-deficient patients.

  Anticancer research 20040101

• Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study.

  Anticancer research 20040101

• [Oxaliplatin].

  Krankenpflege Journal 20040101

• A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.

  Oncology 20040101

• Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumours.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101

• Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20040101

• Pharmacogenomics and colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040101

• Current perspectives in the treatment of metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040101

• Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.

  The oncologist 20040101

• Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?

  The oncologist 20040101

• Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers.

  BMC cancer 20040101

• Therapeutic strategies to improve the efficacy of oxaliplatin in gastrointestinal tumors.

  The International journal of biological markers 20040101

• Neoadjuvant therapy of rectal cancer new treatment perspectives.

  Tumori 20040101

• [Pancreatic carcinoma: progress in therapy].

  Krankenpflege Journal 20040101

• Combined irinotecan and oxaliplatin in patients with advanced pre-treated pancreatic cancer.

  Oncology 20040101

• A phase I and pharmacokinetic study of BAY59: a novel taxane.

  Oncology 20040101

• Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis.

  Oncology 20040101

• FOLFOX3 in heavily pretreated patients with metastatic colorectal cancer.

  The Netherlands journal of medicine 20040101

• 5-fluorouracil leucovorin and oxaliplatin (FOLFOX) in the treatment of metastatic colon cancer with severe liver dysfunction.

  Oncology 20040101

• The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.

  BMC cancer 20040101

• Role of new agents in the treatment of colorectal cancer.

  Surgical oncology 20040101

• Surgical strategies for colorectal liver metastases.

  Surgical oncology 20040101

• Integrating phenotypic and expression profiles to map arsenic-response networks.

  Genome biology 20040101

• Synergistic effects of combination therapy employing antisense oligonucleotides with traditional chemotherapeutics in the PC-3 prostate cancer model.

  Medical oncology (Northwood, London, England) 20040101

• Tailored chemotherapy for colorectal cancer: a new approach to therapy.

  Cancer investigation 20040101

• [Recent results of irinotecan therapy in colorectal cancer].

  Magyar onkologia 20040101

• [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].

  Krankenpflege Journal 20040101

• Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane.

  Oncology 20040101

• Systemic treatment of colorectal cancer in Serbia: what have we done and what can we offer in the new century?

  Acta chirurgica Iugoslavica 20040101

• (Neo)adjuvant strategies of advanced gastric carcinoma: time for a change?

  Digestive diseases (Basel, Switzerland) 20040101

• The RACOX phase I study: radiation (RA), capecitabine (C) and oxaliplatin (OX) as adjuvant treatment of stage II and III rectal cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20040101

• Multiple states of stalled T7 RNA polymerase at DNA lesions generated by platinum anticancer agents.

  The Journal of biological chemistry 20031226

• Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.

  Cancer 20031215

• Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C.

  British journal of cancer 20031215

• X-ray structure and circular dichroism of pure rotamers of bis[guanosine-5'-monophosphate(-1)](N,N,N',N'-tetramethylcyclohexyl-1,2-diamine)platinum(II) complexes that have R,R and S,S configurations at the asymmetric diamine.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20031215

• Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor kappaB signaling.

  Cancer research 20031215

• Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.

  Biochemistry 20031209

• Cis-[Pt(Cl)2(pyridine)(5-SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzyme.

  Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 20031201

• The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines.

  Cancer chemotherapy and pharmacology 20031201

• Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer.

  Farmaco (Societa chimica italiana : 1989) 20031201

• Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignancies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20031201

• Oxaliplatin/fluorouracil/leucovorin in advanced colorectal carcinoma: an asian experience.

  The Annals of pharmacotherapy 20031201

• Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031201

• Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study.

  British journal of cancer 20031201

• Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro.

  British journal of cancer 20031201

• Primary ovarian cancer chemotherapy: current standards of care.

  British journal of cancer 20031201

• [Clinical results of advanced gastric cancer patients treated with oxaliplatin-containing regimen].

  Ai zheng = Aizheng = Chinese journal of cancer 20031201

• [Palliative therapy of colorectal cancer].

  Onkologie 20031201

• [Chemotherapy of advanced colorectal carcinoma: treatment options for elderly patients].

  Onkologie 20031201

• [Novel molecular approaches in the therapy of advanced colorectal carcinoma].

  Onkologie 20031201

• [Patient with stomach cancer with metastases. What is the value of chemotherapy?].

  MMW Fortschritte der Medizin 20031127

• A phase II trial of capecitabine (Xeloda) in recurrent ovarian cancer.

  British journal of cancer 20031117

• A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients.

  British journal of cancer 20031117

• Synthesis, characterization, and in vitro antitumor activity of osteotropic diam(m)ineplatinum(II) complexes bearing a N,N-bis(phosphonomethyl)glycine ligand.

  Journal of medicinal chemistry 20031106

• c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.

  British journal of cancer 20031103

• Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics.

  British journal of cancer 20031103

• Rapid in vitro chemosensitivity analysis of human colon tumor cell lines.

  Toxicology and applied pharmacology 20031101

• Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20031101

• Extravasations of oxaliplatin.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031101

• Toxicities of the platinum antineoplastic agents.

  Expert opinion on drug safety 20031101

• Population pharmacokinetics of oxaliplatin in patients with metastatic cancer.

  Anti-cancer drugs 20031101

• A molecular biological study of anti-tumor mechanisms of an anti-cancer agent Oxaliplatin against established human gastric cancer cell lines.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20031101

• Integrating oxaliplatin and capecitabine in adjuvant therapy of high-risk colorectal cancer.

  Clinical colorectal cancer 20031101

• Development of new agents for the treatment of advanced colorectal cancer.

  Clinical colorectal cancer 20031101

• Randomized trial comparing the addition of oxaliplatin or irinotecan to high-dose leucovorin and 5-Fluorouracil intravenous bolus every two weeks in metastatic colorectal carcinoma: Southern Italy Cooperative Oncology Group 0103.

  Clinical colorectal cancer 20031101

• A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer.

  British journal of cancer 20031020

• Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly.

  British journal of cancer 20031020

• Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031015

• Therapeutic strategies for metastatic colorectal cancer: simultaneous, sequential, or specific?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031015

• Recurrent episodes of involuntary masticatory spasms induced by continuous infusion of oxaliplatin.

  Journal of the National Cancer Institute 20031015

• Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer.

  British journal of cancer 20031006

• Liquid chromatographic determination of oxaliplatin in blood using post-column derivatization in a microwave field followed by photometric detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031005

• Colorectal cancer: integrating oxaliplatin.

  Current treatment options in oncology 20031001

• Review article: colorectal cancer chemotherapy.

  Alimentary pharmacology & therapeutics 20031001

• Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?

  Anti-cancer drugs 20031001

• Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution.

  Anti-cancer drugs 20031001

• Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.

  Anti-cancer drugs 20031001

• Chronotherapy for cancer.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20031001

• [Treatment of metastatic liver carcinoma: chemotherapy and immunotherapy].

  Nihon Geka Gakkai zasshi 20031001

• Systemic therapy for colorectal cancer: focus on newer chemotherapy and novel agents.

  Seminars in radiation oncology 20031001

• Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer.

  Seminars in radiation oncology 20031001

• Irinotecan (Campto) in the treatment of pancreatic cancer.

  Expert review of anticancer therapy 20031001

• Ruthenium complexes with chiral tetradentate imino-sulfoxide ligands.

  Inorganic chemistry 20030922

• Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma.

  British journal of cancer 20030915

• Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.

  British journal of cancer 20030915

• Treatment of T4 tumours: the role of radiotherapy.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20030901

• Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030901

• Phase I study of liposomal doxorubicin and oxaliplatin as salvage chemotherapy in advanced ovarian cancer.

  Anti-cancer drugs 20030901

• [Controversy of treatment for advanced colorectal cancer--intermedisine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030901

• [Polymorphism in colorectal cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20030901

• [Chemotherapy for colon cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20030901

• [5-fluorouracil and leucovorin therapy for advanced colorectal cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20030901

• [Present status of chemotherapy for colorectal cancer in countries outside of Japan].

  Nihon rinsho. Japanese journal of clinical medicine 20030901

• [Treatment of patients with liver metastases from colorectal cancer. More patients can benefit from the treatment!].

  Lakartidningen 20030828

• Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours.

  British journal of cancer 20030818

• Characterization of sequence-dependent synergy between ZD1839 ('Iressa') and oxaliplatin.

  Biochemical pharmacology 20030815

• Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815

• Self-assembly of achiral and chiral macrocyclic ligands: synthesis, protonation constants, conformation and asymmetric catalysis.

  Organic & biomolecular chemistry 20030807

• Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.

  British journal of cancer 20030804

• Hypersensitivity reactions related to oxaliplatin (OHP).

  British journal of cancer 20030804

• Tamoxifen derivatives for delivery of the antitumoral (DACH)Pt group: selective synthesis by McMurry coupling, and biochemical behaviour.

  Chembiochem : a European journal of chemical biology 20030804

• Advanced NSCLC: new cytostatic agents.

  Lung cancer (Amsterdam, Netherlands) 20030801

• Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030801

• Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030801

• Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030801

• Direct chiral resolution of tartaric acid by ion-pair capillary electrophoresis using an aqueous background electrolyte with (1R,2R)-(-)-1,2-diaminocyclohexane as a chiral counterion.

  Electrophoresis 20030801

• Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

  Cancer research 20030801

• [Phase II clinical trial of oxaliplatin alone for refractory advanced colorectal cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20030801

• Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer: a single institution's experience.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20030801

• Vesicant characteristics of oxaliplatin following antecubital extravasation.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20030801

• Capecitabine in combination with irinotecan or oxaliplatin in advanced colorectal cancer.

  Clinical colorectal cancer 20030801

• Activity and safety of oxaliplatin with weekly 5-fluorouracil bolus and low-dose leucovorin as first-line treatment for advanced colorectal cancer.

  Clinical colorectal cancer 20030801

• The latest advances in chemotherapy for gastrointestinal cancers.

  International journal of clinical oncology 20030801

• Raltitrexed-induced hepatotoxicity: multivariate analysis of predictive factors.

  Anti-cancer drugs 20030801

• 5-fluorouracil as a protracted continuous infusion plus irinotecan (CPT-11) in patients with advanced colorectal cancer treated with fluoropyrimidine-based regimens as first line.

  Anti-cancer drugs 20030801

• Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study.

  Anti-cancer drugs 20030801

• New perspectives in the management of pancreas cancer.

  Seminars in oncology 20030801

• Definitive and neoadjuvant therapies for esophageal and gastroesophageal junction tumors: a look back and toward the future.

  Seminars in oncology 20030801

• Current and ongoing trials with irinotecan in the United States.

  Seminars in oncology 20030801

• Induction therapy in patients with metastatic colorectal cancer.

  Seminars in oncology 20030801

• Oxaliplatin-safety profile: neurotoxicity.

  Seminars in oncology 20030801

• Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group.

  Seminars in oncology 20030801

• Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working group.

  Seminars in oncology 20030801

• Oxaliplatin-based combined-modality therapy for rectal cancer.

  Seminars in oncology 20030801

• Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer.

  Seminars in oncology 20030801

• The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas.

  Seminars in oncology 20030801

• Opportunities for newer agents in combination with oxaliplatin.

  Seminars in oncology 20030801

• [Oxaliplatin: high activity at all stages of colon carcinomas].

  Onkologie 20030801

• A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid.

  British journal of cancer 20030721

• DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells.

  Biochemical pharmacology 20030715

• Sudden-onset thrombocytopenia with oxaliplatin.

  Annals of internal medicine 20030715

• Estimation of the glomerular filtration rate in cancer patients: a new formula for new drugs.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030715

• Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030715

• Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030715

• Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study.

  Gynecologic oncology 20030701

• Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.

  Lung cancer (Amsterdam, Netherlands) 20030701

• Protection against oxaliplatin acute neurosensory toxicity by venlafaxine.

  Anti-cancer drugs 20030701

• Oxaliplatin with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced colorectal cancer patients: a phase II study.

  Chemotherapy 20030701

• Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis.

  Surgical oncology clinics of North America 20030701

• Rationale supporting the use of vasoconstrictors for intraperitoneal chemotherapy with platinum derivatives.

  Surgical oncology clinics of North America 20030701

• The role of Pemetrexed (Alimta , LY231514) in lung cancer therapy.

  Clinical lung cancer 20030701

• Re: a multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma.

  Clinical lung cancer 20030701

• A review of systemic therapy for advanced pancreatic cancer.

  Clinical advances in hematology & oncology : H&O 20030701

• A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma.

  Yonsei medical journal 20030630

• A metal-centered hydrophobic pocket recognizing pyridine over piperidine.

  Journal of the American Chemical Society 20030618

• Oral melphalan as a treatment for platinum-resistant ovarian cancer.

  British journal of cancer 20030616

• Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity.

  British journal of cancer 20030616

• Small-cell cancers, and an unusual reaction to chemotherapy: Case 4. Fluorouracil-related small bowel vasculitis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615

• Antiangiogenesis drug promising for metastatic colorectal cancer.

  Lancet (London, England) 20030607

• Nitrogen lone pair interactions in organic molecules: a photoelectron spectroscopic study.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20030601

• Oxaliplatin for colorectal cancer in the United States: better late than never.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030601

• Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030601

• Toxicity of platinum compounds.

  Expert opinion on pharmacotherapy 20030601

• A dose-escalating study of oral eniluracil/5-fluorouracil plus oxaliplatin in patients with advanced gastrointestinal malignancies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030601

• Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030601

• A case report of oxaliplatin extravasation.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030601

• Bimonthly leucovorin, infusion 5-fluorouracil, hydroxyurea, and irinotecan (FOLFIRI-2) for pretreated metastatic colorectal cancer.

  American journal of clinical oncology 20030601

• The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells.

  Seminars in oncology 20030601

• Development of ZD1839 in colorectal cancer.

  Seminars in oncology 20030601

• Current status of oxaliplatin in colorectal cancer.

  Seminars in oncology 20030601

• Treatment of advanced gastric cancer: where we are in 2003.

  Onkologie 20030601

• Second-line treatment of advanced gastric cancer with oxaliplatin plus raltitrexed.

  Onkologie 20030601

• [Toxicity and anti-tumour efficacy of oxaliplatin on Glasgow osteosarcoma induced in mice: a mathematical model].

  Pathologie-biologie 20030601

• Pharmacokinetics of oxaliplatin during chronomodulated infusion in metastatic gastrointestinal cancer patients: a pilot investigation with preliminary results.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20030601

• [Immunoallergic shock to oxaliplatin: a new case].

  Gastroenterologie clinique et biologique 20030601

• Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.

  British journal of cancer 20030519

• Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients.

  International journal of cancer 20030510

• Status of treatment for advanced gastric carcinoma.

  Current oncology reports 20030501

• The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells.

  International journal of oncology 20030501

• Hypersensitivity and idiosyncratic reactions to oxaliplatin.

  Cancer 20030501

• Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia.

  Annals of surgical oncology 20030501

• Lhermitte's sign following oxaliplatin-containing chemotherapy in a cisplatin-pretreated ovarian cancer patient.

  European journal of neurology 20030501

• Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectives.

  Clinical colorectal cancer 20030501

• Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy.

  British journal of cancer 20030422

• Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer.

  British journal of cancer 20030407

• Combination chemotherapy for advanced colorectal cancer.

  British journal of cancer 20030407

• The synthesis of trianglimines: on the scope and limitations of the [3 + 3] cyclocondensation reaction between (1R,2R)-diaminocyclohexane and aromatic dicarboxaldehydes.

  Organic & biomolecular chemistry 20030407

• Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030401

• Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030401

• Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030401

• [A case of irinotecan-resistant colon cancer responding to chronotherapy with oxaliplatin, 5-FU, l-LV].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030401

• Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy.

  British journal of cancer 20030324

• Acute bilateral abducens paralysis due to oxaliplatin.

  Journal of the National Cancer Institute 20030319

• Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030315

• EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer.

  British journal of cancer 20030310

• Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030301

• An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030301

• Skin testing and hypersensitivity reactions to oxaliplatin.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030301

• Recent advances in the pharmacological treatment of colorectal cancer.

  Expert opinion on investigational drugs 20030301

• Irinotecan (CPT11) plus high-dose 5-fluorouracil (5-FU) and leucovorin (LV) as salvage therapy for metastatic colorectal cancer (MCRC) after failed oxaliplatin plus 5-FU and LV: a pilot study in Taiwan.

  Japanese journal of clinical oncology 20030301

• PET-FDG as predictor of therapy response in patients with colorectal carcinoma.

  The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 20030301

• Neoadjuvant chemotherapy in the management of colorectal metastases: A review of the literature.

  Annals of the Academy of Medicine, Singapore 20030301

• [Oxaliplatin in combination with LV5FU2 for advanced/metastatic gastric cancer-a multicenter study].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20030301

• [The aquation of oxaliplatin and the effect of acid].

  Yao xue xue bao = Acta pharmaceutica Sinica 20030301

• A multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma.

  Clinical lung cancer 20030301

• ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.

  Clinical advances in hematology & oncology : H&O 20030301

• Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.

  Biochemistry 20030218

• Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215

• Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis.

  The Prostate 20030201

• Hydrolysis of oxaliplatin-evaluation of the acid dissociation constant for the oxalato monodentate complex.

  Journal of pharmaceutical sciences 20030201

• A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030201

• Biweekly bolus 5-fluorouracil and leucovorin plus oxaliplatin in pretreated patients with advanced colorectal cancer: a dose-finding study.

  Anti-cancer drugs 20030201

• Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair.

  Current cancer drug targets 20030201

• Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma.

  American journal of clinical oncology 20030201

• p53-independent response to cisplatin and oxaliplatin in MMTV-ras mouse salivary tumors.

  Molecular cancer therapeutics 20030201

• The combination of capecitabine and oxaliplatin in metastatic colorectal cancer.

  Clinical colorectal cancer 20030201

• Adjuvant radiation therapy of patients with rectal cancer.

  Clinical colorectal cancer 20030201

• Predictive markers for colorectal cancer: current status and future prospects.

  Clinical colorectal cancer 20030201

• Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.

  Zentralblatt fur Chirurgie 20030201

• Population pharmacokinetics of oxaliplatin.

  Cancer chemotherapy and pharmacology 20030201

• [Chemotherapy for colorectal cancers].

  Journal de chirurgie 20030201

• Chemotherapy for malignant pleural mesothelioma: past results and recent developments.

  British journal of cancer 20030127

• Oxaliplatin (Eloxatin) for advanced colon cancer.

  The Medical letter on drugs and therapeutics 20030120

• Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030115

• A phase II study with 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX-4 regimen) in patients with metastatic renal cell carcinoma.

  Oncology 20030101

• Multicenter phase II study of fractionated bimonthly oxaliplatin with leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer, pre-treated with chemotherapy.

  Oncology reports 20030101

• Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines.

  European journal of cancer (Oxford, England : 1990) 20030101

• Colorectal cancer in the elderly: is palliative chemotherapy of value?

  Drugs & aging 20030101

• Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer.

  Oncology 20030101

• Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient.

  Cancer investigation 20030101

• Recent advances in colorectal cancer therapy.

  Cancer biology & therapy 20030101

• Oxaliplatin plus raltitrexed in the treatment of patients with advanced colorectal cancer: a phase II study.

  Anticancer research 20030101

• A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.

  Anticancer research 20030101

• Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum.

  Reviews in gastroenterological disorders 20030101

• Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status.

  Oncology 20030101

• Adjuvant therapy for colon cancer in the new millenium.

  Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 20030101

• [New insights into the combinability of Eloxation (oxaliplatin): present and future prospects].

  Tumori 20030101

• Implications of genetic testing in the management of colorectal cancer.

  American journal of pharmacogenomics : genomics-related research in drug development and clinical practice 20030101

• 5-fluorouracil, folinic acid and oxaliplatin administered via hepatic arterial infusion as regional second-line therapy for advanced colorectal cancer.

  Oncology 20030101

• Oxaliplatin: third-generation platinum analog.

  Clinical journal of oncology nursing 20030101

• Computed tomographic features of peritoneal carcinomatosis treated by intraperitoneal chemohyperthermia.

  Journal of computer assisted tomography 20030101

• Metastatic colorectal cancer: systemic treatment in the new millennium.

  Cancer control : journal of the Moffitt Cancer Center 20030101

• Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030101

• Irinotecan in metastatic colorectal cancer: dose intensification and combination with new agents, including biological response modifiers.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030101

• Current treatments and future perspectives in colorectal and gastric cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030101

• Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study.

  Anticancer research 20030101

• Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer.

  Anticancer research 20030101

• [Experience in treating elderly patients with disseminated stomach and colon cancer].

  Advances in gerontology = Uspekhi gerontologii 20030101

• [Early evaluation using PET-FDG of the efficiency of neoadjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum].

  Tumori 20030101

• [Combination of neoadjuvant chemotherapy, cryotherapy and surgery in the treatment of unresectable colorectal liver metastases. Long-term results].

  Tumori 20030101

• Treatment of advanced disease and new drugs.

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20030101

• Raltitrexed and mitomycin-C as third-line chemotherapy for colorectal cancer after combination regimens including 5-fluorouracil, irinotecan and oxaliplatin: a phase II study.

  Anticancer research 20030101

• Management of pharyngolaryngeal dysesthesia associated with oxaliplatin therapy.

  Clinical journal of oncology nursing 20030101

• Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugates.

  European journal of medicinal chemistry 20030101

• Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer.

  Drugs 20030101

• A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.

  Cancer investigation 20030101

• Cisplatin and platinum drugs at the molecular level. (Review).

  Oncology reports 20030101

• Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety.

  Drug safety 20030101

• Oxaliplatin: a novel platinum analog with activity in colorectal cancer.

  Oncology nursing forum 20030101

• Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.

  Tumori 20030101

• An update on hepatic arterial infusion chemotherapy for colorectal cancer.

  The oncologist 20030101

• Innovative chemotherapies for stage III colon cancer: a cost-effectiveness study.

  Hepato-gastroenterology 20030101

• New developments in systemic chemotherapy in advanced colorectal cancer.

  Scandinavian journal of gastroenterology. Supplement 20030101

• [Systemic treatment of colorectal cancers--factual standards and perspectives].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20030101

• Nordic 5-fluorouracil/leucovorin bolus schedule combined with oxaliplatin (Nordic FLOX) as first-line treatment of metastatic colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20030101

• Short-time infusion of oxaliplatin (Eloxatin) in combination with capecitabine (Xeloda) in patients with advanced colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20030101

• Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.

  Anticancer research 20030101

• The rational principles of neo-adjuvant therapy for rectal cancer.

  Acta bio-medica : Atenei Parmensis 20030101

• Rectal cancer. Clinical practice guidelines in oncology.

  Journal of the National Comprehensive Cancer Network : JNCCN 20030101

• Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.

  Cancer research 20021215

• Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.

  DNA repair 20021205

• Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.

  Cancer chemotherapy and pharmacology 20021201

• A case of acute tubular necrosis due to oxaliplatin.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021201

• Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021201

• Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021201

• Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC).

  American journal of clinical oncology 20021201

• Interindividual differences in oxaliplatin pharmacokinetics.

  International journal of clinical pharmacology and therapeutics 20021201

• Current status of capecitabine in the treatment of colorectal cancer.

  Oncology (Williston Park, N.Y.) 20021201

• Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer?

  Oncology (Williston Park, N.Y.) 20021201

• Weekly oxaliplatin, high-dose folinic acid and 24h-5-fluorouracil (FUFOX) as salvage therapy in metastatic colorectal cancer patients pretreated with irinotecan and folinic acid/5-fluorouracil regimens.

  Zeitschrift fur Gastroenterologie 20021201

• Pemetrexed: single-agent and combination phase I study overview.

  Seminars in oncology 20021201

• Pemetrexed in the treatment of non-small cell lung cancer.

  Seminars in oncology 20021201

• The role of pemetrexed in the treatment of colorectal cancer.

  Seminars in oncology 20021201

• Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials.

  Seminars in oncology 20021201

• Review of gemcitabine in biliary tract carcinoma.

  Seminars in oncology 20021201

• Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.

  Cytokine 20021124

• Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer.

  British journal of cancer 20021118

• [Chemotherapy improves prognosis in colorectal carcinoma. Soon oral therapy at home?].

  MMW Fortschritte der Medizin 20021114

• The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.

  Molecular pharmacology 20021101

• New drugs for patients with pancreatic cancer.

  Current opinion in oncology 20021101

• Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin.

  European journal of cancer (Oxford, England : 1990) 20021101

• Synthesis, crystal structure and initial biological evaluation of the new enantiomerically pure chiral palladium(II) complex trans-bis[endo-(1R)-1,7,7-trimethylbicyclo[2.2.1]-heptan-2-amino]palladium(II)dichloride.

  European journal of medicinal chemistry 20021101

• Highlights from: 27th congress of the European Society for Medical Oncology. Nice, France. October 18-22, 2002.

  Clinical colorectal cancer 20021101

• Perspectives on the role of sequential or combination chemotherapy for first-line and salvage therapy in advanced colorectal cancer.

  Clinical colorectal cancer 20021101

• Systemic chemotherapy for metastatic colorectal cancer: reasons to combine.

  Clinical colorectal cancer 20021101

• Pharmacological blockage of serotonin biosynthesis and circadian changes in oxaliplatin toxicity in rats.

  Chronobiology international 20021101

• Cellular and molecular aspects of drugs of the future: oxaliplatin.

  Cellular and molecular life sciences : CMLS 20021101

• [Therapy of colorectal carcinoma in internal medicine].

  Praxis 20021023

• Oral cancer treatment: developments in chemotherapy and beyond.

  British journal of cancer 20021021

• Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2.

  British journal of cancer 20021021

• Contribution of apoptosis in the cytotoxicity of the oxaliplatin-irinotecan combination in the HT29 human colon adenocarcinoma cell line.

  Biochemical pharmacology 20021015

• [Gleaning from the American Oncology Congress. A new standard in colorectal carcinoma].

  MMW Fortschritte der Medizin 20021010

• Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma.

  FEBS letters 20021009

• Platinum drugs in the treatment of non-small-cell lung cancer.

  British journal of cancer 20021007

• Alkaline hydrolysis of oxaliplatin--isolation and identification of the oxalato monodentate intermediate.

  Journal of pharmaceutical sciences 20021001

• Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study.

  International journal of radiation oncology, biology, physics 20021001

• Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021001

• [Primary adenocarcinoma of the appendix. Case report and review of the literature].

  Minerva chirurgica 20021001

• Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021001

• Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021001

• Oxaliplatin: results in colorectal carcinoma.

  Critical reviews in oncology/hematology 20021001

• Oncosurgery: a new reality in metastatic colorectal carcinoma.

  Seminars in oncology 20021001

• Oxaliplatin-related side effects: characteristics and management.

  Seminars in oncology 20021001

• Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures.

  Seminars in oncology 20021001

• The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions.

  Seminars in oncology 20021001

• Adjuvant therapy in colon cancer: current status and future directions.

  Cancer treatment reviews 20021001

• [Palliative second-line treatment with oxaliplatin, gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in patients with metastatic pancreatic adenocarcinoma].

  Zeitschrift fur Gastroenterologie 20021001

• Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial.

  British journal of cancer 20020923

• Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients.

  British journal of cancer 20020923

• Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.

  British journal of cancer 20020923

• From the Food and Drug Administration.

  JAMA 20020911

• Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma.

  British journal of cancer 20020909

• Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020901

• Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020901

• Oxaliplatin: bimonthly, biweekly, or semimonthly? No, fortnightly!

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020901

• Topotecan preceded by oxaliplatin using a 3 week schedule: a phase I study in advanced cancer patients.

  European journal of cancer (Oxford, England : 1990) 20020901

• Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients.

  Journal of cancer research and clinical oncology 20020901

• RNA polymerase II large subunit is cleaved by caspases during DNA damage-induced apoptosis.

  Biochemical and biophysical research communications 20020830

• A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.

  British journal of cancer 20020827

• Oxaliplatin loaded PLAGA microspheres: design of specific release profiles.

  International journal of pharmaceutics 20020821

• FDA evaluating oxaliplatin for advanced colorectal cancer treatment.

  Journal of the National Cancer Institute 20020821

• Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020815

• Acute oxaliplatin-induced peripheral-nerve hyperexcitability.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020815

• A 'modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer.

  British journal of cancer 20020812

• Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design.

  Journal of pharmaceutical and biomedical analysis 20020801

• Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells.

  International journal of oncology 20020801

• Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801

• Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer.

  American journal of clinical oncology 20020801

• Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.

  American journal of clinical oncology 20020801

• Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020801

• Exacerbation of oxaliplatin neurosensory toxicity following surgery.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020801

• Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trial.

  Anti-cancer drugs 20020801

• A speedy approval.

  U.S. news & world report 20020801

• Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination Regimen.

  Onkologie 20020801

• Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer.

  Cellular and molecular life sciences : CMLS 20020801

• Eloxatin (Oxaliplatin) for Cancer Therapy 2002. Abstracts.

  Onkologie 20020801

• [Gemcitabine-based combinations in inoperable pancreatic cancers].

  Bulletin du cancer 20020801

• [Role of gemcitabine in the treatment of other malignant tumors].

  Bulletin du cancer 20020801

• [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ].

  Bulletin du cancer 20020801

• Oxaliplatin: a welcome addition to our therapeutic armamentarium.

  Clinical colorectal cancer 20020801

• Oxaliplatin combinations as first-line therapy in advanced colorectal cancer.

  Clinical colorectal cancer 20020801

• Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: a phase II study.

  Clinical colorectal cancer 20020801

• [Clinical study on patients with advanced gastric cancer treated with oxaliplatin combining with hydroxycamptothecine].

  Ai zheng = Aizheng = Chinese journal of cancer 20020801

• Systemic therapy for advanced pancreatic cancer.

  Expert review of anticancer therapy 20020801

• Preferential targeting of apoptosis in tumor versus normal cells.

  Biochimica et biophysica acta 20020718

• Epithelial ovarian cancer: second and third line chemotherapy (review).

  International journal of oncology 20020701

• The cellular pharmacology of oxaliplatin resistance.

  European journal of cancer (Oxford, England : 1990) 20020701

• Nonsurgical methods for liver metastases including cryotherapy, radiofrequency ablation, and infusional treatment: what's new in 2001?

  Current opinion in oncology 20020701

• Another NICE mess.

  The Lancet. Oncology 20020701

• Chemotherapy for metastatic colorectal cancer.

  Drug and therapeutics bulletin 20020701

• Prevention and treatment of peritoneal carcinomatosis in experimental investigations with CPT-11 and oxaliplatin.

  Anti-cancer drugs 20020701

• Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020701

• Synthesis and cytotoxicity of the dihydrated complex of oxaliplatin.

  Cancer letters 20020628

• Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.

  Journal of the National Cancer Institute 20020619

• Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients.

  British journal of cancer 20020617

• Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020615

• Is the NICE process flawed?

  Lancet (London, England) 20020615

• [Oral fluoropyrimidines registered for the treatment of metastatic colorectal carcinoma: a possible gain].

  Nederlands tijdschrift voor geneeskunde 20020615

• [Drug therapy of colorectal carcinoma].

  Wiener klinische Wochenschrift 20020614

• Why hasn't the National Institute been 'NICE' to patients with colorectal cancer? National Institute of Clinical Excellence.

  British journal of cancer 20020605

• Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?

  British journal of cancer 20020605

• Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer.

  British journal of cancer 20020605

• Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020601

• Oxaliplatin: bimonthly, biweekly, or semimonthly?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020601

• Advanced colorectal cancer treatment in Europe: what have we achieved?

  Anti-cancer drugs 20020601

• Particular aspects of platinum compounds used at present in cancer treatment.

  Critical reviews in oncology/hematology 20020601

• Present and future treatment of pancreatic cancer.

  Seminars in oncology 20020601

• New approaches to breast cancer: oxaliplatin combined with 5-fluorouracil and folinic acid in pretreated advanced breast cancer patients: preliminary reports.

  Annals of the New York Academy of Sciences 20020601

• Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.

  Cancer chemotherapy and pharmacology 20020601

• New studies highlight benefit of Xeloda in new combination treatments for colorectal cancer.

  Expert review of anticancer therapy 20020601

• Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.

  British journal of cancer 20020520

• Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020515

• Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020515

• [New drugs in bronchial cancer].

  Presse medicale (Paris, France : 1983) 20020511

• Predictive values of sex and tumour site for survival benefit from 5FU in colorectal cancer.

  British journal of cancer 20020506

• Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.

  Cancer chemotherapy and pharmacology 20020501

• Systemic treatment of colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20020501

• Oxaliplatin (L-OHP) treatment of human myeloma cells induces in vitro growth inhibition and apoptotic cell death.

  European journal of cancer (Oxford, England : 1990) 20020501

• Lhermitte sign and urinary retention: atypical presentation of oxaliplatin neurotoxicity in four patients.

  Cancer 20020501

• Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).

  Annals of oncology : official journal of the European Society for Medical Oncology 20020501

• Future directions in adjuvant therapy for rectal cancer.

  Oncology (Williston Park, N.Y.) 20020501

• Chemoradiation with novel agents for rectal cancer.

  Clinical colorectal cancer 20020501

• Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.

  Clinical colorectal cancer 20020501

• Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020415

• Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity.

  British journal of cancer 20020408

• Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401

• Acute oxaliplatin-induced peripheral nerve hyperexcitability.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401

• Combination of topotecan and oxaliplatin in inoperable hepatocellular cancer patients.

  American journal of clinical oncology 20020401

• The treatment of advanced colorectal cancer: where are we now and where do we go?

  Best practice & research. Clinical gastroenterology 20020401

• A new chemoembolization protocol in refractory liver metastasis of colorectal cancer--a feasibility study.

  Onkologie 20020401

• Capecitabine as second-line treatment for metastatic cholangiocarcinoma: a report of two cases.

  Onkologie 20020401

• Phase I trials of pemetrexed.

  Seminars in oncology 20020401

• Pemetrexed combination therapy in the treatment of non-small cell lung cancer.

  Seminars in oncology 20020401

• Pemetrexed in patients with gastrointestinal carcinoma.

  Seminars in oncology 20020401

• Raltitrexed: current clinical status and future directions.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020401

• Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020401

• Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020401

• The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020401

• Sensitivity of p53-deficient cells to oxaliplatin and thio-TEPA (N, N', N' triethylenethiophosphoramide).

  Breast cancer research and treatment 20020401

• Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma.

  British journal of cancer 20020318

• Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020315

• Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule.

  International journal of radiation oncology, biology, physics 20020315

• Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer.

  British journal of cancer 20020304

• Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype.

  Molecular pharmacology 20020301

• Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences.

  Cancer chemotherapy and pharmacology 20020301

• [Initial results of randomized studies of metastatic colorectal carcinoma urge careful and controlled use of CPT-11].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20020301

• Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020301

• Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020215

• The emerging role of antifolates in the treatment of malignant pleural mesothelioma.

  Seminars in oncology 20020201

• Future treatment options with capecitabine in solid tumours.

  European journal of cancer (Oxford, England : 1990) 20020201

• Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer.

  International journal of radiation oncology, biology, physics 20020201

• Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma.

  British journal of cancer 20020201

• Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020201

• Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020201

• Recent development of anti-cancer drugs for treatment of GI malignancies in Japan.

  Gan to kagaku ryoho. Cancer & chemotherapy 20020201

• Clinical trials of new anticancer agents in recent years in China.

  Gan to kagaku ryoho. Cancer & chemotherapy 20020201

• Gemcitabine-based combination treatment of pancreatic cancer.

  Seminars in oncology 20020201

• Brief communication: use of the multitargeted antifolate pemetrexed (Alimta) in genitourinary cancer.

  Seminars in oncology 20020201

• Prediction of the response of colorectal cancer to systemic therapy.

  The Lancet. Oncology 20020201

• [The new chemotherapy of colorectal cancers].

  Presse medicale (Paris, France : 1983) 20020126

• [Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study].

  Deutsche medizinische Wochenschrift (1946) 20020118

• MutS preferentially recognizes cisplatin- over oxaliplatin-modified DNA.

  The Journal of biological chemistry 20020111

• C(2)-Symmetric dialkoxyphosphoramide and dialkoxythiophosphoramide derivatives of (1R, 2R)-1,2-diaminocyclohexane as chiral ligands for the titanium(IV) alkoxide-promoted asymmetric addition reactions of diethylzinc to arylaldehydes.

  Chirality 20020101

• Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020101

• Replacement of carboplatin by oxaliplatin may be one solution for patients treated for ovarian carcinoma who are hypersensitive to carboplatin.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020101

• Application of capillary electrophoresis-mass spectrometry for the investigation of the binding behavior of oxaliplatin to 5'-GMP in the presence of the sulfur-containing amino acid L-methionine.

  Electrophoresis 20020101

• Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer.

  Cancer investigation 20020101

• Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy.

  BMC cancer 20020101

• Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020101

• Oxaliplatin: a review of evolving concepts.

  Cancer investigation 20020101

• Oxaliplatin: new opportunities for the treatment of gastrointestinal cancer.

  Cancer investigation 20020101

• Chemotherapy-induced peripheral neuropathy.

  Journal of neurology 20020101

• Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status.

  Chronobiology international 20020101

• Chronotherapy of colorectal cancer.

  Chronobiology international 20020101

• Pharmaco-economic comparative evaluation of combination chronotherapy vs. standard chemotherapy for colorectal cancer.

  Chronobiology international 20020101

• Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study.

  BMC cancer 20020101

• Adjuvant and neoadjuvant radiotherapy and concurrent radiochemotherapy for rectal cancer.

  Pathology oncology research : POR 20020101

• New therapeutic options in colon cancer: focus on oxaliplatin.

  Clinical journal of oncology nursing 20020101

• [Therapy of elderly patients with colorectal carcinoma].

  Wiener medizinische Wochenschrift (1946) 20020101

• Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells.

  Oncology reports 20020101

• Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro.

  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20020101

• Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients.

  Journal of biological regulators and homeostatic agents 20020101

• Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity.

  Anticancer research 20020101

• Molecular aspects of resistance to antitumor platinum drugs.

  Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20020101

• Predominance of CIN versus MSI in the development of rectal cancer at young age.

  BMC cancer 20020101

• A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors.

  Oncology 20020101

• Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer. a feasibility pilot study.

  Oncology 20020101

• Folfox 2 regimen in heavily pretreated patients with advanced colorectal cancer.

  Tumori 20020101

• New drug approved for colorectal cancer.

  FDA consumer 20020101

• Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis.

  Oncology 20020101

• Chemotherapy in colorectal cancer: new options and new challenges.

  British medical bulletin 20020101

• [Raltitrexed and oxaliplatin in colorectal cancer: in vitro and in vivo study of a synergistic cytostatic combination].

  Acta medica Austriaca 20020101

• Cellular and molecular pharmacology of oxaliplatin.

  Molecular cancer therapeutics 20020101

• Correlating dose and volume of irradiated lung with pulmonary function tests.

  Cancer journal (Sudbury, Mass.) 20020101

• Effect of concurrent radiation therapy and chemotherapy on pulmonary function in patients with esophageal cancer: dose-volume histogram analysis.

  Cancer journal (Sudbury, Mass.) 20020101

• Pharmacokinetics of oxaliplatin in humans.

  Medical oncology (Northwood, London, England) 20020101

• Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.

  Anticancer research 20020101

• Syntheses and physical properties of quasi-one-dimensional halogen-bridged Cu(II)(-)Pt(IV) mixed-metal complexes [Cu(chxn)(2)][PtX(2)(chxn)(2)]X(4).

  Inorganic chemistry 20011217

• A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

  Cancer research 20011215

• The Cockayne syndrome group B DNA repair protein as an anti-cancer target.

  International journal of oncology 20011201

• Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.

  European journal of cancer (Oxford, England : 1990) 20011201

• ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011201

• Oxaliplatin: available data in non-colorectal gastrointestinal malignancies.

  Critical reviews in oncology/hematology 20011201

• [The role of oxaliplatin in the therapy for advanced colorectal carcinoma].

  Zeitschrift fur Gastroenterologie 20011201

• [Chemotherapy of colorectal carcinoma].

  Der Internist 20011201

• Capecitabine and oxaliplatin in advanced colorectal cancer: a dose-finding study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011201

• An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma.

  British journal of haematology 20011201

• [Application of eloxatin for the treatment of widespread colorectal cancer].

  Klinichna khirurhiia 20011201

• Metastatic colorectal cancer.

  Current treatment options in oncology 20011201

• Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115

• Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011101

• Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.

  British journal of cancer 20011101

• In vitro studies on the mechanisms of oxaliplatin resistance.

  Cancer chemotherapy and pharmacology 20011101

• [Adenocarcinomas of the distal esophagus and gastric cardia: what chemotherapy or chemoradiotherapy for recurrent or metastatic disease?].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20011101

• Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011101

• Perspectives in colorectal cancer meeting. Miami, Florida. September 28-29, 2001.

  Clinical colorectal cancer 20011101

• Capecitabine combinations in the treatment of advanced colorectal cancer.

  Clinical colorectal cancer 20011101

• Irinotecan plus oxaliplatin: a promising combination for advanced colorectal cancer.

  Clinical colorectal cancer 20011101

• 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex.

  Inorganic chemistry 20011022

• [New therapeutic options in chemotherapy of advanced colorectal cancer].

  Medizinische Klinik (Munich, Germany : 1983) 20011015

• Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer.

  The British journal of surgery 20011001

• Comparison of the binding behavior of oxaliplatin, cisplatin and analogues to 5'-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry.

  Journal of inorganic biochemistry 20011001

• Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo.

  Anti-cancer drugs 20011001

• Nucleolar damage correlates with neurotoxicity induced by different platinum drugs.

  British journal of cancer 20011001

• Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011001

• Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011001

• Platinum compounds in the treatment of advanced breast cancer.

  Clinical breast cancer 20011001

• Irinotecan-induced dysarthria.

  Journal of the National Cancer Institute 20010919

• Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010915

• [Recent aspects of palliative treatment of metastasized colorectal carcinoma].

  Medizinische Klinik (Munich, Germany : 1983) 20010915

• Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20010901

• Current and future potential roles of the platinum drugs in the treatment of ovarian cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010901

• Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010901

• Recent advances in the treatment of epithelial ovarian cancer.

  Expert opinion on investigational drugs 20010901

• [Treatment of germ cell tumors at the threshold of the third millennium].

  Orvosi hetilap 20010805

• Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients.

  British journal of cancer 20010801

• New options for outpatient chemotherapy--the role of oral fluoropyrimidines.

  Cancer treatment reviews 20010801

• Occupational contact sensitization to 1,2-diaminocyclohexane.

  Contact dermatitis 20010801

• [Liver metastases--primary or multimodal therapy?].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20010801

• [Oxaliplatin: perspectives and future developments].

  Bulletin du cancer 20010801

• [Oxaliplatin: a first DACH-platinum in oncology].

  Bulletin du cancer 20010801

• [Pharmacokinetic properties of platinium derivatives].

  Bulletin du cancer 20010801

• [Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer].

  Bulletin du cancer 20010801

• [Preclinical studies of oxaliplatin in combination chemotherapy].

  Bulletin du cancer 20010801

• [Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer].

  Bulletin du cancer 20010801

• [Clinical use of oxaliplatin in solid tumors].

  Bulletin du cancer 20010801

• [Oxaliplatin tolerance in the treatment of metastatic colorectal cancers].

  Bulletin du cancer 20010801

• [Oxaliplatin (Eloxatin). Progress in cancer therapy].

  Onkologie 20010801

• Therapeutic advances in the management of metastatic colorectal cancer.

  Expert review of anticancer therapy 20010801

• Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.

  Clinical colorectal cancer 20010801

• Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer.

  Clinical colorectal cancer 20010801

• Review of the role of CPT-11 in the treatment of colorectal cancer.

  Clinical colorectal cancer 20010801

• Oral fluoropyrimidine treatment of colorectal cancer.

  Clinical colorectal cancer 20010801

• [New aspects in chemotherapy of tumors of the digestive tract].

  Vnitrni lekarstvi 20010801

• New chemotherapy approaches in colorectal cancer.

  Current opinion in oncology 20010701

• Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy.

  Anti-cancer drugs 20010701

• [Adjuvant chemotherapy in liver malignancy for improving operability].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20010701

• Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy.

  The European respiratory journal 20010701

• An overview of chemotherapy-induced peripheral sensory neuropathy, focusing on oxaliplatin.

  International journal of palliative nursing 20010701

• The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts.

  The Journal of biological chemistry 20010601

• Reaction after oxaliplatin--prevention with corticosteroids?

  Annals of oncology : official journal of the European Society for Medical Oncology 20010601

• Molecular characterization of the actin-encoding gene and the use of its promoter for a dominant selection system in the methylotrophic yeast Hansenula polymorpha.

  Applied microbiology and biotechnology 20010601

• Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer.

  European journal of cancer (Oxford, England : 1990) 20010501

• Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501

• High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).

  European journal of cancer (Oxford, England : 1990) 20010501

• A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients.

  European journal of cancer (Oxford, England : 1990) 20010501

• A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels.

  Journal of neurophysiology 20010501

• [Platinum compounds in cancer therapy--past, present, and future].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010501

• Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010501

• Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010501

• Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010501

• New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer.

  The Lancet. Oncology 20010501

• Circadian chronotherapy for human cancers.

  The Lancet. Oncology 20010501

• 25th European Society for Medical Oncology Congress. Hamburg, Germany. October 13-17, 2000.

  Clinical colorectal cancer 20010501

• Advances in the treatment of metastatic colorectal cancer.

  Clinical colorectal cancer 20010501

• Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial.

  Cancer 20010401

• 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.

  British journal of cancer 20010401

• The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.

  Oncology (Williston Park, N.Y.) 20010401

• Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy.

  World journal of urology 20010401

• Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010401

• Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010401

• [New chemotherapies for colorectal cancer treatment].

  Gastroenterologie clinique et biologique 20010401

• New drugs in gynecologic cancer.

  Current treatment options in oncology 20010401

• [Chemotherapy of colonic carcinoma in the year 2001].

  Praxis 20010322

• Determinants of prognosis and response to therapy in colorectal cancer.

  Current oncology reports 20010301

• Oxaliplatin: a new agent for colorectal cancer.

  Current oncology reports 20010301

• Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.

  Gastroenterology 20010301

• Update on chemotherapy for advanced colorectal cancer.

  Oncology (Williston Park, N.Y.) 20010301

• New directions in the treatment of advanced colorectal cancer.

  Oncology (Williston Park, N.Y.) 20010301

• Future directions in adjuvant therapy for stage III colon carcinoma.

  Oncology (Williston Park, N.Y.) 20010301

• Comparison of the reactivity of oxaliplatin, pt(diaminocyclohexane)Cl2 and pt(diaminocyclohexane1)(OH2)2(2+) with guanosine and L-methionine.

  Journal of inorganic biochemistry 20010301

• Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010301

• Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS.

  Journal of synchrotron radiation 20010301

• Oxaliplatin-induced Evan's syndrome.

  British journal of cancer 20010201

• Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines.

  British journal of cancer 20010201

• Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies.

  Journal of surgical oncology 20010201

• Adjuvant therapy of colon cancer.

  Seminars in oncology 20010201

• National Surgical Adjuvant Breast and Bowel Project trials in colon cancer.

  Seminars in oncology 20010201

• Combination of oxaliplatin, fluorouracil, and leucovorin in the treatment of fluoropyrimidine-pretreated patients with metastatic colorectal cancer.

  Journal of Korean medical science 20010201

• Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010201

• Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010201

• [Readministration of oxaliplatin using a rapid desensitization method after severe anaphylactic reaction].

  Gastroenterologie clinique et biologique 20010201

• [Chemotherapy of colorectal cancer--which therapy is justified for elderly patients?].

  Onkologie 20010201

• Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010115

• The in vitro antitumour profile of some 1,2-diaminocyclohexane organotin complexes.

  Journal of inorganic biochemistry 20010115

• [Ambulatory chemotherapy schedule for metastatic colorectal cancer].

  Presse medicale (Paris, France : 1983) 20010113

• The changing face of chemotherapy in colorectal cancer.

  British journal of cancer 20010101

• Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression.

  Clinical and experimental immunology 20010101

• Oral fluoropyrimidine-based combination therapy in gastrointestinal cancer.

  Oncology (Williston Park, N.Y.) 20010101

• Idiosyncratic reaction after oxaliplatin infusion.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010101

• Perioperative radiotherapy and concurrent radiochemotherapy in rectal cancer.

  Seminars in surgical oncology 20010101

• Radiation recall with oxaliplatin: report of a case and a review of the literature.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101

• [Oxaliplatin in colorectal cancer].

  Tumori 20010101

• Chronotherapy of colorectal cancer metastases.

  Hepato-gastroenterology 20010101

• Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer.

  Drug safety 20010101

• A systematic overview of chemotherapy effects in colorectal cancer.

  Acta oncologica (Stockholm, Sweden) 20010101

• Chemotherapy of nonoperable colorectal liver metastases.

  Hepato-gastroenterology 20010101

• 5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancer.

  Oncology 20010101

• Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study.

  Oncology 20010101

• Cis- and trans-platinum and palladium complexes: a comparative study review as antitumour agents.

  Bollettino chimico farmaceutico 20010101

• The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101

• Severe anaphylactic reaction to oxaliplatin.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101

• Oxaliplatin-induced radiation recall: timing not a problem.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101

• Treatment of liver metastases from colorectal cancer: what is the best approach today?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20010101

• What is the 'best' platinum: cisplatin, carboplatin, or oxaliplatin?

  Cancer investigation 20010101

• Integrating oxaliplatin into the management of colorectal cancer.

  The oncologist 20010101

• Disease management considerations: disease management considerations.

  Drugs 20010101

• A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer.

  Anticancer research 20010101

• Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer.

  Drugs 20010101

• Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.

  Acta oncologica (Stockholm, Sweden) 20010101

• Present indications for adjuvant therapy in resectable rectal cancer.

  Annali italiani di chirurgia 20010101

• Oxaliplatin and raltitrexed in the treatment of inoperable malignant pleural mesothelioma: results of a pilot study.

  Tumori 20010101

• A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.

  Health technology assessment (Winchester, England) 20010101

• [3rd National Congress of Medical Oncology. Issues in Gynecologic Oncology. Naples, November 7, 2000].

  Tumori 20010101

• [Oxaliplatin: preclinical in vitro studies].

  Tumori 20010101

• [Oxaliplatin and fluorouracil: bolus coadministration regimens].

  Tumori 20010101

• [Oxaliplatin: combinations with thymidylate synthetase inhibitors: two consecutive phase II studies].

  Tumori 20010101

• [Chronotherapy].

  Tumori 20010101